age,sex,drug,reaction,hospitalized
26,1,DURAGESIC-100,DRUG ADMINISTRATION ERROR,0
77,2,BONIVA,Vomiting,0
,2,IBUPROFEN,Dyspepsia,0
,1,LYRICA,Drug ineffective,0
,2,DOXYCYCLINE HYCLATE,Drug hypersensitivity,0
48,2,LIPITOR,Drug hypersensitivity,0
68,2,LETAIRIS,Cough,0
65,2,LETAIRIS,Rhinorrhoea,0
59,2,LETAIRIS,Unevaluable event,0
42,1,LETAIRIS,Hepatic enzyme increased,0
66,2,LYRICA,Back pain,0
76,2,LETAIRIS,Oedema peripheral,1
43,2,ILARIS,Pneumonia,1
81,2,LETAIRIS,Swelling,0
82,1,LETAIRIS,Back pain,0
,1,RANOLAZINE,Death,0
73,2,LETAIRIS,Oedema,0
46,1,BENLYSTA,Angioedema,0
59,2,BELIMUMAB,Tuberculosis of central nervous system,1
46,2,BENLYSTA,Cholecystectomy,1
42,1,TYVASO,Headache,0
71,1,ACETAMINOPHEN.,Adenoviral haemorrhagic cystitis,1
61,2,LETAIRIS,Tremor,0
73,2,PRADAXA,Fall,0
57,2,LETAIRIS,Malaise,0
68,2,LETAIRIS,Swelling,1
29,2,CEFTRIAXONE,Meconium stain,0
53,1,PREDNISONE,Respiratory failure,1
55,2,PACLITAXEL,Type IV hypersensitivity reaction,0
79,2,PARACETAMOLO,Diarrhoea,1
50,1,LETAIRIS,Feeling abnormal,0
38,2,MIRENA,Chemical poisoning,0
80,1,PRADAXA,Proctalgia,0
79,1,LETAIRIS,Swelling,0
,2,SPIRIVA,Dry mouth,0
62,2,LETAIRIS,Localised oedema,1
,1,JANUMET,Metastases to spine,1
59,2,LETAIRIS,Dysphonia,0
34,2,KLACID,Swollen tongue,1
69,1,LETAIRIS,Anaemia,0
22,2,PREDNISONE,Listeriosis,1
54,2,LETAIRIS,Dizziness,0
,1,TASIGNA,Overdose,1
64,2,LETAIRIS,Liver function test abnormal,0
69,2,LETAIRIS,Headache,0
88,2,CITALOPRAM,Haematoma,1
73,2,LETAIRIS,Dyspnoea,0
29,2,MIRENA,Device dislocation,0
93,1,OXYGEN.,Epistaxis,0
,2,MORPHINE SULFATE EXTENDED-RELEASE TABLETS (RHODES 74-862),Cerebrovascular accident,1
71,2,LETAIRIS,Malaise,0
46,2,MIRTAZAPINE (UNKNOWN),Aggression,0
51,2,LETAIRIS,Oedema peripheral,0
,1,CASODEX,Dyspnoea,0
52,2,LETAIRIS,Haemoglobin decreased,0
,1,CASODEX,Heart rate decreased,0
60,2,LETAIRIS,Oedema peripheral,0
10,1,TACROLIMUS (WATSON LABORATORIES),Posterior reversible encephalopathy syndrome,0
82,1,LETAIRIS,Dyspnoea,0
41,1,DOXYCYCLINE,Erection increased,1
29,2,LETAIRIS,Hypertension,0
65,1,CITALOPRAM (UNKNOWN),Hyponatraemia,1
71,2,LETAIRIS,Gastric disorder,0
50,2,LETAIRIS,Unevaluable event,0
31,2,ADCIRCA,Drug hypersensitivity,0
71,2,LETAIRIS,Oedema,0
32,1,LETAIRIS,Oedema,0
70,2,LETAIRIS,Unevaluable event,0
78,1,LETAIRIS,Pollakiuria,0
73,2,LETAIRIS,Feeling abnormal,0
64,2,LETAIRIS,Swelling,0
51,1,LETAIRIS,Nasal congestion,0
49,1,LETAIRIS,Nausea,0
65,2,LETAIRIS,Nasal congestion,0
53,2,PREDNISONE,Loss of consciousness,1
62,1,CASODEX,Diarrhoea,0
59,2,LETAIRIS,Malaise,0
53,1,LETAIRIS,Dyspnoea,0
55,2,LETAIRIS,Nasopharyngitis,0
67,2,LETAIRIS,Respiratory tract infection,0
76,1,LETAIRIS,No therapeutic response,0
57,2,LETAIRIS,Blood count abnormal,0
63,2,LETAIRIS,Unevaluable event,0
75,1,LETAIRIS,Unevaluable event,0
79,2,LETAIRIS,Dyspnoea exertional,0
72,2,LETAIRIS,Fluid retention,1
67,2,LETAIRIS,Cellulitis,0
19,2,LETAIRIS,Dyspnoea,0
32,2,LETAIRIS,Hepatic enzyme decreased,0
44,2,LETAIRIS,Headache,0
75,2,LETAIRIS,Dyspnoea,0
77,1,RAMIPRIL.,Subdural haematoma,1
53,1,LETAIRIS,Peripheral swelling,0
88,2,LETAIRIS,Dyspnoea exertional,0
,1,DEPAKOTE,Tremor,0
62,2,LETAIRIS,Unevaluable event,0
25,1,CITALOPRAM ORAL SOLUTION,Sopor,1
77,1,DONEPEZIL,"Hallucination, visual",0
56,2,LETAIRIS,Headache,0
65,2,LETAIRIS,Hot flush,0
18,2,LETAIRIS,Sinusitis,0
78,1,LETAIRIS,Middle insomnia,0
31,2,LETAIRIS,Sinusitis,0
86,1,LASIX,Oedema,0
67,2,LETAIRIS,Asthenia,0
,1,MICROPAKINE,Cognitive disorder,0
47,2,5-FLUOROURACIL,Ileus paralytic,1
78,2,LETAIRIS,Insomnia,0
63,2,LETAIRIS,Dyspnoea,0
45,1,LETAIRIS,Dyspnoea,0
30,2,LETAIRIS,Laboratory test abnormal,0
54,2,LETAIRIS,Visual impairment,0
62,2,LETAIRIS,Infusion site infection,0
73,2,LETAIRIS,Diarrhoea,0
52,2,LETAIRIS,Dizziness,0
77,2,LETAIRIS,Drug ineffective,0
81,2,LETAIRIS,Thirst,0
68,1,LETAIRIS,Oxygen consumption increased,0
75,2,LETAIRIS,Anaemia,0
75,2,LETAIRIS,Headache,0
74,2,LETAIRIS,Insomnia,0
82,2,REVATIO,Rash,0
43,1,LETAIRIS,Influenza,0
30,2,CEFTRIAXONE,Foetal death,0
,2,MIRENA,Breast cancer,0
36,2,MIRENA,Uterine perforation,1
64,2,REVATIO,Abdominal distension,0
,2,CEFTRIAXONE,Foetal distress syndrome,0
28,2,CEFTRIAXONE,Meconium stain,0
10,1,LETAIRIS,Sinusitis,0
37,2,LETAIRIS,Chest pain,0
84,2,LETAIRIS,Oedema peripheral,1
60,2,LETAIRIS,Pain,0
64,2,LETAIRIS,Peripheral swelling,0
67,2,LETAIRIS,Tooth extraction,0
35,2,LETAIRIS,Syncope,0
50,1,LETAIRIS,Fatigue,0
72,2,LETAIRIS,Fatigue,0
76,1,LETAIRIS,Unevaluable event,0
81,2,LETAIRIS,Insomnia,0
60,2,LETAIRIS,Pain,0
45,2,TYVASO,Cough,0
76,1,LETAIRIS,Ear infection,0
84,1,LETAIRIS,Cardiac failure congestive,1
33,2,LETAIRIS,Dyspnoea,0
41,2,LETAIRIS,Unevaluable event,0
62,1,REVATIO,Unevaluable event,0
46,2,ADCIRCA,Unevaluable event,0
32,2,CEFTRIAXONE,Pyelonephritis,0
68,2,CAPTOPRIL SANDOZ,Blood pressure fluctuation,0
54,2,LETAIRIS,Fluid retention,1
69,2,TYVASO,Fatigue,0
35,2,LETAIRIS,Throat irritation,0
76,1,LETAIRIS,Dyspnoea,0
51,2,LETAIRIS,Dental pulp disorder,0
57,1,LETAIRIS,Therapeutic response decreased,0
82,2,LETAIRIS,Cough,0
48,2,LETAIRIS,Fluid overload,1
74,1,LETAIRIS,Trigeminal neuralgia,0
71,1,TYVASO,Cough,0
75,2,LETAIRIS,Peripheral swelling,0
84,2,LETAIRIS,Nasal disorder,0
93,1,LETAIRIS,Drug ineffective,0
70,2,LETAIRIS,Swelling,0
71,2,LETAIRIS,Myalgia,0
72,2,LETAIRIS,Dyspnoea,0
68,2,LETAIRIS,Arthralgia,0
84,2,BISOPROLOL,Renal failure acute,1
56,2,LETAIRIS,Cough,0
63,2,FUROSEMIDE.,Drug ineffective,0
75,2,LETAIRIS,Dyspnoea exertional,0
66,2,LETAIRIS,Sinus disorder,0
79,2,LETAIRIS,Palpitations,0
55,2,LETAIRIS,Dyspnoea,0
40,1,LETAIRIS,Arthralgia,0
66,2,LETAIRIS,Productive cough,0
39,1,LETAIRIS,Polyuria,0
67,2,LETAIRIS,Pain,0
78,2,LETAIRIS,Vein disorder,0
43,2,LETAIRIS,Arthralgia,0
72,2,REVATIO,Hypotension,0
41,2,LETAIRIS,Dyspnoea,0
78,2,LETAIRIS,Epistaxis,0
39,1,LETAIRIS,Blood glucose increased,0
78,2,REVATIO,Fatigue,0
70,2,LETAIRIS,Fatigue,0
80,2,ZOLPIDEM SANDOZ,Disorientation,0
64,2,LETAIRIS,Nasopharyngitis,0
58,2,LETAIRIS,Dyspepsia,0
33,2,CEFTRIAXONE,Foetal death,0
55,2,METRONIDAZOLE (UNKNOWN),Pharyngeal oedema,0
,2,ZETIA,Hypersensitivity,0
,1,LYRICA,Drug ineffective for unapproved indication,0
49,2,ZITHROMAX,Drug hypersensitivity,0
61,2,LYRICA,Drug ineffective,0
80,2,NORVASC,Sleep disorder,0
56,1,VIAGRA,Headache,0
,1,VIAGRA,Erection increased,0
,2,CHANTIX,Insomnia,0
,2,PROCARDIA,Drug hypersensitivity,0
55,2,LYRICA,Off label use,0
,2,ESTRING,Weight increased,0
,2,PREMARIN,Reaction to drug excipients,0
74,2,LETAIRIS,Decreased appetite,0
,1,DIOVAN,Spinal column stenosis,0
73,1,LETAIRIS,Respiratory disorder,0
,1,"HUMULIN 30% REGULAR, 70% NPH",Blindness,0
68,2,JAKAFI,Abdominal pain,0
,0,BUSULFEX,Acute graft versus host disease,0
,2,LETAIRIS,Infection,1
57,2,LETAIRIS,Peripheral swelling,0
75,1,FORTEO,Femur fracture,1
,1,CISPLATIN (UNKNOWN),Neutropenia,0
29,1,CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)),Pain in extremity,1
40,2,MIRENA,Vaginal haemorrhage,0
,1,LETAIRIS,Cardiac failure congestive,1
4,1,LETAIRIS,Hiccups,0
,2,JAKAFI,Haemoglobin decreased,0
83,1,SODIUM VALPROATE (UNKNOWN),Hepatocellular injury,0
25,2,VICODIN,Adnexa uteri pain,1
,2,JAKAFI,Skin lesion,0
,1,JAKAFI,Endodontic procedure,0
57,1,LETAIRIS,Asthenia,0
73,2,ADCIRCA,Dyspnoea,0
29,2,MIRENA,Uterine perforation,1
71,2,JAKAFI,Dry mouth,0
45,1,JAKAFI,Hepatic enzyme increased,0
62,2,LETAIRIS,Headache,0
,2,LETAIRIS,Oedema peripheral,0
24,1,FANAPT,Oedema peripheral,0
69,1,REVLIMID,Plasma cell myeloma,0
59,1,HUMIRA,Chest pain,1
45,2,LETAIRIS,Throat irritation,0
,2,JAKAFI,Gout,0
11,1,DEPAKOTE,Feeling abnormal,0
49,1,JAKAFI,Pollakiuria,0
32,2,TYVASO,Palpitations,0
71,1,JAKAFI,Pulmonary embolism,1
,1,HUMIRA,Oesophageal perforation,0
,2,JAKAFI,Generalised oedema,0
73,2,ACLASTA,Nerve compression,1
82,2,LETAIRIS,Somnolence,0
,1,DEPAKOTE,Balance disorder,0
84,1,LUPRON DEPOT,Death,0
79,2,JAKAFI,White blood cell count increased,0
16,2,LETAIRIS,Insomnia,0
,2,DEPAKOTE,Urticaria,0
62,2,ACLASTA,Nasopharyngitis,0
73,2,JAKAFI,Fatigue,0
,2,HUMIRA,Breast cancer,0
,0,DEPAKOTE,Fear,0
64,1,LETAIRIS,Fluid retention,0
38,1,BACLOFEN.,Monocyte count decreased,0
65,2,"TIENAM 500MG/500MG, POUDRE POUR PERFUSION",Linear IgA disease,1
60,2,GILENYA,Rheumatoid arthritis,0
,1,JAKAFI,Oedema peripheral,0
,1,DEPAKOTE,Foetal exposure during pregnancy,0
57,1,REMODULIN,Pain in extremity,0
54,2,JAKAFI,Staphylococcal infection,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,0,DEPAKOTE,Bipolar disorder,0
73,2,SANDOSTATIN LAR DEPOT,Asthenia,1
44,2,LETAIRIS,Headache,0
,1,JAKAFI,Fatigue,0
84,2,COUMADIN TABS 2 MG,Subcutaneous haematoma,0
48,2,JAKAFI,Platelet count increased,0
4,2,CLARITIN CHEWABLE TABLETS,Overdose,0
63,2,DEPAKOTE,Dysgeusia,0
48,1,SANDOSTATIN LAR,Death,0
61,2,LETAIRIS,Oedema peripheral,0
62,2,JAKAFI,Ear haemorrhage,0
62,2,ABATACEPT SUBQ INJECTION 125MG/ML,Sepsis,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,DEPAKOTE,Tremor,0
3,1,SABRIL (FOR ORAL SOLUTION),Tonsillectomy,1
38,1,GILENYA,Completed suicide,0
66,2,LETAIRIS,Loss of consciousness,0
62,2,JAKAFI,Sneezing,0
,,JAKAFI,Blood count abnormal,1
58,1,LISINOPRIL HCTZ,Hypertension,0
,1,DEPAKOTE,Balance disorder,0
,2,ACLASTA/ZOLEDRONATE,Bone density decreased,0
9,1,CLARITIN CHEWABLE TABLETS,Overdose,0
58,2,NEULASTA,Surgery,1
,2,DEPAKOTE,Platelet count decreased,0
,2,JAKAFI,Deep vein thrombosis,0
63,2,REBIF,Loss of consciousness,0
2,2,CLARITIN CHEWABLE TABLETS,Overdose,0
47,2,GILENYA,Atrioventricular block first degree,0
,2,ONFI,Adverse event,0
,0,DEPAKOTE,Drug ineffective,0
48,2,AUBAGIO,Muscle spasms,1
,1,JAKAFI,Transfusion,1
92,2,SPIRIVA,Musculoskeletal chest pain,0
71,1,LETAIRIS,Heart rate increased,0
40,1,DEPAKOTE,Convulsion,0
,1,GLIVEC,Death,0
,2,JAKAFI,Increased appetite,0
49,1,SPIRIVA,Incorrect route of drug administration,0
7,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,DEPAKOTE,Hypersensitivity,0
,1,JAKAFI,Pruritus,0
57,1,CITALOPRAM,Mental disorder,0
,0,DEPAKOTE,Pruritus,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
81,2,JAKAFI,Adverse drug reaction,0
23,1,VOVERAN,Acute respiratory distress syndrome,0
,1,DEPAKOTE,Feeling abnormal,0
35,2,LETAIRIS,Blister,0
,2,GLEEVEC,Death,0
,1,DEPAKOTE,Grand mal convulsion,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
10,2,CLARITIN CHEWABLE TABLETS,Overdose,0
69,1,AMIODARONE HCL,Hyperthyroidism,0
82,2,JAKAFI,Haemoglobin decreased,0
,0,NEXPLANON,Device difficult to use,0
,2,DEPAKOTE,Alopecia,0
,2,SOLUMEDROL,Malnutrition,0
78,1,SELARA,Fibroadenoma of breast,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
57,1,DEPAKOTE,Liver function test abnormal,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,DIOVAN,Neoplasm malignant,0
90,2,METHYLPREDNISOLONE ACETATE,Diabetes mellitus,1
38,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,2,LIPITOR,Type 2 diabetes mellitus,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
74,2,LETAIRIS,Haemorrhage,0
,2,DEPAKOTE,Drug hypersensitivity,0
77,1,REVLIMID,Influenza,1
70,1,OMNISCAN,Nephrogenic systemic fibrosis,0
87,2,LETAIRIS,Staphylococcal infection,0
46,1,CLOZARIL,Neutrophil count increased,1
77,1,GRANULOCYTE MACROPHAGE COLONY STIM FACTOR,Dehydration,1
,1,DIVALPROEX SODIUM,Hospitalisation,1
71,1,LETAIRIS,Fatigue,0
,1,GLIVEC,Lower limb fracture,0
,2,JANUVIA,Diarrhoea,0
41,1,DEPAKOTE,Medication residue present,0
66,2,TOFACITINIB CITRATE,Osteomyelitis,0
68,2,TYVASO,Hypotension,0
,0,SIMULECT,Death,0
,0,CUBICIN,Death,0
61,1,DEPAKOTE,Incorrect dose administered,0
74,1,METFORMIN,Erysipelas,1
70,2,LETAIRIS,Fluid retention,0
19,1,CLOZARIL,Atrial septal defect,0
,0,DEPAKOTE,Pancreatic disorder,0
46,1,HUMIRA,Rectal haemorrhage,1
60,2,COLCHICINE.,Weight increased,0
38,2,GLIVEC,Death,0
57,2,DEPAKOTE,Hair growth abnormal,0
43,2,HUMIRA,Organising pneumonia,1
,2,JAKAFI,Somnolence,0
,2,DEPAKOTE,Vomiting,1
,1,ACLASTA,Death,0
70,1,LETAIRIS,Sleep disorder,0
43,1,GILENYA,Chest pain,0
,2,AMPYRA,Depression,1
58,1,JAKAFI,Platelet count increased,0
,2,DEPAKOTE,Rash,0
76,1,AZILECT,Disease progression,0
61,2,LETAIRIS,Malaise,0
,2,NUVIGIL,Reflux laryngitis,0
59,2,AFINITOR,Death,0
,2,DEPAKOTE,Dizziness,0
,0,DEXTROAMPHETAMINE SULFATE,Coeliac disease,0
,2,HUMIRA,Blindness,0
73,2,LETAIRIS,Dyspnoea,0
86,1,AZILECT,Hypertension,0
75,2,GILENYA,Multiple sclerosis,0
,2,DEPAKOTE,Hypersensitivity,0
22,2,NEXPLANON,Implant site pruritus,0
85,2,LETAIRIS,Wrist fracture,0
,2,DEPAKOTE,Abdominal discomfort,0
,1,JANUMET,Neoplasm malignant,0
,2,LETAIRIS,Fall,1
82,2,LETAIRIS,Dyspnoea exertional,0
30,1,DEPAKOTE,Tremor,0
50,1,KALYDECO,Asthenia,1
60,1,PROVENTIL,Chronic obstructive pulmonary disease,1
78,2,LETAIRIS,Fatigue,0
,1,DEPAKOTE,Drug level below therapeutic,0
50,1,OMNISCAN,Nephrogenic systemic fibrosis,0
51,1,DEPAKOTE,Somnolence,0
58,2,LETAIRIS,Feeling abnormal,0
65,2,JAKAFI,Tooth loss,0
50,1,AUBAGIO,Rhinalgia,0
,1,DEPAKOTE,Weight increased,0
18,2,NEXPLANON,Implant site irritation,0
64,1,LETAIRIS,Oedema peripheral,0
42,1,SANDOSTATIN LAR DEPOT,Blood sodium decreased,1
23,1,DEPAKOTE,Nausea,0
65,2,LETAIRIS,Peripheral swelling,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,DEPAKOTE,Fallot^s tetralogy,0
67,2,LETAIRIS,Liver function test abnormal,0
,1,TREANDA,Neuropathy peripheral,0
,1,DIOVAN,Chronic obstructive pulmonary disease,1
79,1,DEPAKOTE,Somnolence,0
,1,LUCRIN,Unevaluable event,0
,2,JAKAFI,Hair texture abnormal,0
75,2,LETAIRIS,Blood potassium increased,0
17,2,TOBI,Lung infection,1
41,2,REBIF,Suicide attempt,1
,0,DEPAKOTE,Confusional state,1
,1,JAKAFI,Diarrhoea,0
59,2,LETAIRIS,Weight increased,0
,2,DEPAKOTE,Eye movement disorder,0
11,2,CICLOSPORIN,Respiratory distress,1
,2,JAKAFI,Rash,0
,2,DEPAKOTE,Hypersensitivity,0
7,1,ONFI,Limb discomfort,0
55,2,CORICIDIN HBP COLD AND FLU,Drug ineffective for unapproved indication,0
67,2,JAKAFI,Haemoglobin decreased,0
,1,OMNISCAN,Nephrogenic systemic fibrosis,0
,0,DEPAKOTE,Hyperammonaemia,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,DEPAKOTE,Flat affect,0
23,1,NEULASTA,Pneumonia,1
,0,DEPAKOTE,Pulmonary valve stenosis congenital,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
54,1,COMETRIQ,Death,0
,2,TEGRETOL,Convulsion,1
49,1,NEULASTA,Investigation,1
,0,DEPAKOTE,Hyperammonaemia,0
43,1,CRESTOR,Liver disorder,0
65,0,HOLOXAN,Disease progression,0
,2,OXYTROL FOR WOMEN,Erythema,0
,2,"ANTIOXIDENT MULTIPLE VITAMINS (A,D,E,K-INTENSIVE) AND MINERALS",Diarrhoea,0
35,2,IMPLANON,Abortion induced,0
53,0,HOLOXAN,Disease progression,0
55,1,WARFARIN,Haemorrhage,0
53,2,INEGY,Renal failure acute,1
,2,DEPAKOTE,Hair disorder,0
,2,COZAAR,Exposure during pregnancy,0
43,2,IRON,Diarrhoea,0
82,1,PREDNISOLONE,Type 2 diabetes mellitus,1
,1,DEPAKOTE,Parkinson^s disease,0
,2,GILENYA,Cholelithiasis,1
46,1,LETAIRIS,Headache,0
32,2,MIRENA,Device expulsion,0
,0,DEPAKOTE,Sedation,0
,2,PRINIVIL,Exposure during pregnancy,0
80,2,LETAIRIS,Tooth disorder,0
39,1,DEPAKOTE,Bone marrow failure,0
,2,ACLASTA,Chronic obstructive pulmonary disease,1
,2,EXELON PATCH,Dementia Alzheimer^s type,0
,1,OMNISCAN,Nephrogenic systemic fibrosis,0
74,1,LETAIRIS,Urinary tract infection,0
,0,DEPAKOTE,Pancreatitis,0
77,2,ADIRO 100,Hypoacusis,1
,1,DIANEAL LOW CALCIUM,Pneumonia,1
43,2,DEPAKOTE,Activities of daily living impaired,0
,2,NEXPLANON,Medical device complication,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,DEPAKOTE,Drug hypersensitivity,0
64,0,HOLOXAN,Disease progression,0
,1,AFRIN NO DRIP,Drug ineffective,0
,0,DEPAKOTE,Pancytopenia,0
,0,70% DEXTROSE INJECTION USP,Incorrect dosage administered,0
,2,ALENDRONATE SODIUM.,Low turnover osteopathy,1
69,2,ENBREL,Visual impairment,0
,2,DEPAKOTE,Adverse event,0
48,0,HOLOXAN,Disease progression,0
71,1,DOXAZOSIN,Loss of proprioception,0
26,2,PARAGARD 380A,Embedded device,0
,1,DEPAKOTE,Back pain,0
53,2,HUMIRA,Hyponatraemia,1
66,0,HOLOXAN,Disease progression,0
,0,DIANEAL LOW CALCIUM,Discomfort,0
68,2,ABRAXANE,Dizziness,1
,2,DEPAKOTE,Wrong technique in drug usage process,0
51,0,HOLOXAN,Disease progression,0
35,2,NEXPLANON,Device difficult to use,0
,1,DEPAKOTE,Off label use,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Myocardial infarction,0
,2,NUVARING,Device expulsion,0
,2,DEPAKOTE,Faeces pale,0
66,0,HOLOXAN,Disease progression,0
25,1,DIANEAL PD2 WITH 1.5% DEXTROSE,Death,0
64,2,NEULASTA,Investigation,1
,2,DEPAKOTE,Ammonia increased,0
50,0,HOLOXAN,Disease progression,0
56,0,HOLOXAN,Disease progression,0
,2,DIVALPROEX SODIUM,Drug ineffective,0
54,0,HOLOXAN,Disease progression,0
54,2,HUMIRA,Arthropathy,1
,2,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Gangrene,1
46,1,DEPAKOTE,Grand mal convulsion,0
,2,DEXAMETHASONE,Drug hypersensitivity,0
62,0,HOLOXAN,Disease progression,0
,2,DEPAKOTE SPRINKLE,Therapy change,0
71,0,RITUXIMAB,Disease progression,0
,2,DEPAKOTE,Full blood count abnormal,0
,1,DIANEAL LOW CALCIUM,Sepsis,1
68,0,HOLOXAN,Neurological decompensation,0
,2,DEPAKOTE,Malaise,0
,1,"FEIBA 500 U INJEKTIO/INFUUSIOKUIVA-AINE JA LIUOTIN, LIUOSTA VARTEN",Thrombosis,0
21,2,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Convulsion,1
,1,DEPAKOTE,Balance disorder,0
,0,DIANEAL LOW CALCIUM,Rib fracture,1
,2,DEPAKOTE,Trigeminal neuralgia,0
,2,DIANEAL PD2,Gastroenteritis viral,1
68,2,AZACITIDINE INJECTABLE,Fluid overload,1
72,2,HUMIRA,Malaise,1
,1,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Hypotension,1
28,1,VALPROATE SEMISODIUM,Carnitine deficiency,1
,2,DIANEAL LOW CALCIUM,Staphylococcal infection,1
64,1,HUMIRA,Muscular weakness,1
,1,DEPAKOTE,Pancreatitis,1
37,1,DIANEAL LOW CALCIUM,Pulmonary haemorrhage,1
75,1,DIOVAN,Pneumonia,1
39,2,DOCETAXEL (UNKNOWN),Anaemia,0
,2,DIANEAL-N PD-4 1.5 PD SOLUTION,Sepsis,0
8,2,DEPAKOTE,Anger,0
63,2,QUETIAPINE (UNKNOWN),Mixed liver injury,0
,2,DIANEAL LOW CALCIUM,Urinary tract infection,0
,2,DEPAKOTE,Granulocytopenia,0
,2,DIANEAL LOW CALCIUM (ULTRABAG),Headache,1
37,2,AUBAGIO,Hypotension,0
,2,DEPAKOTE,Rash,0
67,2,DIANEAL LOW CALCIUM,Post procedural haemorrhage,1
,2,DEPAKOTE,Suicidal ideation,0
81,1,GLIVEC,Haemorrhage,0
,0,DEPAKOTE,Stevens-Johnson syndrome,0
,1,DIANEAL LOW CALCIUM,Myocardial infarction,0
72,2,HUMIRA,Mycobacterium tuberculosis complex test positive,0
,2,ACLASTA,Respiratory failure,0
54,1,DEPAKOTE,Nausea,0
45,1,HUMIRA,Myocardial infarction,0
,0,DEPAKOTE,Balance disorder,0
37,2,NASACORT ALLERGY,Cardiac flutter,0
,2,SPIRIVA,Incorrect route of drug administration,0
62,1,EXJADE,Death,0
28,1,DEPAKOTE,Dreamy state,0
32,2,CLOZAPINE,Parotitis,1
73,1,JAKAFI,Fluid retention,0
23,2,ONFI,Convulsion,1
28,1,CLOZARIL,Bursitis,1
81,2,DEPAKINE,Fall,1
54,1,SANDOSTATIN LAR DEPOT,Diabetes mellitus,1
46,2,TEMODAL,Death,0
,2,DIANEAL LOW CALCIUM,Localised infection,1
51,1,JAKAFI,Platelet count abnormal,0
,2,DEPAKOTE,Alopecia,0
68,1,JAKAFI,Transfusion,0
,2,PARACETAMOL,Rectocele,1
85,1,JAKAFI,Weight decreased,0
42,2,DEPAKOTE,Product quality issue,0
,2,SABRIL (FOR ORAL SOLUTION),Cardiac arrest,1
,1,DEPAKOTE,Unevaluable event,0
39,1,DIANEAL LOW CALCIUM,Death,0
84,1,JAKAFI,Blood pressure increased,0
,1,GLIVEC,Gastrointestinal stromal tumour,0
,0,DEPAKOTE,Hypersensitivity,0
63,1,OMEPRAZOLE.,Blood count abnormal,0
25,2,AMITRIPTYLINE,Injury,1
60,2,SPIRIVA,Incorrect route of drug administration,0
,2,DEPAKOTE,Drug hypersensitivity,0
,1,JAKAFI,Rash,0
72,2,JAKAFI,Platelet count decreased,0
18,2,YAZ,Cerebral venous thrombosis,1
86,1,HARNAL D (TAMSULOSIN HYDROCHLORIDE),Subdural haematoma,0
66,2,RAMIPRIL,Musculoskeletal stiffness,0
,1,DEPAKOTE,Dizziness,0
,2,JAKAFI,Platelet count decreased,0
29,2,YASMIN,Thrombosis,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,DEPAKOTE,Malaise,0
91,2,SPIRIVA,Drug administration error,0
,2,EXJADE,Death,0
53,2,WARFARIN,International normalised ratio fluctuation,1
73,1,DEPAKOTE,Fall,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,DEPAKOTE,Medication error,0
67,2,SPIRIVA,Dyspnoea,0
,2,DIANEAL LOW CALCIUM,Impaired healing,1
31,1,DEPAKOTE,Pancreatitis acute,0
,2,GLIVEC,Death,0
58,2,SPIRIVA,Incorrect route of drug administration,0
45,1,DIANEAL LOW CALCIUM,Gastrointestinal haemorrhage,1
46,2,DEPAKOTE,Ammonia increased,0
,1,SPIRIVA,Coeliac disease,0
59,2,AUBAGIO,Surgery,0
47,2,DEPAKOTE,Cautery to nose,0
,0,LIPITOR,Type 2 diabetes mellitus,0
53,2,ACLASTA,Neoplasm malignant,0
68,2,DEPAKOTE,Drug ineffective,0
,1,JAKAFI,Fatigue,0
,0,LIPITOR,Type 2 diabetes mellitus,0
69,1,SAMSCA,Ventricular tachycardia,0
,2,JAKAFI,Pain,0
70,1,CARDIOASPIRIN,Melaena,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,DEPAKOTE,Mood altered,0
,1,JAKAFI,Flatulence,0
,2,CARBIDOPA AND LEVODOPA,Haemorrhage,0
,0,LIPITOR,Type 2 diabetes mellitus,0
40,1,DEPAKOTE,Memory impairment,0
72,2,JAKAFI,Dizziness,0
92,1,ARKOLAMYL,Psychotic behaviour,0
,2,ACLASTA,Bronchopulmonary aspergillosis,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,HUMIRA,Vaginal haemorrhage,1
76,2,JAKAFI,Hospice care,0
73,1,OMEPRAZEN,Febrile convulsion,0
89,2,GLEEVEC,Death,0
8,1,DEPAKOTE,Drug ineffective,0
7,1,CLARITIN CHEWABLE TABLETS,Overdose,0
46,1,JAKAFI,Sinus disorder,0
,2,OMNISCAN,Nephrogenic systemic fibrosis,0
63,2,DEPAKOTE,Weight increased,0
23,1,CLOZARIL,Circulatory collapse,1
56,2,JAKAFI,Blood lactate dehydrogenase increased,0
89,2,ZEGERID OTC CAPSULES,Drug ineffective,0
,2,DEPAKOTE,Leukopenia,0
,2,LIPITOR,Type 2 diabetes mellitus,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,DEPAKOTE,Headache,0
,2,JAKAFI,Increased appetite,0
,0,LIPITOR,Type 2 diabetes mellitus,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
92,2,EXELON PATCH,Apparent death,0
,1,DEPAKOTE,Headache,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
,2,GILENYA,Peripheral swelling,0
46,2,DEPAKOTE ER,Frustration,0
,,JAKAFI,Memory impairment,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,OXYTROL FOR WOMEN,Inappropriate schedule of drug administration,0
70,1,SINEMET,Hypokinesia,1
,2,DEPAKOTE,Irritability,0
69,1,JAKAFI,Nasopharyngitis,0
29,2,ROCURONIUM BROMIDE,Cardiac arrest,0
,0,DEPAKOTE,Tremor,0
,2,JAKAFI,Therapeutic response unexpected,0
65,1,CERTICAN,Interstitial lung disease,1
43,2,DEPAKOTE,Disorientation,0
,2,DIANEAL PD2 (ULTRABAG),Peritonitis,1
,2,DIANEAL LOW CALCIUM,Cerebrovascular accident,0
,0,DEPAKOTE,Amylase increased,0
19,2,METOTRESSATO TEVA,Mucosal inflammation,1
14,1,DEPAKOTE,Gingivitis,0
4,1,ONFI,Convulsion,0
60,1,DIOVAN HCT,Gastrointestinal stromal tumour,1
,0,DIANEAL LOW CALCIUM,Pancreatitis,1
,2,DEPAKOTE,Drug ineffective,0
50,2,REBIF,Endometriosis,0
,2,LETAIRIS,Headache,0
74,2,JAKAFI,Feeling cold,0
16,2,DOXORUBICIN TEVA,Hepatocellular injury,1
,1,DIANEAL PD2 WITH 1.5% DEXTROSE,Myocardial infarction,0
59,2,DEPAKOTE,Drug prescribing error,0
43,1,MYFORTIC,Kaposi^s sarcoma,0
,1,JAKAFI,Splenomegaly,0
45,2,PACLITAXEL,Gastrointestinal obstruction,1
,0,DEPAKOTE,Medication residue present,0
2,1,CLARITIN CHEWABLE TABLETS,Overdose,0
55,2,JAKAFI,Nausea,0
,2,DEPAKOTE,Neutrophil count decreased,0
,2,LETAIRIS,Tinnitus,0
31,2,ONFI,Abnormal behaviour,1
,2,TASIGNA,Death,0
,0,EPIVAL,Feeling abnormal,0
2,2,CLARITIN CHEWABLE TABLETS,Overdose,0
69,2,IMATINIB,Breast cancer,0
,2,JAKAFI,Fatigue,0
46,2,FEMARA,Blood glucose increased,0
,2,DEPAKOTE,Blood glucose increased,0
77,1,LETAIRIS,Death,0
73,2,SANDOSTATIN LAR,Death,0
63,2,OMEPRAZOLE,Hypomagnesaemia,1
77,1,JAKAFI,Transfusion,0
,2,DEPAKOTE,Body height below normal,0
52,2,LETAIRIS,Extrasystoles,0
33,2,KLACID,Drug ineffective,1
,2,ACLASTA,Coma,0
79,1,ALLOPURINOL.,Muscle abscess,0
,2,DEPAKOTE,Weight increased,0
66,1,LETAIRIS,Stent placement,0
61,1,HUMIRA,Asthenia,1
,2,JAKAFI,Drug intolerance,0
82,1,JAKAFI,Neuralgia,0
43,2,DEPAKOTE,Anxiety,0
,2,LETAIRIS,Headache,0
55,1,HUMIRA,Myocardial infarction,0
,1,JAKAFI,Drug prescribing error,0
73,2,JAKAFI,Diarrhoea,0
,2,XGEVA,Metastases to bone,1
34,1,DEPAKOTE,Convulsion,0
75,1,LETAIRIS,Dyspnoea,0
,1,HUMIRA,Appendix disorder,0
80,2,CALCIUM,Haemorrhage,0
,2,AMITRIPTYLINE,Feeling abnormal,0
,2,HUMIRA,Joint dislocation,0
76,1,LETAIRIS,Scab,0
,1,JAKAFI,Adverse reaction,0
70,1,JAKAFI,Stomatitis,0
48,1,INCIVEK,Injection site rash,0
7,2,EVEROLIMUS,Epilepsy,1
,1,LETAIRIS,Nasopharyngitis,0
,0,JAKAFI,Nausea,0
81,2,AMBRISENTAN,Cardiac disorder,0
66,2,JAKAFI,Hypothyroidism,0
,0,CUBICIN,Infection,0
,0,COPAXONE,Tooth loss,0
65,1,NEULASTA,Investigation,1
81,1,JAKAFI,Pulmonary congestion,0
,2,REVLIMID,Foot deformity,1
37,1,CLOZARIL,Dyspnoea,0
,1,DEPAKOTE,Medication residue present,0
,1,FETZIMA,Testicular torsion,0
59,2,JAKAFI,Epistaxis,0
39,2,PARAGARD 380A,Anaphylactic reaction,0
33,2,EXTAVIA,Multiple sclerosis relapse,1
,2,DEPAKOTE,Tremor,0
,2,OMNISCAN,Nephrogenic systemic fibrosis,0
68,2,JAKAFI,Pain in jaw,0
,0,JAKAFI,White blood cell count increased,0
11,1,EXJADE,Death,0
,1,HUMIRA,Bronchial carcinoma,0
,0,FLUOROURACIL,Pneumonitis,0
,2,ACLASTA,Death,0
82,2,JAKAFI,Muscle spasms,0
47,2,PARAGARD 380A,Embedded device,0
81,1,JAKAFI,Drug dose omission,0
50,1,CYTARABINE,Pneumonia,0
54,2,JAKAFI,Memory impairment,0
77,2,AMBRISENTAN,Death,1
,1,JAKAFI,Hospice care,0
65,1,JAKAFI,Malaise,0
41,2,AUBAGIO,Muscle spasms,1
52,2,RIBAVIRIN,Chills,0
57,2,PACLITAXEL,Bronchospasm,0
,1,VENLAFAXINE HCL,Drug ineffective,0
,2,NEXPLANON,Device breakage,0
,2,GLIVEC,Amnesia,0
,2,PEGINTRON,Pain,0
50,2,ROACTEMRA,Aortic dissection,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
26,2,JAKAFI,Rash,0
,1,AVASTIN,Death,0
,1,ZOLINZA,Drug dose omission,0
47,2,CORICIDIN HBP COLD AND FLU,Feeling abnormal,0
63,2,JAKAFI,Thermal burn,0
55,2,XELODA,Death,0
,1,JAKAFI,Pain,0
68,2,HUMIRA,Hypoaesthesia,0
,1,ZERIT,Fat redistribution,0
,1,JAKAFI,Blood count abnormal,0
30,2,CANESTEN (KAINITING),Exposure during pregnancy,0
,,JAKAFI,Malaise,0
,2,LUPRON DEPOT,Abortion spontaneous,0
58,2,ROACTEMRA,Blood fibrinogen decreased,0
33,2,YAZ,Pulmonary embolism,1
62,2,JAKAFI,Platelet count decreased,0
,2,OXYTROL FOR WOMEN,Dermatitis contact,0
,2,SABRIL (FOR ORAL SOLUTION),Irritability,0
32,2,YAZ,Anxiety,0
,2,HUMIRA,Ileectomy,0
,2,JAKAFI,Diabetes mellitus,0
40,2,YAZ,Anxiety,1
,2,KALETRA,Foetal heart rate decreased,0
77,2,SPIRIVA,Off label use,0
,0,NEXPLANON,Device breakage,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
71,1,OMNISCAN,Nephrogenic systemic fibrosis,0
11,1,TEGRETOL,Vertigo,1
2,1,CLARITIN CHEWABLE TABLETS,Accidental overdose,0
45,2,HUMIRA,Tooth disorder,1
3,1,SABRIL (FOR ORAL SOLUTION),Drug dose omission,0
46,2,COPAXONE,Eye pain,0
76,2,PRADAXA,Deafness,0
75,1,RIBAVIRIN,Renal impairment,0
82,1,PHILLIPS^ MILK OF MAGNESIA LIQUID ORIGINAL,Intestinal haemorrhage,0
62,2,FEMARA,Ocular hyperaemia,1
,2,AMPYRA,Wrist fracture,0
,0,TAVEGIL,Hypotension,1
,2,TEGRETOL,Convulsion,0
,0,BLINDED ALISKIREN,Lower gastrointestinal haemorrhage,1
,2,AMPYRA,Renal failure,0
43,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
49,2,NEORAL,Pulmonary alveolar haemorrhage,0
46,1,AMPYRA,Convulsion,1
55,2,JANUVIA,Pancreatitis acute,1
22,1,CLINDAMYCIN,Bone marrow failure,1
74,1,PROAIR HFA,Large intestine polyp,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,AMPYRA,Abasia,0
87,1,XARELTO,Death,1
85,1,PRADAXA,Haematochezia,1
,2,ONFI,Incorrect dose administered,0
,2,AMPYRA,Paraesthesia,0
87,2,PRADAXA,Cerebrovascular accident,1
69,2,GLIVEC,Death,0
,1,JAKAFI,Rash,0
81,1,PRADAXA,Blood alkaline phosphatase increased,0
,1,CLOZARIL,Electrocardiogram abnormal,0
41,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,0,ALENDRONIC ACID,Foetal cardiac disorder,0
66,2,JAKAFI,Eye haemorrhage,0
,2,MIRENA,Menorrhagia,0
71,2,COMBIVENT,Dysphonia,0
77,2,KERI ORIGINAL,Ocular hyperaemia,0
40,1,GILENYA,Skin lesion,0
58,2,JAKAFI,Rash,0
,2,MIRENA,Uterine perforation,0
,0,LIPITOR,Type 2 diabetes mellitus,0
72,2,JAKAFI,Oral mucosal erythema,0
47,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
65,1,COLCHICINE.,Thrombocytopenia,1
20,1,HABITROL 21 MG,Suicidal ideation,0
63,2,FOLIC ACID,Haemoglobin decreased,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
61,1,POLOCARD,Acute myocardial infarction,1
78,1,SANDOSTATIN LAR,Malignant neoplasm progression,1
,1,GLIVEC,Death,0
54,2,KYNAMRO,Alanine aminotransferase increased,0
,0,NEXPLANON,Device difficult to use,0
,2,AMN107,Dizziness,0
46,2,MIRTAZAPINE,Blepharospasm,0
31,2,MIRENA,Uterine perforation,0
22,2,NUVARING,Device expulsion,0
27,2,IZOTONIK SODYUM KLOR?R PVC,Infusion site erythema,0
75,2,JAKAFI,Laboratory test abnormal,0
23,2,LO LOESTRIN FE,Emotional distress,1
,1,ZYTIGA,Platelet count decreased,0
,1,HUMIRA,Respiratory arrest,0
,2,MIRENA,Uterine perforation,0
45,1,STELARA,Drug eruption,0
28,1,HALDOL,Oropharyngeal spasm,0
70,2,PRADAXA,Melaena,0
64,1,JAKAFI,Pneumonia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
68,2,JAKAFI,Nausea,0
,1,GLEEVEC,Hepatic lesion,0
15,2,REMERGIL,Seizure like phenomena,1
,0,LIPITOR,Type 2 diabetes mellitus,0
75,2,JAKAFI,Flatulence,0
8,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,JAKAFI,Drug dose omission,0
,2,THERAFLU EXTRAGRIP,Rash pruritic,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,MIRENA,Uterine perforation,0
82,1,JAKAFI,Therapeutic response unexpected,0
,2,KETOPROFEN,Urticaria,1
,2,SANDOSTATIN LAR DEPOT,Hip fracture,1
,0,LIPITOR,Type 2 diabetes mellitus,0
62,1,GLIVEC,Death,0
28,2,MIRENA,Device dislocation,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
,0,LIPITOR,Type 2 diabetes mellitus,0
49,2,LETAIRIS,Bronchitis,0
23,2,MIRENA,Device expulsion,0
25,2,PLAN B ONE-STEP,Menstruation delayed,0
82,1,JAKAFI,Fatigue,0
,1,JAKAFI,Decreased appetite,0
,0,LIPITOR,Type 2 diabetes mellitus,0
30,2,LETAIRIS,Toothache,0
,2,PLAN B ONE-STEP,Cough,0
,2,MIRENA,Uterine perforation,0
52,2,ERBITUX SOLN FOR INF 5MG/ML,Dysgeusia,0
40,2,JAKAFI,Influenza like illness,0
84,2,IMBRUVICA,Transient ischaemic attack,1
79,2,LETAIRIS,Unevaluable event,0
71,1,IBRUTINIB,Traumatic haematoma,1
23,2,MIRENA,Uterine perforation,1
34,2,PARAGARD 380A,Menorrhagia,0
70,1,SULFASALAZINE.,Skin discolouration,1
81,2,REVLIMID,Death,0
69,2,LETAIRIS,Malaise,0
,1,EXJADE,Neoplasm progression,0
68,2,JAKAFI,Platelet count increased,0
62,1,REVLIMID,Overdose,1
48,2,LETAIRIS,Nasal congestion,0
6,1,CLARITIN CHEWABLE TABLETS,Inappropriate schedule of drug administration,0
54,1,JAKAFI,Weight loss poor,0
58,2,LETAIRIS,Pain,0
5,2,CLARITIN CHEWABLE TABLETS,Overdose,0
67,1,JAKAFI,Thrombotic microangiopathy,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,PROPECIA,Cognitive disorder,0
78,2,TYVASO,Heart rate increased,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
55,2,JAKAFI,Vitreous floaters,0
21,2,REMODULIN,Muscle spasms,0
,1,ONFI (ORAL SUSPENSION),Increased bronchial secretion,0
,1,JAKAFI,No adverse event,0
63,1,IRINOTECAN (UNKNOWN),Abdominal pain upper,1
72,1,OXALIPLATIN TEVA 5MG/ML,Infusion related reaction,0
28,2,COUMADIN,Migraine,0
60,2,JAKAFI,Platelet count abnormal,0
,2,PLAN B ONE-STEP,Malaise,0
71,2,LETAIRIS,Fall,0
,2,PLAN B ONE-STEP,Vomiting,0
83,1,JAKAFI,Blister,0
60,1,BENDAMUSTINE,Malignant neoplasm progression,0
34,2,GILENYA,Neurogenic bladder,0
13,1,CLARITIN CHEWABLE TABLETS,Overdose,0
73,2,LETAIRIS,Unevaluable event,0
,2,COMPLERA,Pregnancy,0
13,1,IBUPROFEN,Off label use,1
72,2,ASMANEX TWISTHALER,Syncope,0
52,1,LETAIRIS,Syncope,0
26,2,EFFEXOR XR,Spinal disorder,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,OMEPRAZOLE,Ovarian germ cell cancer stage II,0
57,2,LETAIRIS,Urinary tract infection,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
6,2,CLARITIN CHEWABLE TABLETS,Overdose,0
53,2,PROLIA,Femoral neck fracture,0
14,2,CLARITIN CHEWABLE TABLETS,Overdose,0
46,2,LETAIRIS,Influenza,0
12,1,CLARITIN CHEWABLE TABLETS,Overdose,0
64,2,EFFEXOR XR,Chest pain,1
,0,DUROTEP MT,Wrong technique in drug usage process,0
60,2,CAMPATH,Death,0
67,1,DURAGESIC,Drug dose omission,0
65,2,LETAIRIS,Headache,0
,0,DUROTEP MT,Malignant neoplasm progression,0
89,2,CELEBREX,Glaucoma,0
46,1,DARUNAVIR,Syncope,0
70,2,LETAIRIS,Pain in extremity,0
,2,LYRICA,Drug effect incomplete,0
42,1,NODOZ,Renal failure acute,1
,0,HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN,Haemorrhage,0
,0,HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN,Embolism arterial,0
81,,HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN,Skin necrosis,0
,0,HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN,Adhesion,0
62,2,LYRICA,Vasculitis,0
69,1,LETAIRIS,Nasopharyngitis,0
57,1,GABAPENTIN,Alopecia,0
57,1,SUTENT,Death,0
70,2,LETAIRIS,Vomiting,1
,1,VARENICLINE TARTRATE,"Hallucination, auditory",0
65,2,LETAIRIS,Headache,0
,0,NICOTINE,Drug ineffective,0
53,2,EXTAVIA,Major depression,1
18,1,LETAIRIS,Vomiting,0
,1,TOBI,Malaise,1
,1,GLEEVEC,Fear of death,0
36,1,CHAMPIX,Hypertension,0
52,2,LETAIRIS,Oedema peripheral,0
65,2,JAKAFI,Alopecia,0
,2,LYRICA,Limb traumatic amputation,0
64,2,LETAIRIS,Diarrhoea,0
69,1,CELEBREX,Drug ineffective,0
,2,JAKAFI,Hospice care,0
72,2,LYRICA,Back pain,0
44,2,LETAIRIS,Hypotension,0
,1,CHANTIX,Abnormal dreams,0
,2,JAKAFI,Diarrhoea,0
,2,JZOLOFT,Breast cancer,0
82,2,LETAIRIS,Paraesthesia,0
55,2,LYRICA,Dry mouth,0
88,2,CORDARONE,Erythema,0
48,1,LETAIRIS,Nasal dryness,0
,2,CELEBREX,Activities of daily living impaired,0
30,2,LETAIRIS,Dyspnoea exertional,0
,1,LYRICA,Feeling abnormal,0
77,2,LETAIRIS,Hepatic enzyme increased,0
,2,LYRICA,Oedema peripheral,0
52,1,SOLIRIS,Abdominal pain,1
81,1,LETAIRIS,Oedema peripheral,0
,1,EFFEXOR XR,Dizziness,0
,2,SOLIRIS,Myelodysplastic syndrome,0
28,2,LETAIRIS,Headache,0
72,2,XELJANZ,Oral mucosal blistering,0
,1,JAKAFI,Prostatic haemorrhage,0
52,1,ISTODAX,Platelet count decreased,0
63,1,LETAIRIS,Arthralgia,0
,2,LYRICA,Swelling,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
80,2,LETAIRIS,Hypoaesthesia,0
68,2,LYRICA,Drug ineffective,0
68,1,LETAIRIS,Oedema peripheral,0
54,2,TIZANIDINE (TIZANIDINE),Cerebrovascular accident,1
56,1,LETAIRIS,Lung transplant,0
67,2,LYRICA,Dizziness,0
,2,SYNAGIS,Bronchiolitis,1
,2,SOLIRIS,Headache,1
75,2,LETAIRIS,Ligament sprain,0
68,2,XALKORI,Dizziness,0
83,1,CARDIOASPIRIN,Subarachnoid haemorrhage,1
,2,SOLIRIS,Influenza like illness,1
57,2,LETAIRIS,Palpitations,0
,2,LYRICA,Drug ineffective,0
48,1,PRAMIPEXOLE,Dyspnoea,0
,0,SOLIRIS,Haemoglobin decreased,1
62,2,LETAIRIS,Pruritus,0
58,2,EFFEXOR,Dizziness,0
77,2,JAKAFI,Hypoaesthesia,0
78,2,LETAIRIS,Muscle disorder,0
80,2,PLAVIX,Renal impairment,1
,0,PRISTIQ,Drug ineffective,0
63,2,GILENYA,Central nervous system lesion,0
42,2,LETAIRIS,Diarrhoea,0
,2,LYRICA,Weight increased,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
67,1,LETAIRIS,Dyspnoea,0
78,1,PRADAXA,Increased upper airway secretion,0
,1,LYRICA,Pain,0
73,1,PRADAXA,Renal artery thrombosis,0
59,2,INVEGA SUSTENNA,Syncope,0
,2,PRADAXA,Cerebrovascular accident,0
52,2,LETAIRIS,Rash,0
62,2,LYRICA,Local swelling,0
49,1,PEGINTRON,Lip blister,0
,0,SPIRIVA,Coeliac disease,0
,1,EFFEXOR XR,Atrial fibrillation,0
59,2,LETAIRIS,Fatigue,0
,2,OXYTROL FOR WOMEN,Purulent discharge,0
,2,CORTISONE,Drug ineffective,0
52,2,LETAIRIS,Fatigue,0
51,2,VYTORIN,Thyroid nodule removal,1
51,1,LETAIRIS,Oedema,0
67,2,SPIRIVA,Anxiety,0
53,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,EFFEXOR,Chest pain,0
37,2,LETAIRIS,Oedema,0
64,1,SPIRIVA,Pneumonia,1
10,2,CLARITIN CHEWABLE TABLETS,Inappropriate schedule of drug administration,0
,2,LYRICA,Vision blurred,0
52,2,LETAIRIS,Nasopharyngitis,0
,0,ONFI,Feeling abnormal,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,GABAPENTIN,Drug withdrawal syndrome,0
37,1,LETAIRIS,Headache,0
71,1,POMALYST,Death,0
36,2,NORIDAY,Lymphopenia,0
,0,PRADAXA,Deafness,0
61,2,REVLIMID,Mental status changes,1
42,2,LETAIRIS,Hearing impaired,0
42,2,EFFEXOR XR,Diarrhoea,0
62,2,LETAIRIS,Nausea,0
49,2,TASIGNA,Food interaction,0
,1,MYFORTIC,Retinal detachment,0
,1,SPIRIVA,Tremor,0
53,2,TYVASO,Cough,0
47,2,CHANTIX,Rash,0
63,2,LETAIRIS,Fat redistribution,0
,2,SPIRIVA,Hypoaesthesia,0
73,1,EFFEXOR XR,Heart rate irregular,0
55,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
4,1,LETAIRIS,Hordeolum,0
,2,JAKAFI,Constipation,0
30,2,EVIPLERA,Seizure,1
,1,GABAPENTIN,Weight increased,0
42,2,LETAIRIS,Malaise,0
71,1,JAKAFI,Abdominal pain upper,0
58,2,ABATACEPT,Grand mal convulsion,1
,2,OXYTROL FOR WOMEN,Wrong technique in drug usage process,0
59,2,LYRICA,Obesity,0
72,1,JAKAFI,Thrombocytopenia,0
68,2,LETAIRIS,Unevaluable event,0
80,1,EXFORGE,Prostate cancer,1
60,1,COUMADIN,Cardiac failure,1
,2,PLAN B ONE-STEP,Vomiting,0
2,2,LETAIRIS,Oral candidiasis,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
54,2,LYRICA,Drug ineffective,0
63,2,LETAIRIS,Skin haemorrhage,0
73,1,REMINYL,Loss of consciousness,0
67,2,EFFEXOR XR,Dizziness,0
,0,LIPITOR,Type 2 diabetes mellitus,0
56,2,LETAIRIS,Herpes zoster,0
78,2,DABIGATRAN,Deafness,0
24,2,IBUPROFEN (UNKNOWN),Hypoaesthesia oral,0
,0,LIPITOR,Type 2 diabetes mellitus,0
46,1,LYRICA,Malaise,0
,1,GLIVEC,Death,0
51,2,LETAIRIS,Anaemia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
48,1,ATORVASTATIN CALCIUM (UNKNOWN),Neuropathy peripheral,0
,1,CONCERTA,Palpitations,0
,2,LYRICA,Drug ineffective,0
64,2,LETAIRIS,Oedema,1
69,1,JAKAFI,Drug dose omission,0
,0,LIPITOR,Type 2 diabetes mellitus,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,ZYVOX,Feeling hot,0
,0,LIPITOR,Type 2 diabetes mellitus,0
53,2,LETAIRIS,Malaise,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,0,LIPITOR,Type 2 diabetes mellitus,0
52,2,LYRICA,Drug ineffective,0
57,1,TYVASO,Feeling abnormal,0
33,2,PLAN B ONE-STEP,Menstruation irregular,0
,,LIPITOR,Type 2 diabetes mellitus,0
27,2,PLAN B ONE-STEP,Menstruation irregular,0
55,2,NICOTINE,Drug ineffective,0
53,2,LETAIRIS,No therapeutic response,0
,2,SOVALDI,Mania,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,PLAN B ONE-STEP,Diarrhoea,0
56,2,LETAIRIS,Rhinorrhoea,0
,2,PLAN B ONE-STEP,Diarrhoea,0
,0,LIPITOR,Type 2 diabetes mellitus,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
76,2,EFFEXOR XR,Rheumatoid arthritis,0
26,2,PLAN B ONE-STEP,Menstruation irregular,0
49,2,LETAIRIS,Fluid retention,0
9,2,CLARITIN CHEWABLE TABLETS,Overdose,0
62,1,DOCETAXEL (UNKNOWN),Facial bones fracture,1
29,2,LYRICA,Drug ineffective,0
72,2,ADCIRCA,Diarrhoea,0
,1,NEXAVAR,Hepatic failure,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
52,2,NEURONTIN,Drug ineffective,0
80,2,LETAIRIS,Peripheral swelling,0
10,1,CLARITIN CHEWABLE TABLETS,Overdose,0
74,1,CLARITHROMYCIN (UNKNOWN),Dyspnoea,0
,1,GLIPIZIDE,Blood glucose abnormal,0
71,1,LETAIRIS,Swelling,0
35,1,TASIGNA,Death,0
57,1,PREDNISOLONE (UNKNOWN),Depression,0
62,2,LETAIRIS,Unevaluable event,0
,1,CHANTIX,Suicidal ideation,0
65,1,DOXAZOSIN,Cerebrovascular accident,0
60,2,LETAIRIS,Diarrhoea,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,NICOTROL INHALER,Abdominal distension,0
59,2,LETAIRIS,Oedema peripheral,0
,1,CELEBREX,Urticaria,0
74,2,PRAMIPEXOLE,Cerebrovascular accident,1
,1,PRISTIQ,Irritability,0
81,2,LETAIRIS,Cough,0
51,1,VIAGRA,Nasopharyngitis,0
5,1,CLARITIN CHEWABLE TABLETS,Overdose,0
8,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,LYRICA,Depressed mood,0
80,2,LETAIRIS,Fluid retention,1
75,1,MIRALAX,Nausea,0
46,1,INDAPAMIDE,Electrocardiogram QT prolonged,0
,2,LYRICA,Drug ineffective,0
66,2,XELJANZ,Pain in extremity,0
72,1,LETAIRIS,Haemoglobin increased,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
73,1,FRONTAL,Aortic dissection,1
6,1,CLARITIN CHEWABLE TABLETS,Overdose,0
46,2,LETAIRIS,Vein disorder,0
,2,LYRICA,Myocardial infarction,0
,1,CHANTIX,Liver disorder,0
76,2,LETAIRIS,Oral mucosal blistering,0
23,1,PEGASYS,Drug interaction,1
,1,XALATAN,Death,0
84,2,JAKAFI,Pigmentation disorder,0
,2,LYRICA,Pain,0
50,1,ATENOLOL,Anxiety,0
93,2,LETAIRIS,Feeling abnormal,0
,2,JAKAFI,Skin papilloma,0
,2,EFFEXOR XR,Heart rate increased,0
,2,SKELAXIN,Fall,1
87,1,JAKAFI,Epistaxis,0
64,2,LETAIRIS,Fluid retention,0
62,1,TOPROL,Depression,1
58,2,ZYVOX,Erythema,0
88,2,ATENOLOL,Drug interaction,0
,2,JAKAFI,Ear pain,0
81,2,LETAIRIS,Malaise,0
77,2,LIPITOR,Blood potassium decreased,0
58,2,CORTISONE ACETATE,Drug hypersensitivity,0
86,2,FELDENE,Drug hypersensitivity,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
70,2,LETAIRIS,Bronchitis,0
,2,JAKAFI,Blood count abnormal,0
52,2,DOSTINEX,Drug ineffective,0
,2,ADVIL,Dysgeusia,0
88,2,OXYTROL FOR WOMEN,Vision blurred,0
56,2,LETAIRIS,Pain in extremity,0
,1,JAKAFI,Diarrhoea,0
34,2,PARAGARD 380A,Device dislocation,0
84,2,PREMARIN,Drug ineffective,0
,2,CHANTIX,Abdominal discomfort,0
79,2,XALATAN,Diverticulitis,0
77,2,LETAIRIS,Dizziness,0
62,2,JAKAFI,Nausea,0
,1,LIPITOR,Death,0
,2,LYRICA,Drug ineffective,0
,1,ATORVASTATIN CALCIUM,Drug hypersensitivity,0
44,2,LETAIRIS,Sinusitis,0
,2,GEODON,Cardiac disorder,0
42,2,ABRAXANE,Renal failure,1
,2,LIPITOR,Neoplasm malignant,0
59,2,LETAIRIS,Cough,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,LYRICA,Vision blurred,0
48,1,CHAMPIX,Haematuria,0
16,2,LETAIRIS,Catheterisation cardiac,0
,2,ZOLOFT,Weight increased,0
64,2,SOLU-MEDROL,Mania,1
61,2,LETAIRIS,Oedema,0
12,1,CLARITIN CHEWABLE TABLETS,Overdose,0
64,2,CHANTIX,Drug hypersensitivity,0
,2,OXYTROL FOR WOMEN,Off label use,0
78,2,XALATAN,Angiopathy,0
52,2,SIMPONI,Blood pressure increased,0
17,1,PREDNISONE,Mood swings,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,ADVIL MIGRAINE,Drug ineffective,0
74,2,LETAIRIS,Cardiac failure congestive,0
38,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
59,1,SOLU-MEDROL,Cardiac arrest,0
54,1,SUTENT,Fatigue,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
17,2,LETAIRIS,Nasopharyngitis,0
,2,GEODON,Drug interaction,0
5,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,OXYCONTIN (NDA 22-272),Osteopenia,0
69,1,INLYTA,Death,0
59,1,LETAIRIS,Dry throat,0
50,2,LYRICA,Anorgasmia,0
82,2,LETAIRIS,Middle ear effusion,0
,2,CELEBREX,Malaise,0
,,XARELTO,Surgery,1
85,1,XARELTO,Basal ganglia haemorrhage,0
,2,LYRICA,Diplegia,0
70,2,LETAIRIS,Heart rate increased,0
55,2,VENLAFAXINE HCL,Drug ineffective,0
,2,SOVALDI,Mania,1
59,2,LYRICA,Abasia,0
77,2,LETAIRIS,Localised infection,0
66,2,LYRICA,Gastrointestinal disorder,1
67,2,LETAIRIS,No therapeutic response,0
,2,XANAX,Coeliac disease,0
,2,CELEBREX,Rotator cuff syndrome,0
,0,NORVASC,Death,0
80,1,GABAPENTIN,Drug ineffective,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,CHANTIX,Carotid artery occlusion,0
62,1,LETAIRIS,Dyspnoea,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,LYRICA,Suicidal ideation,0
92,2,CARDURA XL,Death,0
78,2,REVLIMID,Respiratory disorder,1
,0,LIPITOR,Type 2 diabetes mellitus,0
50,2,LETAIRIS,Haemoptysis,0
,2,LYRICA,Drug intolerance,0
66,2,LYRICA,Spinal disorder,0
84,1,REVLIMID,Intestinal ischaemia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
71,2,LETAIRIS,Ear congestion,0
,2,LYRICA,Drug ineffective,0
52,2,ATENOLOL,Cardiac stress test abnormal,1
,0,LIPITOR,Type 2 diabetes mellitus,0
62,1,REVLIMID,Haemorrhage,1
61,2,TYVASO,Rash,0
,1,LYRICA,Myocardial infarction,0
,2,LYRICA,Off label use,0
,0,LIPITOR,Type 2 diabetes mellitus,0
62,2,JAKAFI,Bone pain,0
,1,LYRICA,Spinal cord disorder,0
64,1,LETAIRIS,Peripheral swelling,0
20,2,LYRICA,Drug ineffective,0
,0,LIPITOR,Type 2 diabetes mellitus,0
58,2,XELJANZ,Carpal tunnel syndrome,0
60,2,LETAIRIS,Pyrexia,0
,2,CELEBREX,Memory impairment,0
7,1,TOBI,Pneumonia klebsiella,0
57,1,PREDNISOLONE,Condition aggravated,0
82,2,MS CONTIN,Haemoptysis,1
79,1,JAKAFI,White blood cell count increased,0
78,2,LETAIRIS,Pallor,0
38,1,EFFEXOR XR,Loss of consciousness,1
66,2,SUMATRIPTAN SUCCINATE TABLETS,Electrocardiogram Q wave abnormal,0
44,2,HALCION,Intentional overdose,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,JAKAFI,Flatulence,0
43,2,LETAIRIS,Peripheral swelling,0
69,1,LYRICA,Drug ineffective,0
,1,LYRICA,Oedema,0
73,2,JAKAFI,Constipation,0
60,2,LETAIRIS,Decreased appetite,0
58,1,PREDNISONE.,Nephrolithiasis,1
74,1,XALATAN,Condition aggravated,0
,0,JAKAFI,Hepatic enzyme increased,0
65,2,RANOLAZINE,Stent placement,0
,0,LYRICA,Macular fibrosis,0
72,2,JAKAFI,Haemoglobin decreased,0
,0,LYRICA,Drug hypersensitivity,0
,1,JAKAFI,Adverse drug reaction,0
75,1,CISPLATIN,Electrolyte imbalance,0
,1,SIMPONI,Bradycardia foetal,0
,0,EXEMESTANE,Mouth ulceration,0
56,2,LYRICA,Drug ineffective,0
,2,ONFI,Fatigue,0
62,2,JAKAFI,Flatulence,0
69,2,MEROPENEM,Septic shock,0
59,2,ATORVASTATIN,Dysgeusia,0
65,2,JANUVIA,Skin irritation,1
,0,CUBICIN,Death,0
,2,LYRICA,Drug ineffective,0
54,2,JAKAFI,Nasopharyngitis,0
88,1,BYSTOLIC,Nephrolithiasis,0
8,2,CLARITIN CHEWABLE TABLETS,Overdose,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
83,2,LYRICA,Malaise,0
,2,JAKAFI,Incontinence,0
53,1,AMOXICILLIN+CLAVULANATE,Haematuria,0
,2,MIRALAX,Drug ineffective,0
78,1,REVLIMID,Laboratory test abnormal,0
7,1,CLARITIN CHEWABLE TABLETS,Inappropriate schedule of drug administration,0
,0,CELEBREX,Tooth disorder,0
62,2,JAKAFI,Dysgeusia,0
60,1,RIBAVIRIN,Drug reaction with eosinophilia and systemic symptoms,1
27,2,PLAN B,Pregnancy,0
52,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,JAKAFI,Therapeutic response unexpected,0
41,2,LETAIRIS,Dizziness,0
71,1,JAKAFI,White blood cell count increased,0
,0,SOLIRIS,Lymphocele,1
4,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,JAKAFI,Blast cell count decreased,0
59,1,LETAIRIS,Hypotension,0
11,2,FLUOXETINE,Ovarian failure,0
,2,JAKAFI,Laboratory test abnormal,0
64,1,JAKAFI,Diarrhoea,0
65,2,LETAIRIS,Headache,0
97,2,GALANTAMINE,Gastrointestinal haemorrhage,1
28,2,ESCITALOPRAM,Nephrolithiasis,0
,2,LYRICA,Amnesia,0
,1,JAKAFI,Dyspepsia,0
67,2,LETAIRIS,Transplant evaluation,0
53,1,JAKAFI,Blister,0
,2,AFINITOR,Angioedema,0
,2,LYRICA,Dizziness,0
46,2,LETAIRIS,Pain,0
76,2,JAKAFI,Hypertension,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
39,2,FESOTERODINE,Vomiting,0
62,2,LETAIRIS,Sinus congestion,0
,2,JAKAFI,Atrial fibrillation,0
5,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,TRAZODONE,Coeliac disease,0
,2,JAKAFI,Splenomegaly,0
50,2,LETAIRIS,Dyspnoea,0
77,2,ALENDRONIC ACID,Femur fracture,0
,2,CLARAVIS,Neoplasm malignant,0
53,2,RAMIPRIL (UNKNOWN),Cough,0
,0,LIPITOR,Type 2 diabetes mellitus,0
65,1,LETAIRIS,Haemoglobin decreased,0
,2,OXYTROL FOR WOMEN,Inappropriate schedule of drug administration,0
,2,MIRALAX,Incorrect drug administration duration,0
71,2,LIPITOR,Type 2 diabetes mellitus,0
7,1,CLARITIN CHEWABLE TABLETS,Inappropriate schedule of drug administration,0
64,2,LETAIRIS,Cardiac failure congestive,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
68,2,LIPITOR,Glucose tolerance impaired,0
,0,MYCOPHENOLIC ACID,Hepatitis E,0
66,2,LETAIRIS,Chest pain,0
,2,NUVARING,Cervix operation,0
4,2,CLARITIN CHEWABLE TABLETS,Accidental exposure to product by child,0
,0,LIPITOR,Type 2 diabetes mellitus,0
50,2,LETAIRIS,Non-cardiac chest pain,0
,1,AVANDIA,Coronary artery occlusion,1
47,2,LAMICTAL,Transfusion,1
,1,AVANDIA,Cardiac failure congestive,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,,DEFEROXAMINE,Platelet count decreased,0
41,1,AVANDIA,Myocardial infarction,1
70,1,AVANDIA,Myocardial infarction,1
,2,AVANDIA,Myocardial infarction,0
,2,AVANDIA,Death,0
82,2,LETAIRIS,Fall,0
61,2,ALPRAZOLAM (UNKNOWN),Unresponsive to stimuli,1
58,1,XANAX,Non-Hodgkin^s lymphoma,0
45,1,LETAIRIS,Pharyngitis streptococcal,0
,2,AVANDIA,Myocardial infarction,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,ABRAXANE,Throat tightness,0
72,2,LETAIRIS,Nasal congestion,1
62,1,AVANDIA,Myocardial infarction,1
55,2,AVANDIA,Cerebrovascular accident,1
60,2,ASPIRIN.,Arteritis,0
52,1,AVANDIA,Myocardial infarction,1
50,1,AVANDIA,Hypotension,1
,1,REVLIMID,Amnesia,0
71,2,SEROQUEL,Subileus,1
53,2,LETAIRIS,Finger deformity,0
29,2,LAMICTAL,Loss of consciousness,0
48,2,SIMVASTATIN.,Cataract,0
35,1,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abdominal pain upper,1
23,1,CITALOPRAM,Energy increased,0
,1,ONFI,Malaise,0
49,2,LIPITOR,Type 2 diabetes mellitus,0
32,1,LAMICTAL,Convulsion,1
75,2,PRADAXA,Cataract,0
53,2,RAMIPRIL,Cough,0
,2,LETAIRIS,Dyspnoea,1
41,1,TENOFOVIR DISOPROXIL FUMARATE,Death,0
,2,AVAMYS,Optic atrophy,0
,0,LIPITOR,Type 2 diabetes mellitus,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
71,2,DIOVAN,Hip fracture,1
78,2,LETAIRIS,Dyspnoea,0
,2,VENTOLIN,Pneumonia,0
46,2,ADVAIR HFA,Dyspnoea,1
74,1,SIMVASTATIN (UNKNOWN),Muscle spasms,0
86,1,AVODART,Coronary arterial stent insertion,1
45,2,FLOVENT,Pneumonia,0
73,2,LESCOL XL,Type 2 diabetes mellitus,0
82,2,ADVAIR HFA,Investigation,1
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
51,2,VENTOLIN,Bronchitis,1
64,2,ADVAIR HFA,Breast pain,1
22,2,PARAGARD 380A,Device dislocation,0
69,1,AVODART,Dysuria,0
56,1,ZOFRAN,Mental status changes,1
,0,LIPITOR,Type 2 diabetes mellitus,0
73,2,RAMIPRIL,Angioedema,1
6,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,ADVAIR,Pneumonia,0
,2,ADVAIR,Investigation,1
61,1,WARFARIN,Haematuria,1
61,2,ADVAIR HFA,Pneumonia,0
25,2,KIOVIG NORMAL IMMUNOGLOBULIN (HUMAN) 20G/200ML FOR INTRAVENOUS USE INJ,Headache,1
61,2,ADVAIR,Pneumonia viral,0
64,1,ADVAIR HFA,Diplopia,0
68,2,RANITIDINE HYDROCHLORIDE,Dyspnoea,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
73,2,ADVAIR,Ageusia,0
61,2,ADVAIR,Oxygen supplementation,1
44,2,LETAIRIS,Muscle spasms,0
,0,ALBUTEROL,Pneumonia,0
8,0,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,TYKERB,Breast cancer,0
36,1,REMICADE,Palpitations,0
14,1,REMICADE,Pouchitis,1
,2,TYKERB,Breast cancer,0
,0,LIPITOR,Type 2 diabetes mellitus,0
48,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
49,2,LAMICTAL,Brain neoplasm,1
66,2,PROMACTA,Investigation,1
12,2,REMICADE,Lupus-like syndrome,0
,2,SALBUTAMOL SULPHATE,Heart rate increased,1
53,2,TRACLEER,Pneumonitis chemical,1
39,2,TYKERB,Death,0
,1,REMICADE,Finger deformity,0
62,1,VOTRIENT,Pneumonia,1
66,2,REMICADE,Colitis,0
71,2,REMICADE,Small intestinal stenosis,0
,2,EXEMESTANE,Disease progression,0
52,2,FLUOXETINE (UNKNOWN),Arrhythmia,1
69,1,ADVAIR,Diverticulum,1
,1,AVODART,Death,0
55,1,LOVAZA,Myocardial infarction,1
,1,CLARITIN CHEWABLE TABLETS,Overdose,0
62,2,LETAIRIS,Headache,0
,2,VOTRIENT,Tumour excision,1
78,2,TYKERB,Breast cancer,0
,0,EXCEGRAN,Interstitial lung disease,1
58,2,VALPROIC ACID (UNKNOWN),Sopor,0
49,2,LIPITOR,Type 2 diabetes mellitus,0
82,2,LETAIRIS,No therapeutic response,0
82,2,ARIXTRA,Haemorrhage,1
39,2,TRIAZOLAM (UNKNOWN),Coma,0
61,2,LIPITOR,Type 2 diabetes mellitus,0
65,1,PYOSTACINE,Petechiae,1
,2,CHANTIX,Suicidal ideation,0
46,2,LETAIRIS,Oedema peripheral,0
74,1,ARIXTRA,Toxic skin eruption,1
26,2,LAMICTAL,Confusional state,0
,0,LIPITOR,Type 2 diabetes mellitus,0
40,2,RISPERIDONE ACTAVIS,Delusion,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,REQUIP,Sudden onset of sleep,0
,1,RELENZA,Delirium,0
78,1,VOTRIENT 200MG,Intra-abdominal haemorrhage,0
,1,LETAIRIS,Swelling,0
10,1,SERETIDE (50MCG/100MCG),Growth retardation,0
12,1,ATRIANCE,Hemiplegia,1
,0,LIPITOR,Type 2 diabetes mellitus,0
63,2,VOTRIENT,Pulmonary embolism,1
,2,LIPITOR,Type 2 diabetes mellitus,0
60,2,VOTRIENT,Autoimmune haemolytic anaemia,0
60,2,DENOSUMAB,Dizziness,1
4,1,ZINNAT,Erythema,1
87,2,LETAIRIS,Nasal congestion,0
,1,COMBIVIR,Lipodystrophy acquired,0
,0,LIPITOR,Type 2 diabetes mellitus,0
66,2,RANIDIL,Lip oedema,1
57,2,ALDACTAZIDE,Type 2 diabetes mellitus,0
70,2,VOTRIENT,Investigation,1
,2,PARAGARD 380A,Medical device complication,0
,1,AVOLVE,Ascites,0
78,2,UNKNOWN DRUG,Blood pressure decreased,1
35,2,LETAIRIS,Peripheral swelling,0
,0,ZANTAC,Electrocardiogram QT prolonged,0
,1,AVOLVE,Encephalopathy,0
46,2,BABY ASPIRIN,Hyperkalaemia,1
75,2,VOTRIENT,Intestinal operation,1
48,2,LORAZEPAM,Sopor,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,EPIVIR,Hepatitis C,1
,1,COMBIVIR,Epilepsy,1
34,1,FLUTICASONE PROPIONATE + SALMETEROL XINAFOATE,Bone loss,0
79,1,LETAIRIS,Unevaluable event,0
37,2,ACITRETIN,Periarthritis,1
,0,LIPITOR,Type 2 diabetes mellitus,0
44,2,SERETIDE,Pharyngeal oedema,1
4,1,TRIFLUCAN,Intraventricular haemorrhage neonatal,1
84,2,VOTRIENT,Diarrhoea,0
82,2,LETAIRIS,Peripheral swelling,0
,2,EXEMESTANE,Dyspnoea,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
59,1,LETAIRIS,Syncope,0
68,2,DILANTIN,Intestinal obstruction,1
,2,LYRICA,Swelling,0
25,1,RIFAMPICIN,Serum sickness-like reaction,1
,2,LIPITOR,Type 2 diabetes mellitus,0
72,2,LETAIRIS,Blood pressure decreased,0
82,1,ATORVASTATIN,Myalgia,1
,2,METFORMIN HCL,Cardiac disorder,0
67,2,LIPITOR,Type 2 diabetes mellitus,0
27,2,GABAPENTIN,Drug ineffective,0
66,2,LETAIRIS,Pleurisy,0
,2,HUMIRA,Ileal stenosis,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
61,1,LETAIRIS,Abdominal pain,0
50,2,TAKEPRON,Renal abscess,1
55,1,KALETRA,Myocardial infarction,0
,0,LIPITOR,Type 2 diabetes mellitus,0
32,2,LYRICA,Weight increased,0
,2,ZEMPLAR,Cardiac disorder,0
14,2,LETAIRIS,Nasopharyngitis,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
79,2,LETAIRIS,International normalised ratio increased,0
50,2,LIPITOR,Type 2 diabetes mellitus,0
69,2,CRESTOR,Type 2 diabetes mellitus,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
52,2,LETAIRIS,Concussion,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
54,2,DOXYCYCLINE MONOHYDRATE,Congestive cardiomyopathy,1
79,1,LETAIRIS,Eye pruritus,0
38,2,CHANTIX,Irritability,0
,2,SPIRIVA,Coeliac disease,0
,0,LIPITOR,Type 2 diabetes mellitus,0
48,1,LETAIRIS,Dizziness,0
,0,LIPITOR,Type 2 diabetes mellitus,0
53,1,LETAIRIS,Chest pain,0
65,2,CELEBREX,Bone pain,0
68,2,LIPITOR,Type 2 diabetes mellitus,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,0,EXEMESTANE,Pneumothorax,0
41,2,LETAIRIS,Hypersensitivity,0
71,2,MIRALAX,Incorrect drug administration duration,0
40,2,LIPITOR,Neuropathy peripheral,0
57,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
,2,PRISTIQ,Drug withdrawal syndrome,0
55,2,LETAIRIS,Malaise,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,CELEBREX,Abdominal pain upper,0
26,2,METHADONE,Acute respiratory distress syndrome,1
69,2,PACLITAXEL,Cough,1
,0,LIPITOR,Type 2 diabetes mellitus,0
84,2,OSCAL,Product quality issue,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
69,2,LIPITOR,Drug hypersensitivity,0
70,1,LETAIRIS,Confusional state,0
50,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
52,2,ORENCIA,Surgery,1
,2,LYRICA,Drug ineffective,0
51,2,LIPITOR,Type 2 diabetes mellitus,0
58,2,SPIRIVA,Dyspnoea,0
65,2,LETAIRIS,Orthopnoea,0
,0,LIPITOR,Type 2 diabetes mellitus,0
58,1,LYRICA,Drug hypersensitivity,0
,2,LIPITOR,Type 2 diabetes mellitus,0
68,1,MICARDIS HCT,Blood pressure increased,0
49,2,LETAIRIS,Bronchitis,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,ADVIL MIGRAINE,Rash,0
,2,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
,0,LIPITOR,Type 2 diabetes mellitus,0
57,2,ADCIRCA,Feeling abnormal,0
,2,LIPITOR,Dysmorphism,0
57,2,HUMIRA,Brain neoplasm,1
,2,DIANEAL LOW CALCIUM (ULTRABAG),Blood pressure decreased,0
,0,LIPITOR,Type 2 diabetes mellitus,0
64,2,APRESOLINE HYDROCHLORIDE,Drug hypersensitivity,0
77,2,LETAIRIS,Swelling,0
49,1,VISIPAQUE,Rash morbilliform,1
22,2,NAPROXEN.,Cerebral thrombosis,1
,0,LIPITOR,Type 2 diabetes mellitus,0
64,2,LETAIRIS,Fall,0
65,1,ACETYLSALICYLIC ACID({=100 MG),Haematochezia,0
74,2,ACLASTA/ZOLEDRONATE,Breast cancer recurrent,0
,0,LIPITOR,Type 2 diabetes mellitus,0
47,2,LETAIRIS,Loss of consciousness,0
45,2,SUMATRIPTAN.,Cerebrovascular accident,1
58,2,REVLIMID,Gallbladder disorder,1
36,2,ABATACEPT SUBQ INJECTION 125MG/ML,Uterine disorder,0
36,1,CLOZARIL (CLOZAPINE),Weight decreased,0
,0,LIPITOR,Type 2 diabetes mellitus,0
26,2,YAZ,Superior sagittal sinus thrombosis,1
,2,GLEEVEC,Movement disorder,0
54,2,ZOSYN,Toxic skin eruption,0
1,2,CITALOPRAM,Motor developmental delay,0
68,2,REVATIO,Weight decreased,0
,2,ARAVA,Exposure during pregnancy,0
54,2,TASIGNA,Respiratory failure,1
,2,GILENYA,Retinal tear,0
5,2,LETAIRIS,Nasopharyngitis,0
73,2,CARDIOASPIRIN,Apraxia,1
26,2,MIRENA,Device expulsion,0
,0,LIPITOR,Type 2 diabetes mellitus,0
88,1,EXFORGE,Respiratory failure,0
59,1,ADCIRCA,Cough,0
,1,DIANEAL LOW CALCIUM,Cholelithiasis,0
20,2,MIRENA,Device issue,1
81,1,DIANEAL LOW CALCIUM,Weight increased,0
59,2,ADCIRCA,Heart rate increased,0
,2,GILENYA,Chest pain,0
40,1,DIANEAL LOW CALCIUM,Road traffic accident,0
78,1,LETAIRIS,Fatigue,0
,0,LIPITOR,Type 2 diabetes mellitus,0
71,2,LETAIRIS,Product packaging issue,0
65,2,LIPITOR,Type 2 diabetes mellitus,0
,2,DIANEAL LOW CALCIUM,Condition aggravated,1
63,2,LETAIRIS,Headache,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,GAMMAGARD LIQUID,Adverse reaction,0
59,2,LETAIRIS,Nasal congestion,0
58,2,ATORVASTATIN,Type 2 diabetes mellitus,0
,0,ONFI,Infection,0
,,LIPITOR,Type 2 diabetes mellitus,0
79,2,LETAIRIS,Faeces discoloured,0
45,1,CLOZARIL,Neutrophil count decreased,0
,0,NEORAL,Megakaryocytes decreased,0
67,1,LETAIRIS,Nasal congestion,0
,2,DIOVAN,Fall,1
65,1,AFINITOR,Liver injury,1
76,1,LETAIRIS,Oxygen consumption increased,0
72,2,BISOPROLOL,Hallucination,1
54,2,LIPITOR,Type 2 diabetes mellitus,0
61,2,LETAIRIS,Bronchitis,0
66,2,POMALYST,Oral discomfort,0
,1,DIANEAL LOW CALCIUM,Abdominal pain,0
77,2,LETAIRIS,Abdominal pain,0
,1,GLEEVEC,Death,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
42,2,LETAIRIS,Drug dose omission,0
63,0,FLUOROURACILE TEVA,Pulmonary embolism,0
,0,LIPITOR,Type 2 diabetes mellitus,0
31,1,LETAIRIS,Head discomfort,0
,0,LIPITOR,Type 2 diabetes mellitus,0
80,1,LETAIRIS,Palpitations,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Hernia,1
,2,EXCEDRIN EXTRA STRENGTH,Cerebrovascular accident,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,DIANEAL LOW CALCIUM,Oedema peripheral,0
64,2,VELETRI,Blood urea increased,1
82,1,POMALYST,Plasma cell myeloma,0
84,1,JAKAFI,Asthenia,0
19,2,PARAGARD 380A,Device expulsion,0
16,1,LETAIRIS,Urinary tract infection,0
45,1,DIANEAL PD4 GLUCOSE 1.36% W/V / 13.6 MG/ML,Constipation,0
23,2,LETAIRIS,Cough,0
,2,JAKAFI,Respiratory tract congestion,0
14,2,LETAIRIS,Anaemia,0
11,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,DIANEAL LOW CALCIUM,Dehydration,0
56,2,LETAIRIS,Influenza,0
62,0,HOLOXAN,Neurological decompensation,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
46,2,EPOPROSTENOL.,Headache,0
35,2,CORICIDIN HBP COLD AND FLU,Feeling jittery,0
,2,KALYDECO,Cough,0
30,1,DIANEAL LOW CALCIUM (ULTRABAG),Weight increased,0
79,1,LETAIRIS,Pharyngeal oedema,0
,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
4,2,CLARITIN CHEWABLE TABLETS,Accidental exposure to product by child,0
79,2,LETAIRIS,Upper respiratory tract infection,0
,2,OXYTROL FOR WOMEN,Skin irritation,0
7,1,CLARITIN CHEWABLE TABLETS,Overdose,0
58,2,DIANEAL LOW CALCIUM (ULTRABAG),Local swelling,0
47,1,GILENYA,Heart rate irregular,1
,2,LETAIRIS,Cough,0
42,1,CORICIDIN HBP COLD AND FLU,Gastrointestinal tract irritation,0
,2,DIANEAL LOW CALCIUM,Procedural pain,0
2,2,FELBAMATE.,Seizure,0
81,2,LETAIRIS,Dyspnoea,0
16,2,NEXPLANON,Abortion spontaneous,0
83,2,JAKAFI,Flatulence,0
57,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
62,2,LETAIRIS,Dizziness,0
1,1,CLARITIN CHEWABLE TABLETS,Overdose,0
59,2,JAKAFI,Oedema peripheral,0
,0,DIANEAL LOW CALCIUM,Procedural pain,0
4,2,CLARITIN CHEWABLE TABLETS,Overdose,0
84,2,LETAIRIS,Arthritis,0
1,1,CITALOPRAM,Small for dates baby,0
74,1,JAKAFI,Pneumonia,0
33,2,GAMMAGARD LIQUID,Infection,0
,2,KALYDECO,Liver function test abnormal,0
,2,FOLLITROPIN ALFA,Maternal exposure during pregnancy,0
69,2,LETAIRIS,Chest pain,0
88,1,JAKAFI,Weight decreased,0
,2,METFORMIN HYDROCHLORIDE.,Off label use,0
23,2,REMODULIN,Heart rate increased,0
,2,DIANEAL LOW CALCIUM,Abdominal discomfort,0
54,2,LETAIRIS,Liver function test abnormal,0
,2,FOLLITROPIN ALFA,Maternal exposure during pregnancy,0
,0,TASIGNA,Oedema,0
38,2,DIANEAL PD2,Diabetic foot infection,1
30,2,LETAIRIS,Oedema,1
,2,METFORMIN HYDROCHLORIDE.,Maternal exposure during pregnancy,0
26,1,DIANEAL LOW CALCIUM,Fluid overload,0
,2,FOLLITROPIN ALFA,Ectopic pregnancy,0
79,2,LETAIRIS,Cardiac disorder,0
2,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,GILENYA,Wound,1
24,1,DIANEAL LOW CALCIUM (ULTRABAG),Dehydration,0
75,2,LETAIRIS,Treatment noncompliance,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
64,2,JAKAFI,Nasopharyngitis,0
68,2,TYVASO,Seasonal allergy,0
4,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,DIANEAL LOW CALCIUM,Coronary artery occlusion,1
25,1,FAMVIR,Escherichia bacteraemia,1
62,2,LETAIRIS,Nausea,0
8,1,CLARITIN CHEWABLE TABLETS,Overdose,0
57,1,JAKAFI,Tongue ulceration,0
25,2,PLAN B ONE-STEP,Pregnancy after post coital contraception,0
,2,DIANEAL PD2 (ULTRABAG),Swelling,0
70,1,JAKAFI,Dermatitis allergic,0
18,1,IBUPROFEN,Haemoptysis,1
73,1,"BREVIBLOC 2,5 G/10 ML, SOLUTION INJECTABLE ? DILUER (I.V.)",Pulseless electrical activity,0
,0,TRAZODONE,Penile torsion,0
,1,JAKAFI,Platelet count decreased,1
3,0,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,DIANEAL LOW CALCIUM,Hearing impaired,0
,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,AZTREONAM LYSINE,Lung transplant,0
66,2,AMLODIPINE BESYLATE.,Blood pressure decreased,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
2,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,DIANEAL LOW CALCIUM,Procedural pain,0
,2,PROAIR HFA,Drug hypersensitivity,0
79,2,LETAIRIS,Sneezing,0
,2,OXYTROL FOR WOMEN,Application site swelling,0
4,2,CLARITIN REDITABS,Accidental exposure to product by child,0
16,2,CLARITIN CHEWABLE TABLETS,Overdose,0
43,2,MIRENA,Genital haemorrhage,0
45,2,LETAIRIS,Urinary tract infection,0
1,1,PAROXETIN,Pulmonary valve stenosis congenital,0
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
29,2,MIRENA,Device dislocation,0
44,1,REBIF,Disability,0
89,2,EXELON PATCH,Sudden death,0
,0,DIANEAL LOW CALCIUM,Pain,0
75,2,ADCIRCA,Influenza,0
,2,MIRENA,Off label use,0
38,2,CORICIDIN HBP COLD AND FLU,Drug effect delayed,0
74,2,ALENDRONIC ACID,Osteonecrosis,0
,0,HOLOXAN,Bronchopulmonary aspergillosis,0
56,2,LETAIRIS,Gastroenteritis viral,0
52,2,WARFARIN,International normalised ratio increased,1
72,1,ALPHAGAN,Atrial fibrillation,0
57,2,LETAIRIS,Peripheral swelling,0
68,2,REVLIMID,Myelodysplastic syndrome,1
96,2,PRADAXA,Haematochezia,1
50,2,LETAIRIS,Condition aggravated,0
74,2,LETAIRIS,Nasopharyngitis,0
95,2,ACLASTA,Death,1
67,1,LETAIRIS,Peripheral swelling,0
,0,VALPROIC ACID,Diet refusal,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
79,2,LETAIRIS,Dizziness,0
46,1,TRACLEER,Cardioversion,1
71,2,LETAIRIS,Dyspnoea,0
71,1,RISPERIDONE,Incontinence,1
48,1,TRACLEER,Coronary arterial stent insertion,1
12,2,LETAIRIS,Pertussis,0
75,1,LETAIRIS,Cough,0
84,1,REVLIMID,Aneurysm,0
,1,PRADAXA,Death,0
,2,LETAIRIS,Depression,0
52,2,LETAIRIS,Chest pain,0
79,2,ISTODAX,Atrial fibrillation,1
63,1,LETAIRIS,Arthropod bite,0
,0,FEBURIC,Lymphoma,0
69,2,REVATIO,Ocular hyperaemia,0
,2,SPIRIVA,Dyspnoea,0
,0,LIPITOR,Type 2 diabetes mellitus,0
28,2,CELLCEPT,Chest discomfort,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
,1,NORVASC,Death,0
23,2,ABILIFY MAINTENA,Schizoaffective disorder,1
91,2,ADCIRCA,Sinusitis,0
61,1,LYRICA,Death,0
70,2,REVLIMID,Pulmonary embolism,1
57,1,LETAIRIS,Rash,0
47,1,LETAIRIS,Hot flush,0
56,1,SANDOSTATIN LAR DEPOT,Dysuria,1
59,1,ADVAIR HFA,Intestinal mucosal hypertrophy,1
56,1,LETAIRIS,Weight decreased,0
55,2,LETAIRIS,Malaise,0
,0,LIPITOR,Type 2 diabetes mellitus,0
63,1,HUMIRA,Fall,1
48,1,LETAIRIS,Syncope,0
48,2,LETAIRIS,Peripheral swelling,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
64,2,LETAIRIS,Fatigue,0
92,2,LETAIRIS,Fluid retention,0
,0,FEBURIC,Death,0
,0,LIPITOR,Type 2 diabetes mellitus,0
43,2,LETAIRIS,Hypersensitivity,0
80,2,LETAIRIS,Cough,0
,2,MIRENA,Genital haemorrhage,0
44,1,EPOPROSTENOL.,Muscle spasms,0
32,2,PARAGARD 380A,Device dislocation,0
68,2,REVATIO,Fatigue,0
63,2,LETAIRIS,Hypertension,0
,1,PROPECIA,Depression,0
51,2,LIPITOR,Type 2 diabetes mellitus,0
50,2,SPIRONOLACTONE.,Hypoaesthesia,0
58,1,LETAIRIS,Dyspnoea,0
50,2,LIPITOR,Renal failure,0
79,2,LETAIRIS,Cardiac disorder,0
72,2,LETAIRIS,Infection,0
,1,PROPECIA,Alcohol abuse,1
,2,LETAIRIS,Tooth infection,0
,0,LIPITOR,Type 2 diabetes mellitus,0
41,2,LETAIRIS,Oedema peripheral,0
,1,CLARITIN CHEWABLE TABLETS,Overdose,0
22,1,METRONIDAZOLE,Phlebitis,0
,2,LIPITOR,Type 2 diabetes mellitus,0
68,2,ADCIRCA,Chest discomfort,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,0,LIPITOR,Type 2 diabetes mellitus,0
44,2,HEPARIN,Respiratory depression,0
35,2,LETAIRIS,Abdominal distension,0
16,2,ORENCIA,Umbilical hernia,0
,,JAKAFI,Product availability issue,2
,0,LIPITOR,Type 2 diabetes mellitus,0
42,1,LETAIRIS,Dizziness,0
74,2,VELETRI,Death,1
,2,LIPITOR,Type 2 diabetes mellitus,0
4,1,CLARITIN CHEWABLE TABLETS,Overdose,0
66,2,LETAIRIS,Feeling hot,0
76,2,OPSUMIT,Death,0
55,2,CELEBREX,Arthropathy,0
47,2,ZOCOR,Type 2 diabetes mellitus,0
67,1,CISPLATIN,Hyperkalaemia,0
58,2,LETAIRIS,Atrial septal defect,0
48,2,CADUET,Type 2 diabetes mellitus,0
39,2,HUMIRA,Malaise,1
,2,BROMOCRIPTINE,Impulse-control disorder,0
70,2,MAINTATE,Death,0
21,2,HUMIRA,General physical health deterioration,1
,0,LIPITOR,Type 2 diabetes mellitus,0
70,2,CLARITH TAB,Pneumonia,1
67,2,EFFEXOR XR,Spinal disorder,1
53,2,BENICAR,Type 2 diabetes mellitus,0
,2,HUMIRA,Intestinal stenosis,1
65,2,PROAIR HFA,Fall,0
,2,COPAXONE,Influenza like illness,0
50,2,LIPITOR,Blindness,0
,2,PARAGARD 380A,Device expulsion,0
17,1,BUPROPION,Convulsion,1
54,2,HUMIRA,Joint swelling,0
,0,LIPITOR,Type 2 diabetes mellitus,0
76,1,ARA-C,Skin lesion,1
41,2,LETAIRIS,Oedema peripheral,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,ESTREVA,Meningioma,0
,2,TACROLIMUS,Posterior reversible encephalopathy syndrome,0
88,2,LETAIRIS,Vision blurred,0
,0,LIPITOR,Type 2 diabetes mellitus,0
17,2,MIRENA,Pelvic inflammatory disease,0
54,1,LETAIRIS,Oedema,0
21,2,MIRENA,Abdominal pain lower,0
46,,LIPITOR,Type 2 diabetes mellitus,0
47,1,ROCURONIUM BROMIDE,Epiglottic oedema,1
26,2,LETAIRIS,Anaemia,1
,2,JAKAFI,Blood glucose decreased,0
32,2,MIRENA,Uterine perforation,0
,0,LIPITOR,Type 2 diabetes mellitus,0
45,1,OXYCODONE,Chest pain,0
,1,JAKAFI,Hearing impaired,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
48,1,LETAIRIS,Nightmare,0
,1,JAKAFI,Splenomegaly,0
76,2,JAKAFI,Nasal congestion,0
,0,LIPITOR,Type 2 diabetes mellitus,0
94,,LETAIRIS,Oxygen saturation decreased,0
,1,JAKAFI,Pyrexia,0
13,2,CLOZAPINE,"Schizophrenia, undifferentiated type",1
,0,LIPITOR,Type 2 diabetes mellitus,0
69,2,LETAIRIS,Malaise,0
,,JAKAFI,Fatigue,0
,2,LIPITOR,Type 2 diabetes mellitus,0
56,2,LETAIRIS,Nasopharyngitis,0
60,1,MCP,Dyskinesia,0
,0,INTERFERON BETA,Breast cancer,0
46,2,TYVASO,Headache,0
72,2,LIPITOR,Type 2 diabetes mellitus,0
,1,SOVALDI,Death,0
54,2,LETAIRIS,Unevaluable event,0
,2,DIOVAN,Cataract,0
64,2,SIMVASTATIN.,Type 2 diabetes mellitus,0
78,2,LETAIRIS,Rash,0
60,2,BYSTOLIC,Faecal incontinence,1
60,2,ARAVA,Chronic obstructive pulmonary disease,1
,0,LIPITOR,Type 2 diabetes mellitus,0
56,2,LETAIRIS,Upper respiratory tract congestion,0
59,2,ONBREZ,Syringomyelia,0
,2,JAKAFI,Pyrexia,0
63,2,LASIX,Blood pressure decreased,0
70,1,JAKAFI,Blood alkaline phosphatase increased,0
,1,JAKAFI,Adverse drug reaction,0
80,2,LETAIRIS,Dizziness,0
,2,JAKAFI,Upper limb fracture,0
84,1,DULERA,Nasopharyngitis,0
80,1,JAKAFI,Local swelling,0
50,2,OXYCONTIN (NDA 22-272),Death,0
46,2,LETAIRIS,Dyspnoea,0
59,1,AMLODIPINE,Joint swelling,0
50,2,GILENYA,Multiple sclerosis relapse,1
,2,ONBREZ,Pulmonary oedema,0
,2,JAKAFI,Foot fracture,0
75,2,VORINOSTAT,Lower gastrointestinal haemorrhage,1
24,2,LETAIRIS,Peripheral swelling,0
,2,EXELON,Pancreatic carcinoma,0
65,1,JAKAFI,Spleen disorder,0
,1,AMBIEN,Sexual dysfunction,0
2,1,CLARITIN CHEWABLE TABLETS,Overdose,0
37,2,LETAIRIS,Pain in extremity,0
41,2,CORICIDIN HBP COLD AND FLU,Drug ineffective for unapproved indication,0
43,2,ENBREL,Arthralgia,0
,2,JAKAFI,Oropharyngeal pain,0
67,2,ALENDRONIC ACID,Osteonecrosis,0
63,2,LETAIRIS,Pruritus,0
4,2,CLARITIN CHEWABLE TABLETS,Overdose,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
57,1,LANSOPRAZOLE,Chest pain,1
50,2,LETAIRIS,Headache,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
35,2,HALDOL,Uterine cyst,1
34,2,ZOLEDRONATE,Hypersensitivity,1
32,2,LETAIRIS,Body temperature,0
3,1,CLARITIN CHEWABLE TABLETS,Overdose,0
65,2,LETAIRIS,Abdominal pain upper,0
3,2,CLARITIN CHEWABLE TABLETS,Overdose,0
,2,MULTIHANCE,Cardiac arrest,1
53,2,LETAIRIS,Dyspnoea,0
66,2,POMALYST,Plasma cell myeloma,0
85,2,OMNIPAQUE,Acute generalised exanthematous pustulosis,1
20,2,ENBREL,Injection site reaction,0
62,2,LETAIRIS,Peripheral swelling,0
88,2,ALENDRONIC ACID,Osteonecrosis,0
,1,TOBI,Infective pulmonary exacerbation of cystic fibrosis,1
76,2,LETAIRIS,Insomnia,0
,1,SPIRIVA,Lung neoplasm malignant,1
,1,EXFORGE HCT,Diabetes mellitus inadequate control,0
69,1,LETAIRIS,Peripheral swelling,0
,2,PRADAXA,Splenic haemorrhage,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
85,1,PROCRIT,Death,0
,0,ONFI,Infection,0
,2,CLARITIN CHEWABLE TABLETS,Overdose,0
85,2,L-THYROXINE                        /00068001/,Circulatory collapse,1
,2,DIAZEPAM ACTAVIS,Drug ineffective,0
,2,CLOZARIL,Breast cancer metastatic,1
54,2,AMLODIPINE,Bromhidrosis,0
65,2,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Muscle spasms,0
,1,ONFI,Convulsion,0
,0,DIANEAL LOW CALCIUM,Procedural pain,0
54,1,K-DUR,Cardio-respiratory arrest,1
62,2,CLOZARIL,Psychiatric symptom,0
,1,DIANEAL LOW CALCIUM,Death,1
60,1,OXYCONTIN (NDA 22-272),Death,0
,2,LETAIRIS,Upper respiratory tract infection,1
,2,NEXPLANON,Arthropathy,0
74,1,NEXAVAR,Diabetes mellitus,1
72,1,SPIRIVA,Gallbladder disorder,1
,2,DIANEAL LOW CALCIUM,Dehydration,0
,1,LETAIRIS,Dyspnoea exertional,0
,0,SORAFENIB (RAF KINASE INHIBITOR),Anaemia,0
,1,PRADAXA,Upper gastrointestinal haemorrhage,1
,2,TISSEEL VH S/D,Adhesion,0
,1,DIANEAL PD2,Fluid overload,0
48,2,LETAIRIS,Cough,0
,2,SPIRIVA,Blindness,0
84,2,DULCOGAS WILD BERRY,Device colour issue,0
84,2,SPIRIVA,Chronic obstructive pulmonary disease,1
,2,LETAIRIS,Unevaluable event,0
65,1,XELODA,Diarrhoea,0
,0,ENDOXAN-1G,Hypokalaemia,0
,2,PRADAXA,Lower gastrointestinal haemorrhage,1
,2,REBIF,Tremor,0
58,1,LETAIRIS,Exercise tolerance decreased,0
49,1,LETAIRIS,Ankle fracture,0
72,2,SPIRIVA,Off label use,0
,2,NEULASTA,Cardio-respiratory arrest,0
,2,CLARITIN CHEWABLE TABLETS,Accidental exposure to product by child,0
83,2,LETAIRIS,Hypotension,0
57,2,SPIRIVA,Incorrect route of drug administration,0
56,2,TEMODAL,Drug eruption,1
,2,REVLIMID,Death,0
,1,LETAIRIS,Death,0
,0,MORPHINE,Drug withdrawal syndrome neonatal,0
54,1,CIMZIA,Lung disorder,1
6,1,CLARITIN CHEWABLE TABLETS,Overdose,0
30,1,CLARITHROMYCIN (UNKNOWN),Diarrhoea,0
70,1,OMNISCAN,Nephrogenic systemic fibrosis,0
,2,DIANEAL LOW CALCIUM,Fluid retention,0
68,2,NICOTROL INHALER,Pneumonia,1
42,1,NICORETTE QUICKMIST,Tongue blistering,1
64,,LETAIRIS,Dizziness,0
69,1,LEFLUNOMIDE,B-cell lymphoma,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
72,1,LETAIRIS,Flushing,0
,2,PARAGARD 380A,Medical device complication,0
86,2,ACLASTA,Fall,1
77,1,GLYBURIDE.,Syncope,0
38,2,ISENTRESS,Maternal exposure during pregnancy,0
,2,XGEVA,Osteonecrosis of jaw,0
70,2,LETAIRIS,Unevaluable event,0
38,2,XOLAIR,Asthma,1
5,2,CLARITIN CHEWABLE TABLETS,Overdose,0
50,2,ZANTAC (RANITIDINE HYDROCHLORIDE),Somnolence,0
60,2,LETAIRIS,Oedema,1
77,2,PROTAPHANE,Septic shock,0
91,2,OXYTROL FOR WOMEN,Drug ineffective,0
,1,PRADAXA,Upper gastrointestinal haemorrhage,1
,1,TRILEPTAL,Generalised tonic-clonic seizure,0
24,2,LETAIRIS,Dyspnoea,0
38,2,XOLAIR,Myalgia,0
12,1,CLARITIN CHEWABLE TABLETS,Overdose,0
,1,CLOZARIL,Glaucoma,0
84,2,LETAIRIS,Blood count abnormal,0
,0,XGEVA,Osteonecrosis of jaw,0
,0,LEVETIRACETAM,Death,0
73,1,TRACLEER,Death,0
,0,CASODEX,Dermatitis,0
74,2,LETAIRIS,Blood count abnormal,0
22,2,NEXPLANON,Haemorrhage,0
,0,CERTICAN,Abdominal wound dehiscence,1
83,2,LETAIRIS,Pleural effusion,0
,0,IBUPROFEN,Gastrointestinal disorder,0
5,1,ONFI,Myoclonus,0
74,2,LETAIRIS,Dehydration,0
27,1,PARACETAMOL,Drug-induced liver injury,0
,1,PEGINTRON,Circumstance or information capable of leading to medication error,0
68,2,RANITIDINE,Dyspnoea,0
48,2,AVASTIN,Pain,0
,2,HUMIRA,Varicose vein,1
72,2,HERCEPTIN,Cardiac disorder,1
,1,ABSORICA,Depression,0
,0,FENTANYL TRANSDERMAL SYSTEM,Death,0
78,2,ONBREZ,Tremor,0
74,1,NPLATE,Investigation,1
54,2,NEULASTA,Investigation,1
47,1,REBIF,Colon cancer,0
62,2,HUMIRA,Heart rate increased,1
20,2,MABTHERA,Proteinuria,1
,1,HUMIRA,Cardiac murmur,0
56,0,TRASTUZUMAB,Fatigue,0
55,2,SUBOXONE FILM,Wrong technique in drug usage process,0
81,2,ARANESP,Investigation,1
,2,PREDNISOLONE,Breast cancer,0
24,2,BUPRENORPHINE GENERIC,Maternal exposure during pregnancy,0
,1,AVONEX,Concussion,0
43,1,CITALOPRAM,Concussion,0
,2,AVONEX,Hepatic enzyme increased,0
77,2,XELODA,Death,0
,2,SUBOXONE UNSPECIFIED,Terminal state,0
56,1,AVONEX,Pain,0
59,1,ARANESP,Investigation,1
52,2,AVONEX,Drug administered at inappropriate site,0
40,2,AVONEX,Fear of injection,0
,2,AVONEX,Cognitive disorder,0
65,2,AVONEX,Stress,0
60,2,AVONEX,Multiple sclerosis relapse,1
60,2,AVONEX,Morton^s neuralgia,0
,2,AVONEX,Memory impairment,0
41,2,AVONEX,Stress,0
45,2,AVONEX,Malaise,0
47,2,AVONEX,Hypotonia,0
,2,AVONEX,Hearing impaired,0
,2,AVONEX,Fear of injection,0
,0,AVONEX,Hypertension,0
66,1,AVONEX,Underdose,0
21,2,AVONEX,Adverse event,0
,2,AVONEX,Cognitive disorder,0
60,2,AVONEX,Blood pressure increased,0
,1,AVONEX,Vitamin D decreased,0
,2,AVONEX,Screaming,0
,2,AVONEX,Stress,0
,2,AVONEX,Multiple allergies,0
58,2,AVONEX,Back pain,0
,2,AVONEX,Liver disorder,0
40,2,PROZAC,Adverse event,0
,1,ACLIDINIUM,Death,0
35,0,TRUVADA,Drug interaction,0
,2,AVONEX,Injection site haemorrhage,0
,2,AVONEX,Memory impairment,0
34,1,LETAIRIS,Cardiac arrest,0
68,2,OMEPRAZOLE.,Lower respiratory tract infection,1
86,0,ENBREL,Death,0
,1,VERAPAMIL,Cardiogenic shock,1
71,1,TASIGNA,Respiratory failure,1
28,2,SUBOXONE FILM,Gallbladder disorder,1
66,2,ARANESP,Investigation,1
,1,CASODEX,Eczema,0
40,1,SUBOXONE FILM,Intentional underdose,1
51,2,XOLAIR,Vomiting,1
55,1,PROGRAF,Congestive cardiomyopathy,1
,1,BICALUTAMIDE,Muscle twitching,0
61,1,BUPRENORPHINE/NALOXONE GENERIC,Insomnia,1
74,2,ARANESP,Investigation,1
41,2,AVASTIN,Malignant neoplasm progression,1
,0,GILOTRIF,Stomatitis,0
66,2,ARANESP,Death,0
,2,MABTHERA,Cardiac arrest,0
54,2,AVASTIN,Sepsis,0
71,1,ARANESP,Death,1
71,1,ZOMETA,Cyst,1
64,2,ENBREL,Leukaemia,0
,2,SINGULAIR,Respiratory disorder,1
59,1,FTY 720,Basal cell carcinoma,0
,1,ENBREL,Knee arthroplasty,0
70,1,NEULASTA,Investigation,1
19,1,AMOXICILLIN + CLAVULANIC ACID,Bone marrow failure,1
68,2,PROCRIT,Death,0
,1,LUCENTIS,Localised infection,1
,,HUMALOG,Foetal exposure during pregnancy,0
95,2,PROLIA,Death,0
45,1,NEULASTA,Investigation,1
31,2,SERTRALINE,Shared psychotic disorder,0
,0,VIVITROL,Pain,1
,2,ENBREL,Haemorrhage,0
55,2,DENOSUMAB,Wound infection,1
82,2,ARANESP,Cardiac disorder,1
,1,CIALIS,Visual acuity reduced,0
48,2,XELODA,Eating disorder,1
55,1,PEGASYS,Hepatitis C,0
76,1,XGEVA,Death,0
41,2,VIGANTOL,Pregnancy,0
61,2,AVONEX,Epilepsy,1
62,1,AVONEX,Myocardial infarction,1
,2,AVONEX,Apparent death,1
48,2,AVONEX,Gait disturbance,1
,1,AVONEX,Heart valve operation,1
70,2,AVONEX,Musculoskeletal disorder,1
57,1,AVONEX,Pneumonia,1
50,1,AVONEX,Erysipelas,1
63,2,AVONEX,Knee arthroplasty,1
44,2,AVONEX,Pneumonia,1
77,2,FORTEO,Acute myeloid leukaemia,0
51,2,AVONEX,Intervertebral disc degeneration,1
55,2,AVONEX,Gait disturbance,1
74,2,NEULASTA,Investigation,1
45,1,PARACETAMOL,Drug-induced liver injury,1
,2,ACTEMRA,Larynx irritation,1
59,1,VIRAFERONPEG,Transfusion,0
47,2,AMOXICILLIN,Jaundice cholestatic,1
52,2,"HUMALOG 50% LISPRO, 50% NPL",Renal disorder,0
61,2,ABILIFY,Death,0
59,2,TOPIRAMATE,Weight decreased,1
42,2,HUMALOG LISPRO,Blood glucose increased,0
,2,XOLAIR,Malaise,0
46,1,COPEGUS,Drug interaction,0
63,1,NEULASTA,Investigation,1
59,2,ATORVASTATIN,Dysgeusia,0
51,2,XELODA,Dyspnoea,0
,2,FORTEO,Arthralgia,0
80,2,ERIVEDGE,Cough,0
53,1,COPEGUS,Drug interaction,0
54,1,ENBREL,Hip arthroplasty,0
17,2,NEXPLANON,Skin infection,0
,2,NEXPLANON,Depression,0
26,2,OMNISCAN,Nephrogenic systemic fibrosis,0
49,2,ENBREL,Arthropathy,1
,2,COSOPT,Eye irritation,0
68,1,LUCENTIS,Myocardial infarction,0
69,2,HERCEPTIN,Febrile neutropenia,0
,2,XOLAIR,Asthma,1
,2,BONIVA,Thrombosis,0
75,2,ENBREL,Death,0
,2,EMEND,Dysphagia,0
70,2,ENBREL,Lower limb fracture,1
41,2,NEULASTA,Investigation,1
,1,TYSABRI,Lung neoplasm malignant,0
52,2,TYSABRI,Oligodendroglioma,1
66,2,TYSABRI,Quadriparesis,1
38,2,TYSABRI,Adverse drug reaction,1
53,2,VITAMIN D2,Bone disorder,1
55,2,LEFLUNOMIDE.,Weight increased,0
65,2,PANTOPRAZOLE,Anti-neutrophil cytoplasmic antibody positive vasculitis,1
,2,TRUVADA,Ankyloglossia congenital,0
69,1,AVASTIN,Haemorrhage,1
77,2,VECTIBIX,Spinal cord compression,0
62,1,PANTOPRAZOL,Colon adenoma,0
,,FENTANYL CITRATE.,Death,0
76,1,NAPROXEN,Upper gastrointestinal haemorrhage,1
78,1,ARANESP,Investigation,1
58,2,ORENCIA,Impaired healing,0
31,2,MIRTAZAPINE,Shared psychotic disorder,0
,1,PRIVIGEN,Aggression,0
,2,HERCEPTIN,Paraesthesia,1
57,2,XGEVA,Jaw disorder,1
,2,RITUXIMAB,Vasculitis,1
70,1,NEULASTA,Hospitalisation,1
,2,HIZENTRA,Subcutaneous abscess,0
17,2,IMPLANON,Menstruation irregular,0
42,1,TECFIDERA,Angioedema,0
59,1,TECFIDERA,Small intestinal haemorrhage,0
54,2,TECFIDERA,Hip fracture,0
81,2,NPLATE,Platelet count decreased,0
73,2,SENSIPAR,Death,0
61,2,VERAPAMIL,Overdose,1
,2,ENBREL,Paraspinal abscess,1
,2,DULERA,Dysphonia,0
63,2,RITUXIMAB,Femoral neck fracture,1
50,2,ENBREL,Gallbladder disorder,0
29,1,PARACETAMOL,Bradykinesia,1
49,2,XOLAIR,Dyspnoea,1
,1,ACTEMRA,Blood potassium decreased,1
,2,ACTEMRA,Pain in extremity,0
48,2,ENBREL,Peptic ulcer,0
67,2,ACTEMRA,Blood potassium decreased,1
16,1,TECFIDERA,Off label use,0
39,2,TECFIDERA,Overdose,0
65,2,ARANESP,Investigation,1
64,2,ENBREL,Knee arthroplasty,1
,1,LUCENTIS,Dysphagia,0
78,2,NEULASTA,Hospitalisation,1
75,2,ENBREL,Pneumothorax,1
48,2,TECFIDERA,Nasopharyngitis,0
82,2,PROLIA,Death,0
69,2,NEULASTA,Investigation,1
85,2,ARANESP,Investigation,1
43,1,TECFIDERA,Influenza like illness,0
70,2,ENBREL,Diarrhoea,0
41,2,TECFIDERA,Paraesthesia,0
,2,TECFIDERA,Gastric disorder,0
43,1,TECFIDERA,Hyperhidrosis,0
,2,TECFIDERA,Urinary tract infection,0
,2,TECFIDERA,Gastric disorder,0
,1,AVASTIN,Metastases to lymph nodes,0
43,2,TECFIDERA,Sinus headache,0
64,2,TECFIDERA,Paraesthesia,0
,2,TECFIDERA,Fatigue,0
65,2,TECFIDERA,Adverse event,0
,2,TECFIDERA,Gastric disorder,0
35,1,TECFIDERA,Balance disorder,0
82,1,RANIBIZUMAB,Urinary retention,1
37,1,TECFIDERA,Chest pain,0
57,2,TECFIDERA,Defaecation urgency,0
32,2,TECFIDERA,Viral infection,0
51,1,TECFIDERA,Gait disturbance,0
,0,TECFIDERA,Irritability,0
53,2,TECFIDERA,Anxiety,0
,2,TECFIDERA,Enterocolitis bacterial,0
69,2,TECFIDERA,Gastrooesophageal reflux disease,0
,2,TECFIDERA,Headache,0
58,2,TECFIDERA,Dizziness,0
42,2,TECFIDERA,Fatigue,0
37,2,TECFIDERA,Nasopharyngitis,0
42,2,RITUXIMAB,Central nervous system lesion,0
,2,TECFIDERA,Muscular weakness,0
42,2,TECFIDERA,Fatigue,0
35,2,TECFIDERA,Hernia,0
,2,TECFIDERA,Cardiac disorder,0
43,2,TECFIDERA,Headache,0
57,2,TECFIDERA,Gastric disorder,0
66,2,TECFIDERA,Gastrooesophageal reflux disease,0
,2,TECFIDERA,Dehydration,0
41,1,TECFIDERA,Fatigue,0
52,2,TECFIDERA,Ear discomfort,0
35,2,TECFIDERA,Orthostatic hypotension,0
61,2,NEULASTA,Hospitalisation,1
55,2,TECFIDERA,Fatigue,0
,1,TECFIDERA,Fatigue,0
,2,TECFIDERA,Pain of skin,0
54,2,TECFIDERA,Drug ineffective,0
37,1,TECFIDERA,Nasopharyngitis,0
,2,TECFIDERA,Insomnia,0
48,2,TECFIDERA,Rhinorrhoea,0
16,2,NEXPLANON,Implant site pain,0
49,2,TECFIDERA,Urinary tract infection,0
72,2,TECFIDERA,Intentional drug misuse,0
,2,TECFIDERA,Nasopharyngitis,0
,2,TECFIDERA,Alanine aminotransferase,0
39,2,TECFIDERA,Otitis media,0
46,2,TECFIDERA,Overdose,0
53,2,TECFIDERA,Upper respiratory tract congestion,0
,2,TECFIDERA,Urticaria,0
47,2,TECFIDERA,Pneumonia,0
,2,TECFIDERA,Fear,0
,1,TECFIDERA,Memory impairment,0
46,2,TECFIDERA,Headache,0
37,2,TECFIDERA,Feeling abnormal,0
,2,TECFIDERA,Memory impairment,0
60,1,TECFIDERA,Paraesthesia,0
55,2,TECFIDERA,Muscular weakness,0
29,2,TECFIDERA,Sneezing,0
,2,TECFIDERA,Prescribed underdose,0
,2,NEXPLANON,Implant site pruritus,0
50,2,TECFIDERA,Myalgia,0
43,2,TECFIDERA,Chest pain,0
,2,TECFIDERA,Visual impairment,0
41,2,TECFIDERA,Chills,0
46,2,TECFIDERA,Fatigue,0
32,2,TECFIDERA,Dizziness,0
50,2,TECFIDERA,Extra dose administered,0
,2,LUCENTIS,Bronchopneumonia,1
32,2,TECFIDERA,Oropharyngeal pain,0
,2,TECFIDERA,Influenza,0
,2,TECFIDERA,H1N1 influenza,0
43,2,TECFIDERA,Agitation,0
63,2,TECFIDERA,Fatigue,0
68,2,TECFIDERA,Headache,0
34,2,TECFIDERA,Intentional underdose,0
48,2,TECFIDERA,Pain in extremity,0
34,2,TECFIDERA,Visual impairment,0
38,2,TECFIDERA,Influenza like illness,0
48,2,TECFIDERA,Weight increased,0
44,2,TECFIDERA,Headache,0
43,2,TECFIDERA,Muscle spasms,0
55,2,TECFIDERA,Dehydration,0
,0,NEULASTA,Death,0
77,2,TECFIDERA,Neuropathy peripheral,0
51,2,TECFIDERA,Constipation,0
60,2,TECFIDERA,Muscular weakness,0
59,2,TECFIDERA,Paraesthesia,0
47,2,TECFIDERA,Rosacea,0
73,1,MABTHERA,Hemiplegia,1
49,1,TECFIDERA,Tooth infection,0
53,2,TECFIDERA,Asthenia,0
55,1,TECFIDERA,Chills,0
57,1,TECFIDERA,Headache,0
58,1,TECFIDERA,Musculoskeletal stiffness,0
,1,TECFIDERA,Paraesthesia,0
63,2,TECFIDERA,Intentional drug misuse,0
24,2,TECFIDERA,Headache,0
50,2,TECFIDERA,Dizziness,0
,2,TECFIDERA,Hyperhidrosis,0
68,1,TECFIDERA,Headache,0
,2,ACTEMRA,Breast mass,0
62,1,TECFIDERA,Drug ineffective,0
54,2,TECFIDERA,Gait disturbance,0
60,2,TECFIDERA,Neutropenia,0
42,2,TECFIDERA,Prescribed underdose,0
29,2,TECFIDERA,Intentional underdose,0
62,2,TECFIDERA,Dizziness,0
71,2,TECFIDERA,Off label use,0
50,2,TECFIDERA,Foot operation,0
,1,TECFIDERA,Fatigue,0
42,2,TECFIDERA,Ear infection,0
58,1,TECFIDERA,Muscle spasms,0
65,1,AVONEX,Fatigue,0
43,2,TECFIDERA,Insomnia,0
43,1,TECFIDERA,Cystitis,0
51,2,TECFIDERA,Dizziness,0
35,2,TECFIDERA,Muscle spasms,0
,2,PEGASYS,White blood cell count decreased,0
44,2,TECFIDERA,Mobility decreased,0
,2,TECFIDERA,Adverse event,0
24,2,TECFIDERA,Headache,0
,2,TYSABRI,Multiple sclerosis relapse,1
46,2,TECFIDERA,Mobility decreased,0
,2,TECFIDERA,Coordination abnormal,0
29,2,TYSABRI,Hand-foot-and-mouth disease,0
66,2,TECFIDERA,Gastric disorder,0
,2,TYSABRI,Confusional state,0
61,2,TECFIDERA,Dyspnoea,0
,2,TYSABRI,Peroneal nerve palsy,0
47,1,TECFIDERA,Paraesthesia,0
28,1,TYSABRI,Nasopharyngitis,0
39,2,TECFIDERA,Influenza,0
49,2,TYSABRI,Frustration,0
56,2,TYSABRI,Pain,0
55,1,TECFIDERA,Dyspnoea,0
34,2,TYSABRI,Cough,0
48,2,TECFIDERA,Chest pain,0
44,2,TYSABRI,Malaise,0
55,2,TECFIDERA,Infection,0
,2,TYSABRI,Memory impairment,0
55,2,TECFIDERA,Multiple sclerosis,0
,2,TYSABRI,Intervertebral disc protrusion,0
52,1,TYSABRI,Multiple sclerosis relapse,0
,0,TECFIDERA,Alopecia,0
,1,TYSABRI,Tinnitus,0
48,2,TYSABRI,Headache,0
,2,TECFIDERA,Muscle spasms,0
,2,TYSABRI,Confusional state,0
41,1,TECFIDERA,Abdominal distension,0
53,2,TYSABRI,Anxiety,0
40,2,TECFIDERA,Urticaria,0
43,2,TYSABRI,Hypersensitivity,0
63,2,TECFIDERA,Muscle spasms,0
38,2,TYSABRI,Malaise,0
54,1,TYSABRI,Malaise,0
,2,TECFIDERA,Cough,0
64,2,TYSABRI,Multiple sclerosis relapse,0
,2,TYSABRI,Drug ineffective,0
56,1,TECFIDERA,Dysgeusia,0
,2,TYSABRI,Cognitive disorder,0
40,2,TECFIDERA,Visual impairment,0
,2,TYSABRI,Memory impairment,0
,2,TECFIDERA,Depression,0
28,1,TYSABRI,Pain,0
43,2,TECFIDERA,Dysgeusia,0
63,2,TYSABRI,Respiratory disorder,0
56,2,TECFIDERA,Anxiety,0
,1,TECFIDERA,Affect lability,0
,1,TYSABRI,Optic nerve disorder,0
54,2,TECFIDERA,Headache,0
,2,TYSABRI,Headache,0
25,2,TECFIDERA,Paraesthesia,0
34,2,TYSABRI,Respiratory tract infection,0
52,2,TECFIDERA,Headache,0
61,2,TYSABRI,Gait disturbance,0
49,2,TYSABRI,Abdominal pain,0
,1,TECFIDERA,Drug ineffective,0
29,1,TYSABRI,Asthenia,0
,2,TECFIDERA,Weight decreased,0
,2,TYSABRI,Urinary tract infection,0
48,2,TECFIDERA,Influenza like illness,0
36,2,TYSABRI,Vertigo,0
,2,TYSABRI,Confusional state,0
43,2,TECFIDERA,Muscular weakness,0
,2,TYSABRI,Fatigue,0
72,2,TECFIDERA,Influenza,0
,2,TYSABRI,Depression,0
,2,TECFIDERA,Adverse event,0
46,2,TYSABRI,Fatigue,0
,1,TYSABRI,Paraesthesia,0
68,1,ALTEPLASE,Cerebral haemorrhage,0
,2,TYSABRI,Cough,0
,2,TECFIDERA,Musculoskeletal pain,0
65,2,TYSABRI,Primary progressive multiple sclerosis,0
52,2,TECFIDERA,Urticaria,0
36,1,TYSABRI,Fatigue,0
51,1,TECFIDERA,Rhinorrhoea,0
71,2,TECFIDERA,Constipation,0
39,2,TECFIDERA,Depression,0
38,2,TECFIDERA,Dizziness,0
,2,TECFIDERA,Depression,0
,2,TECFIDERA,Depression,0
25,2,TECFIDERA,Dehydration,0
52,2,TECFIDERA,Fatigue,0
61,2,TECFIDERA,Alopecia,0
46,2,TECFIDERA,Joint swelling,0
32,2,TECFIDERA,Urticaria,0
,1,TECFIDERA,Genital rash,0
,1,TECFIDERA,Cognitive disorder,0
32,2,TECFIDERA,Headache,0
66,2,TECFIDERA,Reynold^s syndrome,0
52,2,TECFIDERA,Hyperhidrosis,0
49,2,TECFIDERA,Dysgeusia,0
,2,TECFIDERA,Herpes zoster,0
49,2,HERCEPTIN,Febrile neutropenia,0
45,2,AMOXICILLIN + CLAVULANIC ACID,Toxic epidermal necrolysis,0
,2,TECFIDERA,Emotional disorder,0
26,2,TECFIDERA,Blood pressure increased,0
,2,TECFIDERA,Alopecia,0
55,2,TECFIDERA,Paraesthesia,0
,1,TECFIDERA,Fatigue,0
55,2,TECFIDERA,Gastrooesophageal reflux disease,0
39,2,TECFIDERA,Weight increased,0
39,2,TECFIDERA,Influenza,0
55,2,TECFIDERA,Diplopia,0
66,2,TECFIDERA,Adverse event,0
65,2,TECFIDERA,Constipation,0
67,2,TECFIDERA,Alopecia,0
71,2,TECFIDERA,Alopecia,0
,2,TECFIDERA,Fatigue,0
,2,NPLATE,Therapeutic response decreased,0
29,1,TECFIDERA,Intentional underdose,0
63,1,SIMVASTATIN,Lichen planus,0
84,1,NPLATE,Investigation,1
31,1,ENBREL,Decreased immune responsiveness,0
43,2,NEULASTA,Investigation,1
59,2,ENBREL,Diabetes mellitus,0
39,1,NEULASTA,Investigation,1
65,2,ATORVASTATIN,Asthma,0
53,1,XGEVA,Investigation,1
78,2,SPRYCEL,Yellow skin,0
69,2,CETIRIZINE,Urinary incontinence,0
67,1,NPLATE,Death,1
63,1,XELODA,Disease progression,0
71,1,NEULASTA,Investigation,1
59,1,SIMVASTATIN,Cough,0
70,1,ARANESP,Investigation,1
51,1,ENBREL,Iritis,0
75,1,XGEVA,Death,1
49,2,XELODA,Vomiting,0
77,1,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,Haemoglobin decreased,0
,2,RANIBIZUMAB,Lung neoplasm malignant,1
,2,CODEINE SULFATE,Nausea,0
38,2,XGEVA,Death,0
,1,COMTAN,Chromaturia,1
84,2,ARANESP,Investigation,1
43,2,ENBREL,Fall,0
63,1,NEULASTA,Investigation,1
22,2,PARACETAMOL,Abdominal pain,1
65,1,ATORVASTATIN,Urticaria,0
66,2,OLANZAPINE,Sepsis,1
75,2,NACOM 100 MG/25 MG TABLETTEN,Loss of consciousness,1
63,2,AMLODIPINE,Cough,0
79,1,XELODA,Disease progression,0
38,2,IVIG,Coronary artery thrombosis,0
,2,PRADAXA,Increased appetite,0
72,2,ENBREL,Angioedema,0
39,2,NEULASTA,Intestinal operation,1
,2,NEXPLANON,Headache,0
63,1,ACTEMRA,Pneumocystis jirovecii pneumonia,1
70,1,SIMVASTATIN,Gastrointestinal motility disorder,1
54,1,ENBREL,Death,0
58,1,CIMZIA,Pleurisy,1
29,2,NEULASTA,Investigation,1
69,2,NEULASTA,Leukoencephalopathy,0
77,1,ZOLADEX,Interstitial lung disease,1
82,0,METHOTREXATE,Death,1
,1,THALIDOMIDE,Cardiac failure,0
,1,GAZYVA,Pneumonia,0
39,2,IMPLANON,Device deployment issue,0
51,0,PROLIA,Retinal vein occlusion,1
62,2,FLUOROURACIL,Infusion related reaction,1
,2,ACTEMRA,Acute coronary syndrome,0
83,2,ARANESP,Investigation,1
4,1,HIZENTRA,Pseudocroup,0
3,1,VISINE ORIGINAL,Accidental exposure to product by child,1
,2,TAKE ACTION,Vomiting,0
75,1,FLUOROURACIL,Chest pain,1
41,2,ENBREL,Headache,1
74,0,ENBREL,Death,0
21,1,MIRTAZAPINE,Altered state of consciousness,0
78,2,ENBREL,Lung neoplasm malignant,0
80,2,SPIRIVA,Dyspnoea,0
54,1,CIPROFLOXACIN,Cardiac arrest,0
51,1,ENBREL,Rheumatoid arthritis,0
56,1,AMIODARONE,Drug-induced liver injury,1
,2,NICOTINE GUM,Diabetes mellitus,0
22,1,AMOXICILLIN/CLAVULANIC ACID,Drug-induced liver injury,1
39,2,IVIG,Infarction,0
85,2,ERIVEDGE,Presyncope,0
48,2,NEULASTA,Investigation,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
59,1,PARACETAMOL,Drug-induced liver injury,0
61,2,NEULASTA,Death,0
59,2,NEULASTA,Investigation,1
,2,IMPLANON,Device difficult to use,0
40,2,NEULASTA,Cough,1
85,2,ABATACEPT SUBQ INJECTION 125MG/ML,Fall,1
35,2,YAZ,Deep vein thrombosis,0
54,2,VINORELBINE,Disease progression,0
,2,ORENCIA,Toxicity to various agents,0
38,2,YAZ,Pulmonary embolism,1
67,2,ENBREL,Local swelling,1
51,1,IRINOTECAN,Ascites,1
58,2,ERIVEDGE,Headache,0
,2,NEXPLANON,Device breakage,0
26,2,NEXPLANON,Device expulsion,0
41,1,ALLOPURINOL,Intentional overdose,0
31,2,ACETAMINOPHEN,Drug-induced liver injury,1
71,2,LUNESTA,Breast cancer,0
,2,GONAL-F,Mood altered,0
69,1,NOVONORM,Intervertebral disc degeneration,1
,2,GONAL-F,Mood altered,0
54,1,CRESTOR,Cardiac arrest,1
,2,FORTEO,Compression fracture,1
,2,CLARAVIS,Mood altered,0
81,2,FORTEO,Pneumonia,1
,2,FORTEO,Pancreatic carcinoma,0
,1,HUMALOG,Visual acuity reduced,1
20,2,ENBREL,Loss of consciousness,0
,2,FOSAMAX,Blood parathyroid hormone increased,0
72,2,RANMARK,Hyperglycaemia,1
21,2,QUETIAPINE,Depression,1
69,1,OXALIPLATIN,Angina pectoris,1
,0,VYVANSE,Off label use,0
,2,SOLIRIS,Fatigue,1
0,2,REMICADE,Low birth weight baby,1
27,2,REMICADE,Premature labour,1
,0,DURAGESIC MATRIX,Investigation,1
56,1,FENTANYL TRANDERMAL SYSTEM,Oesophageal carcinoma,1
25,2,SYNTHROID,Anxiety,1
,1,DULERA,Obstructive airways disorder,0
68,1,NEULASTA,Investigation,1
52,2,VICTOZA,Drug interaction,1
,0,NEUPOGEN,Anaphylactic reaction,0
66,1,NEULASTA,Investigation,1
82,1,DENOSINE,Blood glucose decreased,0
44,1,NEXIUM,Pain,1
68,1,SANDOSTATIN LAR,Terminal state,0
17,1,ZENATANE,Mood swings,0
,2,GONAL-F,Mood altered,0
73,2,AVASTIN,Atrial flutter,0
68,2,NEULASTA,Investigation,1
,2,EVISTA,Breast cancer female,0
69,1,SANDOSTATIN LAR DEPOT,Death,1
,1,INTRAVENOUS IMMUNOGLOBULIN,Anaphylactic reaction,0
66,2,MORPHINE,Abdominal discomfort,0
67,1,INTRAVENOUS HUMAN IMMUNOGLOBULIN,Neurological decompensation,0
76,1,HUMALOG LISPRO,Atypical pneumonia,0
47,2,PLAQUENIL,Urinary tract infection,1
77,2,CARBOPLATIN SUN 10 MG/ML KONZENTRAT ZUR HERSTELLUNG EINER INFUSIONSL?G,Anaphylactic shock,0
,0,BRILINTA,Coronary artery restenosis,0
52,2,CIMZIA,Appendicitis,1
66,2,METHOTREXATE,Rectal abscess,0
,0,DIVALPROEX SODIUM DELAYED RELEASE CAPSULES (SPRINKLES),Oedema peripheral,0
11,1,DIVALPROEX SODIUM DELAYED RELEASE CAPSULES (SPRINKLES),Generalised oedema,0
,1,DIVALPROEX SODIUM DELAYED RELEASE CAPSULES (SPRINKLES ),Withdrawal syndrome,0
52,2,DIVALPROEX SODIUM DELAYED RELEASE CAPSULES 125 MG (SPRINKLES) (VALPROATE SEMISODIUM),Weight increased,0
78,2,LISINOPRIL,Dermatitis bullous,0
23,2,NUVARING,Abortion induced,0
65,1,BRILINTA,Haemoglobin decreased,0
54,2,CIMZIA,Arthritis bacterial,1
,,REVLIMID,Hepatorenal syndrome,1
76,2,CERTOLIZUMAB PEGOL RA,Interstitial lung disease,1
60,1,CODEINE SULFATE,Anxiety,0
22,2,VALACYCLOVIR,Drug-induced liver injury,0
,2,GONAL-F,Mood altered,0
,0,LEVETIRACETAM,Respiratory failure,0
69,2,NILOTINIB,Cerebrovascular accident,0
,1,ZYTIGA,Liver function test abnormal,0
32,1,INVOKANA,Diabetic ketoacidosis,1
77,1,EXELON PATCH,Cerebrovascular accident,1
65,2,PARACETAMOL,Sensory disturbance,0
53,2,CLOZARIL,Agranulocytosis,1
37,1,KOGENATE FS,Cholecystectomy,1
64,2,DONEPEZIL/DONEPEZIL HYDROCHLORIDE,Vomiting,0
74,2,XELODA,Gingival swelling,0
81,2,SOTALOL,Malaise,0
62,1,HUMALOG LISPRO,Incorrect dose administered,1
,1,CLOZARIL,Overdose,1
53,2,HALDOL,Rhabdomyolysis,0
28,2,HALDOL,Self injurious behaviour,0
44,2,FABRAZYME,Urinary tract infection,0
48,2,PACLITAXEL/PACLITAXEL LIPOSOME,Hypersensitivity,0
76,2,RANIBIZUMAB,Cerebrovascular accident,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,HUMIRA,Osteoarthritis,1
,2,SOLIRIS,Mineral supplementation,0
17,2,YAZ,Asthenia,0
,0,NPLATE,Platelet count abnormal,0
36,2,ITRACONAZOLE,Anaphylactic shock,1
,0,VELCADE,Gastrointestinal disorder,0
,2,PEGINTRON,Pain,0
51,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,0,VELCADE,Palmar-plantar erythrodysaesthesia syndrome,1
80,2,LUCENTIS,Endophthalmitis,0
55,2,HERCEPTIN,Ventricular hypokinesia,0
66,2,NILOTINIB,Coronary artery disease,1
31,1,TASIGNA,Lower respiratory tract infection,0
71,2,CAELYX,Paraneoplastic dermatomyositis,0
,2,DOXIL (DOXORUBICIN HYDROCHLORIDE),Epistaxis,0
54,2,CAELYX (DOXORUBICIN HYDROCHLORIDE),Prurigo,0
,1,BETASERON,Pre-existing condition improved,0
57,2,IBUPROFEN,Lethargy,1
13,2,ZYRTEC,Coeliac disease,0
,2,CETIRIZINE HYDROCHLORIDE.,Angioedema,0
,0,LEVETIRACETAM,Cardiac failure,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,0,LEVETIRACETAM,Cardiac failure,0
90,2,DOXORUBICINE TEVA,Anaemia,0
,0,LEVETIRACETAM,Respiratory failure,0
,0,VELCADE,Gastrointestinal disorder,0
,1,IBUPROFEN.,Tinnitus,0
85,1,SPIRIVA,Incorrect route of drug administration,0
6,1,BENADRYL,Toxicity to various agents,0
49,2,ACTEMRA,Syncope,0
,1,SANDOSTATIN LAR,Pain,1
,0,VELCADE,Gastrointestinal disorder,0
66,2,REVLIMID,Glaucoma,0
,0,VELCADE,Gastrointestinal disorder,0
44,2,HIZENTRA,Gastroenteritis Escherichia coli,1
,0,ISENTRESS,Fat redistribution,0
,2,DIOVAN,Cerebrovascular accident,0
49,2,EPILIZINE,Convulsion,0
28,2,KEPPRA,Pyrexia,1
72,2,SPIRIVA,Product quality issue,0
86,2,PROLIA,Arthropathy,0
,1,GLIVEC,Death,0
,1,GLIVEC,Death,0
25,1,GLIVEC,Death,0
,2,DULERA,Chest discomfort,0
61,2,ACLASTA,Death,0
55,1,ZOMETA,Death,0
40,1,GLIVEC,Death,0
,1,GLIVEC,Death,0
,1,CORICIDIN HBP COLD AND FLU,Dizziness,0
35,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
50,1,CICLOSPORIN,Acute myeloid leukaemia recurrent,0
,1,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
,0,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
40,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
44,1,CORICIDIN HBP COLD AND FLU,Sleep disorder,0
40,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
65,1,CORICIDIN HBP COLD AND FLU,Respiratory tract congestion,0
44,1,CORICIDIN HBP COLD AND FLU,Adverse event,0
,2,EPIPEN,Drug effect decreased,0
56,2,TRASTUZUMAB EMTANSINE,Acute coronary syndrome,1
46,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
,2,BUDESONIDE CAPSULES,Rectal haemorrhage,0
,2,NEXIUM,Gastrooesophageal reflux disease,1
50,2,INEXIUM,Renal colic,1
62,2,SYMBICORT,Dyspnoea,1
35,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,CORICIDIN HBP COUGH AND COLD,Chest pain,0
54,2,CORICIDIN HBP COLD AND FLU,Sleep disorder,0
39,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,CORICIDIN HBP COUGH AND COLD,Rash,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
58,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
,2,CORICIDIN HBP COLD AND FLU,Rash,0
35,2,CORICIDIN HBP COLD AND FLU,Fatigue,0
75,2,CLOPIDOGREL TABLETS USP,Nausea,0
73,1,CLOPIDOGREL TABLETS USP,Confusional state,0
,1,ZOLPIDEM TARTRATE TABLETS,Hypersensitivity,0
,2,FENTORA,Endometrial cancer metastatic,0
32,2,LANTUS,Abortion,0
25,2,YAZ,Abdominal distension,1
49,2,CIPRO,Drug hypersensitivity,0
,1,CLOZAPINE TABLETS,Laryngeal cancer,0
12,1,METHYLPHENIDATE HYDROCHLORIDE,Accelerated idioventricular rhythm,0
67,1,XARELTO,Death,1
,1,NUCYNTA,Stevens-Johnson syndrome,0
89,2,XARELTO,Blindness,1
40,1,RIVAROXABAN,Dyspnoea,1
70,1,XARELTO,Hypoglycaemic coma,1
66,2,INVEGA SUSTENNA,Drug dose omission,0
25,0,INVEGA SUSTENNA,Refusal of treatment by patient,0
,1,XARELTO,Toxicity to various agents,1
77,2,XARELTO,Transient ischaemic attack,1
71,2,XARELTO,Paraesthesia,0
86,1,XARELTO,Erythema multiforme,1
67,1,XARELTO,Bone marrow failure,1
75,1,XARELTO,Cerebral haemorrhage,1
,2,SABRIL (TABLET),Incorrect dose administered,0
49,1,AVEED,Paraesthesia,0
46,1,XARELTO,Dizziness,1
55,1,XARELTO,Cardiac arrest,0
58,1,XARELTO,Pulmonary embolism,1
89,1,XARELTO,Haemorrhage,1
,2,XARELTO,Upper gastrointestinal haemorrhage,1
41,2,TOPAMAX,Suicide attempt,1
81,1,XARELTO,Cardiac arrest,1
86,2,XARELTO,Haematoma,1
75,2,CALCIUM AND VITAMIN D,Subarachnoid haemorrhage,1
77,1,KEPPRA,Purple glove syndrome,0
63,2,RENVELA,Pharyngeal operation,0
64,2,SIMPONI,Cardiac failure acute,0
50,1,SIMPONI,Polychondritis,1
,2,SIMPONI,Sepsis,1
,2,SIMPONI,Herpes zoster,0
51,2,SIMPONI,Gallbladder disorder,0
68,1,GLIVEC,Death,0
,2,ABILIFY MAINTENA,Psychiatric symptom,1
,1,LUCENTIS,Visual acuity reduced,0
65,1,GLIVEC,Death,0
17,1,GLIVEC,Death,0
,0,VELCADE,Death,0
,2,SANDOSTATIN LAR DEPOT,Death,0
64,2,OMNISCAN,Nephrogenic systemic fibrosis,0
76,2,SINGULAIR,Bronchitis,0
,2,IMPLANON,Device deployment issue,0
,2,SOLIRIS,Haemolysis,1
,2,COMBIVENT,Dyspnoea,0
82,1,COMBIVENT,Drug effect decreased,0
7,2,OXCARBAZEPINE,Drug-induced liver injury,1
80,2,CODEINE SULFATE,Hypersensitivity,0
63,1,COMBIVENT,Overdose,0
,2,JANUMET,Dyspnoea,0
57,2,CIPRO,Drug hypersensitivity,0
91,2,DRONEDARONE,Rectal haemorrhage,1
31,2,HUMIRA,Dermatitis,1
84,2,REVLIMID,Death,0
,2,HUMIRA,Bone erosion,0
62,1,PLAVIX,Drug interaction,1
,1,REVLIMID,Memory impairment,0
0,1,VITAMINE C PCH TABLET 500 MG,Cleft palate,0
,1,RANIBIZUMAB,Cardiac disorder,0
,2,REVLIMID,Vaginal haemorrhage,0
72,2,DRONEDARONE,Gingival bleeding,1
55,2,ARAVA,Erysipelas,1
,0,KEPPRA,Toxic optic neuropathy,0
72,2,REVLIMID,Metastatic malignant melanoma,0
74,1,JAKAVI,Splenic rupture,1
,0,REVLIMID,Death,0
59,1,CIMZIA,Abscess,0
,2,YASMIN,Drug dose omission,0
67,2,POMALYST,Infection,0
67,2,COAPROVEL,Haemorrhage,0
69,2,DRONEDARONE,Haemorrhage,1
,2,GILENYA,Central nervous system lesion,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
54,1,TAZOCIN,Drug reaction with eosinophilia and systemic symptoms,0
66,2,REVLIMID,Pulmonary oedema,1
42,1,NEULASTA,Investigation,1
46,1,NEULASTA,Hospitalisation,1
84,2,DRONEDARONE,Haemorrhage,1
72,2,COAPROVEL,Hypertension,0
60,2,NEULASTA,Surgery,0
81,2,REVLIMID,Plasma cell myeloma,0
,2,REVLIMID,Death,0
72,2,NEUPRO,Tremor,0
,1,VORINOSTAT,Pericardial effusion,1
37,2,RID 1-2-3 SYSTEM,Urinary tract infection,0
45,2,YAZ,Pulmonary embolism,0
41,2,YAZ,Pulmonary embolism,1
48,2,YAZ,Deep vein thrombosis,0
45,2,NEULASTA,Hospitalisation,1
80,2,DRONEDARONE,Subdural haematoma,1
74,2,CLOPIDOGREL,Vaginal haemorrhage,0
,1,AZATHIOPRINE,Premature baby,0
62,2,MYCOPHENOLATE MOFETIL,Pneumonia aspiration,0
67,2,CIMZIA,Lower respiratory tract infection,0
,2,REVLIMID,Death,0
42,2,ENBREL,Impaired healing,1
66,1,IRBESARTAN,Abdominal pain upper,1
60,1,ERLOTINIB TABLET,Off label use,0
71,1,ERLOTINIB,Dizziness,1
69,1,ERLOTINIB TABLET,Anaemia,0
35,2,ERLOTINIB TABLET,Haemorrhage intracranial,1
70,2,ERLOTINIB TABLET,Haemoptysis,1
55,1,ERLOTINIB TABLET,Incorrect dose administered,0
,2,ERLOTINIB TABLET,Local swelling,0
54,2,ERLOTINIB TABLET,Nephrolithiasis,1
69,2,ERLOTINIB TABLET,Neutropenia,0
61,1,ERLOTINIB TABLET,Epistaxis,0
73,1,ERLOTINIB TABLET,Death,0
70,1,ERLOTINIB TABLET,Death,0
,2,ERLOTINIB TABLET,Pulmonary thrombosis,0
,1,ERLOTINIB TABLET,Blood disorder,0
,1,ERLOTINIB TABLET,Dyspepsia,0
57,1,ERLOTINIB TABLET,Death,0
89,1,ERLOTINIB TABLET,Abdominal pain,0
59,1,ERLOTINIB TABLET,Death,0
77,2,ERLOTINIB TABLET,Fall,1
,1,ERLOTINIB TABLET,Death,0
60,1,ERLOTINIB TABLET,Incorrect dose administered,0
,2,ERLOTINIB TABLET,Death,0
67,1,ERLOTINIB TABLET,Incorrect dose administered,0
43,1,ERLOTINIB TABLET,Death,0
,1,ERLOTINIB TABLET,Off label use,0
73,1,ERLOTINIB TABLET,Fall,1
,2,ERLOTINIB TABLET,Incorrect dose administered,0
63,2,PROGRAF,Death,0
65,1,XTANDI,Malignant neoplasm progression,0
,2,VESICARE,Oesophageal carcinoma,0
81,1,VESICARE,Drug interaction,0
58,2,ALEVE CAPLET,Gastric haemorrhage,0
,2,TARCEVA,Death,0
57,2,BAYER GENUINE ASPIRIN ORIGINAL STRENGTH,Hypersensitivity,0
,1,TARCEVA,Death,0
4,2,VALIUM,Convulsion,0
64,2,ERLOTINIB TABLET,Death,0
30,1,PROGRAF,Drug ineffective,0
,1,MYRBETRIQ,Renal failure,0
,1,VESICARE,Drug ineffective,0
78,1,LEXISCAN,Joint stiffness,0
79,1,XTANDI,Chest pain,0
,1,BETANIS,Hepatic function abnormal,0
72,1,LEXISCAN,Unresponsive to stimuli,0
63,1,TARCEVA,Interstitial lung disease,1
,1,XTANDI,Investigation,1
,1,XTANDI,Investigation,1
85,1,XTANDI,Balance disorder,0
67,2,TARCEVA,Abdominal symptom,1
57,1,PROGRAF,Drug ineffective,0
59,2,PROGRAF,Drug ineffective,0
62,2,TARCEVA,Eye swelling,0
,2,DEXAMETHASONE,Drug interaction,0
,2,TARCEVA,Pleural effusion,1
96,1,XTANDI,Pancreatic carcinoma metastatic,0
61,1,XTANDI,Surgery,1
85,1,ASPIRIN.,Hearing impaired,0
80,2,ERLOTINIB TABLET,Death,0
52,2,CORDARONE,Arthralgia,1
80,1,XTANDI,Death,0
3,1,DOXORUBICIN,Febrile neutropenia,1
,1,FLUOROURACIL,Deep vein thrombosis,1
62,1,DRONEDARONE,Haemorrhage,1
45,2,XELJANZ,Haemorrhage,0
8,1,CELECOX,Electrocardiogram QT prolonged,0
69,2,SUTENT,Death,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
89,2,CORDARONE,Drug interaction,1
,1,SUTENT,Cardiac disorder,1
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,JZOLOFT,Liver disorder,1
,2,EFFEXOR XR,Bacterial infection,0
60,2,REVATIO,Pulmonary hypertension,0
65,2,VENLAFAXINE HCL,Feeling abnormal,0
68,2,XALKORI,Death,0
54,1,SUTENT,Abscess,1
80,2,REVLIMID,Invasive ductal breast carcinoma,0
,1,LYRICA,Back disorder,0
,2,EFFEXOR XR,Circulatory collapse,0
58,1,SUTENT,Death,0
68,1,XALKORI,Hypotension,1
65,2,CELEBREX,Chest pain,0
,2,LYRICA,Back disorder,0
53,2,EFFEXOR XR,Fall,0
63,1,BENDAMUSTINE,Ataxia,0
80,2,ERLOTINIB TABLET,Asphyxia,1
,2,OXYTROL FOR WOMEN,Scab,0
23,2,PARAGARD 380A,Pregnancy,0
25,2,REBIF,Female sterilisation,0
,2,ACTEMRA,Increased tendency to bruise,0
74,2,DRONEDARONE,Gastrointestinal haemorrhage,1
,2,IMPLANON,Weight increased,0
19,2,YAZ,Drug dose omission,0
78,2,DRONEDARONE,Gastrointestinal haemorrhage,1
36,1,NEULASTA,Fluid replacement,1
56,2,GADOLINIUM (UNSPECIFIED),Nephrogenic systemic fibrosis,0
24,2,CARBOPLATIN,Non-small cell lung cancer,0
52,2,HERCEPTIN,Ventricular extrasystoles,0
69,2,CETIRIZINE HYDROCHLORIDE 16208/0066 10 MG,Urinary incontinence,0
50,1,PACLITAXEL,Septic shock,0
44,2,YAZ,Deep vein thrombosis,1
49,2,YAZ,Pulmonary embolism,1
66,1,VICTOZA,Pancreatic carcinoma stage IV,0
6,1,AMILORIDE HYDROCHLORIDE,Acute prerenal failure,0
20,2,YAZ,Pulmonary embolism,1
69,2,PROMETHAZINE HYDROCHLORIDE WITH CODEINE SYRUP,Hypoaesthesia oral,0
78,2,MUCINEX DM,Muscle spasms,0
,0,PROMETHAZINE HYDROCHLORIDE WITH CODEINE SYRUP,Malaise,0
,1,PROMETHAZINE HYDROCHLORIDE WITH CODEINE SYRUP,Drug ineffective,0
84,2,VICTOZA,Adenocarcinoma pancreas,0
,0,LIRAGLUTIDE FLEXPEN,Trisomy 21,0
,1,VICTOZA,Pancreatic carcinoma,0
,2,HUMIRA,Chest pain,1
,1,NOVORAPID,Hospitalisation,1
71,1,JANUVIA,Pancreatic carcinoma,1
,2,RIFINAH,Road traffic accident,0
62,2,BYETTA,Pancreatic carcinoma,1
67,1,LEVEMIR,Cerebrovascular accident,1
42,2,YAZ,Pulmonary embolism,0
84,1,VIMPAT,Ataxia,1
74,1,INEXIUM,Lymphoma,0
67,2,VICTOZA,Diabetic retinal oedema,0
26,2,YAZ,Pulmonary embolism,1
59,1,ENBREL,Diverticulitis,1
,1,VICTOZA,Cholecystectomy,1
79,1,DRONEDARONE,Gastrointestinal haemorrhage,1
6,2,NOVOLIN GE NPH PENFILL,Influenza,1
83,1,OMEPRAZOLE,Weight decreased,0
44,2,YAZ,Transverse sinus thrombosis,1
33,2,YAZ,Pulmonary embolism,1
,2,VICTOZA,Thyroid cancer,0
,0,DRONEDARONE,Haemorrhage,0
35,2,METHOCARBAMOL TABLETS 750MG,Skin discolouration,0
38,2,METHOCARBAMOL TABLETS 500MG,Gastrointestinal pain,0
27,2,YASMIN,Pain,1
50,2,OCELLA,Deep vein thrombosis,0
65,1,PRADAXA,Paraesthesia oral,0
19,2,YAZ,Pain in extremity,1
72,1,PROSCAR,Prostate cancer,1
12,2,NAGLAZYME,Pneumonia,1
30,2,YAZ,Pulmonary embolism,1
36,2,YAZ,Deep vein thrombosis,0
,0,BLOPRESS,Rhabdomyolysis,0
23,2,YASMIN,Pain,0
,0,ADDERALL XR,Depression,0
55,2,LETROZOLE TABLETS 2.5MG,Heart rate irregular,1
21,2,CICLOSPORIN,Liver disorder,0
75,2,NEXIUM,Neoplasm malignant,0
31,2,LEFLUNOMIDE,Exposure during pregnancy,0
40,2,ARAVA,Exposure during pregnancy,0
,2,CORICIDIN HBP COLD AND FLU,Drug ineffective for unapproved indication,0
52,1,PRIVIGEN,Sepsis,0
72,1,AFLIBERCEPT,Pilonidal cyst,0
36,2,DOCOSAHEXANOIC ACID,Chest pain,1
87,2,OXYTROL FOR WOMEN,Drug effect decreased,0
96,2,ZESTORETIC,Fall,1
,2,HIZENTRA,Post procedural sepsis,1
55,2,PRIVIGEN,Antibody test positive,1
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
,1,INVOKANA,Renal failure,1
73,2,CRESTOR,Neoplasm malignant,0
46,2,TRACLEER,Fluid overload,1
,2,SIMVASTATIN,Fatigue,0
,1,OXYTROL FOR WOMEN,Off label use,0
,1,LUCENTIS,Blindness unilateral,0
,1,HIZENTRA,Splenomegaly,0
,2,DRONEDARONE,Haemorrhage,1
72,2,DRONEDARONE,Gastrointestinal haemorrhage,1
29,2,LETAIRIS,Oral surgery,0
55,2,NEULASTA,Hospitalisation,1
84,2,DRONEDARONE,Diarrhoea haemorrhagic,1
41,2,HYDROCHLOROTHIAZIDE.,Anxiety,1
59,2,SORAFENIB (RAF KINASE INHIBITOR),Eating disorder,1
37,2,CECLOR,Migraine,1
50,2,NEULASTA,Investigation,1
,2,YASMIN,Pulmonary embolism,0
19,2,RITALIN,Anxiety,1
29,2,PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN,Cerebrovascular accident,1
49,2,ALEVE TABLET,Extra dose administered,0
69,2,NEULASTA,Hospitalisation,1
48,2,AMOXICILLIN.,Thrombosis,1
32,2,YASMIN,Pulmonary embolism,1
59,2,NEULASTA,Investigation,1
45,2,YAZ,Deep vein thrombosis,1
38,2,RESTORIL,General physical health deterioration,1
70,2,ALEVE CAPLET,Rash,0
,2,ALEVE CAPLET,Mydriasis,0
,2,ALEVE CAPLET,Drug ineffective,0
31,2,ALEVE TABLET,Inappropriate schedule of drug administration,0
,2,ALEVE CAPLET,Pruritus,0
4,1,DECADRON,Drug administered to patient of inappropriate age,0
72,2,STILNOX,Bronchial obstruction,1
32,2,YASMIN,Deep vein thrombosis,1
86,1,ALEVE CAPLET,Drug ineffective,0
37,2,REMERON,Coma,1
,2,MIRAPEX,Restless legs syndrome,0
43,2,EPIRUBICIN HYDROCHLORIDE,Neutropenia,0
62,1,THYMOGLOBULIN,Anaemia,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
54,2,CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)),Retinal vein thrombosis,0
82,1,DRONEDARONE,Rectal haemorrhage,1
78,2,PRADAXA,Erythema,0
,2,COMBIVENT,Drug ineffective,0
70,2,SPIRIVA,Dyspnoea,0
,2,DR. SCHOLLS CLEAR AWAY WART REMOVER,Exposure during pregnancy,0
65,2,JANUMET,Death,1
,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
77,2,NEULASTA,Investigation,1
63,1,NEULASTA,Hospitalisation,1
70,2,NEULASTA,Hospitalisation,1
60,2,NEULASTA,Hospitalisation,1
69,2,INDAPAMIDE,Unresponsive to stimuli,1
36,2,MIRENA,Cerebrovascular accident,0
71,2,LIPITOR,Type 2 diabetes mellitus,0
73,2,LIPITOR,Arthritis,0
44,2,LIPITOR,Type 2 diabetes mellitus,0
76,2,AROMASIN,Death,0
79,2,CEPHALEXIN.,Type 2 diabetes mellitus,0
,2,TOVIAZ,Coeliac disease,0
48,1,NEULASTA,Hospitalisation,1
69,2,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
96,2,NORVASC,Death,0
68,1,ADVIL,International normalised ratio increased,1
47,2,LIPITOR,Neuropathy peripheral,0
,0,LIPITOR,Type 2 diabetes mellitus,0
72,1,FLUOROURACILE PFIZER,Disease progression,1
54,2,LIPITOR,Type 2 diabetes mellitus,0
46,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
76,1,REVATIO,Chronic obstructive pulmonary disease,0
67,2,LIPITOR,Type 2 diabetes mellitus,0
,1,IRINOTECAN HCL,Necrotising fasciitis,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,0,EXEMESTANE,Infection,1
58,2,LIPITOR,Type 2 diabetes mellitus,0
86,2,PLAVIX,Cardiac disorder,0
63,2,PACLITAXEL,Pneumonitis,0
68,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
56,2,PRAVASTATIN.,Type 2 diabetes mellitus,0
69,2,ATORVASTATIN CALCIUM.,Neuropathy peripheral,0
,2,CISPLATIN,Off label use,0
72,2,CISPLATIN,Second primary malignancy,0
,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
77,2,CALCITRIOL.,Type 2 diabetes mellitus,0
54,2,CARBOPLATIN,Acute myeloid leukaemia,0
48,2,LIPITOR,Type 2 diabetes mellitus,0
76,1,LANTUS,Death,0
61,1,LANTUS,Cardiac arrest,0
,2,NUVARING,Adverse event,0
75,2,DRONEDARONE,Gastrointestinal haemorrhage,1
67,2,DIOVAN,Spinal fracture,1
,2,ZOLPIDEM TARTRATE EXTENDED RELEASE - WINTHROP,Road traffic accident,0
68,2,LOSARTAN POTASSIUM 50 MG,Chillblains,0
25,2,REBIF,Urinary tract infection,1
60,1,SAMSCA,Hepatitis acute,0
72,1,DRONEDARONE,Epistaxis,1
50,1,LANTUS,Abdominal hernia repair,1
61,1,SIGNIFOR,Hyponatraemia,0
92,2,LASIX,Renal failure acute,0
,2,PROGRAF,Platelet count decreased,1
,0,GLIVEC,Mobility decreased,0
,2,LETAIRIS,Loss of consciousness,0
65,2,LETAIRIS,Nausea,0
46,1,DRONEDARONE,Gastrointestinal haemorrhage,1
,2,LETAIRIS,Intestinal obstruction,1
84,1,LANTUS,Acute myocardial infarction,0
,2,DRONEDARONE,Eye haemorrhage,0
23,2,LETAIRIS,Fluid retention,1
76,1,ENBREL,Headache,0
69,1,DRONEDARONE,Gastrointestinal haemorrhage,1
70,2,LANTUS,Leukaemia,0
,1,CLARITIN LIQUIGELS,Pneumonectomy,1
60,1,ANDROGEL,Cardiac arrest,1
67,1,NEULASTA,Hospitalisation,1
,2,PARAGARD 380A,Device expulsion,0
62,2,LUMIZYME,Respiratory disorder,1
81,2,DRONEDARONE,Rectal haemorrhage,1
9,2,TRIMETHOPRIM+SULFAMETHOXAZOLE,Drug reaction with eosinophilia and systemic symptoms,0
,1,DEPO-TESTOSTERONE,Myocardial infarction,1
35,2,CHLORPROMAZINE HYDROCHLORIDE,Drug abuse,0
19,2,VITAMIN D3,Forced expiratory volume decreased,1
7,1,PRADAXA,Death,0
54,2,LIPITOR,Asthenia,0
87,1,PRAZAXA,Gastrointestinal haemorrhage,1
27,1,DABIGATRAN,Cystitis haemorrhagic,1
85,2,DABIGATRAN,Gastrointestinal haemorrhage,1
56,1,DABIGATRAN,Upper gastrointestinal haemorrhage,1
41,1,CLINDAMYCIN,Stevens-Johnson syndrome,1
50,2,SODIUM FLUORIDE,Angioedema,0
65,2,CISPLATIN,Myelodysplastic syndrome,0
54,1,BOTOX,Headache,0
54,2,DULOXETINE,Nervousness,0
,0,EYLEA (AFLIBERCEPT) (INJECTION) (AFLIBERCEPT),Pseudoendophthalmitis,0
,2,DRONEDARONE,Rectal haemorrhage,1
30,2,CARBOPLATIN,Dyspnoea,0
72,1,VORINOSTAT,Pyelonephritis,1
,0,LIALDA,Microalbuminuria,0
3,1,MIRALAX,Cystitis,0
42,2,HYDROCORTISONE (HYDROCORTISONE),Myelopathy,1
36,1,Z PACK,Swollen tongue,0
12,1,"EQUATE ASPIRIN 250MG, ACETAMINOPHEN 250MG, CAFFEINE  65MG FILM COATED WHITE TABLETS",Dyspnoea,1
46,2,MIRVASO,Flushing,0
47,1,COPAXONE,Paralysis,0
79,2,ACLASTA,Upper limb fracture,0
44,2,LIDOCAINE,Anaphylactoid reaction,1
54,2,SYMBICORT,Cataract subcapsular,0
63,2,ADCIRCA,Eye oedema,0
51,2,METHYLPREDNISOLONE,Throat tightness,0
43,1,ULTRA BRITE BAKING SODA AND PEROXIDE WHITENING TOOTHPASTE,Diabetic coma,1
56,1,DRONEDARONE,Haemorrhoidal haemorrhage,0
28,2,ESCITALOPRAM,Haemorrhage in pregnancy,0
,1,SABRIL (FOR ORAL SOLUTION),Pneumonia,1
24,2,MIRENA,Ectopic pregnancy,1
72,1,DRONEDARONE,Gastrointestinal haemorrhage,1
73,1,DABIGATRAN,Gastrointestinal haemorrhage,1
59,1,DEPO TESTOSTERONE,Cerebrovascular accident,1
87,2,DABIGATRAN,Anaemia,1
48,2,WARFARIN,Dizziness,0
,0,"INFLIXIMAB, RECOMBINANT",Pneumonitis chemical,0
,1,"INFLIXIMAB, RECOMBINANT",Transitional cell carcinoma,0
,2,JANUVIA,Nausea,0
34,1,NEXIUM,Umbilical hernia,0
70,1,DRONEDARONE,Gastrointestinal haemorrhage,1
35,1,AZATHIOPRINE,Nausea,0
,1,EXFORGE,Hepatic cancer,0
47,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,1,METOPROLOL,Leukaemia,0
67,2,JANUVIA,Drug hypersensitivity,0
37,1,FLUOXETINE,Ill-defined disorder,0
0,2,ESCITALOPRAM,Congenital aural fistula,0
52,2,DRONEDARONE,Subdural haemorrhage,1
,,CAPECITABINE (UNKNOWN),Malignant neoplasm progression,0
,0,LETROZOLE (UNKNOWN),Breast cancer,0
,2,PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07%,Cystoid macular oedema,0
67,2,LIPITOR,Type 2 diabetes mellitus,0
47,2,SYNTHROID,Type 2 diabetes mellitus,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
48,2,LIPITOR,Type 2 diabetes mellitus,1
65,2,LIPITOR,Type 2 diabetes mellitus,0
,2,IMPLANON,Gallbladder non-functioning,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
65,2,LIPITOR,Type 2 diabetes mellitus,0
50,2,LIPITOR,Type 2 diabetes mellitus,0
65,1,CRESTOR,Small fibre neuropathy,0
71,2,TAFLOTAN,Deafness,0
83,1,DRONEDARONE,Subdural haemorrhage,1
,2,WARFARIN,Haemorrhage,0
60,2,CISPLATIN,Rash generalised,1
81,2,PROLIA,Adverse reaction,1
65,1,BRILINTA,Renal failure acute,0
65,2,KYPROLIS,Clostridium difficile infection,1
41,2,VFEND,Cytomegalovirus test positive,1
68,2,DRONEDARONE,Haemorrhage,1
57,2,COAPROVEL,Nephrolithiasis,0
1,1,SABRIL (FOR ORAL SOLUTION),Pneumonia,1
47,2,COPAXONE,Joint swelling,0
71,1,DRONEDARONE,Haemorrhage,1
73,2,SYMBICORT,Breast cancer,0
60,1,ADVIL PM,Adrenal insufficiency,1
,1,CRESTOR,Small fibre neuropathy,0
47,2,SABRIL (TABLET),Conjunctivitis,0
,2,FOSAVANCE,Breast cancer,0
,2,OXYTROL FOR WOMEN,Application site rash,0
56,2,DRONEDARONE,Ulcer haemorrhage,1
,1,PRADAXA,Cerebrovascular accident,0
,2,PRADAXA,Cerebrovascular accident,0
70,1,DABIGATRAN,Loss of consciousness,1
80,1,PRADAXA,Diplopia,0
85,2,PERPHENAZINE TABLETS 2MG,Urinary tract infection,1
55,2,MORPHINE,Respiratory distress,0
71,2,SPIRIVA,Cataract,0
41,1,HUMIRA,Convulsion,0
,2,ACLASTA,Death,0
78,1,DRONEDARONE,Gastrointestinal haemorrhage,1
57,1,BOCEPREVIR,Death,0
28,2,MIRENA,Uterine perforation,1
,0,DRONEDARONE,Conjunctival haemorrhage,0
62,1,TRACLEER,Coronary artery occlusion,0
,2,NUVARING,Inappropriate schedule of drug administration,0
82,1,JANUVIA,Death,0
80,1,DRONEDARONE,Gastrointestinal haemorrhage,1
76,2,ENBREL,Neoplasm malignant,0
73,2,TRACLEER,Death,0
57,2,TRACLEER,Surgery,1
,0,VYVANSE,Drug ineffective for unapproved indication,0
19,1,VYVANSE,Increased appetite,0
,0,COPEGUS,Eczema,0
67,2,LISINOPRIL,Coronary artery occlusion,1
,2,VYVANSE,Mood swings,0
33,2,MIRENA,Chlamydia test positive,0
72,2,TRACLEER,Death,0
40,2,BOSENTAN,Oedema peripheral,1
26,2,MIRENA,Infertility female,1
25,2,MIRENA,Injury,1
19,2,MIRENA,Abortion spontaneous,0
,2,MIRENA,Menorrhagia,0
23,2,MIRENA,Drug ineffective,0
36,2,FAMOTIDINE.,Weight decreased,1
45,2,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
56,2,LIPITOR,Neuralgia,0
,2,LIPITOR,Type 2 diabetes mellitus,0
71,1,DRONEDARONE,Lower gastrointestinal haemorrhage,1
59,2,PRESERVISION,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
46,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
45,2,LIPITOR,Type 2 diabetes mellitus,1
44,2,LIPITOR,Type 2 diabetes mellitus,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
76,2,LIPITOR,Type 2 diabetes mellitus,0
65,2,LIPITOR,Tooth loss,0
72,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
69,2,LIPITOR,Type 2 diabetes mellitus,0
41,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
45,,LIPITOR,Type 2 diabetes mellitus,0
57,2,LIPITOR,Type 2 diabetes mellitus,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
68,2,LIPITOR,Type 2 diabetes mellitus,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
70,2,LIPITOR,Type 2 diabetes mellitus,0
51,2,LIPITOR,Type 2 diabetes mellitus,0
46,2,LIPITOR,Type 2 diabetes mellitus,0
54,2,LIPITOR,Fatigue,0
,0,SOLIRIS,Bone marrow transplant,1
59,2,DILTIAZEM,Laceration,1
,2,MIRALAX,Inappropriate schedule of drug administration,0
73,1,DRONEDARONE,Haemorrhage,1
24,2,HUMIRA,Sudden hearing loss,0
,0,COPEGUS,Pancytopenia,0
29,1,ARANESP,Depression,1
68,1,OMNISCAN,Nephrogenic systemic fibrosis,0
49,2,TRACLEER,Depression,1
80,2,PROLIA,Death,0
76,2,VENTAVIS,Parathyroid gland operation,1
45,2,TRACLEER,Pulmonary arterial hypertension,0
44,2,VENTAVIS,Tongue neoplasm malignant stage unspecified,1
48,2,TRACLEER,Death,0
1,1,VENLAFAXINE,Neonatal respiratory distress syndrome,0
60,2,TRACLEER,Pulmonary arterial hypertension,0
45,2,REMICADE,Cholelithiasis,0
,0,MK-0000,Eye swelling,0
66,2,VENTAVIS,Scleroderma,0
74,2,REMICADE,Syncope,0
56,1,XGEVA,Angioplasty,1
81,1,DRONEDARONE,Haemorrhage,1
55,1,TRACLEER,Pulmonary arterial hypertension,0
59,1,REMICADE,Scar,1
26,1,REMICADE,Herpes zoster,0
,1,REMICADE,Inguinal hernia,0
44,2,TRACLEER,Respiratory failure,0
,0,REMICADE,Lupus-like syndrome,0
30,2,CLARITHROMYCIN,Iris atrophy,0
53,1,VIAGRA,Depressed mood,0
,2,TRACLEER,Death,0
61,1,TRACLEER,Death,0
,2,VENLAFAXINE HCL,Atrial fibrillation,1
59,2,EFFEXOR XR,Memory impairment,0
30,2,ADVIL,Drug ineffective,0
,2,PANTOPRAZOLE,Gait disturbance,0
58,2,LIPITOR,Drug hypersensitivity,0
,2,LYRICA,Drug ineffective,0
,2,VENLAFAXINE HCL,Heart rate increased,0
78,2,MEDROL,Drug hypersensitivity,0
,1,ATORVASTATIN CALCIUM,Nightmare,0
,1,EFFEXOR XR,Chest pain,0
16,2,ADVIL,Hypersensitivity,0
,2,PRISTIQ,Drug ineffective,0
75,2,ALTACE,Drug hypersensitivity,0
57,2,EFFEXOR XR,Drug hypersensitivity,0
,2,CELEBREX,Nasopharyngitis,0
,1,MORPHINE SULFATE.,Drug hypersensitivity,0
,2,EFFEXOR XR,Fatigue,0
63,2,REVATIO,Bronchitis,0
,0,VIAGRA,Drug ineffective,0
70,1,INLYTA,Decreased appetite,0
57,2,PREMARIN,Vulvovaginal discomfort,0
32,2,VENLAFAXINE ER,Dizziness,0
,1,LYRICA,Insomnia,0
53,2,LYRICA,Suicidal ideation,0
,2,CLINDAMYCIN PHOSPHATE,Skin disorder,0
28,2,ATORVASTATIN CALCIUM,Myalgia,0
55,1,CHANTIX,Dyspnoea,0
,2,PRISTIQ,Alopecia,0
57,2,SUTENT,Palmar-plantar erythrodysaesthesia syndrome,0
76,2,SUTENT,Fatigue,0
,1,LIPITOR,Myalgia,0
,2,DIFLUCAN,Drug hypersensitivity,0
71,1,SUTENT,Diarrhoea,0
36,2,MORPHINE SULFATE.,Drug hypersensitivity,1
63,2,LIPITOR,Drug hypersensitivity,0
84,2,ADVIL,Drug effect incomplete,0
31,2,LYRICA,Drug interaction,0
58,2,GLIMEPIRIDE (GLIMEPIRIDE),Weight increased,0
,1,LYRICA,Headache,0
73,2,XALKORI,Upper respiratory tract infection,0
,2,CHANTIX,Stress,0
,2,ATORVASTATIN CALCIUM,Muscle spasms,0
61,2,LIPITOR,Drug hypersensitivity,0
63,2,CHANTIX,Drug hypersensitivity,0
,2,CHANTIX,Malaise,0
49,1,VIAGRA,Drug ineffective,0
,2,CLINDAMYCIN PHOSPHATE,Rash,0
,1,SILDENAFIL CITRATE,Malaise,0
52,2,VENLAFAXINE HCL,Chest pain,0
69,2,SERTRALINE HCL,Bladder pain,0
,2,CLINDAMYCIN PHOSPHATE,Rash,0
,1,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Application site vesicles,0
,2,CELEBREX,Erythema,0
58,2,XELJANZ,Headache,0
,2,TIKOSYN,Arrhythmia,0
83,2,CELEBREX,Drug hypersensitivity,0
,2,ALAVERT,Drug ineffective,0
43,2,LYRICA,Pain in extremity,0
77,1,LIPITOR,Drug hypersensitivity,0
,2,CHANTIX,Vomiting,0
,2,PICATO,Adverse reaction,0
43,2,PROACTIV + SKIN SMOOTHING EXFOLIATOR,Swelling face,0
,2,NORVASC,Drug hypersensitivity,0
73,2,ADVIL,Dysgeusia,0
66,1,METHOTREXATE SODIUM,Amoebic colitis,1
,1,CHANTIX,Drug ineffective,0
66,2,SEPTRA,Drug hypersensitivity,0
,2,ADVIL ALLERGY SINUS,Drug ineffective,0
52,2,ZOLOFT,Drug ineffective,0
65,2,PICATO,Application site paraesthesia,0
,1,NORVASC,Drug hypersensitivity,0
,2,LIPITOR,Muscle spasms,0
,2,LYRICA,Fibromyalgia,0
,1,CHANTIX,Pruritus,0
78,2,ZITHROMAX,Rash,0
87,2,LETAIRIS,Dyspnoea,0
34,2,PROACTIV+ SKIN SMOOTHING EXFOLIATOR,Swelling face,1
,2,CLINDAMYCIN HCL,Drug hypersensitivity,0
21,2,MIRENA,Urinary tract infection,1
49,2,LETAIRIS,Sinusitis,0
43,2,VENTAVIS,Acute myocardial infarction,1
72,2,LETAIRIS,Dyspnoea,0
50,1,VIAGRA,Intentional drug misuse,0
,2,CELEBREX,Aphonia,0
74,2,LETAIRIS,Fluid retention,0
,2,CODEINE SULFATE,Drug hypersensitivity,0
51,1,LETAIRIS,Diarrhoea,0
50,1,REVATIO,Upper respiratory tract infection,0
37,2,MIRENA,Uterine perforation,0
69,2,LETAIRIS,Cardiac failure congestive,1
88,2,LETAIRIS,Fatigue,0
60,1,LETAIRIS,Cholelithiasis,0
,1,LIPITOR,Muscle fatigue,0
72,2,ADCIRCA,Eye disorder,0
47,1,"NYQUIL COLD + FLU ALCOHOL 10% NIGHTTIME RELIEF, CHERRY FLAVOR(ETHANOL 10 %, DEXTROMETHORPHAN HYDROBROMIDE 30 MG, DOXYLAMINE SUCCINATE 12.5 MG, PARACETAMOL 650 MG) ORAL LIQUID, 30ML",Grand mal convulsion,0
73,2,LETAIRIS,Swelling,0
,2,MIRENA,Rash,0
83,2,LIPITOR,Abdominal pain,0
72,2,LEVOTHYROXINE SODIUM.,Lacrimation increased,0
46,1,DEPO-TESTOSTERONE,Drug ineffective,0
53,2,LETAIRIS,Unevaluable event,0
38,2,MIRENA,Device difficult to use,0
79,1,EYLEA,Drug hypersensitivity,0
58,0,NEURONTIN,Drug hypersensitivity,0
52,2,METHYLPHENIDATE HYDROCHLORIDE,Drug ineffective,0
,1,LYRICA,Hypoaesthesia,0
,1,GLIPIZIDE XL,Drug ineffective,0
,0,ARTHROTEC,Drug hypersensitivity,0
,2,EFFEXOR,Heart rate increased,0
,2,PRISTIQ,Feeling abnormal,0
,2,CELEBREX,Drug hypersensitivity,0
84,2,EYLEA,Blindness,0
18,1,IBUPROFEN UNKNOWN PRODUCT,Haemoptysis,1
24,2,IBUPROFEN UNKNOWN PRODUCT,Hypoaesthesia oral,0
68,2,PROLIA,Confusional state,0
68,1,PRAZAXA,Benign prostatic hyperplasia,1
15,1,IBUPROFEN UNKNOWN PRODUCT,Renal failure acute,1
60,2,LETAIRIS,Dyspnoea exertional,0
68,1,LETAIRIS,Rash,0
82,2,REVATIO,Nasal congestion,0
85,2,COMBIVENT,Body height decreased,0
63,1,NOSTRILLA NASAL DECONGESTANT ORIGINAL FAST RELIEF-12 HOUR,Nasal discomfort,0
57,2,LETAIRIS,Dizziness,0
47,2,LETAIRIS,Influenza,0
46,2,LETAIRIS,Headache,0
62,1,LETAIRIS,Fall,0
,2,ABILIFY,Type 2 diabetes mellitus,0
50,2,SPIRIVA,Osteoarthritis,1
81,1,LETAIRIS,Nasal congestion,0
39,2,LETAIRIS,Hepatic pain,0
45,2,LETAIRIS,Fluid retention,0
38,2,ONCASPAR,Generalised oedema,1
66,2,LETAIRIS,Pain,0
79,2,LETAIRIS,Nausea,0
53,2,LETAIRIS,Headache,0
70,1,LETAIRIS,Fluid retention,1
79,2,LETAIRIS,Pruritus,0
37,2,LETAIRIS,Nasopharyngitis,0
55,2,LETAIRIS,Hypotension,0
45,2,LETAIRIS,Dyspnoea,0
55,2,RABEPRAZOLE,Malaise,0
65,2,LETAIRIS,Fatigue,0
71,2,PICATO,Application site dryness,0
86,1,LETAIRIS,Pain in extremity,0
70,1,ADCIRCA,Dizziness,0
67,2,LETAIRIS,Influenza,0
70,2,LETAIRIS,Dyspnoea,0
73,2,LETAIRIS,Dizziness,0
49,2,REMICAID,Pustular psoriasis,0
62,2,LETAIRIS,Blister,0
71,1,LETAIRIS,Oedema,0
,1,PICATO,Application site dryness,0
,2,SPIRIVA,Leukaemia,0
44,2,LETAIRIS,Malaise,0
83,2,GLIMEPIRIDE.,Fluid retention,1
77,2,LETAIRIS,Malaise,0
71,2,ADCIRCA,Fall,0
51,2,LETAIRIS,Nasopharyngitis,0
79,1,LETAIRIS,Rash,0
,0,VYVANSE,Exposure during pregnancy,0
71,2,TELMISARTAN,Malaise,0
,2,"PICATO (0.015 %, GEL)",Vision blurred,0
60,2,LETAIRIS,Headache,0
78,2,LETAIRIS,Dyspnoea,0
68,1,LIDOCAINE HCL,Pyrexia,1
73,2,LETAIRIS,Cough,0
70,1,LETAIRIS,Unevaluable event,0
30,2,TYVASO,Cough,0
78,2,LETAIRIS,Dyspnoea,0
75,2,LETAIRIS,Epistaxis,0
56,2,TYVASO,Coagulopathy,0
53,1,LETAIRIS,Pneumonia,0
,0,SIMVASTATIN,Disturbance in attention,0
79,1,LETAIRIS,Vein disorder,0
47,1,ADCIRCA,Syncope,0
,2,LETAIRIS,Iron deficiency anaemia,0
77,1,LETAIRIS,Malaise,0
84,1,LETAIRIS,Cough,0
61,2,ADCIRCA,Dizziness,0
,0,VYVANSE,Somnolence,0
,1,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Erythema,0
57,2,LETAIRIS,Catheterisation cardiac,0
74,2,CLOPIDOGREL (CLOPIDOGREL),Contusion,0
76,2,LETAIRIS,Mass,0
62,2,LETAIRIS,Peripheral swelling,0
42,2,LEVETIRACETAM,Drug reaction with eosinophilia and systemic symptoms,0
60,2,LETAIRIS,Pain in extremity,0
69,2,LETAIRIS,Dyspnoea,0
39,2,REMODULIN,Infusion site discomfort,0
64,2,LETAIRIS,Gout,0
50,1,LEVOTHYROXINE,Blood thyroid stimulating hormone increased,0
71,2,LETAIRIS,Sinus headache,0
60,2,REVATIO,Unevaluable event,0
68,1,LETAIRIS,Throat irritation,0
46,2,LETAIRIS,Pain,0
81,2,LETAIRIS,Oedema peripheral,0
79,2,REVATIO,Fluid retention,0
72,2,ACTIMMUNE,Anaemia,0
71,1,TYVASO,Rash,0
45,2,LETAIRIS,Chest pain,0
54,2,COUMADIN,Catheter site haemorrhage,0
77,1,LETAIRIS,Spinal column stenosis,0
70,2,LETAIRIS,Oedema peripheral,0
58,2,LETAIRIS,Fatigue,0
45,2,REVATIO,Immune system disorder,0
64,2,LETAIRIS,Dyspnoea,0
51,2,DEMADEX,Liver function test abnormal,0
64,2,PICATO,Application site pruritus,0
47,2,TYVASO,Chest pain,0
79,1,CIPROFLOXACIN,Acute generalised exanthematous pustulosis,1
76,2,LETAIRIS,Wheezing,0
61,2,LETAIRIS,Pneumonia,0
68,2,LETAIRIS,Drug intolerance,0
82,2,LETAIRIS,Gait disturbance,0
78,2,LETAIRIS,Chest pain,0
,0,LIALDA,Malaise,0
,0,LIALDA,Headache,0
36,2,OXYCODONE/ACETAMINOPHEN,Anxiety,0
65,2,LETAIRIS,Oropharyngeal pain,0
76,1,LETAIRIS,Tooth infection,0
69,1,"EPINEPHRINE INJECTION, USP (1071-25) 1 MG/ML",Kounis syndrome,1
54,2,LETAIRIS,Malaise,0
23,2,LETAIRIS,Clostridial infection,0
71,2,LETAIRIS,Vomiting,0
60,2,REVATIO,Nasal congestion,0
74,2,LETAIRIS,Dyspnoea,0
,0,VYVANSE,Inappropriate schedule of drug administration,0
,0,VYVANSE,Inappropriate schedule of drug administration,0
48,2,"NICORETTE NICOTINE POLACRILEX CHERRY LOZENGE, 4MG",Coeliac disease,0
47,2,LETAIRIS,Nasopharyngitis,0
,1,NIQUITIN,Death,0
76,1,LETAIRIS,Haemoglobin decreased,0
58,1,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Application site erythema,0
44,1,LETAIRIS,Nausea,0
49,1,TYVASO,Cough,0
48,2,LETAIRIS,Bronchitis,0
42,2,LETAIRIS,Bronchitis,0
67,2,CARBIDOPA /LEVODOPA,Dizziness,0
,1,LETAIRIS,Pulmonary oedema,0
46,2,LETAIRIS,Nasal congestion,0
71,1,SANTYL OINTMENT (NO PREF. NAME),Drug ineffective,1
70,1,LETAIRIS,No therapeutic response,0
54,2,LETAIRIS,Swelling,0
,2,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Application site pain,0
,2,LETAIRIS,Dyspnoea,0
80,2,LETAIRIS,Acute sinusitis,1
77,2,LETAIRIS,Dyspnoea,0
89,2,PERFALGAN,Thrombophlebitis superficial,1
85,2,DRONEDARONE,Rectal haemorrhage,1
63,2,DULOXETINE,Glucose tolerance impaired,0
83,2,LETAIRIS,Swelling,0
35,2,LETAIRIS,Pain,0
84,1,LETAIRIS,Oedema,0
14,2,ADCIRCA,Decreased appetite,0
15,2,LETAIRIS,Swelling face,0
17,2,FUROSEMIDE,Renal failure acute,1
75,2,REVATIO,Wheezing,0
79,2,ADCIRCA,Dyspnoea,0
89,2,LETAIRIS,Unevaluable event,0
25,2,METHYLPHENIDATE HCI,Product substitution issue,0
54,2,LETAIRIS,Fatigue,0
7,1,LETAIRIS,Heart rate increased,0
48,2,LETAIRIS,Infection,0
45,1,LETAIRIS,Syncope,0
,0,VYVANSE,Drug effect decreased,0
68,2,TYVASO,Chest pain,0
66,2,LETAIRIS,Pruritus,0
65,2,LETAIRIS,Upper respiratory tract infection,0
73,2,TADALAFIL,Nasal congestion,0
53,2,LETAIRIS,Dizziness,0
53,1,ADCIRCA,Bronchitis,0
58,2,"ATROPINE SULFATE INJECTION, USP (0101-25) 1MG/ML",Convulsion,0
58,2,LETAIRIS,Sinusitis,0
86,1,OLMETEC (OLMESARTAN MEDOXOMIL),Rash,0
,2,SOLIRIS,Bone marrow transplant,0
24,1,METHYLPHENIDATE ER,Drug ineffective,0
56,2,LETAIRIS,Yawning,0
50,2,REMODULIN,Pruritus,0
84,2,LETAIRIS,Fatigue,0
84,2,LETAIRIS,Ear infection,0
,2,LETAIRIS,Product packaging issue,0
,1,DEPAKOTE,Foetal anticonvulsant syndrome,1
59,1,LETAIRIS,Swelling,0
48,2,LETAIRIS,Cough,0
37,2,LETAIRIS,Arrhythmia,0
64,2,LETAIRIS,Muscle spasms,0
79,2,LETAIRIS,Hypotension,0
47,1,ONDANSETRON,Serotonin syndrome,0
47,1,ADCIRCA,Rhinorrhoea,0
55,2,LETAIRIS,Peripheral swelling,0
59,2,LETAIRIS,Haemodynamic instability,0
58,2,BUDESONIDE,Swelling face,0
75,2,LETAIRIS,Fatigue,0
62,2,REMODULIN,Influenza,0
70,2,LETAIRIS,Dyspnoea,0
53,2,LETAIRIS,Productive cough,0
48,2,VENTAVIS,Dizziness,0
66,2,LETAIRIS,Insomnia,0
42,2,REVATIO,Oedema,0
36,2,LETAIRIS,Malaise,0
50,2,TYVASO,Unevaluable event,0
69,2,LETAIRIS,Dyspnoea,0
43,1,VARENICLINE TARTRATE,Malaise,1
56,2,LETAIRIS,Unevaluable event,0
72,2,LETAIRIS,Fluid retention,1
78,1,LETAIRIS,Insomnia,0
41,2,LETAIRIS,Syncope,0
65,2,REMODULIN,Accidental overdose,0
30,0,SERTRALINE,Weight increased,1
57,2,LETAIRIS,Lacrimal disorder,0
46,2,LETAIRIS,Nasal congestion,0
56,2,LETAIRIS,Nasal congestion,0
,1,PICATO,Application site erythema,0
51,2,CODEINE/PROMETHAZINE,Drug ineffective,0
72,2,LETAIRIS,Ear congestion,0
50,2,TYVASO,Cough,0
67,1,LETAIRIS,Condition aggravated,0
35,2,LETAIRIS,Presyncope,0
,0,COPAXONE,Cerebral venous thrombosis,1
58,2,FAMOTIDINE,Dizziness,0
42,2,LETAIRIS,Bronchitis,0
68,2,TYVASO,Cough,0
63,2,LETAIRIS,Plantar fasciitis,0
70,2,LETAIRIS,Chest pain,0
,1,ARTHROTEC,Abdominal discomfort,0
64,2,PICATO,Application site erythema,0
65,2,LETAIRIS,Dry mouth,0
60,2,LETAIRIS,Sinusitis,1
69,1,DELFLEX PD SOLUTIONS 1.5%,Peritoneal cloudy effluent,0
26,2,FETZIMA,Sleep terror,0
73,2,LETAIRIS,Dyspnoea,0
48,2,LETAIRIS,Decreased appetite,0
36,2,LETAIRIS,Pulmonary arterial hypertension,0
48,1,LETAIRIS,Fibrosis,0
38,2,EPOPROSTENOL.,Diarrhoea,0
75,1,BRILINTA,Dyspnoea,1
60,2,PICATO,Application site erythema,0
70,2,LETAIRIS,Pharyngitis,0
61,2,ADCIRCA,Upper respiratory tract congestion,0
78,2,LETAIRIS,Rectal haemorrhage,0
37,2,DELFLEX WITH DEXTROSE 1.5%,Fungal peritonitis,1
71,2,LETAIRIS,Dehydration,0
21,2,LETAIRIS,Cough,0
61,2,LETAIRIS,Dizziness,0
62,1,TESTOSTERONE,Anuria,1
72,2,LETAIRIS,Weight increased,0
82,2,LETAIRIS,Drug hypersensitivity,0
55,2,DIGOXIN.,Palpitations,0
75,1,ADCIRCA,Peripheral swelling,0
45,2,LETAIRIS,Unevaluable event,0
,1,PICATO,Drug administered at inappropriate site,0
61,1,ANDROGEL,Dyspnoea,1
56,2,LETAIRIS,Dyspnoea,0
70,2,LETAIRIS,Oxygen saturation decreased,0
20,2,TYVASO,Dizziness,0
43,2,REVATIO,Rash,0
44,2,LETAIRIS,Syncope,0
63,1,LETAIRIS,Fall,0
,2,PROPOFOL,Toxic shock syndrome,1
,2,PICATO,Application site swelling,0
73,2,LETAIRIS,Dyspnoea,0
69,2,LETAIRIS,Sinusitis,0
64,2,REVATIO,Oedema,0
70,2,LETAIRIS,Peripheral swelling,0
61,2,ORTHOVISC,Headache,0
49,2,LETAIRIS,Dyspnoea,0
68,1,ZYTIGA,Shock,1
61,2,DOXIL,Palmar-plantar erythrodysaesthesia syndrome,1
58,1,PAROXETINE HYDROCHLORIDE,Nausea,1
66,2,LETAIRIS,Rash,0
58,2,ADCIRCA,Nasopharyngitis,0
56,2,LETAIRIS,Unevaluable event,0
45,0,CIPROFLOXACIN,Hallucination,0
58,2,LETAIRIS,Joint swelling,0
40,2,ADCIRCA,Headache,0
82,2,LETAIRIS,Drug ineffective,0
16,2,LETAIRIS,Flushing,0
54,1,REVATIO,Dyspnoea,0
61,2,LETAIRIS,Balance disorder,0
76,2,BACLOFEN,Vomiting,1
72,2,LETAIRIS,Cough,0
71,1,LETAIRIS,Malaise,0
43,2,LETAIRIS,Influenza,0
71,2,ADCIRCA,Nasopharyngitis,0
56,2,ADCIRCA,Fluid retention,1
64,1,LETAIRIS,Nasal congestion,0
65,2,COREG,Hypotension,0
88,2,LETAIRIS,Abdominal pain,0
83,1,DRONEDARONE,Gastrointestinal haemorrhage,1
17,1,MYORISAN,Panic attack,0
,,REMODULIN,Infusion site pruritus,0
55,2,LETAIRIS,Heart rate increased,0
59,2,LETAIRIS,Wheezing,0
53,1,LETAIRIS,Dry mouth,0
35,2,LETAIRIS,Pallor,0
58,2,LETAIRIS,Weight increased,0
92,2,LETAIRIS,Visual impairment,0
82,2,LETAIRIS,Anaemia,0
41,1,LETAIRIS,Influenza,0
51,2,LETAIRIS,Muscular weakness,0
16,1,MYORISAN,Aggression,0
72,2,LETAIRIS,Hypotension,0
49,2,LETAIRIS,Therapy cessation,0
63,2,LETAIRIS,Nasopharyngitis,0
53,2,LETAIRIS,Pain in extremity,0
62,1,LETAIRIS,Feeling cold,0
88,2,EYELEA,Cerebrovascular accident,1
47,1,LISINOPRIL,Drug hypersensitivity,0
48,2,LETAIRIS,Dizziness,0
48,2,LETAIRIS,Headache,0
82,2,LETAIRIS,Unevaluable event,0
82,2,LETAIRIS,Dyspnoea,0
66,2,LETAIRIS,Oedema peripheral,0
53,2,LETAIRIS,Unevaluable event,0
72,2,LETAIRIS,Arthralgia,0
63,2,ALENDRONIC ACID,Bone pain,0
,2,BENLYSTA,Systemic lupus erythematosus,0
77,1,ARZERRA,Death,1
38,2,TYVASO,Cough,0
74,2,LETAIRIS,Blood pressure decreased,0
14,1,LETAIRIS,Emergency care,0
62,2,LETAIRIS,Fall,0
66,2,LETAIRIS,Dyspnoea exertional,0
80,1,"FIRMAGON /01764801/FIRMAGON) (240 MG, 80 MG) (NOT SPECIFIED)",Hypokalaemia,1
58,2,VENTAVIS,Cough,0
13,2,LETAIRIS,Pulmonary arterial hypertension,0
73,2,LETAIRIS,Catheterisation cardiac,0
62,2,MELOXICAM (MELOXICAM),Drug hypersensitivity,0
65,2,LETAIRIS,Sinusitis,0
47,2,LETAIRIS,Dizziness,0
,0,"VICOTZA (LIRAGLUTIDE SOLUTION FOR INJECTION, 6MG/ML",Paraesthesia oral,0
60,2,LETAIRIS,Dyspnoea,0
40,2,LETAIRIS,Malaise,0
47,2,LETAIRIS,Oedema,0
42,2,LETAIRIS,Gastroenteritis viral,0
41,2,LETAIRIS,Swelling,0
69,1,LETAIRIS,Malaise,0
52,2,LETAIRIS,Dyspnoea,0
49,2,LETAIRIS,Cough,0
63,2,CRESTOR,Myalgia,0
59,2,LETAIRIS,Heart rate decreased,0
76,2,LETAIRIS,Dyspnoea,0
54,1,LETAIRIS,Vision blurred,0
50,1,LETAIRIS,Nausea,0
69,2,LETAIRIS,Hypotension,0
29,2,TRAMADOL (TRAMADOL HYDROCHLORIDE),Off label use,0
69,2,LETAIRIS,Eye inflammation,0
82,1,ARICEPT,Dyskinesia,0
56,2,LETAIRIS,Thyroid neoplasm,0
68,2,LETAIRIS,Deafness unilateral,0
23,2,ADCIRCA,Catheter site infection,0
45,2,TYVASO,Swelling face,0
73,2,LETAIRIS,Unevaluable event,0
78,1,SILDENAFIL CITRATE.,Dyspnoea,0
74,2,ICLUSIG,Skin ulcer,1
57,1,CIPROFLOXICIN,Hypoaesthesia,1
60,2,LETAIRIS,Muscular weakness,0
6,2,TRACLEER,Dyspnoea,0
58,2,LETAIRIS,Nasal congestion,0
56,2,LETAIRIS,Drug dose omission,0
6,1,LETAIRIS,Sinusitis,0
59,1,LETAIRIS,Limb injury,0
50,2,LETAIRIS,Device dislocation,0
53,1,LETAIRIS,Swelling face,0
1,1,ATROVENT,Skin discolouration,1
64,2,ADCIRCA,Medical device complication,0
20,2,ACTIMMUNE,Hospitalisation,1
60,2,LETAIRIS,Fluid retention,1
54,2,LETAIRIS,Medical device complication,0
50,1,LETAIRIS,Nausea,1
78,1,PRAVASTATINA,Haemoglobin decreased,0
89,2,LETAIRIS,Unevaluable event,0
57,2,TYVASO,Fatigue,0
82,2,LETAIRIS,Cardiac failure,1
33,1,LETAIRIS,Feeling abnormal,0
73,2,LASIX,Peripheral swelling,0
42,2,HYDROCORTISONE.,Balance disorder,0
61,1,LETAIRIS,Hypersensitivity,1
48,2,LETAIRIS,Unevaluable event,0
60,1,ANDROGEL,Cerebrovascular accident,1
,2,FENTORA,Death,0
20,1,XEPLION,Inappropriate schedule of drug administration,1
50,1,LETAIRIS,Dry mouth,0
24,2,REMICADE,Psychotic disorder,1
81,2,PROLIA,Renal impairment,0
,1,REMICADE,Gastric disorder,0
40,1,REMICADE,Dislocation of vertebra,1
,1,SIMPONI,Mobility decreased,1
72,1,SIMPONI,Lymphoproliferative disorder,0
60,2,LETAIRIS,Nasopharyngitis,0
27,2,TORADOL,Uterine perforation,1
66,1,METOPROLOL TARTRATE,Dyspnoea,1
69,,REVATIO,Drug ineffective,0
62,2,LETAIRIS,Oedema peripheral,0
27,2,MIRENA,Device dislocation,1
23,2,MIRENA,Uterine perforation,1
71,1,LETAIRIS,Balance disorder,0
73,2,LETAIRIS,Peripheral swelling,0
78,2,LETAIRIS,Fall,0
51,1,LISINOPRIL,Intentional overdose,1
57,2,REMODULIN,Asthenia,1
49,1,LETAIRIS,Death,0
64,2,LETAIRIS,Wrong technique in product usage process,0
,2,LETAIRIS,Influenza like illness,0
55,2,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Malaise,0
,2,ESTRING,Weight increased,0
71,2,LETAIRIS,Localised infection,0
34,2,BLEOMYCIN (SALT NO SPECIFIED)/UNKNOWN/UNKNOWN,Hypotension,0
49,2,LETAIRIS,Respiratory tract congestion,0
,2,LYRICA,Dizziness,0
58,2,LIPITOR,Glucose tolerance impaired,0
60,1,TESTIM,Cerebrovascular accident,0
,2,XALKORI,Dysphagia,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
58,2,LETAIRIS,Respiratory tract congestion,0
63,1,NOXAFIL,Death,0
35,2,CARMEX HEALING LIP BALM,Lip swelling,0
76,1,HYZAAR,Depression,1
64,2,VENLAFAXINE HCL,Disorientation,0
59,2,TYVASO,Cough,0
57,2,XALKORI,Pneumonitis,1
66,2,LYRICA,Drug ineffective,0
45,2,REVATIO,Stress,0
23,1,ICY HOT,Chemical injury,0
,0,NIFEDIPINE,Local swelling,0
51,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LYRICA,Pain,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
50,2,TYVASO,Dizziness,0
16,1,REMICADE,Irritable bowel syndrome,1
17,2,REMICADE,Clostridium difficile infection,1
7,2,REMICADE,Inflammatory bowel disease,1
34,2,COSYNTROPIN,Chest discomfort,1
,2,LYRICA,Depression,0
,0,SUTENT,Death,0
,1,PROTONIX,Pain,0
,1,INVEGA SUSTENNA,Therapeutic response decreased,0
,2,CHANTIX,Abnormal dreams,0
63,2,CAPZASIN HP ARTHRITIS PAIN RELIEF,Chemical injury,0
31,2,MIRENA,Uterine perforation,1
,2,VELCADE,Injection site nodule,0
72,2,DULOXETINE,Serotonin syndrome,1
,2,ADVIL,Insomnia,0
74,2,LIPITOR,Type 2 diabetes mellitus,0
28,2,MIRENA,Pain,1
56,2,PACLITAXEL (UNKNOWN),Dyspnoea,1
75,2,LETAIRIS,Local swelling,0
57,2,CARBOPLATIN (UNKNOWN),Neutropenia,0
87,2,FENTANYL PATCH,Mental status changes,1
36,2,ASPERCREME HEAT RELIEVING GEL,Chemical injury,0
45,2,LIPITOR,Neuropathy peripheral,1
,2,LETAIRIS,Oxygen saturation decreased,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LETAIRIS,Nasopharyngitis,0
,0,ETOPOSIDE,Chest pain,0
,2,AZITHROMYCIN,Upper limb fracture,0
,1,CHANTIX,Drug ineffective,0
83,1,ALBUTEROL SULFATE,Accidental exposure to product,0
56,2,CELEBREX,Abdominal pain upper,0
27,2,MIRTAZAPINE.,Visual impairment,0
66,1,ZOLOFT,Drug hypersensitivity,0
18,2,NUVARING,Pulmonary embolism,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
44,2,PRISTIQ,Paraesthesia,0
30,2,ZOLOFT,Drug screen false positive,0
,2,ZITHROMAX,Drug hypersensitivity,0
12,2,METHYLPREDNISOLONE SODIUM SUCCINATE,Encephalitis,1
,2,CLINDAMYCIN PHOSPHATE,Skin disorder,0
65,1,CADUET,Drug hypersensitivity,0
,2,CHANTIX,Constipation,0
69,2,XARELTO,Asthenia,1
62,2,VENLAFAXINE HCL,Cerebrovascular accident,0
49,2,LIPITOR,Type 2 diabetes mellitus,0
77,1,TESTIM,Cerebrovascular accident,0
,2,LETAIRIS,Fatigue,0
69,1,LYRICA,Dizziness,0
79,2,LETAIRIS,Nasal congestion,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
79,2,LETAIRIS,Epistaxis,0
62,2,VICTOZA,Nausea,0
75,1,USTEKINUMAB,Malignant melanoma in situ,0
15,2,FERRIPROX,Agranulocytosis,0
41,1,STELARA,Atrial fibrillation,0
54,1,STELARA,Lymphopenia,1
56,1,STELARA,Syncope,0
48,2,STELARA,Pneumonia,0
68,2,USTEKINUMAB,Dementia Alzheimer^s type,0
33,2,AUBAGIO,Central nervous system lesion,0
46,1,STELARA,Basal cell carcinoma,0
41,2,STELARA,Adenoma benign,0
64,1,ZYTIGA 250MG JANSSEN BIOTECH,Disease progression,0
82,1,PROTONIX,Myocardial infarction,0
77,2,LETAIRIS,Dysphonia,0
,0,LIALDA,Drug ineffective,0
,1,LETAIRIS,Dizziness,0
,0,LIALDA,Drug ineffective,0
3,2,PROPOFOL,Metabolic acidosis,0
55,2,METHYLPREDNISOLONE (WATSON LABORATORIES),Meningitis fungal,1
86,1,XTANDI 40MG ASTELLAS,Disease progression,0
78,2,AVONEX,Fall,1
,0,LIALDA,Diarrhoea,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LYRICA,Malaise,0
,0,LIALDA,Headache,0
38,1,STELARA,Diverticular perforation,1
73,1,ETOPOSIDE,Death,0
57,2,LIPITOR,Type 2 diabetes mellitus,0
72,2,VIAGRA,Respiratory failure,0
,0,LIALDA,Nausea,0
36,2,MIRENA,Device dislocation,0
,2,FENTORA,Death,0
,2,LETAIRIS,Feeling abnormal,0
46,2,XENAZINE,Diabetic ketoacidosis,1
47,1,EZETROL,Trigeminal palsy,0
30,2,CYMBALTA,Device dislocation,0
,2,MIRENA,Genital haemorrhage,0
71,2,PRADAXA,Atrial fibrillation,0
30,1,ADCIRCA,Syncope,0
90,2,ZANTAC (RANITIDINE HYDROCHLORIDE),Constipation,0
35,2,ACETAMINOPHEN.,Asthenia,1
18,1,HYDROCORTISONE,Drug effect decreased,0
65,1,METHYLPREDNISOLONE,Meningitis fungal,0
76,2,XENAZINE,Asthenia,0
66,2,METHYLPREDNISOLONE,Meningitis fungal,1
,0,XARELTO,Thrombosis,0
,1,XARELTO,Fall,0
,1,XARELTO,Investigation,1
,0,XARELTO,Pulmonary embolism,0
77,1,FLOMAX CAPSULES,Disorientation,0
,1,MIRENA,Penile pain,0
42,2,VENLAFAXINE,Condition aggravated,0
,2,MIRENA,Ovarian cyst,0
70,2,XENAZINE,Hospitalisation,1
,2,LETAIRIS,Feeling abnormal,0
67,2,TERIFLUNOMIDE.,Hospitalisation,1
,2,DIANEAL LOW CALCIUM,Joint swelling,0
37,1,METHYLPREDNISOLONE (WATSON LABORATORIES),Injection site pain,1
71,1,OXALIPLATIN,Hypersensitivity vasculitis,1
,1,DIANEAL LOW CALCIUM (ULTRABAG),Pneumonia,1
,2,ENBREL 50MG AMGEN,Rash,0
,2,OXYTROL FOR WOMEN,Erythema,0
,2,LETAIRIS,Dyspnoea,0
,1,DIANEAL LOW CALCIUM,Death,0
,1,DIANEAL LOW CALCIUM,Bronchitis,1
26,2,OPANA ER,Microangiopathic haemolytic anaemia,1
,2,DIANEAL LOW CALCIUM,Blood pressure fluctuation,0
61,2,DIANEAL LOW CALCIUM (ULTRABAG),Fluid overload,1
42,2,FEMSEVEN CONTI,Hypersensitivity,0
,1,TESTOPEL,Implant site infection,0
84,1,DIANEAL LOW CALCIUM,Nasopharyngitis,0
,2,DIANEAL LOW CALCIUM,Pleural effusion,1
29,2,MIRENA,Uterine perforation,1
30,2,MIRENA,Pregnancy with contraceptive device,0
87,1,DARBEPOETIN ALFA,Pathological fracture,0
25,1,DIANEAL LOW CALCIUM,Dehydration,0
24,1,OPANA ER,Microangiopathic haemolytic anaemia,1
72,2,DIANEAL LOW CALCIUM,Influenza like illness,1
57,1,DIANEAL PD2,Fall,1
65,1,DIANEAL LOW CALCIUM,Abdominal distension,0
,0,LIALDA,Constipation,0
46,1,ENBREL,Pyrexia,0
,1,DIANEAL LOW CALCIUM,Abdominal hernia,0
,1,DIANEAL LOW CALCIUM,Decreased appetite,0
,1,DIANEAL LOW CALCIUM,Pneumonia,1
18,2,BACLOFEN INTRATHECAL 2000MCG/ML,Gait disturbance,0
,1,CODEINE SULFATE,Drug hypersensitivity,0
19,2,RIFAMPIN,Rash papulosquamous,0
59,2,DIANEAL LOW CALCIUM,Dehydration,1
70,2,OXYTROL FOR WOMEN,Pollakiuria,0
67,1,DIANEAL LOW CALCIUM,Herpes zoster,1
,2,DIANEAL LOW CALCIUM (ULTRABAG),Fluid overload,0
,0,CUBICIN,Septic shock,0
,2,AFINITOR 5MG NOVARTIS,Drug ineffective,0
80,2,DIANEAL LOW CALCIUM,Pulmonary oedema,1
,1,DIANEAL LOW CALCIUM,Pancreatitis,1
,0,CUBICIN,Death,0
41,2,XYREM,Off label use,0
49,2,AUBAGIO,Stress fracture,0
,2,DIANEAL LOW CALCIUM,Hernia,1
26,2,AUBAGIO,Paraesthesia,1
,2,DIANEAL LOW CALCIUM (ULTRABAG),Fluid overload,0
,1,DIANEAL LOW CALCIUM,Weight fluctuation,0
26,2,NEXPLANON,Cellulitis,0
,2,CLARITIN,Drug effect decreased,0
57,1,"IRINOTECAN, 125 MG/M2, PFIZER",Cauda equina syndrome,1
89,2,ESCITALOPRAM,Partial seizures with secondary generalisation,1
,2,DIANEAL LOW CALCIUM,Local swelling,0
5,1,CITALOPRAM,Pulmonary arterial hypertension,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
46,2,DIANEAL LOW CALCIUM,Hypotension,0
,2,SABRIL (TABLET),Pneumonia,1
,2,MIRENA,Genital haemorrhage,0
76,1,FIRMAGON,Diarrhoea,1
,1,DIANEAL LOW CALCIUM,Dehydration,1
71,1,DIANEAL LOW CALCIUM,Cerebrovascular accident,1
83,2,ACIDO ALENDRONICO TEVA 70 MG COMP EFG 4 COMP,Atrial flutter,0
,2,DIANEAL LOW CALCIUM,Dehydration,1
,2,DIANEAL LOW CALCIUM,Cerebrovascular accident,1
81,2,LOPERAMIDE,Intestinal obstruction,1
81,1,FIRMAGON,Injection site pain,0
65,1,NEXAVAR,Pruritus generalised,0
,2,DIANEAL PD2,Infection,1
,1,DIANEAL LOW CALCIUM,Procedural pain,0
,1,AVANDIA,Myocardial infarction,0
,2,DIANEAL LOW CALCIUM,Hypotension,0
86,2,DIANEAL LOW CALCIUM (ULTRABAG),Gastric disorder,1
77,1,DEGARELIX (GONAX) 240 MG,Cardiac failure congestive,1
52,1,DIANEAL LOW CALCIUM,Diabetes mellitus inadequate control,1
79,2,TOBI,Hearing impaired,0
,2,DIANEAL LOW CALCIUM,Hypotension,0
,2,DIANEAL LOW CALCIUM (ULTRABAG),Infection,0
52,2,DIANEAL LOW CALCIUM,Pneumonia,1
,2,DIANEAL LOW CALCIUM,Hypotension,0
,2,DIANEAL PD2,Pulmonary oedema,1
77,1,OXYGEN,Anaphylactic reaction,1
32,1,SUCCINYLCHOLINE,Pyrexia,1
,1,DIANEAL LOW CALCIUM,Swollen tongue,1
84,2,ADVAIR HFA,Addison^s disease,0
,2,DIANEAL LOW CALCIUM,Procedural pain,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Cardiac failure congestive,1
,2,DIANEAL LOW CALCIUM,Extremity necrosis,0
,1,EPZICOM,Nephrolithiasis,1
64,1,ADVAIR,Pneumonia,1
61,1,ONDANSETRON,Non-alcoholic steatohepatitis,1
73,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,1,ADVAIR,Investigation,1
,1,DIANEAL LOW CALCIUM,Hernia,1
,1,DIANEAL LOW CALCIUM,Procedural pain,0
,2,ADVAIR,Cardiac operation,0
85,1,WARFARIN,Gastric haemorrhage,1
55,2,PROMETHAZINE,Breast cancer metastatic,0
27,1,DURAPHAT,Hypersensitivity,0
,2,WELLBUTRIN XL,Anaphylactoid reaction,0
,1,RIFAMPIN,International normalised ratio decreased,0
58,2,ADVAIR HFA,Pneumonia,1
57,1,ADVAIR,Death,0
68,1,DIANEAL LOW CALCIUM,Influenza,0
,1,SOLIRIS,Ill-defined disorder,1
48,2,ADVAIR,Pneumonia,0
,2,PROAIR HFA,Drug ineffective,0
84,2,ADVAIR,Blindness,0
44,2,VOTRIENT,Death,0
57,1,CARBOPLATIN,Pneumonia,1
49,2,COREG CR,Cardiac failure congestive,0
68,2,DIANEAL LOW CALCIUM,Fall,0
50,1,AVANDIA,Adverse event,0
,1,DIANEAL LOW CALCIUM,Swelling,0
48,2,PROPRANOLOL,Overdose,0
58,2,SERETIDE,Breast cancer,0
57,2,VEGF TRAP-EYE,Cardiac failure,1
63,2,TYKERB,Pneumonia aspiration,1
3,2,AEROLIN,Pertussis,1
,1,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Post procedural infection,1
68,1,AVANDIA,Adverse event,0
62,2,AVANDIA,Adverse event,0
,1,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
50,1,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,1
,2,SERETIDE,Death,0
,1,CORICIDIN HBP COLD AND FLU,Somnolence,0
67,2,BEVACIZUMAB(RHUMAB VEGF),Abnormal behaviour,1
,1,LOVAZA,Myocardial infarction,0
62,2,PAZOPANIB,Seroma,1
75,2,ORENCIA,Eye disorder,0
,,SOLIRIS,Unevaluable event,1
,2,DIANEAL LOW CALCIUM (ULTRABAG),Myocardial infarction,0
,2,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Peripheral swelling,1
62,1,BRILINTA,Thrombocytopenia,0
59,2,CAPTOPRIL,Drug hypersensitivity,1
80,1,BEVACIZUMAB(RHUMAB VEGF),Dyspnoea,0
33,2,DIANEAL PD2 WITH 1.5% DEXTROSE,Death,1
80,2,DIANEAL LOW CALCIUM,Myocardial infarction,1
72,2,DIANEAL LOW CALCIUM,Sepsis,1
,2,DIANEAL LOW CALCIUM,Discomfort,0
38,2,RELENZA,Toxic skin eruption,0
59,1,INTRON A,Blood creatine phosphokinase increased,0
,2,KIVEXA,Blood glucose increased,1
31,2,ARRANON,Abasia,0
77,1,DIANEAL LOW CALCIUM,Dysphonia,0
57,2,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Hernia,1
67,0,DRONEDARONE,Gastrointestinal haemorrhage,1
81,2,NADROPARINE CALCIUM,Thrombosis,0
51,1,ERBITUX,Dizziness,0
,2,SERETIDE,Macroglossia,1
82,2,KIOVIG,Transient ischaemic attack,0
89,1,AVOLVE,Interstitial lung disease,1
,0,REQUIP LP,Abnormal behaviour,1
63,2,RELENZA,Ageusia,0
,1,A+D MEDICATED OINTMENT,Condition aggravated,0
96,2,VALTREX,Altered state of consciousness,0
42,2,GAMMAGARD LIQUID,Throat tightness,1
11,1,RELENZA,Stevens-Johnson syndrome,1
59,1,DIMETHYL FUMARATE,Rash,0
39,2,RELENZA,Dysgeusia,0
38,2,CORICIDIN HBP COLD AND FLU,Therapeutic product ineffective,0
65,2,VOTRIENT,Hepatocellular injury,0
40,2,AZITHROMYCIN,Pain,0
16,2,LAMICTAL,Stevens-Johnson syndrome,1
34,2,ZANAMIVIR,Multi-organ failure,0
,0,DIANEAL LOW CALCIUM,Abdominal distension,0
69,1,ALKERAN,Atrial flutter,1
59,1,GLYCOPYRROLATE INJECTION,Angle closure glaucoma,0
28,2,LAMICTAL,Loss of consciousness,0
,2,FENTANYL,Neoplasm malignant,0
43,1,ZINACEF,Anaphylactic shock,1
35,1,PEG ASPARAGINASE,Flushing,0
,2,DIANEAL LOW CALCIUM,Blood albumin decreased,1
55,2,VOTRIENT,Stomatitis,0
44,2,CHANTIX,Drug ineffective,0
,1,GAMMAGARD S/D,Hepatitis C,0
41,2,TYVERB,Neurotoxicity,0
77,2,SERETIDE,Burning sensation,0
,2,TYVERB,Disease progression,0
,1,DIANEAL LOW CALCIUM,Hypertension,0
80,2,ZOVIRAX,Oedema peripheral,0
,1,LAMOTRIGINE,Neonatal respiratory distress syndrome,1
,2,DIANEAL LOW CALCIUM (ULTRABAG),Urinary tract infection,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
,2,DIANEAL LOW CALCIUM (ULTRABAG),Gastric infection,0
,1,LAMOTRIGINE,Liver disorder,1
,2,DIANEAL LOW CALCIUM,Cardiac failure congestive,1
57,2,GSK2126458,Dehydration,1
30,2,OMNISCAN,Nephrogenic systemic fibrosis,0
49,2,DIANEAL LOW CALCIUM (ULTRABAG),Peritonitis bacterial,0
75,1,REVLIMID 5 MG,Asthenia,1
,2,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
54,1,DIANEAL PD-2 PERITONEAL DIALISIS SOLUTION ULTRABAG WITH 2.5% DEXTROSE,Cardiac disorder,1
61,2,TIARAMIDE HYDROCHLORIDE,Headache,0
80,1,IBUPROFEN,Gastroenteritis viral,1
72,1,METRONIDAZOLE,Anaphylactic shock,0
,2,CELEBREX,Pain,0
38,2,MULTIHANCE,Anaphylactic reaction,1
62,1,DIANEAL LOW CALCIUM,Fluid overload,0
,2,NITROGLYCERIN IN 5% DEXTROSE INJECTION,Product container issue,0
,0,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
85,2,BACTRIM,Hyperkalaemia,1
59,2,ATORVASTATIN,Dysgeusia,0
48,1,CLOPIDOGREL,Haematuria,0
52,2,LIPITOR,Type 2 diabetes mellitus,0
54,2,EMTRICITABINE/TENOFOVIR,Aphasia,0
,2,COPAXONE,Secondary progressive multiple sclerosis,0
,2,DIANEAL LOW CALCIUM,Intestinal perforation,1
51,1,CHOLESTYRAMINE.,Constipation,1
52,2,LIPITOR,Diabetic neuropathy,0
67,1,MIRALAX,Drug ineffective,0
,0,HURRICANE SPRAY,Methaemoglobinaemia,1
,2,GAMMAGARD LIQUID,Expired drug administered,0
,1,DIANEAL PD2 (ULTRABAG),Pneumonia,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,DIANEAL LOW CALCIUM,Dyspepsia,0
16,2,FLUOXETINE,Convulsion,0
72,2,DRONEDARONE,Gastrointestinal haemorrhage,1
63,1,IRINOTECAN,Pneumocystis jirovecii infection,1
51,2,ORSYTHIA,Feeling abnormal,0
,2,DIANEAL PD2,Staphylococcal infection,1
68,1,TENORMIN,Drug hypersensitivity,0
,2,LIPITOR,Type 2 diabetes mellitus,0
28,2,METRONIDAZOLE,Abdominal wall haemorrhage,1
83,1,DIANEAL LOW CALCIUM,Urticaria,0
35,2,VELIVET BARR,Breast disorder,0
48,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,HYDROCHLOROTHIAZIDE.,Hypothyroidism,0
14,2,METOCLOPRAMIDE,Torticollis,0
48,2,LIPITOR,Renal disorder,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
67,0,PROPOFOL 1% FRESENIUS (PROPOFOL) (PROPOFOL),Pneumonia,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
43,2,NOVOLOG,Drug dispensing error,1
87,2,DOXAZOSIN,Local swelling,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
,1,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
44,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
62,1,VERSED,Respiratory depression,1
53,2,LIPITOR,Type 2 diabetes mellitus,0
,1,DIANEAL LOW CALCIUM,Abdominal pain,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
79,2,DRONEDARONE,Epistaxis,0
38,2,DIANEAL LOW CALCIUM,Influenza,0
60,2,TEMOZOLOMIDE 140MG TEVA,Dehydration,1
,1,SUTENT,Pneumonia,0
73,2,LIPITOR,Type 2 diabetes mellitus,1
34,2,DIANEAL LOW CALCIUM,Convulsion,1
,1,OXYTROL FOR WOMEN,Drug ineffective,0
81,1,DRONEDARONE,Haemorrhage,1
,2,PROPOFOL,Completed suicide,0
73,2,GAMMAGARD LIQUID,Seizure like phenomena,0
64,2,LIPITOR,Type 2 diabetes mellitus,0
65,1,AMLODIPINE,Local swelling,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
,0,GASTROGRAFIN,Drug ineffective,0
,1,SPIRIVA,Incorrect route of drug administration,0
27,1,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
75,2,LIPITOR,Type 2 diabetes mellitus,0
88,2,OXYTROL FOR WOMEN,Cystitis,0
82,2,LISINOPRIL.,Type 2 diabetes mellitus,0
,0,GASTROGRAFIN,Product odour abnormal,0
,1,GAMMAGARD LIQUID,Neutropenia,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
,1,SOLIRIS,Transfusion,0
,2,LIPITOR,Type 2 diabetes mellitus,0
63,0,GILENYA,Central nervous system lesion,0
7,2,TYGACIL,Blood fibrinogen decreased,0
28,2,CITALOPRAM,Urinary retention,1
31,2,TASIGNA,Maternal exposure during pregnancy,0
77,1,THALIDOMIDE,Myelodysplastic syndrome,0
,2,GILENYA,Benign breast neoplasm,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Peritonitis bacterial,0
,2,0.9% SODIUM CHLORIDE INJECTION,Diabetic vascular disorder,0
49,2,LIPITOR,Abdominal pain upper,0
,0,GASTROGRAFIN,Drug ineffective,0
61,1,DIANEAL LOW CALCIUM (ULTRABAG),Catheter site infection,0
,0,GASTROGRAFIN,Poor quality drug administered,0
80,2,ARICEPT,Haemoptysis,1
62,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
65,2,DRONEDARONE,Rectal haemorrhage,1
52,2,BETAFERON,Gamma-glutamyltransferase increased,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
,1,EFFEXOR,Arterial disorder,1
77,2,LIPITOR,Type 2 diabetes mellitus,0
84,2,MEMANTINE,Diarrhoea,1
,2,LIPITOR,Type 2 diabetes mellitus,0
58,2,GLUCOSAMINE,Glucose tolerance impaired,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
25,1,REMODULIN,Nasopharyngitis,0
48,2,LIPITOR,Type 2 diabetes mellitus,0
57,1,POMALYST,Hypersensitivity,1
,1,COUMADIN,Atrial fibrillation,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,SUTENT,Death,0
69,2,ADCIRCA,Fatigue,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
,2,DRONEDARONE,Gastrointestinal haemorrhage,0
38,2,LIPITOR,Type 2 diabetes mellitus,0
79,1,LETAIRIS,Restless legs syndrome,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LETAIRIS,Dyspnoea,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
34,1,ALKA-SELTZER PLUS COLD FORMULA,Aphagia,0
25,2,LETAIRIS,Weight decreased,0
,2,LIPITOR,Type 2 diabetes mellitus,0
54,2,LETAIRIS,Oedema,1
,2,ZOLOFT,Insomnia,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
65,2,LETAIRIS,Ocular hyperaemia,0
44,1,LETAIRIS,Nausea,0
90,1,CARDIOASPIRIN,Haematemesis,1
47,2,LIPITOR,Type 2 diabetes mellitus,0
69,2,LIPITOR,Type 2 diabetes mellitus,0
62,2,OXYTROL FOR WOMEN,Discomfort,0
51,2,LETAIRIS,Constipation,0
79,2,LETAIRIS,Fatigue,0
33,2,LIPITOR,Type 2 diabetes mellitus,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
73,2,LETAIRIS,Headache,0
78,1,LETAIRIS,Arthropathy,0
,0,GASTROGRAFIN,Drug ineffective,0
14,1,TYVASO,Oxygen supplementation,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
66,2,LETAIRIS,Viral infection,0
81,2,LETAIRIS,Anaemia,0
,0,PROVENTIL,Adverse event,0
,2,GASTROGRAFIN,Abdominal pain,0
65,2,LIPITOR,Type 2 diabetes mellitus,0
,0,VPRIV,Death,0
8,2,LETAIRIS,Sinusitis,0
,1,DR. SCHOLLS CLEAR AWAY WART REMOVER,Drug ineffective,0
33,2,VELETRI,Malaise,0
,2,AFINITOR,Cholecystitis,1
62,2,LIPITOR,Type 2 diabetes mellitus,0
75,2,REMODULIN,Flushing,0
,1,GASTROGRAFIN,Aspiration,0
62,2,LETAIRIS,Unevaluable event,0
44,2,REVATIO,Nasopharyngitis,0
67,2,LOPID,Type 2 diabetes mellitus,0
48,2,SERTRALINE HCL,Abdominal pain upper,0
,1,PICATO,Product packaging quantity issue,0
11,1,LETAIRIS,Cough,0
,2,OXYTROL FOR WOMEN,Wrong technique in drug usage process,0
74,2,TRACLEER,Animal bite,0
43,1,LETAIRIS,Unevaluable event,0
66,2,LIPITOR,Weight increased,0
67,2,LETAIRIS,Back pain,0
,0,VPRIV,Bone infarction,0
81,2,LETAIRIS,Unevaluable event,0
,1,DR. SCHOLL^S INGROWN TOENAIL PAIN RELIEVER,Drug effect decreased,0
53,1,LETAIRIS,Hypersensitivity,0
66,2,PICATO,Dysgeusia,0
68,2,REVATIO,Dyspnoea,0
50,2,LETAIRIS,Dyspnoea,0
65,2,ACETYLSALICYLIC ACID (} 100 MG),Analgesic asthma syndrome,0
65,1,CYTARABINE (MANUFACTURER UNKNOWN) (CYTARABINE) (CYTARABINE),Disease progression,0
58,2,LETAIRIS,Productive cough,0
26,2,LETAIRIS,Malaise,0
77,2,LETAIRIS,Atrial fibrillation,0
79,2,LETAIRIS,Pain,0
,0,GASTROGRAFIN,Drug ineffective,0
,1,PICATO,Incorrect dose administered,0
62,2,LETAIRIS,Cough,0
89,2,LETAIRIS,Asthenia,0
40,2,LETAIRIS,Nasal congestion,0
50,1,REMODULIN,Haemorrhage,0
78,1,GASTROGRAFIN,Product colour issue,0
80,2,ALEVE GELCAPS,Drug ineffective,0
34,2,REVATIO,Respiratory disorder,0
,2,PICATO,Application site vesicles,0
43,2,REVATIO,Productive cough,0
35,2,LETAIRIS,Unevaluable event,0
,2,GILENYA,Skin cancer,0
51,2,LETAIRIS,Pain in extremity,0
81,2,LETAIRIS,Dyspnoea,0
82,1,LETAIRIS,Drug ineffective,0
68,2,REVATIO,Fluid retention,0
,1,LYRICA,Convulsion,0
39,2,REVATIO,Influenza,0
29,2,TYVASO,Nasopharyngitis,0
55,2,LETAIRIS,Drug hypersensitivity,1
41,2,LETAIRIS,Bronchitis,0
67,2,ADVICOR,Type 2 diabetes mellitus,0
66,2,CIALIS,Nasal congestion,0
44,1,LETAIRIS,Chest pain,0
62,2,LETAIRIS,Dizziness,0
70,2,LETAIRIS,Peripheral swelling,1
75,2,LETAIRIS,Sinusitis,0
53,2,LETAIRIS,Dyspnoea,0
60,1,LETAIRIS,Gastrooesophageal reflux disease,0
83,2,LETAIRIS,Back disorder,0
58,1,PICATO,Incorrect drug administration duration,0
,1,BAYER GENUINE ASPIRIN ORIGINAL STRENGTH,Respiratory distress,0
,2,ALEVE CAPLET,Pre-existing condition improved,0
51,1,XALKORI,Death,0
64,1,OXYGEN.,Palpitations,0
52,2,REVATIO,Dyspnoea,0
52,2,LETAIRIS,Hepatic enzyme increased,0
68,2,LETAIRIS,Flushing,0
70,2,LETAIRIS,Dizziness,0
26,2,ALEVE CAPLET,Extra dose administered,0
69,2,LETAIRIS,Vertigo,0
65,2,PICATO,Application site dryness,0
78,2,LETAIRIS,No therapeutic response,0
77,2,LETAIRIS,Dyspnoea,0
68,2,LETAIRIS,Pyrexia,0
45,2,TYVASO,Diarrhoea,0
62,2,ADCIRCA,Intervertebral disc protrusion,0
,2,CLARITIN,Drug ineffective,0
54,2,LETAIRIS,Pain,0
,1,PICATO,Application site vesicles,0
,0,VYVANSE,Logorrhoea,0
56,2,LETAIRIS,Dyspnoea,0
81,1,LETAIRIS,Weight fluctuation,0
54,2,HYDROCHLOROTHIAZIDE.,Anaemia,0
53,2,LETAIRIS,Heart rate increased,0
62,1,LETAIRIS,Rash,0
57,2,REVATIO,Fatigue,0
85,2,LETAIRIS,Drug ineffective,0
82,1,LETAIRIS,Dyspnoea,0
56,2,LETAIRIS,Fluid retention,1
83,2,LETAIRIS,Dyspnoea,0
43,2,LETAIRIS,Dyspnoea,0
49,2,TYVASO,Sinusitis,0
70,2,LETAIRIS,Nasopharyngitis,0
55,2,LETAIRIS,Myalgia,0
,0,VYVANSE,Drug ineffective,0
41,2,LETAIRIS,Swelling,0
69,2,LETAIRIS,Tremor,0
69,1,LETAIRIS,Ocular hyperaemia,0
71,2,LETAIRIS,Fluid retention,0
59,1,LETAIRIS,Headache,0
70,2,TYVASO,Sinusitis,0
59,2,PICATO,Application site dryness,0
67,2,LETAIRIS,Back injury,0
,1,AFRIN SEVERE CONGESTION SPRAY WITH MENTHOL,Drug ineffective,0
,1,ACLASTA,Fall,0
45,2,TYVASO,Throat tightness,0
69,1,LETAIRIS,Oedema peripheral,0
32,2,REMODULIN,Infusion site reaction,0
62,2,ADCIRCA,Nasopharyngitis,0
44,2,TYVASO,Dizziness,0
71,2,LETAIRIS,Nasopharyngitis,0
48,2,LETAIRIS,Headache,0
72,2,LETAIRIS,Heart rate increased,0
,2,"PICATO (0.015 %, GEL)",Drug ineffective,0
5,2,LETAIRIS,Cough,0
53,2,LETAIRIS,Systemic lupus erythematosus,0
,2,ALEVE CAPLET,Therapeutic response unexpected,0
70,2,LETAIRIS,Peripheral swelling,0
36,2,LETAIRIS,Medical device implantation,0
76,2,LETAIRIS,Cataract,0
65,2,LETAIRIS,Unevaluable event,0
,0,VYVANSE,Drug effect decreased,0
39,2,"XYREM (SODIUM OXYBATE) ORAL SOLUTION, 500MG/ML",Cardiac ablation,0
53,2,REVATIO,Rash,0
38,2,LETAIRIS,Headache,0
72,1,LETAIRIS,Arthritis,0
48,2,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Application site pain,0
74,2,LETAIRIS,Dyspnoea,0
56,1,REVATIO,Oedema,0
85,2,LETAIRIS,Somnolence,0
53,2,ADCIRCA,Headache,0
58,2,LETAIRIS,Dizziness,0
79,1,LETAIRIS,Cardiac failure congestive,1
62,2,LETAIRIS,Drug hypersensitivity,0
35,2,TYVASO,Bronchitis,0
61,2,REVATIO,Polyarthritis,0
85,1,EXELON PATCH,Death,0
57,1,LETAIRIS,Malaise,0
,0,ALEVE CAPLET,Drug ineffective,0
81,2,LETAIRIS,Dizziness,0
72,2,LETAIRIS,Feeling abnormal,0
80,2,ADCIRCA,Peripheral swelling,0
57,1,ADCIRCA,Nausea,1
82,1,LETAIRIS,Nasal congestion,0
,1,COREG,Arrhythmia,0
74,2,LETAIRIS,Pruritus generalised,0
44,2,LETAIRIS,Respiratory tract infection,0
86,2,LETAIRIS,Abdominal pain upper,0
76,2,LETAIRIS,Unevaluable event,0
84,1,LETAIRIS,Peripheral swelling,0
59,2,LETAIRIS,Respiratory tract congestion,0
61,2,LETAIRIS,Oedema peripheral,0
31,2,ADCIRCA,Bronchitis,0
52,2,LETAIRIS,Vasodilatation,0
61,2,VENTAVIS,Dizziness,0
73,1,LETAIRIS,Blood count abnormal,1
42,1,TASIGNA,Incorrect dose administered,0
48,1,ALEVE CAPLET,Drug ineffective,0
13,1,ADCIRCA,Pyrexia,0
67,2,ADCIRCA,Bronchitis,0
75,2,LETAIRIS,Tooth extraction,0
91,2,LETAIRIS,Fall,0
52,2,LETAIRIS,Phlebitis,0
79,1,REVATIO,Feeling abnormal,0
47,2,LETAIRIS,Dyspnoea,0
75,2,LETAIRIS,Peripheral swelling,0
41,2,LETAIRIS,Influenza,0
66,2,LETAIRIS,Pulmonary arterial hypertension,0
63,2,LETAIRIS,Dyspnoea,0
74,2,LASIX,Influenza,0
79,1,LETAIRIS,Cough,0
57,2,LETAIRIS,Peripheral swelling,0
56,2,LETAIRIS,Swelling,0
59,2,ADCIRCA,Unevaluable event,0
61,1,LETAIRIS,Peripheral swelling,0
69,1,ADCIRCA,Upper respiratory tract infection,0
82,2,LETAIRIS,Nasopharyngitis,0
63,2,REMODULIN,Constipation,0
68,1,LETAIRIS,Nasal congestion,0
81,2,LETAIRIS,Muscle spasms,0
85,2,LETAIRIS,Unevaluable event,0
51,2,LETAIRIS,Hepatic enzyme increased,0
73,2,ADCIRCA,Sinus disorder,0
75,2,LETAIRIS,Nasopharyngitis,0
41,2,LETAIRIS,Burning sensation,0
47,2,LETAIRIS,Influenza,0
64,2,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Arthropathy,0
,2,LETAIRIS,Pain in extremity,0
68,2,LETAIRIS,Sinusitis,0
67,1,LETAIRIS,Arthritis,0
58,2,LETAIRIS,Sinusitis,0
75,2,LETAIRIS,Cough,0
70,2,LETAIRIS,Cystitis,0
67,1,LETAIRIS,Cough,0
34,2,OXYGEN.,Epistaxis,0
62,2,LETAIRIS,Device leakage,0
56,2,LETAIRIS,Influenza,0
50,2,LETAIRIS,Palpitations,0
76,1,LETAIRIS,Oropharyngeal pain,0
42,2,LETAIRIS,Parotid gland enlargement,0
65,2,LETAIRIS,Dyspnoea,0
,2,ACLASTA,Cardiac disorder,1
75,2,LETAIRIS,Oxygen supplementation,0
61,2,LETAIRIS,Influenza,0
43,2,LETAIRIS,Laryngitis,0
47,2,VELETRI,Headache,0
64,1,LETAIRIS,Iron deficiency anaemia,0
86,2,LETAIRIS,Fluid retention,0
78,1,ZOMETA,Myocardial infarction,1
78,2,LETAIRIS,Back pain,0
,1,GILENYA,Malaise,0
31,1,REVATIO,Flushing,0
45,2,LETAIRIS,Nasopharyngitis,0
43,2,SILDENAFIL CITRATE.,Hepatic enzyme increased,0
68,1,LETAIRIS,Peripheral swelling,0
13,2,REMODULIN,Dizziness,0
12,2,ADCIRCA,Syncope,0
55,2,TYVASO,Influenza,0
66,2,LETAIRIS,Oropharyngeal pain,0
54,2,LETAIRIS,Dyspnoea,0
45,2,SILDENAFIL.,Arthralgia,0
61,2,LETAIRIS,Oedema,0
51,1,ADCIRCA,Swelling,1
78,2,REVATIO,Oedema,0
68,1,LETAIRIS,Musculoskeletal chest pain,0
,2,REVATIO,Fall,0
66,2,REVATIO,Pneumonia,0
67,2,ADCIRCA,Dizziness,0
55,1,ADVAIR HFA,Nasal congestion,0
77,2,XYREM,Drug interaction,0
53,2,REVATIO,Dizziness,0
72,2,VENTAVIS,Nasopharyngitis,0
57,2,LETAIRIS,Weight decreased,0
45,1,LETAIRIS,Dizziness,0
76,1,LETAIRIS,Swelling,1
50,2,SILDENAFIL.,Condition aggravated,0
53,2,LETAIRIS,Dyspnoea,0
77,2,LETAIRIS,Paraesthesia,0
79,2,LETAIRIS,Oedema,0
33,2,LETAIRIS,Head discomfort,0
40,1,CLOZARIL,Pathogen resistance,1
68,2,LETAIRIS,Oedema peripheral,0
25,2,LETAIRIS,Rash,0
,2,LETAIRIS,Oedema peripheral,0
42,2,TYVASO,Influenza,0
54,2,LETAIRIS,Fluid retention,0
68,2,LETAIRIS,Malaise,0
72,2,LETAIRIS,Nasopharyngitis,0
,1,TYVASO,Nasopharyngitis,0
55,2,XYREM,Brain injury,0
81,2,LETAIRIS,Abdominal discomfort,0
72,1,LETAIRIS,Upper respiratory tract infection,0
73,1,LETAIRIS,Nasopharyngitis,0
80,2,ADCIRCA,Nasal congestion,0
52,2,ADCIRCA,Pneumonia,0
57,1,LETAIRIS,Fluid retention,0
57,1,PREDNISOLONE,Mental disorder,0
77,1,LETAIRIS,Syncope,0
64,1,LETAIRIS,Sinus disorder,0
78,2,LETAIRIS,Chronic obstructive pulmonary disease,0
82,2,RECLAST,Malaise,0
52,2,ADCIRCA,Drug prescribing error,0
63,1,XOFIGO,Gastrointestinal disorder,0
63,2,LETAIRIS,Medical device complication,0
71,2,REVATIO,Peripheral swelling,0
52,1,LETAIRIS,Back injury,0
45,2,LETAIRIS,Drug ineffective,0
32,1,XYREM,Nephrolithiasis,0
69,2,REVATIO,Somnolence,0
74,2,LETAIRIS,Dyspnoea,0
84,2,LETAIRIS,Unevaluable event,0
54,1,LETAIRIS,No therapeutic response,0
56,1,LETAIRIS,Dyspnoea,0
76,2,LETAIRIS,Unevaluable event,0
32,2,LETAIRIS,Pleurisy,0
59,2,LETAIRIS,Constipation,0
69,2,LETAIRIS,Hair texture abnormal,0
60,1,AVELOX,Deafness,0
66,2,LETAIRIS,Nasopharyngitis,0
66,1,TAMSULOSIN,Oedema peripheral,0
81,1,REVATIO,Arthralgia,0
28,2,LETAIRIS,Dizziness,0
73,2,LETAIRIS,Vision blurred,0
51,2,EPOPROSTENOL.,Oral fungal infection,0
69,1,LETAIRIS,No therapeutic response,0
27,2,REVATIO,Cough,0
74,2,LETAIRIS,Pain,0
53,1,LETAIRIS,Rhinorrhoea,0
44,2,LASIX,Dyspnoea,1
73,2,REVATIO,Dizziness,0
56,2,LETAIRIS,Constipation,0
71,2,LETAIRIS,Fluid retention,1
70,2,LETAIRIS,Dyspnoea,0
63,2,VENTAVIS,Gastric disorder,0
75,2,LETAIRIS,Unevaluable event,0
72,2,LETAIRIS,Skin discolouration,0
65,2,REMODULIN,Headache,0
46,2,REVATIO,Dyspnoea exertional,0
67,2,LETAIRIS,Fatigue,0
,1,PULMICORT FLEXHALER,Asthma,0
78,2,LETAIRIS,Nasopharyngitis,0
43,2,ADCIRCA,Wrong technique in product usage process,0
87,2,LETAIRIS,Fatigue,0
58,2,OXYTROL FOR WOMEN,Hypersensitivity,0
,1,SILDENAFIL.,Pulmonary arterial hypertension,0
81,2,LETAIRIS,Dry mouth,0
82,2,LETAIRIS,Ligament sprain,0
69,2,LETAIRIS,Fluid retention,0
56,2,PICATO,Application site vesicles,0
71,2,PACLITAXEL,Dehydration,1
,1,AFINITOR,Death,0
27,2,PARAGARD 380A,Vaginal haemorrhage,0
43,2,TYVASO,Influenza,0
43,2,LETAIRIS,Chest pain,0
66,2,LETAIRIS,Dyspnoea,0
16,2,ARIPIPRAZOLE,Bundle branch block right,0
,1,BYETTA PEN DISPOSABLE,Arterial occlusive disease,1
,0,ARIPIPRAZOLE,Pneumonia,1
74,2,LETAIRIS,Dyspnoea,0
61,2,BYDUREON,Loss of consciousness,0
47,2,LETAIRIS,Bedridden,0
33,2,NUVIGIL,Fatigue,0
68,1,KOMBIGLYZE XR,Pancreatitis,0
63,1,BYETTA PEN DISPOSABLE,Cardiac aneurysm,0
74,2,LETAIRIS,Nasopharyngitis,0
84,1,LETAIRIS,Chest discomfort,0
55,2,FLOLAN,Fluid retention,0
63,2,PICATO,Application site erythema,0
54,2,LETAIRIS,Asthenia,0
,1,GLEEVEC,Bladder neoplasm,0
75,2,LETAIRIS,Insomnia,0
68,2,LETAIRIS,Angioedema,0
,2,ORENCIA,Granulomatosis with polyangiitis,0
60,2,LETAIRIS,Drug administration error,0
67,2,ORENCIA FOR INJ 250 MG/VIAL,Tinnitus,0
57,2,LETAIRIS,Nasopharyngitis,0
55,2,LETAIRIS,Malaise,0
56,1,SYNTHROID,Metastases to central nervous system,1
,2,CLARITIN,Drug ineffective,0
82,2,LETAIRIS,Oedema peripheral,0
63,2,"PICATO (INGENOL MEBUTATE) (0.015 %, GEL)",Application site rash,0
53,2,LETAIRIS,Respiratory tract congestion,0
68,2,LETAIRIS,Cardiac failure congestive,0
,1,SOMATULINE DEPOT INJECTION (90MG),Gallbladder disorder,1
75,1,GUAIFENESIN.,Blister,0
71,2,OXYTROL FOR WOMEN,Drug effect delayed,0
66,2,LETAIRIS,Feeling jittery,0
,1,XALKORI,Local swelling,0
66,2,LETAIRIS,Lung infection,0
,2,AFRIN NO DRIP SEVERE CONGESTION,Drug ineffective,0
70,1,GLIBENCLAMIDE,Portal vein thrombosis,1
46,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
65,1,LETAIRIS,Weight decreased,0
,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,,AMOXICILLIN / CLAVULANSAURE,Pancytopenia,1
37,2,LETAIRIS,Incision site rash,0
53,2,LETAIRIS,Insomnia,0
72,1,PICATO,Application site erythema,0
70,2,FENTANYL CITRATE,Anaphylactic shock,0
29,2,LETAIRIS,Headache,0
,0,SERTRALINE,Kidney duplex,0
76,2,LETAIRIS,Sinusitis,0
53,2,FLOLAN,Dermatitis contact,0
,2,REMINYL,Sudden death,0
,2,PARAGARD 380A,Metrorrhagia,0
11,1,LETAIRIS,Vomiting,0
64,2,LETAIRIS,Nasal congestion,0
61,2,ORENCIA FOR INJ,Basal cell carcinoma,0
1,2,LESTAURTINIB,Febrile neutropenia,1
,2,DILTIAZEM SANDOZ,Renal pain,0
72,2,OXYTROL FOR WOMEN,Dermatitis contact,0
45,1,GLIVEC,Muscular weakness,0
,2,FLECTOR,Rash generalised,0
,2,LETAIRIS,Nasal congestion,0
37,2,XYREM,Abortion spontaneous,0
74,2,OXYTROL FOR WOMEN,Diarrhoea,0
,1,BYETTA,Pancreatic carcinoma,0
84,2,PROLIA,Pulmonary embolism,0
59,1,ETANERCEPT,Pulmonary fibrosis,0
,2,EFFEXOR XR,Drug ineffective,0
71,1,MONOPRIL,Pancreatic carcinoma,0
,0,SPIRIVA,Incorrect route of drug administration,0
74,2,BACLOFEN INTRATHECAL,Respiratory failure,0
64,1,COMBIVENT,Dyspnoea,0
25,2,ORENCIA,Intestinal perforation,1
,0,CLOZARIL,Asthma,1
,2,CLOZARIL,Paranoia,1
,2,EVISTA,Rectal haemorrhage,0
23,2,VITAMIN D,Intracranial pressure increased,1
,0,CUBICIN,Extradural abscess,0
31,1,BARACLUDE,Blood creatine phosphokinase increased,0
,2,ABILIFY,Diabetes mellitus,0
61,2,LIPITOR,Type 2 diabetes mellitus,0
65,2,VITAMIN E                          /00110501/,Thyroid cancer,0
,2,LIPITOR,Type 2 diabetes mellitus,0
53,1,CLOZARIL,Cardiac arrest,0
55,2,PICATO,Application site pustules,0
,2,SIMPONI,Eosinophilia,1
81,2,JAKAFI,Malaise,0
64,2,OXALIPLATIN,Sepsis,1
64,1,SUTENT,Organ failure,0
78,2,LYRICA,Arthropathy,0
48,1,SOMATULINE,Pituitary tumour removal,0
,2,VENLAFAXINE HCL,Drug ineffective,0
54,2,EFFEXOR XR,Cardiac disorder,0
,1,PICATO,Incorrect drug administration duration,0
62,2,JAKAFI,Hospitalisation,1
,2,PARAGARD 380A,Embedded device,0
,2,LIPITOR,Type 2 diabetes mellitus,0
92,2,ZOLOF,Cardiac failure,1
34,1,AMOXI 1A PHARMA,Swelling face,1
16,1,HUMIRA,C-reactive protein increased,1
75,1,RAPAMUNE,Haemorrhage,0
39,1,REGORAFENIB,General physical health deterioration,0
82,2,PICATO,Application site swelling,0
66,2,SINTROM,Syncope,1
56,2,DELSYM ADULT GRAPE LIQUID,Anxiety,0
,1,CELEBREX,Death,0
65,2,OXYTROL FOR WOMEN,Drug effect decreased,0
68,2,RIVAROXABAN,Basal ganglia haemorrhage,1
67,2,XARELTO,Subdural haemorrhage,0
79,1,XARELTO,Basal ganglia haemorrhage,1
65,2,XARELTO,Brain death,1
89,1,XARELTO,Gastrointestinal haemorrhage,1
,2,REMICADE,Lung neoplasm malignant,0
68,1,REMICADE,Thrombosis,1
44,2,REMICADE,Depression,0
74,1,REMICADE,Diverticulitis,1
56,2,PICATO,Eyelid ptosis,0
60,1,SANDOSTATIN LAR DEPOT,Hypercalcaemia,0
43,2,REMICADE,Fistula,0
56,1,REMICADE,Arterial occlusive disease,0
56,2,REMICADE,Appendicitis,1
58,1,CLOZARIL,Neutropenia,0
7,2,MONTELUKAST SODIUM,Sinus tachycardia,0
42,2,DURAGESIC,Drug withdrawal syndrome,0
61,2,ACTEMRA,Pneumonia,1
94,1,LEUPRORELIN,Metastasis,0
,2,OMNITROPE,Pinealoblastoma,0
36,2,STELARA,Liver function test abnormal,0
,2,STELARA,Respiratory tract infection viral,0
,2,PROLIA,Spinal fracture,0
65,2,PICATO,Application site exfoliation,0
,2,OXYTROL FOR WOMEN,Insomnia,0
72,2,HYDRALAZINE,Cardiac arrest,1
,2,LETAIRIS,Breast cancer stage IV,0
50,2,OGASTORO,Macroglossia,1
,2,OXYTROL FOR WOMEN,Application site erythema,0
34,2,LIPITOR,Type 2 diabetes mellitus,0
64,2,LIPITOR,Type 2 diabetes mellitus,0
55,1,XARELTO,Transient ischaemic attack,0
,1,XARELTO,Gastrointestinal haemorrhage,1
,1,XARELTO,Haemorrhage intracranial,0
79,2,XARELTO,Cerebral thrombosis,1
,1,XARELTO,Pleural effusion,1
63,1,CELECOX,Enterocolitis bacterial,1
,1,XARELTO,Haemorrhage,0
63,1,NPLATE,Hospitalisation,1
85,1,GABAPENTIN,Erythema,1
57,2,LIPITOR,Type 2 diabetes mellitus,0
,,REVLIMID,Neuropathy peripheral,0
,1,INSPRA,Creatinine renal clearance decreased,0
,2,AZATHIOPRINE,HELLP syndrome,0
,1,EFIENT,Basal cell carcinoma,0
79,2,REMICADE,Back pain,0
,2,PARAGARD 380A,Pregnancy with contraceptive device,0
,0,REMICADE,Psoriatic arthropathy,0
52,2,LETAIRIS,Rash pustular,0
4,1,MIRALAX,Incorrect drug administration duration,0
,1,XELJANZ,Respiratory tract infection,0
49,2,HUMIRA,Alopecia areata,0
50,2,CORICIDIN HBP COLD AND FLU,Drug ineffective for unapproved indication,0
88,2,GLEEVEC,Fall,1
,2,CODEINE SULFATE,Drug hypersensitivity,0
,1,REMICADE,Uveitis,0
27,1,REMICADE,Intestinal adenocarcinoma,0
,0,ALENDRONIC ACID (UNKNOWN),Foetal cardiac disorder,0
67,1,METFORMIN HYDROCHLORIDE,Metabolic acidosis,1
56,2,LIPITOR,Visual impairment,0
51,2,BUTRANS TRANSDERMAL PATCH,Hallucination,0
86,2,FUROSEMIDE,Drug abuse,1
22,2,QUARTETTE,Metrorrhagia,0
78,1,MDV3100,Hypoxic-ischaemic encephalopathy,1
82,1,NPLATE,Pain,0
,2,ACLASTA,Cerebral haemorrhage,0
66,2,LETAIRIS,Anaemia,0
48,2,LIPITOR,Type 2 diabetes mellitus,0
,2,CLARITIN LIQUIGELS,Therapeutic product ineffective,0
48,2,LETAIRIS,Oedema,0
67,2,LETAIRIS,Peripheral swelling,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
64,2,LIPITOR,Diabetic neuropathy,0
59,2,LETAIRIS,Systemic lupus erythematosus,0
,,"INFLIXIMAB, RECOMBINANT",Adverse event,0
73,2,SANDOSTATIN LAR DEPOT,Cataract,1
68,,LETAIRIS,Photopsia,0
5,2,VENLAFAXINE HCL,Ventricular tachycardia,1
,1,DR. SCHOLLS CALLUS REMOVERS,Skin discolouration,0
76,2,LETAIRIS,Fluid overload,1
58,1,LETAIRIS,Drug ineffective,0
42,2,AMITRIPTYLINE,Ataxia,0
80,2,LETAIRIS,Peripheral swelling,0
,2,XALATAN,Arrhythmia,0
81,1,ALIFLUS,Obsessive thoughts,0
79,2,HUMIRA,Asthenia,1
72,1,LETAIRIS,Headache,0
69,2,PRIMPERAN,Oesophageal ulcer,1
52,2,SPIRIVA,Heart rate irregular,0
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
66,1,ADCIRCA,Dyspnoea,0
82,2,LETAIRIS,Dizziness,0
,2,FLUOXETINE (UNKNOWN),Ovarian germ cell cancer stage II,0
70,2,LETAIRIS,Sinusitis,0
80,2,REVATIO,Unevaluable event,0
49,2,QUARTETTE,Muscle spasms,0
79,1,TRIFLUCAN,Renal failure acute,1
1,2,AZATHIOPRINE,Patent ductus arteriosus,0
77,2,LETAIRIS,Ocular icterus,0
70,2,LETAIRIS,Dermatitis contact,0
69,1,LETAIRIS,Drug ineffective,0
,0,REVLIMID,Death,0
73,2,LETAIRIS,Dyspnoea,0
81,2,ADCIRCA,Malaise,0
45,2,AUBAGIO,Anal abscess,1
74,2,PRAMIPEXOLE (UNKNOWN),Cerebrovascular accident,1
75,1,LETAIRIS,Dyspnoea,0
79,2,HYDROCHLOROTHIAZIDE.,Blood pressure decreased,0
,2,QUARTETTE,Drug screen positive,0
56,2,LETAIRIS,Peripheral swelling,0
68,1,LETAIRIS,Renal failure,1
,2,LETAIRIS,Hypotension,0
61,2,LETAIRIS,Gastroenteritis viral,0
56,2,TYVASO,Cough,0
,1,TEGRETOL,Acute myeloid leukaemia,0
66,1,FUROSEMIDE.,Oedema peripheral,0
77,1,LETAIRIS,Oedema peripheral,0
69,2,LETAIRIS,Fluid retention,0
,2,OXYTROL FOR WOMEN,Application site erythema,0
57,2,SALMETEROL XINAFOATE,Urticaria,1
46,2,ADCIRCA,Back pain,0
75,2,LETAIRIS,Dyspnoea exertional,0
45,2,LETAIRIS,Unevaluable event,0
54,2,AMLODIPINE (UNKNOWN),Bromhidrosis,0
80,2,AVELOX,Electrocardiogram QT prolonged,0
50,2,ADCIRCA,Hypersensitivity,0
65,2,LETAIRIS,Feeling cold,0
73,2,LETAIRIS,Dyspnoea,0
61,1,LETAIRIS,Fatigue,0
,1,EXELON PATCH,Cardiac disorder,0
53,2,LETAIRIS,Migraine,0
79,2,REVATIO,Dyspnoea,0
67,2,LETAIRIS,Fluid retention,0
22,1,LETAIRIS,Erythema,0
50,2,LETAIRIS,Nasal congestion,0
,0,TAXOTERE,Paraplegia,0
65,1,LETAIRIS,Dysgeusia,0
76,1,LETAIRIS,Rash pruritic,0
64,2,ADCIRCA,Headache,0
36,2,ADCIRCA,Cough,0
73,2,LETAIRIS,Fatigue,0
65,1,DOXAZOSIN (UNKNOWN),Cerebrovascular accident,0
74,2,LETAIRIS,Unevaluable event,0
25,1,CITALOPRAM HYDROCHLORIDE,Drug abuse,1
72,2,OXYTROL FOR WOMEN,Off label use,0
60,1,HALOPERIDOL,Cardiotoxicity,1
44,2,DEXAMETHASONE INJECTION (MANUFACTURER UNKNOWN) (DEXAMETHASONE SODIUM PHOSPHATE ) (DEXAMETHASONE SODIUM PHOSPHATE),Fluid overload,1
51,2,LETAIRIS,Malaise,0
79,2,LETAIRIS,Back injury,0
,1,RASILEZ,Death,0
60,2,OXYGEN.,Feeling abnormal,0
55,1,LETAIRIS,Dyspnoea,0
52,2,REVATIO,Renal disorder,0
61,2,ADCIRCA,Blister,0
82,2,LETAIRIS,Peripheral swelling,0
72,2,LETAIRIS,Vomiting,0
56,1,LETAIRIS,Oedema,1
56,2,LETAIRIS,Dizziness,1
63,2,LETAIRIS,Malaise,0
72,1,ADCIRCA,Haemorrhage,0
33,1,LETAIRIS,Pyrexia,0
20,2,REVATIO,VIIth nerve paralysis,0
69,2,LETAIRIS,Nasal congestion,0
,2,LETAIRIS,Nasopharyngitis,0
75,2,LETAIRIS,Dizziness,1
45,2,REMODULIN,Infusion site pain,0
85,1,ALPRAZOLAM,Erythema,1
30,2,TEMODAL,Hepatocellular injury,1
76,1,LETAIRIS,Contusion,0
,1,ZEGERID OTC CAPSULES,Overdose,0
56,2,LETAIRIS,Malaise,0
69,2,LETAIRIS,Dyspnoea,0
59,1,LETAIRIS,Cough,0
63,2,LETAIRIS,Fluid retention,0
59,1,LETAIRIS,Diarrhoea,0
54,1,AUBAGIO,Disease progression,0
70,2,LETAIRIS,Nasopharyngitis,0
58,2,ADALIMUMAB,Malaise,1
81,2,LETAIRIS,Drug administration error,0
60,2,ADCIRCA,Ear infection,0
50,1,LETAIRIS,Pneumonia,0
67,2,LETAIRIS,Sinusitis,1
79,1,LETAIRIS,Headache,0
36,2,ADCIRCA,Abdominal discomfort,0
63,2,ADCIRCA,Urinary tract infection,0
78,1,LETAIRIS,Peripheral swelling,0
,1,LETAIRIS,Peripheral swelling,0
,2,TYVASO,Abdominal discomfort,0
56,2,LETAIRIS,Headache,0
47,2,TYVASO,Dizziness,0
73,2,LETAIRIS,Peripheral swelling,0
44,2,LETAIRIS,Hepatic enzyme increased,0
64,1,TYVASO,Pneumonia,0
82,2,REMODULIN,Hypersensitivity,0
79,2,LETAIRIS,Dyspnoea,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
61,2,LETAIRIS,Echocardiogram,0
80,2,ROPINIROLE,Acute psychosis,1
47,2,EPOPROSTENOL.,Tooth infection,0
41,2,TRAMADOL (UNKNOWN),Grand mal convulsion,0
67,2,TYVASO,Fall,0
85,2,LETAIRIS,Dyspnoea,0
58,1,ADCIRCA,Epistaxis,0
68,2,LETAIRIS,Sleep disorder,0
85,1,LETAIRIS,Oedema,1
51,2,LETAIRIS,Headache,0
75,2,LETAIRIS,Dyspnoea,0
54,2,LETAIRIS,Infusion site infection,0
37,2,PARAGARD 380A,Embedded device,0
63,2,TYVASO,Mental status changes,0
69,2,TYVASO,Fatigue,0
77,2,LETAIRIS,Nasal congestion,0
77,2,LETAIRIS,Nasopharyngitis,0
18,2,REMODULIN,Infection,0
69,2,LETAIRIS,Fall,0
64,2,REVATIO,Nasal congestion,0
,1,LETAIRIS,Unevaluable event,0
52,2,REMODULIN,Unevaluable event,0
56,2,LETAIRIS,Headache,0
8,1,TYVASO,Nasopharyngitis,0
74,2,LETAIRIS,Malaise,0
72,1,LETAIRIS,Anaemia,0
65,2,LETAIRIS,Asthma,0
62,1,LETAIRIS,Nasopharyngitis,0
12,2,VX-770,Infective pulmonary exacerbation of cystic fibrosis,1
67,2,VENTAVIS,Cough,0
66,1,REVATIO,Dyspnoea,0
57,2,DEXAMETHASONE,Syncope,1
76,2,LETAIRIS,Back pain,0
48,2,TYVASO,Laryngeal pain,0
45,2,LETAIRIS,Nasal congestion,0
65,2,AMLODIPINE,Nasal congestion,0
68,1,LETAIRIS,Gait disturbance,0
75,2,LETAIRIS,Colonoscopy,0
67,2,LETAIRIS,Feeling abnormal,0
61,1,LETAIRIS,Oedema,1
78,2,COUMADIN,Chest pain,0
69,2,LETAIRIS,Respiratory tract infection,0
55,2,LETAIRIS,Bronchitis,0
26,2,CLARITHROMYCIN,Dyspnoea,0
63,2,LETAIRIS,Weight decreased,0
61,2,LETAIRIS,Pruritus,0
67,1,LETAIRIS,Cough,0
60,2,LETAIRIS,Weight increased,0
88,2,LETAIRIS,Visual impairment,0
67,2,WARFARIN,Fatigue,0
56,2,LETAIRIS,Oedema peripheral,0
,1,VICTRELIS,General physical health deterioration,0
70,2,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Chest discomfort,0
,2,LETAIRIS,Throat irritation,0
38,1,REVATIO,Pulmonary arterial pressure increased,0
69,2,LETAIRIS,Red blood cell count decreased,0
66,2,LETAIRIS,Dry mouth,0
57,1,LETAIRIS,Diarrhoea,0
63,1,LETAIRIS,Chest pain,0
42,2,LETAIRIS,Dysfunctional uterine bleeding,0
61,1,TYVASO,Throat irritation,0
35,2,LETAIRIS,Nausea,0
96,2,LETAIRIS,Nasopharyngitis,0
56,1,LETAIRIS,Nausea,0
70,2,LETAIRIS,Unevaluable event,0
50,2,LETAIRIS,Wheezing,0
78,2,LETAIRIS,Dyspnoea,0
55,2,LETAIRIS,Hypotension,0
86,2,LETAIRIS,Diarrhoea,0
44,2,IBUPROFEN,Nephrocalcinosis,0
43,2,LETAIRIS,Nausea,0
69,2,LETAIRIS,Hot flush,0
72,2,LETAIRIS,Hypotension,0
63,2,REMODULIN,Eating disorder,0
39,2,LETAIRIS,Nasopharyngitis,0
66,1,LETAIRIS,Catheterisation cardiac,0
38,1,LETAIRIS,Dyspnoea,0
35,2,LETAIRIS,Malaise,0
45,2,VENTAVIS,Dizziness,0
76,1,WARFARIN,Infection,0
69,2,LETAIRIS,Dyspnoea,0
74,1,LETAIRIS,Dyspnoea,0
82,2,LETAIRIS,Fluid retention,0
54,2,LETAIRIS,Nasal congestion,0
,1,CLARITIN LIQUIGELS,Drug effect decreased,0
85,2,LETAIRIS,Dizziness,0
64,2,LETAIRIS,Dizziness,0
63,2,LETAIRIS,Oedema,0
78,1,LETAIRIS,Dyspnoea,0
,2,JETREA,Blindness transient,0
69,1,LETAIRIS,Nasopharyngitis,0
67,1,LETAIRIS,Glossodynia,0
81,2,LETAIRIS,Headache,0
48,1,RAMIPRIL.,Formication,0
73,2,SILDENAFIL.,Weight decreased,0
,2,LETAIRIS,Weight decreased,0
48,2,TYVASO,Malaise,0
73,2,LETAIRIS,Dizziness,0
69,2,LETAIRIS,Nervousness,0
70,2,WARFARIN,Oedema,0
55,2,REVATIO,Condition aggravated,0
59,1,PROTAMINE SULFATE,Anaphylactic reaction,0
68,2,LETAIRIS,Fall,0
41,2,LETAIRIS,Nasal congestion,0
86,2,LETAIRIS,Night sweats,0
78,2,LETAIRIS,Apnoea,0
61,2,LETAIRIS,Headache,1
54,2,LETAIRIS,Oedema peripheral,0
70,2,LETAIRIS,Nasal ulcer,0
,1,LETAIRIS,Oedema peripheral,0
70,2,LETAIRIS,Drug effect decreased,0
55,2,LETAIRIS,Nasopharyngitis,0
80,1,LETAIRIS,Swelling,0
53,2,LETAIRIS,Dizziness,0
62,2,ADCIRCA,Gout,0
45,2,LETAIRIS,Erythema,0
54,2,LETAIRIS,Headache,0
46,1,LETAIRIS,Dizziness,0
79,1,LETAIRIS,Dizziness,0
51,2,LETAIRIS,Sinusitis,1
56,2,LETAIRIS,Dyspnoea,0
30,1,LETAIRIS,Acne,0
74,2,LETAIRIS,Heart rate increased,0
35,2,COUMADIN,Unevaluable event,0
,2,LETAIRIS,Skin lesion,0
86,2,LETAIRIS,Epistaxis,0
62,2,LETAIRIS,Chest discomfort,0
65,2,COUMADIN,Pain,0
51,1,TYVASO,Malaise,0
51,2,ADCIRCA,Influenza like illness,0
66,1,LETAIRIS,Dyspnoea,0
68,2,LETAIRIS,Cough,0
60,1,LETAIRIS,Dysuria,0
65,2,ADCIRCA,Vocal cord paralysis,0
57,2,BACLOFEN.,Paraesthesia,1
41,1,LETAIRIS,Hypersensitivity,0
73,2,LETAIRIS,Oedema,0
45,2,TYVASO,Headache,0
42,2,LETAIRIS,Pulmonary arterial hypertension,0
32,2,SILDENAFIL.,Nausea,0
70,1,LETAIRIS,Psychomotor retardation,0
41,1,LETAIRIS,Chest pain,0
33,2,LETAIRIS,Nasal congestion,0
78,2,LETAIRIS,Nasal congestion,1
72,2,LETAIRIS,Condition aggravated,0
69,1,ADCIRCA,Foreign body sensation in eyes,0
54,2,LETAIRIS,Oesophageal pain,0
,2,LETAIRIS,Platelet count decreased,0
78,2,LETAIRIS,Anaemia,0
33,2,LETAIRIS,Nasal congestion,0
77,2,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Nasal congestion,0
,2,LETAIRIS,Rash pruritic,0
63,2,METHOTREXATE (UNKNOWN),Hypomagnesaemia,1
72,2,ADCIRCA,Fluid retention,1
73,2,LETAIRIS,Sinus disorder,0
91,2,LETAIRIS,Cystitis,0
,1,LETAIRIS,Hypotension,0
34,1,LETAIRIS,Oedema peripheral,0
,2,LETAIRIS,Infusion site infection,0
57,2,TYVASO,Malaise,0
41,2,LETAIRIS,Peripheral swelling,0
6,2,LETAIRIS,Asthenia,0
54,2,LETAIRIS,Anxiety,0
7,1,LETAIRIS,Diabetes mellitus,0
,2,MIRALAX,Diarrhoea,0
59,2,LETAIRIS,Dyspnoea,0
37,2,LETAIRIS,Catheter site discharge,0
48,2,LETAIRIS,Alanine aminotransferase increased,0
,2,LETAIRIS,Accident,1
70,2,LETAIRIS,Peripheral swelling,1
55,2,LETAIRIS,Headache,0
73,2,TYVASO,Sinusitis,0
35,1,LETAIRIS,Weight decreased,1
35,2,COUMADIN,Tonsillitis,0
61,2,LETAIRIS,Sinus disorder,0
54,,LETAIRIS,Blood count abnormal,0
76,2,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Right ventricular failure,0
73,2,LETAIRIS,Fatigue,0
64,2,WARFARIN,Malaise,0
,0,SOLIRIS,Drug dose omission,0
,2,OXYTROL FOR WOMEN,Rash pustular,0
27,2,ADCIRCA,Device related infection,0
68,2,LETAIRIS,Feeling abnormal,0
59,1,LETAIRIS,Oedema peripheral,0
75,1,LETAIRIS,Muscle spasms,0
,2,EPIPEN,Device failure,0
19,2,PREDNISOLONE,Hepatic function abnormal,0
75,2,LETAIRIS,Sinus congestion,0
50,2,LETAIRIS,Oedema,0
75,1,PREDNISOLONE.,Dyspnoea,1
62,2,LETAIRIS,Middle insomnia,0
74,2,ORENCIA,Cerebrovascular accident,0
17,1,LETAIRIS,Headache,0
76,2,LETAIRIS,Fatigue,0
53,2,LETAIRIS,Catheter site pruritus,0
68,2,LETAIRIS,Unevaluable event,0
19,1,SABRIL     (TABLET),Generalised tonic-clonic seizure,0
68,2,REVATIO,Dyspnoea,0
64,1,FORTESTA,Aortic dissection,0
77,1,COMBIVENT,Drug ineffective,0
66,2,PRADAXA,Swelling,0
54,2,LETAIRIS,Peripheral swelling,0
51,2,COUMADIN,Viral infection,0
69,2,LETAIRIS,Fluid retention,1
65,1,LETAIRIS,Oedema,0
73,2,OXYTROL FOR WOMEN,Application site swelling,0
68,2,CYCLOPHOSPHAMIDE TABLETS USP,Hepatic failure,1
60,2,LETAIRIS,Knee operation,0
,0,ACLASTA,Death,0
62,1,LETAIRIS,Tremor,0
,2,LETAIRIS,Vomiting,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
,1,CLARITIN,Drug effect decreased,0
32,2,LETAIRIS,Nasal congestion,0
69,1,LETAIRIS,Chest discomfort,0
57,1,MUCINEX MAXIMUM STRENGTH,Amnesia,1
,2,LETAIRIS,Device malfunction,0
,2,PICATO,Application site vesicles,0
56,2,LISINOPRIL.,Type 2 diabetes mellitus,0
66,1,VENTAVIS,Fluid retention,1
64,2,LETAIRIS,Haemoptysis,0
,2,LETAIRIS,Wheezing,0
78,2,CITALOPRAM (UNKNOWN),Hyponatraemia,1
34,2,PARAGARD 380A,Device expulsion,0
63,1,IBRUTINIB,Leukocytosis,0
90,1,LETAIRIS,Oedema,0
,2,LETAIRIS,Syncope,0
52,1,TAMSULOSIN,Incorrect drug administration duration,1
59,1,PICATO,Application site vesicles,0
74,,LETAIRIS,Oedema peripheral,0
63,2,LETAIRIS,Nasopharyngitis,0
55,2,LETAIRIS,Malaise,0
,2,LETAIRIS,Asthenia,0
44,2,LETAIRIS,Hepatic enzyme increased,0
57,2,LETAIRIS,Nasal congestion,0
,2,LETAIRIS,Depressed mood,0
51,1,PICATO,Application site swelling,0
77,1,LETAIRIS,Type 2 diabetes mellitus,1
,2,NUVIGIL,Drug ineffective,0
74,1,LETAIRIS,Respiratory tract congestion,0
70,2,TYVASO,Oral fungal infection,0
,1,LETAIRIS,Fluid retention,1
66,2,LETAIRIS,Malaise,0
,2,PICATO,Application site erythema,0
,2,LETAIRIS,Hypotension,0
,2,IBRUTINIB,Hypokalaemia,0
23,2,REYATAZ,Abortion spontaneous,0
57,1,CISPLATIN.,Atrial fibrillation,1
81,2,LETAIRIS,Allergic respiratory symptom,0
58,1,IMBRUVICA,Febrile neutropenia,1
,0,IMBRUVICA,Dysphagia,1
64,2,LETAIRIS,Oedema,0
,2,LETAIRIS,Bronchitis,0
69,2,DONEPEZIL,Osteoporosis,0
57,1,ETOPOSIDE.,Malignant neoplasm progression,1
,2,LETAIRIS,Diarrhoea,0
,2,CIPRO,Drug hypersensitivity,0
46,2,PICATO,Application site erythema,0
71,1,REBETOL,Asthenia,1
16,2,BLEOMICINA TEVA,Neutropenia,0
88,2,MORPHINE,Rash,0
,1,PRADAXA,Pulmonary alveolar haemorrhage,1
,2,ZANTAC (RANITIDINE HYDROCHLORIDE),Flatulence,0
47,1,ROCURONIUM BROMIDE,Epiglottic oedema,1
65,2,LETAIRIS,White blood cell count decreased,0
91,1,AERIUS,Diarrhoea,1
,1,PICATO,Drug administered at inappropriate site,0
64,2,LIPITOR,Type 2 diabetes mellitus,0
,1,LETAIRIS,Syncope,0
,2,LETAIRIS,Drug ineffective,0
22240,2,XEROQUEL,Deep vein thrombosis,0
85,2,OXYTROL FOR WOMEN,Urinary incontinence,0
67,2,REVATIO,Dry mouth,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
51,2,XELJANZ,Diarrhoea,0
,2,COPPERTONE ULTRAGUARD LOTION SPF 50,Circumstance or information capable of leading to medication error,0
61,2,PICATO,Application site erythema,0
75,1,TYVASO,Pulmonary arterial hypertension,0
18,2,PLAN B ONE-STEP,Secretion discharge,0
,2,KALETRA,Death,0
64,1,TREANDA,Neutropenia,1
,2,NUVIGIL,Nausea,0
6,2,CYCLOPENTOLATE HCL,Metabolic acidosis,1
48,2,PICATO GEL,Application site pain,0
,1,SPIRIVA,Incorrect route of drug administration,0
68,2,AFINITOR,Death,0
51,1,EFFIENT,Myocardial infarction,1
32,2,NUVARING,Deep vein thrombosis,0
,2,PICATO GEL,Off label use,0
65,1,GEMCITABINE HYDROCHLORIDE,Decreased appetite,1
81,1,BENDAMUSTINE,Pulmonary embolism,1
47,2,CORICIDIN HBP COLD AND FLU,Feeling abnormal,0
78,2,TRACLEER,Hypertension,1
70,2,ZETIA,Faeces discoloured,0
17,2,SABRIL (TABLET),Suicidal ideation,0
,2,NORVASC,Ovarian cyst,0
46,2,TRACLEER,Sepsis,1
77,1,NEXAVAR,Hepatic failure,0
73,2,SYSTANE ULTRA HIGH PERFORMANCE,Injury corneal,0
55,1,COMBIVENT,Off label use,0
63,2,BETAXOLOL HCL,Drug ineffective,0
,1,HUMIRA,Meniscus injury,1
,2,PICATO GEL,Application site vesicles,0
60,2,SERTRALINE HCL,Multiple chemical sensitivity,0
,1,LUPRON DEPOT,Hypertension,1
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
,1,ESCITALOPRAM,Hepatocellular injury,0
53,2,AUBAGIO,Liver disorder,0
,2,CORICIDIN HBP CHEST CONGESTION AND COUGH,Blood pressure increased,0
,,METFORMIN HYDROCHLORIDE.,Acute kidney injury,1
55,1,PICATO,Application site erythema,0
,1,OXCARBAZEPINE,Suicidal ideation,1
1,2,SABRIL (TABLET),Feeding disorder,1
74,1,JAKAFI,Abdominal pain,0
58,2,TRACLEER,Coronary arterial stent insertion,0
86,2,TRACLEER,Cardiac failure congestive,0
79,2,JAKAFI,Headache,0
65,1,DISOTHIAZIDE,Painful respiration,1
,0,JAKAFI,Anaemia,0
38,2,JANUVIA,Diarrhoea,0
63,1,LIPITOR,Drug hypersensitivity,0
,2,JAKAFI,Asthenia,0
54,2,MAXITROL,Palpitations,1
60,2,JAKAFI,Dizziness,0
,2,FOSAMAX,Ankle fracture,1
79,2,JAKAFI,Back pain,0
,,CISPLATIN.,Hypertension,0
,2,PICATO GEL,Product packaging quantity issue,0
33,2,PARAGARD 380A,Device breakage,0
21,1,CISPLATINO TEVA ITALIA,Bronchopneumonia,0
78,1,JAKAFI,Blood creatinine increased,0
51,1,ALIMTA,Death,0
54,1,JAKAFI,Flushing,0
56,1,HUMIRA,Cardiomegaly,1
75,1,HUMIRA,Myocardial infarction,0
75,2,METHYLPREDNISOLONE,Gastrointestinal haemorrhage,1
,1,JAKAFI,Rhinorrhoea,0
,0,PICATO GEL,Eye burns,0
87,2,JAKAFI,Blood count abnormal,0
71,1,BETAXOLOL HCL,Drug ineffective,0
,2,JANUMET,Renal disorder,0
57,2,ABRAXANE,General physical health deterioration,1
,2,JAKAFI,Pain in extremity,0
57,2,JAKAFI,Malaise,0
81,2,CODEINE SULFATE,Nausea,0
55,2,GEMCITABINE HYDROCHLORIDE,Death,0
74,1,JAKAFI,Platelet count decreased,0
,1,CORICIDIN HBP COLD AND FLU,Euphoric mood,0
67,1,PICATO GEL,Swollen tear duct,0
73,2,JAKAFI,Vertigo,0
,1,CORICIDIN HBP CHEST CONGESTION AND COUGH,Dizziness,0
,1,SABRIL,Convulsion,0
74,1,AZOPT,Drug ineffective,0
70,2,JAKAFI,Chills,0
69,0,JAKAFI,Oropharyngeal pain,0
,2,LYRICA,Drug ineffective,0
56,2,EFFEXOR XR,Drug hypersensitivity,0
,1,WARFARIN SODIUM,Myasthenia gravis,0
55,1,TIMOLOL,Death,0
,0,COPAXONE,Alcohol interaction,0
,2,SAMSCA,Death,0
,1,PRADAXA,Muscle atrophy,0
,1,REVLIMID,Death,0
81,2,JAKAFI,Nausea,0
,2,NEXPLANON,Cerebrovascular accident,1
63,2,JAKAFI,Platelet count decreased,1
74,1,CIPROFLOXACIN,Weight decreased,0
,1,TRAVATAN Z,Extrasystoles,0
74,1,JAKAFI,Upper respiratory tract infection,0
64,1,TRACLEER,Death,0
,2,JAKAFI,Bone pain,0
52,2,PICATO GEL,Application site erythema,0
70,2,AZOPT,Drug ineffective,0
,2,TIMOLOL FALCON,Blood pressure increased,0
,0,JAKAFI,Ulcerative keratitis,0
71,1,JAKAFI,Diarrhoea,0
,2,DR. SCHOLLS CORN REMOVERS,Drug ineffective,0
50,0,JAKAFI,Platelet count decreased,1
,1,ADCIRCA,Gastrointestinal haemorrhage,1
74,1,DIAMICRON,Abdominal pain,1
42,2,PICATO GEL,Inflammation,0
72,1,JAKAFI,Rash erythematous,0
,1,JAKAFI,Pain in extremity,0
38,2,VELETRI,Arrhythmia,1
50,0,TRUVADA,Drug interaction,0
63,2,JAKAFI,Rash,0
67,2,JAKAFI,Flatulence,0
58,2,JAKAFI,Diarrhoea,0
76,2,TRACLEER,Haemorrhage,1
72,1,AZOPT,Drug ineffective,0
76,1,JAKAFI,Dyspnoea,0
,1,JAKAFI,Fatigue,0
30,1,JAKAFI,Diarrhoea,0
,2,AZOPT,Palpitations,0
,2,JAKAFI,Abdominal pain upper,0
,0,JAKAFI,Nasopharyngitis,0
72,2,AZOPT,Diplopia,1
90,2,JAKAFI,Bone pain,0
,1,JAKAFI,Hypoaesthesia,0
,2,AZOPT,Depression,0
71,1,JAKAFI,Upper respiratory tract infection,0
58,2,JAKAFI,Gait disturbance,0
79,1,TRACLEER,Death,0
75,2,JAKAFI,Oral fungal infection,0
,1,JAKAFI,Pain in extremity,0
55,2,VICTOZA,Pancreatitis chronic,0
80,1,JAKAFI,Platelet count decreased,0
70,2,JAKAFI,Blister,0
63,1,BYETTA,Thyroid cancer,0
58,1,PIOGLITAZONE HCL,Demyelination,1
70,1,JAKAFI,Weight decreased,0
,2,JAKAFI,Abnormal dreams,0
,2,JAKAFI,Blood glucose decreased,0
,0,ZOCOR,Death,0
,2,JAKAFI,Pollakiuria,0
,1,JAKAFI,Blood count abnormal,0
,2,JAKAFI,Pyrexia,0
65,2,PRADAXA,Foreign body,0
70,2,JAKAFI,Oropharyngeal pain,0
58,1,JAKAFI,Hypoaesthesia,0
76,1,JAKAFI,Nasopharyngitis,0
67,1,JAKAFI,Headache,0
,2,JAKAFI,Platelet count decreased,0
75,1,JAKAFI,Fatigue,0
75,1,JAKAFI,Platelet count decreased,1
62,1,JAKAFI,Fatigue,0
66,2,JAKAFI,Constipation,0
,1,JAKAFI,Nasopharyngitis,0
76,2,CODEINE SULFATE,Nausea,0
37,2,LUPRON DEPOT,Chest pain,0
64,2,JAKAFI,Stomatitis,0
,2,JAKAFI,Pyrexia,0
,1,JAKAFI,Skin odour abnormal,0
63,1,JAKAFI,Wrong technique in drug usage process,0
55,1,JAKAFI,Migraine,0
71,1,JAKAFI,Blood potassium increased,0
,1,JAKAFI,Pain,0
76,1,JAKAFI,Platelet count increased,0
74,1,JAKAFI,Epistaxis,0
51,2,JAKAFI,Increased appetite,0
69,2,JAKAFI,Neck pain,0
78,2,VENTAVIS,Death,1
,2,JAKAFI,Liver function test abnormal,0
80,1,JAKAFI,Diarrhoea,0
,0,JAKAFI,Platelet count decreased,1
73,2,IBUPROFEN.,Back injury,0
72,1,JAKAFI,Fatigue,0
,2,JAKAFI,Flatulence,0
,1,JAKAFI,Abdominal discomfort,0
,1,JAKAFI,Pain in extremity,0
,0,JAKAFI,Accidental overdose,0
,0,ADENURIC,Acute generalised exanthematous pustulosis,1
,2,JAKAFI,Urinary tract infection,0
,1,PICATO GEL,Lymphadenopathy,0
75,0,JAKAFI,Platelet count decreased,0
87,2,JAKAFI,Platelet count decreased,1
,1,JAKAFI,Malaise,0
61,1,JAKAFI,Bone pain,0
73,2,JAKAFI,Transfusion,1
59,2,JAKAFI,Chest pain,0
77,1,JAKAFI,Blood creatinine increased,0
,1,JAKAFI,Rash,0
,2,JAKAFI,Oral herpes,0
76,2,JAKAFI,Chills,0
81,2,JAKAFI,Therapeutic response unexpected,0
79,2,JAKAFI,Bronchitis,0
63,2,JAKAFI,Muscle spasms,0
76,1,PREDNISOLONE (UNKNOWN),Dyspnoea,1
,1,JAKAFI,Pruritus,0
,2,JAKAFI,Stomatitis,0
,2,JAKAFI,Depression,0
67,2,CODEINE SULFATE,Urticaria,0
64,1,JAKAFI,Dry eye,0
,2,JAKAFI,Headache,0
60,2,JAKAFI,Nausea,0
79,2,JAKAFI,Gout,0
,2,JAKAFI,Somnolence,0
86,1,JAKAFI,Renal function test abnormal,0
72,1,JAKAFI,Oedema peripheral,0
,2,JAKAFI,Insomnia,0
,,HYDROXYZINE,Vomiting,1
,1,JAKAFI,Epistaxis,0
,1,JAKAFI,Eye swelling,0
58,2,JAKAFI,Pyrexia,0
85,1,JAKAFI,Asthenia,0
74,2,JAKAFI,Confusional state,0
49,2,JAKAFI,Paraesthesia,0
65,1,JAKAFI,Vomiting,0
,0,JAKAFI,Gait disturbance,0
66,1,JAKAFI,Pain in extremity,0
,2,HUMIRA,Foot deformity,0
,2,JAKAFI,Night sweats,0
73,2,JAKAFI,Eye infection,0
73,1,JAKAFI,Back pain,0
,2,JAKAFI,Fatigue,0
75,1,JAKAFI,Nasopharyngitis,0
76,2,JAKAFI,Blood uric acid increased,0
55,2,JAKAFI,Drug dispensing error,0
,1,JAKAFI,Abasia,0
71,1,JAKAFI,Abdominal distension,0
84,1,JAKAFI,Wound,0
75,2,JAKAFI,Bone pain,0
65,1,JAKAFI,Nocturia,0
,2,JAKAFI,Muscular weakness,0
65,2,JAKAFI,Blood count abnormal,0
83,1,JAKAFI,Wound haemorrhage,0
62,2,EUTIROX,Oedema peripheral,1
63,2,HUMIRA,Heart valve incompetence,1
71,2,JAKAFI,Splenomegaly,0
73,2,JAKAFI,Ear infection,0
79,1,JAKAFI,Oedema,0
78,2,JAKAFI,Tooth loss,0
,2,JAKAFI,Bone pain,0
80,2,JAKAFI,Musculoskeletal discomfort,0
77,2,JAKAFI,Rash,0
,1,JAKAFI,White blood cell count increased,0
,2,JAKAFI,Influenza like illness,0
,2,JAKAFI,Pain in extremity,0
,1,JAKAFI,Genital herpes,0
70,2,JAKAFI,Haemoglobin decreased,1
84,2,JAKAFI,Haematochezia,0
68,2,JAKAFI,Platelet count abnormal,0
76,2,JAKAFI,Constipation,0
,1,JAKAFI,Alanine aminotransferase increased,0
77,2,JAKAFI,Therapy change,0
69,2,JAKAFI,Sinusitis,0
,1,JAKAFI,Splenomegaly,0
62,1,JAKAFI,Blood pressure increased,0
,2,JAKAFI,Unevaluable event,0
82,1,JAKAFI,Diarrhoea,0
,2,JAKAFI,Feeling abnormal,0
64,1,JAKAFI,Night sweats,0
71,1,JAKAFI,Contusion,0
66,1,JAKAFI,Fatigue,0
40,2,JAKAFI,Mood swings,0
64,2,JAKAFI,Decreased appetite,0
,1,JAKAFI,Rash,0
,2,MIRALAX,Muscle spasms,0
63,1,JAKAFI,Splenectomy,0
,2,NUVARING,Hypertension,0
,1,JAKAFI,Tenderness,0
,1,JAKAFI,Fatigue,0
74,2,JAKAFI,Vision blurred,0
73,2,JAKAFI,Genital rash,0
,2,JAKAFI,Abdominal pain,0
70,2,JAKAFI,Muscular weakness,0
,0,FEBURIC,Lipids abnormal,0
83,2,JAKAFI,Diarrhoea,0
83,2,JAKAFI,Haemoglobin decreased,0
63,2,JAKAFI,Muscular weakness,0
64,1,JAKAFI,Nail discolouration,0
80,2,JAKAFI,Trigeminal neuralgia,0
82,1,JAKAFI,No therapeutic response,0
86,1,JAKAFI,Abdominal pain,0
75,2,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Night sweats,0
69,1,JAKAFI,Transfusion,0
73,2,JAKAFI,Abdominal discomfort,0
77,1,JAKAFI,Gastrooesophageal reflux disease,0
34,1,JAKAFI,Platelet count decreased,1
65,2,JAKAFI,Ear pain,0
56,2,JAKAFI,Anaemia,0
,2,JAKAFI,Skin reaction,0
74,1,JAKAFI,Haemorrhagic diathesis,0
76,2,JAKAFI,Hypoaesthesia,0
74,1,JAKAFI,Dyspnoea exertional,0
70,1,JAKAFI,Dry eye,0
,1,JAKAFI,Ulcer,0
69,1,JAKAFI,Gout,0
,1,JAKAFI,Abdominal pain upper,0
67,2,JAKAFI,Haemoglobin decreased,0
58,1,JAKAFI,Joint swelling,0
,1,JAKAFI,Transfusion,0
,1,JAKAFI,Fatigue,0
76,1,JAKAFI,Oedema peripheral,0
69,2,JAKAFI,Tremor,0
74,1,STALEVO,Psoriasis,0
78,1,JAKAFI,Accidental overdose,0
69,2,JAKAFI,Platelet count abnormal,0
83,2,JAKAFI,Dyspnoea exertional,0
84,2,JAKAFI,Fatigue,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
54,2,OMNIPAQUE,Hyperthermia,0
,2,JAKAFI,Flatulence,0
65,2,JAKAFI,Blood count abnormal,0
73,1,JAKAFI,Anaemia,1
59,1,JAKAFI,Fatigue,0
76,1,JAKAFI,Blood count abnormal,1
61,2,JAKAFI,Dyspnoea,0
79,2,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Raynaud^s phenomenon,0
59,2,JAKAFI,Back pain,0
,0,TRADJENTA,Urinary tract infection,0
80,2,JAKAFI,Pain in extremity,0
,1,JAKAFI,Sinusitis,0
,1,JAKAFI,Infection,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,JAKAFI,Anaemia,0
38,2,JAKAFI,Dyspnoea,0
,1,JAKAFI,Tooth infection,0
,1,JAKAFI,Transfusion,0
,2,JAKAFI,Flatulence,0
70,2,JAKAFI,Blood cholesterol increased,0
,2,JAKAFI,Fatigue,0
,1,METFORMIN HCL,Diabetes mellitus inadequate control,0
73,1,JAKAFI,Chills,0
67,2,JAKAFI,Diarrhoea,0
,1,JAKAFI,International normalised ratio increased,0
81,2,JAKAFI,Influenza like illness,0
,1,JAKAFI,White blood cell count increased,0
,2,JAKAFI,Muscular weakness,0
49,2,HUMIRA,Gastritis,1
,2,JAKAFI,Fatigue,0
74,1,JAKAFI,Joint swelling,0
60,2,JAKAFI,Epistaxis,0
,2,JAKAFI,Musculoskeletal chest pain,0
,1,JAKAFI,Haemoglobin decreased,0
67,2,JAKAFI,Platelet count decreased,0
68,1,JAKAFI,Diarrhoea,0
81,2,JAKAFI,Epistaxis,0
75,1,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Malaise,0
70,2,JAKAFI,Weight decreased,0
79,1,JAKAFI,Transfusion,1
65,2,JAKAFI,Pain in extremity,0
76,1,JAKAFI,Fatigue,0
78,1,JAKAFI,Oral fungal infection,0
,2,JAKAFI,Asthenia,0
70,1,JAKAFI,Seasonal allergy,0
68,2,JAKAFI,Migraine,0
80,2,JAKAFI,Platelet count decreased,0
63,2,JAKAFI,Respiratory tract infection,0
76,1,JAKAFI,Paraesthesia,0
0,2,CIMZIA,Premature baby,1
,2,JAKAFI,Rash,0
64,2,CYTARABINE,Enterocolitis haemorrhagic,1
69,1,JAKAFI,Liver tenderness,0
59,1,JAKAFI,Anaemia,1
66,2,JAKAFI,Macular degeneration,0
,1,DIANEAL LOW CALCIUM,Hypotension,0
,2,JAKAFI,Restless legs syndrome,0
88,1,IBUPROFEN,Renal disorder,0
67,1,CIMZIA,Oral herpes,0
,2,JAKAFI,Laboratory test abnormal,0
63,1,JAKAFI,Liver function test abnormal,0
,2,JAKAFI,Feeling abnormal,0
,2,LIORESAL INTRATECAL,Skin depigmentation,0
82,1,JAKAFI,Fatigue,0
61,1,JAKAFI,Platelet count decreased,0
74,1,JAKAFI,Platelet count decreased,1
81,1,PRAMIPEXOLE,Neuroleptic malignant syndrome,1
37,1,PREDNISONE,Retinal detachment,0
85,2,VISIPAQUE,Rash erythematous,0
57,2,HUMIRA,Dysphagia,0
77,2,JAKAFI,Tremor,0
69,1,JAKAFI,Arthralgia,0
6,1,DEXAMETHASONE,Hypertriglyceridaemia,0
,2,JAKAFI,Skin disorder,0
77,1,JAKAFI,Venous thrombosis limb,0
79,2,JAKAFI,Rash,0
35,2,CERTOLIZUMAB PEGOL RA,Nausea,0
75,2,JAKAFI,Fall,0
64,2,ENOXAPARIN SODIUM,Incision site haemorrhage,1
81,2,JAKAFI,Haemoglobin decreased,0
70,1,JAKAFI,Platelet count decreased,0
,0,A + D ORIGINAL OINTMENT,Drug ineffective,0
68,1,JAKAFI,Arthralgia,0
75,2,JAKAFI,Facial pain,0
,2,JAKAFI,Diarrhoea,0
71,2,JAKAFI,Pruritus generalised,0
74,1,JAKAFI,Abdominal discomfort,0
64,2,JAKAFI,Blood creatinine increased,0
80,1,JAKAFI,Asthenia,0
,2,JAKAFI,Pain,0
0,1,PALIVIZUMAB,Febrile convulsion,1
78,2,JAKAFI,Stomatitis,0
,2,JAKAFI,Night sweats,0
,,JAKAFI,Abdominal pain lower,0
51,1,JAKAFI,Arthralgia,0
,2,JAKAFI,Oral herpes,0
67,1,JAKAFI,Platelet count decreased,0
,1,JAKAFI,Adverse reaction,0
66,2,WARFARIN,Death,1
64,1,JAKAFI,Haemoglobin decreased,0
66,1,JAKAFI,Haemoglobin decreased,0
,2,JAKAFI,Withdrawal syndrome,0
37,2,CEFPODOXIME PROXETIL,Tubulointerstitial nephritis,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,JAKAFI,Hernia repair,0
,2,JAKAFI,Blood uric acid increased,0
71,1,JAKAFI,Hypertension,0
,2,JAKAFI,Amnesia,0
69,1,SIMVASTATIN.,Acute kidney injury,0
72,1,JAKAFI,Pain in extremity,0
91,2,VANCOMYCIN,Death,1
28,2,PARAGARD 380A,Device expulsion,0
74,2,HUMIRA,Hernia,0
54,2,JAKAFI,Diarrhoea,0
56,2,HYDROCORTISONE,Hypokalaemia,0
,2,JAKAFI,Fatigue,0
75,2,JAKAFI,Cough,0
86,2,JAKAFI,Blood count abnormal,0
,2,JAKAFI,Alopecia,0
86,1,JAKAFI,Fatigue,0
,1,JAKAFI,Abdominal pain,0
,1,JAKAFI,Incorrect dose administered,0
73,1,JAKAFI,Thrombocytopenia,0
,1,SYNTHROID,Tooth abscess,0
62,1,JAKAFI,Nephrolithiasis,0
69,2,JAKAFI,Haematocrit decreased,0
,2,JAKAFI,Back pain,0
83,1,JAKAFI,Pyrexia,0
73,2,JAKAFI,Increased appetite,0
,2,JAKAFI,Bone pain,0
,1,JAKAFI,Gastrointestinal haemorrhage,0
,2,JAKAFI,Thrombocytopenia,0
56,2,JAKAFI,Fatigue,0
83,1,JAKAFI,Transfusion,1
52,1,PEPCID AC,Abdominal pain,0
76,2,JAKAFI,Haemoglobin decreased,0
,1,SYMBICORT,Death,0
,2,TEGRETOL,Convulsion,0
,2,JAKAFI,Haemorrhage,0
64,1,JAKAFI,Blood creatinine increased,0
35,1,QUETIAPINE,Drug interaction,0
70,1,JAKAFI,Musculoskeletal chest pain,0
84,2,JAKAFI,Haemoglobin decreased,0
70,2,JAKAFI,Stomatitis,0
82,1,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Drug ineffective for unapproved indication,0
79,2,ETHAMBUTOL,Death,1
70,2,NEOTIAPIM,Swelling,0
33,2,JAKAFI,Alopecia,0
77,1,JAKAFI,Blood potassium increased,0
66,1,JAKAFI,Arthralgia,0
,1,CLARITIN LIQUIGELS,Overdose,0
,2,JAKAFI,Laboratory test abnormal,0
75,2,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Tooth infection,0
58,2,BEVACIZUMAB,Coma,1
60,2,JAKAFI,Spleen disorder,0
74,2,JAKAFI,Insomnia,0
,2,JAKAFI,Acne,0
39,1,BAKTAR,Atypical mycobacterial infection,0
36,1,LETAIRIS,Cough,0
51,1,BRILIQUE,Angina pectoris,1
66,2,JAKAFI,Nausea,0
19,2,RIFAMPICIN,Myocardial infarction,1
71,2,JAKAFI,Asthenia,0
81,2,JAKAFI,Haemoglobin decreased,0
69,1,NITROFURANTOIN,Organising pneumonia,1
65,1,JAKAFI,Paraesthesia,0
71,1,JAKAFI,Reaction to drug excipients,0
29,2,LETAIRIS,Erythema,0
58,0,JAKAFI,Cough,0
,2,JAKAFI,Insomnia,0
69,2,JAKAFI,Diplopia,0
77,1,JAKAFI,Haemoglobin decreased,0
18,2,LETAIRIS,Staphylococcal infection,0
,1,JAKAFI,Anaemia,0
51,2,LETAIRIS,Rash pruritic,0
71,1,JAKAFI,Personality change,0
61,2,LETAIRIS,Cough,0
,0,TRADJENTA,Urinary tract infection,0
80,1,JAKAFI,Amnesia,0
80,1,JAKAFI,Haemoglobin decreased,0
58,2,LETAIRIS,Abdominal distension,0
57,2,LETAIRIS,Gastrointestinal haemorrhage,0
65,1,JAKAFI,Arthralgia,0
,2,JAKAFI,Fatigue,0
83,1,JAKAFI,Osteoarthritis,0
35,2,LETAIRIS,Throat irritation,0
,,LETAIRIS,Fatigue,0
,2,JAKAFI,Alopecia,0
52,2,JAKAFI,Arthralgia,0
59,2,JAKAFI,Haemoglobin decreased,1
32,2,LETAIRIS,Chest pain,0
58,2,LETAIRIS,Nasopharyngitis,0
64,2,JAKAFI,Toothache,0
66,2,JAKAFI,Alopecia,0
,2,NEXPLANON,Device kink,0
56,2,LETAIRIS,Nasal congestion,0
65,2,JAKAFI,Haemoglobin decreased,0
,0,JAKAFI,Renal failure,0
,1,JAKAFI,Dyspnoea,0
79,1,JAKAFI,Infection,0
59,2,LETAIRIS,Anaemia,0
59,1,LETAIRIS,Peripheral swelling,0
75,1,JAKAFI,Hypoaesthesia,0
74,2,JAKAFI,Syncope,0
74,1,JAKAFI,Anaemia,0
,,JAKAFI,Anaemia,0
68,2,LETAIRIS,Weight decreased,0
76,1,VENTAVIS,Swelling,0
80,2,JAKAFI,Alopecia,0
60,2,LETAIRIS,Unevaluable event,0
70,2,JAKAFI,Fall,0
65,1,JAKAFI,Drug dose omission,0
53,1,LETAIRIS,Fatigue,0
71,2,LETAIRIS,Gait disturbance,0
,2,JAKAFI,Muscle spasms,0
71,1,JAKAFI,Pruritus,0
66,1,SPIRIVA,Increased upper airway secretion,0
71,1,RISPERIDONE (UNKNOWN),Abasia,1
,2,LETROZOLE (UNKNOWN),Breast cancer,0
55,2,LETAIRIS,Chromaturia,0
,1,JAKAFI,Pancytopenia,0
86,1,JAKAFI,Eye infection,0
81,2,JAKAFI,Arthralgia,0
74,1,PICATO GEL,Application site pain,0
56,2,LETAIRIS,Cough,0
76,1,LETAIRIS,Muscle spasms,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,JAKAFI,Balance disorder,0
,0,JAKAFI,Eye infection,0
,1,JAKAFI,Treatment noncompliance,0
41,2,LETAIRIS,Back pain,0
26,2,LETAIRIS,Nasopharyngitis,0
65,1,JAKAFI,Fall,0
75,2,JAKAFI,Alopecia,0
,2,JAKAFI,Dyspnoea,0
82,2,REVATIO,Diarrhoea,0
54,2,PICATO GEL,Application site discomfort,0
52,2,LETAIRIS,Feeling hot,0
64,1,SIMVASTATIN.,Muscle fatigue,0
67,2,OXYTROL FOR WOMEN,Application site burn,0
,1,JAKAFI,Malaise,0
84,1,JAKAFI,Nasopharyngitis,0
52,2,LETROZOLE (UNKNOWN),Breast cancer,0
65,2,LETAIRIS,Hypersensitivity,0
49,1,LETAIRIS,Syncope,0
51,2,PICATO GEL,Application site paraesthesia,0
65,1,JAKAFI,Abdominal distension,0
1,1,METOPROLOL (UNKNOWN),Congenital hydronephrosis,0
83,2,LETAIRIS,Dizziness,0
91,2,LETAIRIS,Feeling abnormal,0
68,2,LETAIRIS,Malaise,0
,2,JAKAFI,Arthralgia,0
60,2,LETAIRIS,Dizziness,0
51,2,OXYCODONE,Insomnia,0
40,2,LETAIRIS,Malaise,0
82,2,LETAIRIS,Nasal congestion,0
,1,JAKAFI,Dizziness,0
67,2,JAKAFI,Dyspnoea,0
78,2,LETAIRIS,Oedema peripheral,0
,1,PICATO GEL,Off label use,0
27,2,LETAIRIS,Nasopharyngitis,0
62,1,CICLOSPORIN,Metastatic malignant melanoma,1
72,2,LETAIRIS,Headache,0
,1,JAKAFI,Depression,0
63,2,LETAIRIS,Swelling,1
,0,JAKAFI,Pruritus,0
86,2,LETAIRIS,Middle insomnia,0
85,2,LETAIRIS,Peripheral swelling,1
46,2,LETAIRIS,Dyspnoea,0
,1,JAKAFI,Skin disorder,0
,2,PICATO GEL,Application site dryness,0
69,1,JAKAFI,Bone pain,0
55,2,LETAIRIS,Epistaxis,0
50,2,LETAIRIS,Dizziness,0
45,2,LETAIRIS,Dizziness,0
,2,JAKAFI,Fatigue,0
83,2,LETAIRIS,Incorrect dose administered,0
65,2,JAKAFI,Nausea,0
67,2,PICATO GEL,Application site irritation,0
56,2,VELETRI,Fatigue,0
62,2,LETAIRIS,Productive cough,0
58,2,LETAIRIS,Oedema,0
,1,JAKAFI,Back pain,0
65,2,ADCIRCA,Nausea,0
64,2,LETAIRIS,Overdose,0
77,2,LETAIRIS,Dyspnoea,0
68,2,RANITIDINE (UNKNOWN),Dyspnoea,0
60,1,LETAIRIS,Nasal congestion,0
27,2,LETAIRIS,Dizziness,0
64,1,HUMIRA,Dental caries,0
50,2,LETAIRIS,Headache,0
50,1,LETAIRIS,Pain,0
78,2,INDAPAMIDE (UNKNOWN),Hyponatraemia,1
52,2,LETAIRIS,Swelling,0
61,2,LETAIRIS,Lung cyst,0
74,2,LETAIRIS,Seasonal allergy,0
54,1,LETAIRIS,Fluid retention,0
51,2,LETAIRIS,Disturbance in attention,0
,2,LETAIRIS,Rash generalised,0
66,2,VENTAVIS,Haemoptysis,0
48,2,LETAIRIS,Fall,0
55,2,LETAIRIS,Ligament sprain,0
23,1,ADCIRCA,Pilonidal cyst,0
80,2,LETAIRIS,Insomnia,0
61,2,REMODULIN,Injection site pruritus,0
55,2,LETAIRIS,Headache,0
76,2,LETAIRIS,Cough,0
69,2,LETAIRIS,Depression,0
64,2,LETAIRIS,Nasal congestion,0
77,2,LETAIRIS,Pruritus allergic,0
44,2,LETAIRIS,Bronchitis,0
80,2,LETAIRIS,Dyspnoea,0
46,2,LETAIRIS,Malaise,0
57,2,LETAIRIS,Headache,0
14,2,TOBI PODHALER,Cough,0
74,2,LETAIRIS,Drug ineffective,0
78,2,LETAIRIS,Malaise,0
66,2,LETAIRIS,Weight increased,0
56,2,LETAIRIS,Hypersensitivity,0
57,2,LETAIRIS,Fatigue,0
,2,LETROZOLE (UNKNOWN),Hot flush,0
70,1,LETAIRIS,Malaise,0
67,2,LETAIRIS,Arthralgia,0
56,2,REVATIO,Peripheral swelling,0
50,2,LETAIRIS,Vomiting,0
73,2,LETAIRIS,Sinusitis,0
81,2,SIMVASTATIN (UNKNOWN),Drug-induced liver injury,1
76,2,LETAIRIS,Nasal disorder,0
80,2,LETAIRIS,Nasopharyngitis,0
70,1,LETAIRIS,Fall,0
86,2,LETAIRIS,Hypersensitivity,0
80,2,LETAIRIS,Fluid retention,1
86,2,LETAIRIS,Malaise,0
65,2,REVATIO,Oedema peripheral,0
14,2,ADCIRCA,Chest pain,0
62,2,LETAIRIS,Fatigue,0
55,2,LETAIRIS,Malaise,0
61,2,LETAIRIS,Sinusitis,0
58,2,LETAIRIS,Hypoaesthesia,0
57,2,LETAIRIS,Decreased appetite,0
58,1,LETAIRIS,Syncope,0
73,1,LETAIRIS,Dyspnoea,0
55,2,LETAIRIS,Nausea,0
85,1,LETAIRIS,Dizziness,0
49,2,LETAIRIS,Insomnia,0
59,2,REMODULIN,Heart rate increased,0
58,2,LETAIRIS,Gastroenteritis viral,0
7,1,LETAIRIS,Nail discolouration,0
65,2,LETAIRIS,Dyspnoea,0
62,2,LETAIRIS,Nasal congestion,0
32,2,LETAIRIS,Arthralgia,0
82,2,LETAIRIS,Nasal congestion,0
47,2,CLARITHROMYCIN (UNKNOWN),Nausea,0
35,2,LETAIRIS,Drug dose omission,0
15,1,LETAIRIS,Pain,0
54,2,LETAIRIS,Nasal congestion,0
39,2,ADCIRCA,Pain in jaw,0
70,2,LETAIRIS,Insomnia,0
44,2,LETROZOLE (UNKNOWN),Breast cancer,0
40,2,LETAIRIS,Chest pain,0
36,2,LETAIRIS,Chest pain,0
81,2,LETAIRIS,Dyspnoea,0
,2,GEMCITABINE (UNKNOWN),Haemolytic uraemic syndrome,0
53,2,LETAIRIS,Unevaluable event,0
55,1,LETAIRIS,Anaemia,0
49,2,LETAIRIS,Chest pain,0
,2,LETAIRIS,Nasopharyngitis,0
51,2,LETAIRIS,Ocular icterus,0
66,2,LETAIRIS,Asthenia,1
76,2,FUROSEMIDE.,Oedema peripheral,0
67,2,LETAIRIS,Asthenia,0
64,2,LETAIRIS,Peripheral swelling,0
34,2,LETAIRIS,Peripheral swelling,0
61,2,LETAIRIS,Respiratory tract congestion,0
55,2,LETAIRIS,Fatigue,0
8,2,LETAIRIS,Bronchitis,0
47,2,LETAIRIS,Rhinorrhoea,0
56,2,ADCIRCA,Liver function test abnormal,0
68,2,FUROSEMIDE.,Oedema peripheral,0
,2,LETAIRIS,Fluid retention,0
52,1,LETAIRIS,Nausea,0
40,2,LETAIRIS,Laryngitis,0
72,1,LETAIRIS,Halo vision,0
77,2,LETAIRIS,Fluid overload,0
79,1,LETAIRIS,Dizziness,0
47,2,LETAIRIS,Syncope,0
77,2,LETAIRIS,Epistaxis,0
53,2,TYVASO,Diarrhoea,0
,1,MIRALAX,Choking,0
88,2,LETAIRIS,Respiratory tract congestion,0
,1,REMODULIN,Injection site erythema,0
77,2,LETAIRIS,Sinusitis,0
51,1,REMODULIN,Weight decreased,0
,2,LETAIRIS,Pneumonia,0
89,2,LETAIRIS,Swelling,0
74,2,LETAIRIS,Eye disorder,0
38,2,LETAIRIS,Oedema,0
81,1,LETAIRIS,Nasal congestion,0
88,2,LETAIRIS,Anxiety,0
57,2,LETAIRIS,Oxygen consumption increased,0
53,1,TYVASO,Throat irritation,0
46,2,LETAIRIS,Throat irritation,0
57,2,LETAIRIS,Rash,0
68,1,LETAIRIS,Drug ineffective,0
44,1,LETAIRIS,Headache,0
50,1,LETAIRIS,Tooth extraction,0
70,2,LETAIRIS,Peripheral swelling,0
79,2,TYVASO,Influenza,0
77,2,WARFARIN,Hot flush,0
84,2,ADCIRCA,Dyspnoea,0
56,2,LETAIRIS,Syncope,0
,2,INVOKANA,Diabetic foot infection,1
72,1,INVOKANA,Urticaria,0
,2,LETAIRIS,Back pain,0
72,2,ADCIRCA,Hypotension,0
35,2,ADCIRCA,Intentional product misuse,0
61,2,REMODULIN,Oedema peripheral,0
65,2,LETAIRIS,Peripheral swelling,0
62,2,LETAIRIS,Drug ineffective,0
75,2,LETAIRIS,Cor pulmonale,0
76,2,LETAIRIS,Epistaxis,0
56,2,LETAIRIS,Dyspnoea,0
61,2,LETAIRIS,Herpes zoster,0
61,2,SILDENAFIL.,Nasopharyngitis,0
86,2,LETAIRIS,Exercise tolerance decreased,0
28,2,LETAIRIS,Chest pain,0
59,2,DICLOFENAC,Renal failure acute,1
78,2,LETAIRIS,Peripheral swelling,0
30,2,LETAIRIS,Headache,0
59,1,OXYCODONE,Anaemia,0
75,1,LETAIRIS,Chronic obstructive pulmonary disease,0
63,2,LETAIRIS,Dyspnoea,0
69,2,COUMADIN,Chest pain,0
68,2,LETAIRIS,Cough,0
50,1,REVATIO,Liver disorder,0
67,2,REVATIO,Pyrexia,0
73,2,LETAIRIS,Overdose,0
54,2,LETAIRIS,Dyspnoea,0
76,2,LETAIRIS,Constipation,0
59,1,LETAIRIS,Seasonal allergy,0
77,2,LETAIRIS,Anaemia,1
59,2,LETAIRIS,Peripheral swelling,0
36,2,LETAIRIS,Headache,0
77,1,LETAIRIS,Fluid retention,0
28,2,ADCIRCA,Sunburn,0
71,2,TYVASO,Diarrhoea,0
33,2,LETAIRIS,Transaminases increased,0
75,2,LETAIRIS,Sneezing,0
63,2,LETAIRIS,Visual impairment,0
77,2,LETAIRIS,Peripheral swelling,0
16,1,BENEFIX,Chest pain,0
65,2,LETAIRIS,Anaemia,0
73,2,LETAIRIS,Fatigue,0
73,1,TYVASO,Bronchitis,0
65,2,CPAP,Weight decreased,1
72,2,ADCIRCA,Drug dose omission,0
74,2,LETAIRIS,Infusion site reaction,0
42,2,EPOPROSTENOL.,Middle ear effusion,0
56,2,FLOLAN,Injection site infection,0
78,1,LETAIRIS,Blister,0
78,2,LETAIRIS,Dyspnoea,0
72,2,LETAIRIS,Cough,0
77,2,LETAIRIS,Anaemia,0
,1,MYFORTIC,Death,0
52,2,LETAIRIS,Syncope,0
67,2,LETROZOLE (UNKNOWN),Breast cancer,0
14,1,ADCIRCA,Dyspnoea,0
,2,LETAIRIS,Nasal congestion,0
71,1,LETAIRIS,Dyspnoea,0
85,1,LETAIRIS,Oedema peripheral,0
74,1,ADCIRCA,Nasopharyngitis,0
,2,LETAIRIS,Anaemia,0
51,1,ADCIRCA,Fatigue,0
68,2,LETROZOLE (UNKNOWN),Breast cancer,0
76,1,LETAIRIS,Fluid retention,0
78,1,LETAIRIS,Nasal congestion,0
27,1,LETAIRIS,Hypotension,0
42,1,LETAIRIS,Unevaluable event,0
13,1,TOBI,Respiratory disorder,1
,1,LETAIRIS,Cough,0
67,2,LETAIRIS,Bronchitis,0
69,2,LETAIRIS,Diarrhoea,0
,1,LETAIRIS,Unevaluable event,0
73,2,LETAIRIS,Nasal congestion,0
,2,LETAIRIS,Oedema peripheral,0
59,2,LETAIRIS,Muscle strain,0
51,2,ADCIRCA,Feeling abnormal,0
72,2,LETAIRIS,Hyperhidrosis,0
61,1,LETAIRIS,Swelling,1
,1,LETAIRIS,Musculoskeletal pain,0
,1,LETAIRIS,Chest discomfort,0
58,1,LETAIRIS,Nightmare,0
72,1,LETAIRIS,Swelling,0
54,2,LETAIRIS,Sleep study,0
22,2,PARAGARD 380A,Abdominal pain lower,0
63,2,LETAIRIS,Cough,0
77,2,LETAIRIS,Bronchitis,0
59,2,REVATIO,Pyrexia,0
79,2,LETAIRIS,Discomfort,0
57,2,SOVALDI,Dyspnoea,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
64,2,REMODULIN,Sinus congestion,0
76,2,LETAIRIS,Unevaluable event,0
70,2,LETAIRIS,Dysphonia,0
55,2,EXCEDRIN EXTRA STRENGTH,Drug dependence,0
,2,LETAIRIS,Oedema peripheral,1
64,2,COUMADIN,Hypersensitivity,0
47,2,LETAIRIS,Headache,0
32,2,TYVASO,Headache,0
,2,LETAIRIS,Malaise,0
50,2,LETAIRIS,Pruritus,0
61,2,LETAIRIS,Rash,0
57,2,LETAIRIS,Weight decreased,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,1,LETAIRIS,Dizziness,0
58,1,SILDENAFIL CITRATE.,Fall,0
51,2,LETAIRIS,Nasal congestion,0
78,2,SILDENAFIL.,Epistaxis,0
77,2,GAS-X EXTSTR CHEWABLE TABS CHERRY CREME,Urinary tract infection,0
48,1,TRUVADA,Osteoporosis,1
38,2,REMODULIN,Vomiting,1
76,1,LETAIRIS,Swelling,0
70,2,LETAIRIS,Seasonal allergy,0
,1,TAMSULOSIN CAPSULES,Adverse drug reaction,0
29,1,AMOXICILLIN + CLAVULANATE POTASSIUM,Acute generalised exanthematous pustulosis,1
26,1,OTRIVIN,Drug dependence,0
74,2,LETAIRIS,Weight increased,0
,2,LETAIRIS,Rash,0
88,2,LETAIRIS,Fatigue,0
29,2,TRUVADA,Ageusia,0
,2,PARAGARD 380A,Device expulsion,0
75,2,LETAIRIS,Oedema,0
53,2,ADCIRCA,Headache,0
32,2,LETAIRIS,Dyspnoea,0
44,2,LETAIRIS,Fluid retention,1
,1,RANOLAZINE,Fabry^s disease,0
,1,CLOZARIL,Bacteraemia,1
74,2,LETAIRIS,Oedema peripheral,0
5,2,EX-LAX REG STR CHOCOLATED LAX PCS SEN,Gastrointestinal pain,0
69,1,LETAIRIS,Fluid retention,0
,2,LINZESS,Blood pressure decreased,0
56,2,LETAIRIS,Panic attack,0
65,2,JAKAFI,Constipation,0
73,1,LETAIRIS,Dizziness,0
54,1,ADCIRCA,Headache,0
65,1,DOXAZOSIN,Cerebrovascular accident,0
,1,CLOZARIL,Ankle fracture,1
42,2,WARFARIN,Pain in extremity,0
78,2,JAKAFI,Pyrexia,0
75,2,LETAIRIS,Influenza,0
70,2,LETROZOLE (UNKNOWN),Breast pain,0
82,1,JAKAFI,Pain in extremity,0
47,1,ADCIRCA,Eye swelling,0
27,1,REMODULIN,Drug dose omission,0
,2,LETAIRIS,Diarrhoea,0
51,2,CVS,Vomiting,1
,1,JAKAFI,Haemoglobin decreased,0
54,2,LETAIRIS,Middle ear effusion,0
13,2,REVATIO,Diarrhoea,0
69,2,LETAIRIS,Fatigue,0
65,1,RANOLAZINE,Pneumonia,0
69,1,JAKAFI,Diarrhoea,0
54,2,LETAIRIS,Aspartate aminotransferase increased,0
53,2,LETAIRIS,Rash,0
48,2,LETAIRIS,Pruritus,0
76,1,JAKAFI,Pain in extremity,0
63,2,JAKAFI,Haemoglobin decreased,0
87,1,ACETYLSALICYLIC ACID,Anaemia,1
,2,LETAIRIS,Cough,0
,2,LETAIRIS,Rhinitis allergic,0
57,1,JAKAFI,Diarrhoea,0
,,DOXYFERM,Pulmonary embolism,0
65,1,DEXAMETHASONE,Bronchopulmonary aspergillosis,1
79,1,ACETYLSALICYLIC ACID,Epistaxis,0
70,1,LETAIRIS,Limb discomfort,0
61,1,JAKAFI,Platelet count decreased,0
91,2,JAKAFI,Diarrhoea,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,1,LETAIRIS,Influenza,0
,2,SINGULAIR,Reaction to drug excipients,0
85,2,JAKAFI,Hyperphagia,0
65,1,JAKAFI,Dyspnoea exertional,0
79,1,VOLTAREN GEL,Hip fracture,1
,1,JAKAFI,Haemoglobin decreased,0
76,2,JAKAFI,Fatigue,0
,1,LETAIRIS,Dyspnoea,0
,2,LETAIRIS,Fibromyalgia,0
64,2,JAKAFI,Haemoglobin decreased,0
75,1,JAKAFI,Asthenia,0
71,1,JAKAFI,Anaemia,0
,0,EXCEDRIN UNKNOWN,Neoplasm malignant,0
,2,LETAIRIS,Heart rate increased,0
77,2,LETAIRIS,Red blood cell count decreased,1
86,2,JAKAFI,Nocturia,0
71,2,JAKAFI,Blister,0
,2,ALLOPURINOL.,Chills,0
63,1,PARACETAMOL,Lobar pneumonia,0
78,1,LETAIRIS,Allergic respiratory symptom,0
42,1,CLINDAMYCIN,Injection site necrosis,0
60,2,JAKAFI,Nausea,0
74,2,JAKAFI,Haemoglobin decreased,0
66,2,ASA,Blood pressure increased,1
57,1,JAKAFI,Adverse event,0
87,1,JAKAFI,Haemoglobin decreased,0
71,2,LETAIRIS,Nausea,0
,0,JAKAFI,Colitis,0
,2,JAKAFI,Hepatic pain,0
47,1,OMNISCAN,Nephrogenic systemic fibrosis,0
65,2,SOVALDI,Dyspnoea,0
21,1,AZTREONAM LYSINE,Respiratory failure,0
,0,JAKAFI,Gouty arthritis,0
67,2,JAKAFI,Diarrhoea,0
73,2,JAKAFI,Anaemia,0
,2,SPIRIVA,Off label use,0
,1,FENTORA,Death,0
,1,EXJADE,Psoriasis,0
,0,JAKAFI,Constipation,0
63,1,JAKAFI,Platelet count decreased,0
79,1,JAKAFI,Anaemia,1
48,1,ACETYLSALICYLIC ACID,Haematuria,0
73,2,JAKAFI,Constipation,0
57,1,RANOLAZINE,Myocardial infarction,1
68,2,SOVALDI,Pancreatitis,1
,1,CODATEN,Blister,0
77,2,JAKAFI,Paraesthesia,0
75,1,JAKAFI,Rash,0
76,2,JAKAFI,Constipation,0
53,1,CRESTOR,Coronary artery disease,0
51,2,HUMIRA,Transient ischaemic attack,1
,1,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Dyspnoea,0
,1,TRUVADA,Renal disorder,0
49,2,JAKAFI,Neuropathy peripheral,0
,1,JAKAFI,Rash,0
70,1,JAKAFI,Tinea cruris,0
,2,NICOTINELL TTS 30,Asthma,0
,2,JAKAFI,Fluid retention,0
,0,JAKAFI,Anaemia,0
,1,JAKAFI,Vision blurred,0
71,2,JAKAFI,Haemoglobin decreased,1
54,2,PRIVATE LABEL,Speech disorder,0
,2,JAKAFI,Pain in extremity,0
,0,JAKAFI,Creatinine renal clearance increased,0
,1,JAKAFI,Abdominal distension,0
75,1,JAKAFI,Night sweats,0
65,1,JAKAFI,Fatigue,0
70,2,JAKAFI,Neuropathy peripheral,0
69,2,JAKAFI,Asthenia,0
76,2,JAKAFI,Haemoglobin decreased,0
81,2,JAKAFI,Pruritus,0
,2,JAKAFI,Malaise,0
77,2,ACLASTA,Death,0
63,2,JAKAFI,Nausea,0
51,1,HUMIRA,Rotator cuff syndrome,0
70,2,JAKAFI,Rash papular,0
76,1,PRADAXA,Death,1
,,JAKAFI,Death,2
87,2,JAKAFI,Diarrhoea,0
,0,JAKAFI,Radiotherapy,0
,1,PRADAXA,Gastrointestinal haemorrhage,1
78,1,JAKAFI,Diarrhoea,0
,2,ACLASTA,Aortic stenosis,0
,1,JAKAFI,Platelet count decreased,0
64,2,DABIGATRAN,Abdominal pain,1
,,AMITRIPTYLINE,Nausea,0
67,1,JAKAFI,Back pain,0
76,1,SPIRIVA,Incorrect route of drug administration,0
70,2,METOPROLOL,Drug ineffective,0
77,1,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Diarrhoea,0
,2,TEGRETOL,Nephrolithiasis,0
,2,JAKAFI,Pain in extremity,0
68,2,JAKAFI,Fatigue,0
76,1,JAKAFI,Gastrooesophageal reflux disease,0
,0,JAKAFI,Oedema peripheral,0
67,2,JAKAFI,Ligament sprain,0
70,1,JAKAFI,Skin lesion,0
78,1,JAKAFI,Constipation,0
76,2,JAKAFI,Palpitations,0
76,2,CASPOFUNGIN ACETATE,Drug ineffective,0
79,2,JAKAFI,Nausea,0
67,2,JAKAFI,Increased appetite,0
,2,JAKAFI,Fatigue,0
70,1,JAKAFI,Feeling abnormal,0
,2,JAKAFI,Diarrhoea,0
70,1,JAKAFI,Anxiety,0
,2,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Muscle spasms,0
,1,JAKAFI,Muscular weakness,0
79,2,JAKAFI,Rash,0
,2,JAKAFI,Cardiac flutter,0
,0,JAKAFI,Fatigue,0
67,2,JAKAFI,Anaemia,0
,1,JANUVIA,Pancreatic carcinoma,0
,2,JAKAFI,Pain in extremity,0
40,1,CLOZARIL,"Hallucination, visual",0
81,2,JAKAFI,Anaemia,0
83,1,JAKAFI,Migraine,0
,0,JAKAFI,Rash,0
75,1,PRADAXA,Encephalopathy,1
,0,JAKAFI,Adverse event,0
,2,JAKAFI,Drug dose omission,0
81,1,JAKAFI,Epistaxis,0
85,2,PRADAXA,Cerebral haemorrhage,1
87,2,JAKAFI,Back pain,0
56,1,JAKAFI,Rash pruritic,0
,1,JAKAFI,Adverse event,0
84,1,PRADAXA,Haemorrhage intracranial,1
90,1,JAKAFI,Disturbance in attention,0
58,1,JAKAFI,Hypersomnia,0
85,1,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Haemoglobin decreased,0
,,JAKAFI,Anaemia,1
62,1,JAKAFI,Vision blurred,0
66,2,JAKAFI,Anaemia,0
91,2,JAKAFI,Splenomegaly,0
1,1,DEPAKINE,Overdose,1
,2,JAKAFI,Nausea,0
87,2,JAKAFI,Dry mouth,0
,2,JAKAFI,Tooth injury,0
85,2,ACLASTA,Dementia,0
87,2,JAKAFI,Asthenia,0
77,2,JAKAFI,Pain of skin,0
,2,DR. SCHOLL^S ONE STEP CORN REMOVERS,Burns third degree,0
88,2,JAKAFI,Nausea,0
,2,JAKAFI,Blood potassium increased,0
79,1,JAKAFI,Chills,0
74,2,JAKAFI,Pruritus,0
,2,JAKAFI,Haemorrhage,0
,1,JAKAFI,Treatment noncompliance,0
71,1,JAKAFI,White blood cell count abnormal,0
,0,JAKAFI,Abdominal pain,0
67,2,VITAMIN D                          /00107901/,Diarrhoea,0
81,2,JAKAFI,Upper respiratory tract infection,0
63,2,DABIGATRAN,Mouth haemorrhage,1
61,1,JAKAFI,Pain,0
66,2,JAKAFI,Diarrhoea,0
25,2,IMPLANON,Surgery,0
,1,JAKAFI,Disease progression,0
76,1,JAKAFI,Haemoglobin abnormal,0
83,1,JAKAFI,Skin lesion,0
,2,JAKAFI,Gout,0
,2,JAKAFI,Oral pain,0
,0,JAKAFI,Abdominal distension,0
,1,JAKAFI,Malaise,0
78,2,JAKAFI,Nausea,0
86,2,JAKAFI,Platelet count decreased,0
68,1,JAKAFI,Gout,0
62,2,JAKAFI,Insomnia,0
63,1,JAKAFI,Splenomegaly,0
74,1,JAKAFI,Skin lesion,0
52,2,JAKAFI,Constipation,0
,0,JAKAFI,Diarrhoea,0
85,2,JAKAFI,Asthenia,0
59,2,JAKAFI,Swelling face,0
87,2,JAKAFI,Diarrhoea,0
81,2,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Bone pain,0
86,1,JAKAFI,Platelet count decreased,0
57,2,JAKAFI,Haemoglobin decreased,0
,2,JAKAFI,Adverse drug reaction,0
,1,JAKAFI,Rhinorrhoea,0
49,1,JAKAFI,Haemoglobin decreased,0
,0,JAKAFI,Acne,0
,2,JAKAFI,Adverse drug reaction,0
71,1,JAKAFI,Rheumatoid arthritis,0
78,2,JAKAFI,Haemoglobin decreased,0
48,2,TAMOXIFEN,Metastases to lymph nodes,0
,0,JAKAFI,Diverticulitis,0
63,1,JAKAFI,Platelet count abnormal,0
61,1,JAKAFI,Hypoaesthesia,0
71,1,JAKAFI,Diarrhoea,0
58,1,MICARDIS,Fatigue,0
79,1,JAKAFI,Adverse event,0
,0,JAKAFI,Feeling abnormal,0
65,2,JAKAFI,Blood creatinine increased,0
,2,JAKAFI,Malaise,0
,1,JAKAFI,Adverse drug reaction,0
,1,JAKAFI,Dyspnoea exertional,0
,1,JAKAFI,Adverse reaction,0
,0,JAKAFI,Asthenia,0
79,2,JAKAFI,Dyspnoea,0
63,1,JAKAFI,Nausea,0
,1,JAKAFI,Blood glucose fluctuation,0
64,1,JAKAFI,Musculoskeletal pain,0
80,2,JAKAFI,Anaemia,0
74,2,JAKAFI,Platelet count decreased,0
65,1,JAKAFI,Oral mucosal blistering,0
83,2,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Pain in extremity,0
,0,JAKAFI,Fall,0
57,1,RANOLAZINE,Angina pectoris,0
,1,JAKAFI,Haemoglobin decreased,0
74,1,JAKAFI,Arthralgia,0
,0,JAKAFI,Dyspnoea,0
63,2,JAKAFI,Tendonitis,0
72,2,JAKAFI,Condition aggravated,0
58,2,JAKAFI,Platelet count decreased,0
51,2,AUGMENTIN,Vaginal ulceration,1
48,2,JAKAFI,Vision blurred,0
79,1,JAKAFI,Condition aggravated,0
14,1,FLUDARABINE,Death,0
80,2,JAKAFI,Fatigue,0
74,2,JAKAFI,Insomnia,0
64,1,JAKAFI,Thrombocytopenia,0
,0,JAKAFI,Liver function test abnormal,0
54,2,JAKAFI,Neck pain,0
64,2,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Feeling abnormal,0
,2,JAKAFI,Fatigue,0
,2,VITAMIN D3,Limb discomfort,0
80,1,JAKAFI,Disease progression,0
74,1,JAKAFI,Tremor,0
,1,JAKAFI,Blood test abnormal,0
71,1,JAKAFI,Platelet count decreased,0
85,2,JAKAFI,Oedema,0
68,2,JAKAFI,Fatigue,0
,2,JAKAFI,White blood cell count increased,0
33,2,JAKAFI,Sinusitis,0
,1,JAKAFI,Adverse drug reaction,0
,1,JAKAFI,Restless legs syndrome,0
,0,JAKAFI,Arthralgia,0
73,2,JAKAFI,Bone pain,0
,0,JAKAFI,Treatment noncompliance,0
80,1,JAKAFI,Pneumonia,0
,1,JAKAFI,Thrombocytopenia,0
65,1,JAKAFI,Haematocrit decreased,0
74,1,JAKAFI,Dyspnoea,0
,2,JAKAFI,Malaise,0
79,2,JAKAFI,Splenomegaly,0
74,1,JAKAFI,Dysgeusia,0
59,2,JAKAFI,Fatigue,0
,0,JAKAFI,Abdominal discomfort,0
,1,JAKAFI,Platelet count increased,0
,2,COPAXONE,Injection site reaction,0
62,1,JAKAFI,Hypothyroidism,0
78,2,JAKAFI,Hepatomegaly,0
,1,DEPAKINE,Epilepsy,0
72,1,JAKAFI,Thrombocytopenia,0
75,2,JAKAFI,Diarrhoea,0
74,2,JAKAFI,Bone pain,0
86,1,JAKAFI,Haemoglobin decreased,0
,,VITAMIN C,Anaemia,0
83,1,JAKAFI,Hospice care,0
,2,JAKAFI,Rash,0
74,2,JAKAFI,Diarrhoea,0
,2,JAKAFI,Decreased appetite,0
60,2,JAKAFI,Local swelling,0
81,2,JAKAFI,Iron overload,0
50,2,JAKAFI,Pain in extremity,0
,2,JAKAFI,Splenomegaly,0
48,2,JAKAFI,Tinnitus,0
9,1,VALPROATE SODIUM,Diet refusal,1
75,2,JAKAFI,Flatulence,0
,2,JAKAFI,Arthralgia,0
80,1,JAKAFI,Diarrhoea,0
,1,JAKAFI,Transfusion,0
,0,JAKAFI,Transfusion,0
,2,JAKAFI,Emphysema,0
73,1,JAKAFI,Chromaturia,0
68,2,JAKAFI,Platelet count decreased,0
63,2,JAKAFI,Back pain,0
,0,JAKAFI,Platelet count abnormal,0
77,2,JAKAFI,Anaemia,0
74,2,JAKAFI,Pain in extremity,0
,1,LETAIRIS,Dyspnoea,1
53,2,JAKAFI,Blood pressure increased,0
76,2,JAKAFI,Platelet count decreased,0
40,2,ADCIRCA,Gastric disorder,1
,0,JAKAFI,Abdominal pain,0
49,2,JAKAFI,Vision blurred,0
,0,JAKAFI,Anaemia,0
68,2,JAKAFI,Abdominal pain,0
81,1,JAKAFI,Weight decreased,0
87,1,JAKAFI,Pollakiuria,0
,1,JAKAFI,Weight increased,0
55,2,JAKAFI,Cough,0
,1,JAKAFI,Blood count abnormal,1
73,2,JAKAFI,Thrombocytopenia,0
66,1,JAKAFI,Platelet count increased,0
80,1,JAKAFI,Thrombocytopenia,0
52,2,JAKAFI,Condition aggravated,0
46,1,FENTORA,Diabetes mellitus inadequate control,0
65,2,JAKAFI,Cough,0
64,1,JAKAFI,Tooth infection,0
,2,JAKAFI,Anaemia,0
65,1,JAKAFI,Splenomegaly,0
46,2,JAKAFI,Hyperhidrosis,0
54,1,JAKAFI,Epistaxis,0
,1,JAKAFI,Abdominal distension,0
80,1,JAKAFI,Rash pruritic,0
74,1,JAKAFI,Haemoglobin decreased,0
75,1,JAKAFI,Platelet count decreased,0
37,2,JAKAFI,Drug dose omission,0
,0,JAKAFI,Rash,0
,2,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Decreased appetite,0
77,2,LETAIRIS,Sinusitis,0
77,2,JAKAFI,Eye infection,0
68,1,JAKAFI,Nasopharyngitis,0
56,2,LETAIRIS,Lethargy,0
,2,JAKAFI,Decreased appetite,0
79,1,JAKAFI,Muscular weakness,0
83,1,JAKAFI,Dyspnoea,0
60,2,JAKAFI,Disease progression,0
79,2,JAKAFI,Anaemia,0
80,1,JAKAFI,Haemoglobin decreased,1
,0,JAKAFI,Anxiety,0
84,1,JAKAFI,Platelet count decreased,0
47,1,JAKAFI,Blood bilirubin increased,0
62,2,JAKAFI,Splenomegaly,0
71,1,JAKAFI,Diarrhoea,0
,1,JAKAFI,White blood cell count increased,0
81,2,JAKAFI,Muscle spasms,0
74,1,JAKAFI,Cough,0
78,1,JAKAFI,Dyspnoea,0
71,2,JAKAFI,Candida infection,0
70,1,JAKAFI,Thrombocytopenia,0
,0,JAKAFI,Vomiting,0
73,2,JAKAFI,Haemoglobin decreased,0
,0,JAKAFI,Malaise,0
67,2,JAKAFI,Macular degeneration,0
,2,JAKAFI,Influenza,0
,0,JAKAFI,Influenza like illness,0
,0,JAKAFI,Eye infection,0
,1,JAKAFI,Drug dose omission,0
88,1,PRADAXA,Lower gastrointestinal haemorrhage,0
,2,LETAIRIS,Device related infection,1
71,1,JAKAFI,Transfusion,0
82,1,JAKAFI,Diarrhoea,0
,2,JAKAFI,Fatigue,0
57,1,JAKAFI,Thrombocytopenia,0
,2,JAKAFI,Blood potassium increased,0
,2,JAKAFI,Rash,0
,2,JAKAFI,Malaise,0
65,1,JAKAFI,Splenomegaly,0
,0,JAKAFI,Haemoglobin decreased,0
,2,JAKAFI,Increased appetite,0
70,1,JAKAFI,Haemoglobin decreased,0
77,1,JAKAFI,Colon neoplasm,0
,1,LETAIRIS,Local swelling,0
78,1,JAKAFI,Thrombocytopenia,0
,2,JAKAFI,Nausea,0
74,2,JAKAFI,Sinusitis,0
70,2,JAKAFI,Arthralgia,0
82,1,JAKAFI,Bone pain,0
77,2,JAKAFI,Alopecia,0
,2,JAKAFI,Sleep disorder,0
,2,JAKAFI,Skin ulcer,0
66,2,JAKAFI,Platelet count decreased,0
,1,JAKAFI,Malaise,0
,1,JAKAFI,Nasopharyngitis,0
81,1,JAKAFI,Aspartate aminotransferase increased,0
,2,JAKAFI,Haemoglobin decreased,0
,2,LETAIRIS,Diarrhoea,0
60,2,JAKAFI,Skin ulcer,0
70,1,JAKAFI,Diarrhoea,0
56,1,JAKAFI,Gout,0
75,1,JAKAFI,White blood cell count decreased,0
70,1,JAKAFI,Haemoglobin decreased,0
90,2,JAKAFI,Platelet count decreased,0
,1,JAKAFI,Drug intolerance,0
,1,JAKAFI,Diarrhoea,0
62,2,JAKAFI,Abdominal distension,0
77,2,JAKAFI,White blood cell count increased,0
74,2,JAKAFI,Bone pain,0
,2,JAKAFI,Infection,0
,0,JAKAFI,Blood count abnormal,0
,0,JAKAFI,Micturition frequency decreased,0
,0,JAKAFI,Flatulence,0
70,1,JAKAFI,Night sweats,0
,0,JAKAFI,Chest pain,0
47,1,JAKAFI,Haemoglobin decreased,0
74,2,JAKAFI,Fatigue,0
71,2,JAKAFI,Splenomegaly,0
,2,JAKAFI,Influenza,0
,2,HUMIRA,Giant cell tumour of tendon sheath,0
55,1,JAKAFI,Pyrexia,0
,0,JAKAFI,Nausea,0
,2,JAKAFI,Inflammation,0
,2,JAKAFI,Diarrhoea,0
,1,JAKAFI,Skin lesion,0
,2,JAKAFI,Haemorrhage,0
69,1,JAKAFI,Dizziness,0
,2,JAKAFI,Platelet count decreased,0
70,2,JAKAFI,Fatigue,0
73,2,JAKAFI,Influenza,0
,,HYDROCHLOROTHIAZIDE.,Aneurysm,0
81,1,JAKAFI,Anaemia,0
64,1,JAKAFI,Epistaxis,0
,2,JAKAFI,Anaemia,0
,0,JAKAFI,Arthralgia,0
70,1,JAKAFI,Night sweats,0
84,2,JAKAFI,Rash pruritic,0
86,2,JAKAFI,Diarrhoea,0
,2,JAKAFI,Neuropathy peripheral,0
,,FLOMAX,Platelet count increased,0
77,2,JAKAFI,Rash,0
49,1,JAKAFI,Blood pressure increased,0
70,2,JAKAFI,Musculoskeletal chest pain,0
52,1,JAKAFI,Platelet count decreased,0
71,1,JAKAFI,Nausea,0
80,1,JAKAFI,White blood cell count decreased,0
52,1,JAKAFI,Local swelling,0
,0,JAKAFI,Influenza,0
67,1,JAKAFI,Cardiac murmur,0
,0,JAKAFI,Arthralgia,0
38,2,JAKAFI,Migraine,0
,0,JAKAFI,Thrombocytopenia,0
74,1,JAKAFI,Adverse drug reaction,0
,0,JAKAFI,Influenza,0
82,1,JAKAFI,Anaemia,0
78,1,ARANESP,Transfusion,0
81,1,JAKAFI,Blood potassium increased,0
,0,JAKAFI,Splenomegaly,0
51,2,TRADJENTA,Drug ineffective,0
74,1,JAKAFI,Dyspnoea,1
54,0,JAKAFI,Haemoglobin decreased,0
61,2,JAKAFI,Rash pruritic,0
55,1,JAKAFI,Blood pressure increased,0
,1,JAKAFI,Haemorrhage,0
71,2,JAKAFI,Transfusion,0
,2,JAKAFI,Flatulence,0
73,1,JAKAFI,White blood cell count increased,0
69,1,JAKAFI,Anaemia,0
,2,JAKAFI,Nausea,0
68,1,JAKAFI,Splenomegaly,0
,2,JAKAFI,Abdominal pain,0
,0,JAKAFI,Toothache,0
70,2,JAKAFI,Malaise,0
86,1,JAKAFI,Hospice care,0
73,2,JAKAFI,Nasopharyngitis,0
,,LEVOTHYROXIN,Blood count abnormal,0
66,2,JAKAFI,Flatulence,0
,1,JAKAFI,Pneumonia,0
91,2,JAKAFI,Bronchitis,0
71,1,JAKAFI,Diarrhoea,0
,2,JAKAFI,Malaise,0
56,2,JAKAFI,Abasia,0
68,2,JAKAFI,Parvovirus infection,0
65,2,JAKAFI,Rash,0
72,2,JAKAFI,Anaemia,0
,0,JAKAFI,Pain in extremity,0
66,2,JAKAFI,Postoperative wound infection,0
75,1,JAKAFI,Increased appetite,0
56,1,JAKAFI,Nausea,0
73,2,JAKAFI,Dyspnoea,0
,1,JAKAFI,Spleen disorder,0
,0,JAKAFI,Platelet count decreased,0
,2,JAKAFI,White blood cell count increased,0
59,2,JAKAFI,Anaemia,0
,1,JAKAFI,Epistaxis,0
86,1,JAKAFI,Fall,0
,2,JAKAFI,Vomiting,0
82,2,JAKAFI,Blood potassium increased,0
55,1,JAKAFI,Nasopharyngitis,0
,1,JAKAFI,Splenomegaly,0
77,1,JAKAFI,Nasopharyngitis,0
66,2,JAKAFI,Breast tenderness,0
54,1,JAKAFI,Alanine aminotransferase increased,0
86,1,JAKAFI,Diplopia,0
,2,LETAIRIS,Scleroderma,0
65,1,SPIRIVA,Incorrect route of drug administration,0
64,2,JAKAFI,Hepatic enzyme increased,0
77,2,JAKAFI,Increased appetite,0
,2,JAKAFI,Anaemia,1
59,2,JAKAFI,Lactose intolerance,0
71,2,JAKAFI,Haemoglobin decreased,0
77,2,JAKAFI,Fluid retention,0
52,2,JAKAFI,Rectal haemorrhage,0
66,2,JAKAFI,Blood uric acid increased,0
88,1,JAKAFI,Platelet count abnormal,0
,1,JAKAFI,Memory impairment,0
,2,JAKAFI,Feeling abnormal,0
22,2,SEROQUEL,Intentional overdose,0
71,1,JAKAFI,Anaemia,0
,0,JAKAFI,Back pain,0
71,1,JAKAFI,Anaemia,0
63,2,JAKAFI,Salivary hypersecretion,0
74,1,JAKAFI,Fatigue,0
59,1,JAKAFI,Diarrhoea,0
88,2,JAKAFI,Dyspnoea,0
76,2,JAKAFI,Dehydration,0
,0,JAKAFI,Pyrexia,0
,2,JAKAFI,Hypertension,0
,2,JAKAFI,Hypertension,0
71,1,JAKAFI,Nausea,0
,1,JAKAFI,Platelet count decreased,0
78,1,JAKAFI,Anaemia,0
57,2,JAKAFI,Eye infection,0
87,1,JAKAFI,Chest pain,0
,2,JAKAFI,Platelet count decreased,0
77,1,JAKAFI,Splenomegaly,0
46,2,JAKAFI,Nasopharyngitis,0
71,1,JAKAFI,Nasopharyngitis,0
64,2,JAKAFI,Headache,0
,1,JAKAFI,Local swelling,0
65,1,JAKAFI,Abdominal discomfort,0
80,1,JAKAFI,Skin lesion,0
70,2,ETOPOSIDE.,Cellulitis,1
76,1,JAKAFI,Platelet count increased,0
62,1,JAKAFI,Platelet count decreased,0
,1,JAKAFI,Acne,0
85,1,JAKAFI,Pruritus,0
,2,JAKAFI,Platelet count decreased,0
72,1,JAKAFI,Disease progression,0
78,1,JAKAFI,Fatigue,0
66,2,JAKAFI,Diarrhoea,0
65,2,JAKAFI,Nasopharyngitis,0
80,1,JAKAFI,Diarrhoea,0
,0,JAKAFI,Chest discomfort,0
77,2,JAKAFI,Cellulitis,0
58,1,JAKAFI,Nausea,0
47,1,JAKAFI,Fatigue,0
84,2,JAKAFI,Fatigue,0
51,2,JAKAFI,Fatigue,0
84,1,JAKAFI,Diarrhoea,0
66,2,JAKAFI,Hypertension,0
,1,JAKAFI,Nonspecific reaction,0
,1,JAKAFI,No adverse event,0
65,2,JAKAFI,Cough,0
,2,JAKAFI,Gout,0
77,1,JAKAFI,Rash,0
96,1,JAKAFI,Haemoglobin decreased,0
,2,JAKAFI,Arthralgia,0
68,1,JAKAFI,Flatulence,0
64,1,JAKAFI,Splenomegaly,0
83,2,JAKAFI,Tinea pedis,0
,1,DULERA,Incorrect dose administered by device,0
,2,JAKAFI,Blood count abnormal,0
73,1,JAKAFI,Night sweats,0
,2,JAKAFI,Diarrhoea,0
,2,JAKAFI,Abdominal pain,0
,2,JAKAFI,Fatigue,0
,1,JAKAFI,Blood test abnormal,0
49,1,JAKAFI,Abdominal pain,0
81,1,JAKAFI,Abdominal pain,0
,0,JAKAFI,No adverse event,0
70,1,JAKAFI,Anaemia,0
80,1,JAKAFI,Anaemia,0
,2,JAKAFI,Dermatitis,0
82,2,JAKAFI,Arthritis,0
68,2,JAKAFI,Abdominal distension,0
,1,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Night sweats,0
82,1,JAKAFI,White blood cell count increased,0
80,1,JAKAFI,Haemoglobin decreased,0
74,2,JAKAFI,Arthralgia,0
57,2,JAKAFI,Fatigue,0
75,1,JAKAFI,Biopsy bone marrow,0
57,1,COMBIGAN,Cataract,0
58,1,JAKAFI,Abdominal pain upper,0
56,2,JAKAFI,Haemoglobin decreased,0
,0,JAKAFI,No adverse event,0
69,2,JAKAFI,Fatigue,0
,2,JAKAFI,Adverse drug reaction,0
66,1,JAKAFI,Influenza,0
,1,JAKAFI,Nasopharyngitis,0
40,1,JAKAFI,Insomnia,0
83,1,JAKAFI,Weight decreased,0
,2,JAKAFI,Transfusion,0
,1,JAKAFI,Asthenia,0
,2,JAKAFI,Cough,0
70,1,JAKAFI,Splenomegaly,0
,2,JAKAFI,Pruritus,0
70,1,JAKAFI,Myalgia,0
,1,JAKAFI,Blood iron decreased,0
70,2,JAKAFI,Dizziness,0
69,1,JAKAFI,Arthralgia,0
69,1,JAKAFI,Platelet count decreased,0
83,1,JAKAFI,Non-cardiac chest pain,0
,1,JAKAFI,Malaise,0
,1,JAKAFI,White blood cell count decreased,1
72,1,JAKAFI,Diarrhoea,0
83,1,JAKAFI,Skin irritation,0
62,1,JAKAFI,Memory impairment,0
76,1,JAKAFI,Haemoglobin decreased,0
,1,LETAIRIS,Pneumonia,0
75,2,JAKAFI,Neuropathy peripheral,0
57,2,JAKAFI,Fatigue,0
82,1,JAKAFI,Musculoskeletal pain,0
,2,JAKAFI,Medication error,0
,1,JAKAFI,Fatigue,0
53,2,JAKAFI,Skin lesion,0
91,1,JAKAFI,Back pain,0
,2,JAKAFI,Asthenia,0
70,1,JAKAFI,Heart rate decreased,0
54,1,JAKAFI,Fatigue,0
,2,JAKAFI,Anxiety,0
76,1,JAKAFI,Epistaxis,0
56,2,JAKAFI,Full blood count increased,0
70,1,JAKAFI,Malaise,0
,2,JAKAFI,Fatigue,0
,1,JAKAFI,Malaise,0
68,1,JAKAFI,Tooth extraction,0
73,1,JAKAFI,Chills,0
69,1,JAKAFI,Blood count abnormal,1
,1,JAKAFI,Epistaxis,0
93,2,JAKAFI,Palpitations,0
,1,JAKAFI,Diarrhoea,0
,1,JAKAFI,Hypertension,0
73,2,JAKAFI,Dry skin,0
,1,JAKAFI,Wound drainage,0
,1,JAKAFI,Ascites,0
76,1,JAKAFI,Anaemia,0
95,2,ADCIRCA,Cardiac failure congestive,1
,1,JAKAFI,Mouth ulceration,0
,1,JAKAFI,Platelet count decreased,0
74,2,JAKAFI,Dry mouth,0
77,1,JAKAFI,Haemoglobin decreased,0
71,2,JAKAFI,Malaise,0
71,1,JAKAFI,Anaemia,0
,1,JAKAFI,Gout,0
79,1,JAKAFI,Asthenia,0
,2,JAKAFI,Platelet count decreased,1
57,1,JAKAFI,Prothrombin time shortened,0
74,1,JAKAFI,Painful respiration,0
59,2,JAKAFI,Diarrhoea,0
,,LISINOPRIL.,Fatigue,0
59,2,JAKAFI,Haemoglobin abnormal,0
,1,JAKAFI,Haemorrhage,0
73,2,JAKAFI,Pollakiuria,0
,2,JAKAFI,Blood count abnormal,0
65,2,JAKAFI,Dyspepsia,0
77,1,JAKAFI,Abdominal discomfort,0
70,1,JAKAFI,Anaemia,0
68,1,JAKAFI,Urticaria,0
56,1,ADALIMUMAB,Malignant melanoma stage I,2
,1,JAKAFI,Unevaluable event,0
,2,JAKAFI,White blood cell count increased,0
,2,JAKAFI,Flatulence,0
0,1,BUPRENORPHINE GENERIC,Foetal exposure during pregnancy,1
76,1,JAKAFI,Drug intolerance,0
75,2,JAKAFI,Platelet count increased,0
,2,JAKAFI,Sluggishness,0
72,1,JAKAFI,Feeling cold,0
,1,JAKAFI,Splenomegaly,0
73,1,JAKAFI,Platelet count decreased,0
74,1,JAKAFI,Arthralgia,0
,,VITAMIN D2,Dehydration,0
,1,JAKAFI,Fatigue,0
,1,JAKAFI,Wheezing,0
79,2,JAKAFI,Sinus disorder,0
67,1,JAKAFI,Diarrhoea,0
,1,JAKAFI,General physical health deterioration,0
84,2,JAKAFI,Pain,0
66,1,JAKAFI,Splenomegaly,0
52,2,JAKAFI,Increased appetite,0
57,2,VIREAD,Diarrhoea,1
,1,LETAIRIS,Transfusion,1
83,2,JAKAFI,Platelet count decreased,0
,2,JAKAFI,Ear discomfort,0
67,1,JAKAFI,Haemoglobin abnormal,0
,2,JAKAFI,Rash,0
50,2,LETAIRIS,Chest pain,0
66,2,JAKAFI,Emergency care examination,0
76,2,JAKAFI,Fatigue,0
66,2,JAKAFI,Diarrhoea,0
,1,JAKAFI,Accidental exposure to product,0
65,1,JAKAFI,Increased appetite,0
74,2,JAKAFI,Abdominal pain upper,0
67,1,JAKAFI,Dyspepsia,0
,1,TENOFOVIR DISOPROXIL FUMARATE,Acute hepatic failure,0
60,1,JAKAFI,Splenomegaly,0
60,1,JAKAFI,Discomfort,0
86,2,FUROSEMIDE,Renal failure acute,1
,2,LETAIRIS,Dyspnoea,0
70,1,JAKAFI,Increased appetite,0
20,2,LETAIRIS,Pyelonephritis,1
,1,SUBOXONE FILM,Convulsion,0
,2,JAKAFI,No adverse event,0
,2,JAKAFI,Nausea,0
66,2,JAKAFI,Syncope,0
,1,LYRICA,Prostatic disorder,0
80,1,JAKAFI,Oral candidiasis,0
70,2,JAKAFI,Rash,0
,,LOSARTAN.,Product label issue,0
,1,JAKAFI,Pain,0
75,1,JAKAFI,Renal impairment,0
64,2,JAKAFI,Diarrhoea,0
,,VITAMIN B12,Death,1
,2,JAKAFI,Increased appetite,0
83,1,JAKAFI,Haemoglobin decreased,0
,1,JAKAFI,Mouth ulceration,0
74,2,JAKAFI,Irritable bowel syndrome,0
,2,OXYTROL FOR WOMEN,Drug administered at inappropriate site,0
,2,LETAIRIS,Malaise,0
,2,SUBUTEX,Maternal exposure during pregnancy,0
,1,JAKAFI,Pruritus,0
,2,JAKAFI,Hospice care,0
28,2,BUPRENORPHINE GENERIC,Wrong technique in drug usage process,0
,0,JAKAFI,Fatigue,0
,1,JAKAFI,Transfusion,0
66,1,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,0
60,1,JAKAFI,Splenomegaly,0
,2,JAKAFI,Platelet count decreased,0
70,2,LETAIRIS,Death,0
,1,JAKAFI,Asthma,0
,1,JAKAFI,Musculoskeletal pain,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,BUPRENORPHINE UNSPECIFIED,Maternal exposure during pregnancy,0
,2,JAKAFI,Back pain,0
71,1,JAKAFI,Malaise,0
,2,JAKAFI,Somnolence,0
69,1,JAKAFI,Blister,0
,,JAKAFI,Alopecia,0
62,1,JAKAFI,Gastrointestinal disorder,0
,1,JAKAFI,Drug dose omission,0
,2,JAKAFI,Abdominal discomfort,0
,1,JAKAFI,Drug dose omission,0
,1,JAKAFI,Exposure to contaminated water,0
52,1,JAKAFI,Fatigue,0
56,2,JAKAFI,Somnolence,0
80,2,JAKAFI,Asthenia,0
60,1,JAKAFI,Flatulence,0
89,1,JAKAFI,Haemoglobin decreased,0
54,1,JAKAFI,Memory impairment,0
55,1,JAKAFI,Muscle spasms,0
,2,JAKAFI,Dyspnoea,0
64,2,JAKAFI,Incorrect dose administered,0
,2,JAKAFI,Malaise,0
80,2,JAKAFI,Feeling abnormal,0
86,1,JAKAFI,Asthenia,0
63,1,FTY 720,Multiple sclerosis,1
89,1,EXELON PATCH,Respiratory arrest,1
75,1,JAKAFI,Eye haemorrhage,0
64,2,JAKAFI,Stomatitis,0
68,1,JAKAFI,Nausea,0
63,2,JAKAFI,Epistaxis,0
,2,JAKAFI,Onychomycosis,0
73,2,JAKAFI,General physical condition abnormal,0
64,2,JAKAFI,Malaise,0
74,2,JAKAFI,Myalgia,0
,2,JAKAFI,Platelet count abnormal,0
68,2,JAKAFI,Myalgia,0
,1,SUBUTEX,Foetal exposure during pregnancy,0
65,2,LETAIRIS,Stress,0
,,PRAVASTATIN.,Tremor,0
77,1,JAKAFI,Skin discolouration,0
72,2,JAKAFI,Bone pain,0
86,2,JAKAFI,Dehydration,0
,1,JAKAFI,Malaise,0
,2,SUBUTEX,Hospitalisation,1
83,1,EXELON PATCH,Respiratory arrest,1
78,2,JAKAFI,Blood iron decreased,0
,2,JAKAFI,Pneumonia,0
20,2,IMPLANON,Pain,0
,2,LETAIRIS,Herpes zoster,1
77,2,JAKAFI,Red blood cell count decreased,1
84,1,JAKAFI,Constipation,0
71,1,JAKAFI,Sinusitis,0
,1,JAKAFI,Blood pressure increased,0
,1,JAKAFI,Platelet count increased,0
,2,LETAIRIS,Pharyngitis,0
,2,JAKAFI,Diarrhoea,0
72,2,JAKAFI,Hypoaesthesia,0
80,2,JAKAFI,Abdominal discomfort,0
88,2,JAKAFI,Diarrhoea,0
56,1,JAKAFI,International normalised ratio increased,0
74,2,JAKAFI,Anaemia,0
,2,JAKAFI,Diarrhoea,0
75,1,JAKAFI,Haemoglobin decreased,0
,2,LETAIRIS,Chest discomfort,1
72,2,JAKAFI,Back pain,0
56,2,JAKAFI,Nausea,0
33,2,SUBOXONE FILM,Maternal exposure during pregnancy,0
97,2,GALANTAMINE,Gastrointestinal haemorrhage,1
,2,JAKAFI,Neuropathy peripheral,0
79,2,JAKAFI,Anaemia,0
,2,REMODULIN,Pain,0
,1,JAKAFI,Glossodynia,0
,2,JAKAFI,Diarrhoea,0
,1,JAKAFI,Adverse drug reaction,0
93,2,JAKAFI,Tooth infection,0
73,1,JAKAFI,Rhinorrhoea,0
58,1,JAKAFI,Pain,0
,1,JAKAFI,Adverse drug reaction,0
81,2,JAKAFI,Platelet count decreased,0
64,1,JAKAFI,Constipation,0
,2,JAKAFI,Hospice care,0
,1,PRADAXA,Lower gastrointestinal haemorrhage,1
,2,JAKAFI,Skin lesion,0
57,2,RAMIPRIL,Bronchospasm,1
,1,JAKAFI,Splenomegaly,0
72,1,NEULASTA,Investigation,1
64,1,JAKAFI,Abdominal pain,0
62,1,JAKAFI,Chest pain,0
,1,JAKAFI,No adverse event,0
82,2,LETAIRIS,Oxygen consumption increased,0
49,1,REVLIMID,Rectal adenocarcinoma,0
,1,JAKAFI,Therapeutic procedure,0
,1,JAKAFI,Blister,0
72,2,JAKAFI,Abdominal pain upper,0
,1,JAKAFI,Red blood cell count decreased,1
62,2,JAKAFI,Splenomegaly,0
,2,OMNISCAN,Nephrogenic systemic fibrosis,0
79,2,JAKAFI,Diarrhoea,0
,2,JAKAFI,Fatigue,0
64,2,JAKAFI,Platelet count decreased,0
66,2,JAKAFI,Anaemia,0
,1,JAKAFI,Unevaluable event,0
69,1,RAMIPRIL,Gingival pain,0
82,2,JAKAFI,Breast disorder female,0
52,2,JAKAFI,Rash pruritic,0
,2,JAKAFI,Dyspepsia,0
,1,JAKAFI,Eye disorder,0
,2,LETAIRIS,Device damage,1
58,1,JAKAFI,Decreased appetite,0
,1,SODIUM VALPROATE,Autism,0
59,2,JAKAFI,Vomiting,0
,2,LETAIRIS,Lung neoplasm malignant,1
,2,SIMVASTATIN.,Fatigue,0
35,2,MYFENAX,Vision blurred,0
,2,PRADAXA,Haemorrhage,1
66,1,JAKAFI,Headache,0
,1,JAKAFI,Oropharyngeal pain,0
,2,INTEGRILIN,Death,1
59,1,TENOFOVIR DISOPROXIL FUMARATE,Diabetes mellitus,0
53,2,OMNISCAN,Nephrogenic systemic fibrosis,0
,2,JAKAFI,Adverse drug reaction,0
73,1,PRADAXA,Rectal haemorrhage,1
80,2,JAKAFI,Alopecia,0
,0,REVLIMID,Death,0
,2,JAKAFI,Haemoglobin decreased,0
58,1,NEULASTA,Transfusion,1
,1,JAKAFI,Rash,0
25,2,EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Pregnancy,1
72,2,JAKAFI,Renal disorder,0
71,1,NEULASTA,Hospitalisation,1
72,2,FOSAMAX PLUS D,Atypical femur fracture,1
,1,ATRIPLA,Urine abnormality,0
63,2,METHOTREXATE,Hypomagnesaemia,1
,2,CETIRIZINE HYDROCHLORIDE.,Condition aggravated,0
,0,ATRIPLA,Sleep disorder,0
46,1,INDAPAMIDE,Electrocardiogram QT prolonged,0
39,1,TENOFOVIR DISOPROXIL FUMARATE,Extrapulmonary tuberculosis,1
,1,AMITIZA,Pancreatitis,1
82,2,VIDAZA,Anal fistula,0
32,2,OMNISCAN,Nephrogenic systemic fibrosis,0
70,1,OXALIPLATINO TEVA,Dyspnoea,0
19,2,NUVARING,Anxiety,0
63,1,OXALIPLATINO TEVA,Acute myocardial infarction,1
61,1,CIALIS,Arrhythmia,0
,2,EVISTA,Pulmonary embolism,0
70,2,HUMALOG LISPRO,Gastrooesophageal reflux disease,1
60,1,CIALIS,Arrhythmia,0
52,1,FORTEO,Plasma cell myeloma,0
85,2,FORTEO,Convulsion,0
19,2,HUMALOG LISPRO,Blood glucose increased,1
,1,HUMULIN R,Oesophageal carcinoma,0
,1,HUMALOG,Cerebrovascular accident,0
66,1,PREDNISOLONE,Upper respiratory tract infection,1
66,1,NEULASTA,Investigation,1
76,1,PREDNISOLONE.,Death,1
,2,CLARAVIS,Alopecia,0
57,2,XELODA,Disease progression,0
37,1,NEULASTA,Investigation,1
64,2,XELODA,Disease progression,0
,2,XELODA,Death,0
85,2,ZEMPLAR,Urinary tract infection,0
,0,SUSTIVA TABS 600 MG,Dysphagia,0
59,2,VICTRELIS,Drug interaction,0
,1,ENBREL,Ocular vascular disorder,0
61,1,AVASTIN,Death,0
21,2,NEXPLANON,Deep vein thrombosis,1
52,2,NEULASTA,Hospitalisation,1
44,2,TAMIFLU,Leukopenia,0
,1,XGEVA,Osteonecrosis of jaw,0
56,1,COPEGUS,Pancytopenia,0
68,2,HERCEPTIN,Cardiotoxicity,0
,2,VYTORIN,Bladder disorder,1
60,2,NEULASTA,Hospitalisation,1
,2,REBIF,Swelling face,0
58,2,XOLAIR,Peripheral swelling,0
44,2,LEUPRORELIN,Colitis ulcerative,0
29,2,HUMIRA,Haemoglobin decreased,1
,1,HUMIRA,Arthropathy,1
80,2,DEXAMETHASONE,Hypotension,1
82,1,XGEVA,Osteonecrosis of jaw,0
65,1,ARANESP,Investigation,1
61,2,ENBREL,Staphylococcal osteomyelitis,0
57,1,AVASTIN,Nausea,0
,1,XGEVA,Convulsion,1
,0,FENTANYL CITRATE,Death,0
62,2,ARANESP,Surgery,1
4,2,ENBREL,Autoimmune disorder,1
74,2,ETANERCEPT,Atelectasis,0
77,2,PROLIA,Impaired healing,0
,0,DIVALPROEX SODIUM ER TABLETS,Convulsion,0
,0,DOXYCYCLINE,Drug eruption,1
,0,CABERGOLINE,Haemolytic anaemia,1
62,2,MABTHERA,Transient ischaemic attack,0
48,2,VICTRELIS,Dyspnoea,0
61,2,ARANESP,Hospitalisation,1
,0,PROLIA,Osteonecrosis of jaw,0
72,2,5-FLUOROURACIL,Lethargy,1
25,1,CISPLATIN,Drug-induced liver injury,0
60,2,ENBREL,Endometrial cancer,1
50,2,ENBREL,Renal failure,1
80,1,RAMIPRIL,Malaise,1
64,2,ENBREL,Mobility decreased,1
73,1,RIBAVIRIN,Renal failure acute,1
53,1,COPEGUS,Drug interaction,0
71,2,ENBREL,Hepatic failure,0
79,2,MICONAZOLE,Haemorrhage intracranial,0
74,2,PROLIA,Cardiac disorder,1
64,1,FLORID,Immunosuppressant drug level increased,0
68,1,FLORID,Immunosuppressant drug level increased,0
47,2,TAXOTERE,Malaise,1
76,2,ENBREL,Agranulocytosis,1
26,1,LATUDA,Hypotension,0
53,2,CELLCEPT,Pseudomonal sepsis,0
79,1,DOXORUBICIN,Death,0
80,1,LEUPRORELIN,Death,0
60,1,NEULASTA,Investigation,1
39,1,NEULASTA,Investigation,1
,2,NEUTROGENA DEEP MOISTURE DAY WITH SUNSCREEN BROAD SPECTRUM SPF20,Loss of consciousness,0
74,2,NEULASTA,Investigation,1
49,2,ENBREL,Haemorrhoids,0
76,1,NEULASTA,Hospitalisation,1
,2,XGEVA,Hypocalcaemia,1
48,2,NEULASTA,Investigation,1
58,1,NEULASTA,Hospitalisation,1
68,2,NEULASTA,Transfusion,0
79,1,NEULASTA,Hospitalisation,1
63,2,PROLIA,Kidney infection,0
47,2,ENBREL,Emergency care,0
45,2,AVASTIN,Disease progression,0
,2,HERCEPTIN,Drug ineffective,0
72,2,ZOCOR,Drug ineffective,0
57,2,PEGASYS,Hepatitis C,0
40,2,ROACTEMRA,Thrombocytopenia,1
,2,PROLIA,Death,1
59,2,XELODA,Intestinal ulcer,1
87,2,PROLIA,Death,0
50,2,HERCEPTIN,Febrile neutropenia,0
74,2,FLUOROURACIL,Respiratory failure,1
52,1,HYDROCHLOROTHIAZIDE,Hypersensitivity vasculitis,0
86,1,DARBEPOETIN ALFA,Prostate cancer,0
,1,CISPLATIN,Haematotoxicity,0
54,2,SIMVASTATIN,Back pain,1
63,2,SIMVASTATIN,Fall,1
53,2,REBETOL,No therapeutic response,0
68,1,TACROLIMUS,Lymphadenopathy mediastinal,1
31,2,QUETIAPINE,Oligohydramnios,1
,1,ASMANEX TWISTHALER,Dyspnoea,0
25,2,RITUXIMAB,Gastric ulcer,1
,1,ENBREL,Death,0
,1,KLOR-CON,Intestinal obstruction,1
41,2,TRASTUZUMAB,Diarrhoea,0
,1,OMEPRAZOLE,Renal cell carcinoma,0
60,2,ENBREL,Retrograde amnesia,1
,2,PROLIA,Paraesthesia,0
37,1,ENBREL,Diverticulitis,0
14,2,NUTROPIN,Rosai-Dorfman syndrome,0
41,2,DICLOFENAC,Pyrexia,0
,0,LIALDA,Depression,0
69,2,LIALDA,Cervical spinal stenosis,0
55,1,CIMZIA,Rash,1
47,2,ENBREL,Cough,0
62,2,ACETYLCYSTEINE.,Psoriasis,0
,2,HERCEPTIN,Death,0
78,1,LUCENTIS,Herpes ophthalmic,0
57,2,TYSABRI,Death,0
41,2,TYSABRI,Progressive multifocal leukoencephalopathy,1
,2,TYSABRI,Opportunistic infection,1
,2,TYSABRI,Death,0
52,2,TYSABRI,Lung neoplasm,0
30,1,TYSABRI,Iris melanoma,1
52,2,TYSABRI,Multiple sclerosis relapse,1
27,1,TYSABRI,Arthralgia,1
60,2,TYSABRI,Arthritis,1
23,1,SOLU-MEDROL,Anaemia,1
51,1,AVONEX,Diabetic coma,1
,2,AVONEX,Ectopic pregnancy,0
,1,AVONEX,Neck surgery,1
,2,AVONEX,Hysterectomy,0
40,2,AVONEX,Intracranial aneurysm,0
61,2,AVONEX,Gastrooesophageal reflux disease,1
55,2,AVONEX,Gait disturbance,1
,2,AVONEX,Hysterectomy,0
,2,TYSABRI,General symptom,0
,2,TYSABRI,Coordination abnormal,0
46,2,TYSABRI,Osteoporosis,0
,2,TYSABRI,Malaise,0
32,2,TYSABRI,Nasopharyngitis,0
40,1,TYSABRI,Stress,0
51,2,TYSABRI,Migraine,0
,2,TYSABRI,Feeling abnormal,0
,2,TYSABRI,Multiple sclerosis relapse,0
,2,TYSABRI,Memory impairment,0
49,1,TYSABRI,Multiple sclerosis relapse,1
,2,TYSABRI,Depression,0
,2,TYSABRI,Blindness,0
,2,TYSABRI,Multiple sclerosis relapse,0
46,2,TYSABRI,Muscular weakness,0
53,1,TYSABRI,Fatigue,0
,2,TYSABRI,Pain,0
59,1,TYSABRI,Pain in extremity,0
,2,TYSABRI,Decubitus ulcer,0
,1,TYSABRI,Multiple sclerosis,0
,2,TYSABRI,White blood cell count increased,0
,1,TYSABRI,Cognitive disorder,0
24,1,TYSABRI,Influenza like illness,0
50,1,TYSABRI,Blood glucose increased,0
58,2,TYSABRI,Adverse drug reaction,0
,2,TYSABRI,Pain,0
61,2,TYSABRI,Pain in extremity,0
52,2,TYSABRI,Influenza like illness,0
,2,TYSABRI,Asthenia,0
60,1,TYSABRI,Memory impairment,0
45,2,TYSABRI,Musculoskeletal disorder,0
,1,TYSABRI,Anxiety,0
,2,TYSABRI,Anxiety,0
42,2,TYSABRI,Multiple sclerosis relapse,1
40,1,TYSABRI,Stress,0
58,2,TYSABRI,Blood glucose increased,0
,2,TYSABRI,Road traffic accident,0
31,2,TYSABRI,Multiple sclerosis relapse,0
,2,TYSABRI,Memory impairment,0
57,2,TYSABRI,Fall,0
,2,TYSABRI,Optic neuritis,0
28,2,TYSABRI,Intervertebral disc protrusion,0
50,2,TYSABRI,Sinusitis,0
33,2,TYSABRI,Diarrhoea,0
69,1,TYSABRI,Asthenia,0
45,1,TYSABRI,Hypoaesthesia,0
33,2,TYSABRI,Poor quality sleep,0
54,2,TYSABRI,Bronchitis,0
40,2,TYSABRI,Anaemia,0
65,1,AVONEX,Visual impairment,0
51,1,AVONEX,Back pain,0
62,2,AVONEX,Gait disturbance,0
55,2,AVONEX,Injection site bruising,0
70,1,AVONEX,Peripheral swelling,0
43,2,AVONEX,Haemorrhage,0
,2,AVONEX,Underdose,0
51,2,AVONEX,Injection site mass,0
36,1,AVONEX,Drug dose omission,0
,2,AVONEX,Confusional state,0
54,2,AVONEX,Injection site cyst,0
32,2,AVONEX,Inadequate diet,0
46,2,AVONEX,Multiple sclerosis,0
72,1,AVONEX,Malaise,1
63,2,AVONEX,Laryngitis,0
,1,AVONEX,Visual acuity reduced,0
62,2,AVONEX,Adverse drug reaction,0
,2,AVONEX,Memory impairment,0
61,2,AVONEX,Oropharyngeal pain,0
,2,AVONEX,Memory impairment,0
47,2,AVONEX,Impatience,0
39,2,AVONEX,Weight increased,0
,2,AVONEX,Cognitive disorder,0
,1,AVONEX,Scab,0
35,2,AVONEX,Fall,0
23,2,AVONEX,Increased tendency to bruise,0
,2,AVONEX,Drug dose omission,0
,2,AVONEX,Nervousness,0
48,2,AVONEX,Nervousness,0
68,2,AVONEX,Thermal burn,0
,2,AVONEX,Stress,0
,2,AVONEX,Blindness,0
67,1,INTRAVENOUS HUMAN IMMUNOGLOBULIN,Drug ineffective for unapproved indication,0
,2,BERIPLEX P/N 500,Acute myocardial infarction,0
,1,AVONEX,Nervousness,0
60,2,PREDNISOLONE.,Erythema,0
65,2,AVONEX,Visual impairment,0
51,2,AVONEX,Injection site bruising,0
51,2,TECFIDERA,Multiple sclerosis relapse,1
,2,AVONEX,Cognitive disorder,0
44,2,TECFIDERA,Multiple sclerosis relapse,1
,2,AVONEX,Gait disturbance,0
,2,TECFIDERA,Multiple sclerosis relapse,1
,2,AVONEX,Adverse event,0
73,2,AVONEX,Herpes zoster,0
53,2,TECFIDERA,Rash pruritic,0
38,2,TECFIDERA,Urinary tract infection,1
1,1,QUETIAPINE.,Selective eating disorder,0
64,1,TECFIDERA,Urinary tract infection,1
51,2,TECFIDERA,Liver disorder,1
,2,TECFIDERA,Impaired self-care,1
70,2,TECFIDERA,Hip fracture,1
,2,TECFIDERA,Coma,1
52,2,TECFIDERA,Convulsion,0
54,2,TECFIDERA,Prescribed underdose,1
,2,TECFIDERA,Angioedema,0
51,1,TECFIDERA,Hot flush,1
35,2,TECFIDERA,Thrombosis,0
60,2,TECFIDERA,Asthenia,1
,0,TECFIDERA,Viral infection,1
48,2,TECFIDERA,Hysterectomy,1
31,2,TECFIDERA,Convulsion,0
29,2,TECFIDERA,Malaise,1
55,2,ENBREL,Thrombophlebitis superficial,0
,2,IMPLANON,Device breakage,0
18,1,DEPAKINE CHRONO,Epilepsy,0
1,1,QUETIAPINE.,Cleft palate,0
,1,ASMANEX TWISTHALER,Drug dose omission,0
,0,CLOPIDOGREL,Urinary tract infection,0
45,2,CIMZIA,Obstruction,0
,2,XOLAIR,Allergic granulomatous angiitis,0
33,2,NEXPLANON,Caesarean section,1
1,2,CELESTONE,Agitation,0
49,1,ENBREL,Nasal congestion,0
64,1,ENBREL,Pyrexia,1
60,1,CIMZIA,Cystitis,1
,2,IMPLANON,Vulvovaginal swelling,0
6,1,INTRAVENOUS IMMUNOGLOBULIN,VIth nerve paralysis,0
6,1,INTRAVENOUS IMMUNOGLOBULIN,VIth nerve paralysis,0
57,2,ROVALCYTE,Febrile neutropenia,1
,2,NEXPLANON,Abasia,0
,1,XGEVA,Sepsis,0
,2,ROFERON-A,Drug intolerance,0
69,2,MABTHERA,Hemiplegia,1
,1,RITUXIMAB,Renal colic,1
51,2,COMBIVENT,Paraesthesia,0
40,2,PEGASYS,Death,0
72,2,PROLIA,Death,0
64,2,ENBREL,Surgery,0
32,2,CIMZIA,Psychotic disorder,0
88,2,PROLIA,Transient ischaemic attack,1
82,1,ARANESP,Death,0
,2,JANUMET,Renal failure,1
91,2,PROLIA,Death,0
,2,NUVARING,Device expulsion,0
17,2,NUVARING,Chest discomfort,0
21,2,ZENATANE,Exposure during pregnancy,0
,2,JANUVIA,Lipase increased,1
,1,PEGFILGRASTIM,Back pain,1
72,1,COUMADIN,Gastrointestinal haemorrhage,1
3,1,ABILIFY TABS 15 MG,Schizophrenia,1
80,2,ORENCIA,Spinal column stenosis,1
68,1,ERBITUX SOLN FOR INF,Thrombocytopenia,0
63,1,ORENCIA,Urinary incontinence,0
75,2,YERVOY,Death,0
,2,RITUXIMAB,Foot deformity,1
84,1,ELIQUIS,Haematuria,0
80,1,ARANESP,Blood urine present,1
,0,ERBITUX SOLN FOR INF 5MG/ML,Meningitis,0
75,1,GLUCOPHAGE TABS,Renal failure acute,1
68,1,ERBITUX SOLN FOR INF,Haematotoxicity,0
61,2,ARANESP,Death,0
50,2,ENBREL,Pain,0
66,2,ELIQUIS,Rotator cuff syndrome,0
,2,ELIQUIS,Gastrectomy,0
33,2,DEPAKOTE,Abortion induced,0
39,2,NEURONTIN/KETAMINE/AMITRIPTYLINE,Crying,0
71,1,XGEVA,Death,0
63,1,XGEVA,Investigation,1
79,1,XGEVA,Investigation,1
84,1,MORPHINE,Renal failure,0
59,2,XALATAN,Ophthalmic herpes zoster,0
,2,XALATAN,Intraocular pressure increased,0
,0,LYRICA,"Hallucination, visual",0
,0,LIPITOR,Type 2 diabetes mellitus,0
52,2,VENLAFAXINE ER,Cellulitis,0
,0,PROCARDIA,Cardiac disorder,0
53,2,GABAPENTIN,Foot fracture,0
83,2,REVATIO,Oxygen saturation decreased,1
56,2,LIPITOR,Apparent death,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
79,2,REVATIO,Respiratory failure,0
82,0,XALATAN,Cataract,0
75,2,VENLAFAXINE HCL,Cardiac flutter,0
88,2,REVATIO,Hip fracture,0
,2,INTRONA,Myelofibrosis,1
85,1,CARBIDOPA/LEVODOPA,International normalised ratio increased,0
90,2,PROLIA,Sepsis,0
71,2,ENBREL,Loss of consciousness,1
73,1,XGEVA,Investigation,1
,0,INTUNIV,Accidental exposure to product by child,1
,0,LIALDA,Colitis,0
,0,VYVANSE,Speech disorder,0
8,2,VYVANSE,Formication,0
,0,VYVANSE,Palpitations,0
,0,VYVANSE,Psychotic disorder,1
52,2,TACROLIMUS,Headache,0
75,2,MK-3475,Fatigue,1
,1,JANUMET,Blood glucose abnormal,1
,1,AVASTIN,Death,0
83,2,ATORVASTATIN,Pain in extremity,0
32,2,RIBAVIRIN,Renal failure,1
64,2,FENISTIL (GERMANY),Pancytopenia,1
61,1,TAXOTERE,Nausea,1
79,1,ELIQUIS,Headache,1
,2,JANUMET,Gastrointestinal disorder,0
,1,BRILINTA,Thrombosis,0
64,2,FOSAVANCE,Movement disorder,0
34,2,CELLCEPT,Thrombotic microangiopathy,0
,2,FASLODEX,Throat tightness,0
90,0,CLONAZEPAM,Sleep disorder,0
71,2,WARFARIN,Fatigue,1
61,1,VANCOMYCIN,Renal failure acute,1
64,1,LEVAQUIN,Tendonitis,0
87,1,XARELTO,Anaemia,1
74,2,PANOBINOSTAT,Pneumonia,1
61,2,NEUPOGEN,Investigation,1
,1,OMNISCAN,Nephrogenic systemic fibrosis,0
77,1,ETANERCEPT,Adenocarcinoma of colon,1
80,2,ROSUCOR,Yellow skin,1
,2,NEUTROGENA DEEP CLEAN INVIGORATING FOAMING SCRUB,Swelling face,0
,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Diarrhoea,0
,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Muscle spasms,0
26,1,HIZENTRA,Pneumonia,0
57,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Pruritus generalised,0
32,2,FLUCONAZOL,Hyperhidrosis,0
,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Adverse event,0
34,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Rash erythematous,0
,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Extra dose administered,0
52,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Diarrhoea,0
70,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Drug ineffective,0
86,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Diarrhoea,0
80,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Drug ineffective,0
42,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Drug ineffective,0
,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Fatigue,0
60,1,ZYTIGA 250 MG JANSSEN BIOTECH,Pulmonary oedema,1
53,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Drug ineffective,0
,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Drug ineffective,0
46,2,LANSOPRAZOLE DR CAPSULES 15MG OTC,Alopecia,0
80,2,NEUTROGENA RAPID WRINKLE REPAIR NIGHT MOISTURIZER,Pruritus,0
45,1,PASIREOTIDE,Pleural effusion,1
,1,TAMIFLU,Rhabdomyolysis,0
67,1,ENBREL,Hernia,0
66,1,CEFTRIAXONE,Swelling face,0
57,2,PROLIA,Tooth abscess,0
,0,HERCEPTIN,Disease progression,0
93,2,"EXJADE, 500 MG, NOVARTIS",Hallucination,0
88,1,CARVEDILOL,Dizziness,1
64,1,BUPRENORPHINE/NALOXONE,Stupor,1
25,2,SERTRALINE,Pre-eclampsia,0
64,1,ENOXAPARIN,Injection site rash,1
61,2,PONATINIB,Cerebrovascular accident,1
21,2,QUETIAPINE,Bipolar I disorder,1
38,0,ENBREL,Fear,0
55,2,HERCEPTIN,Neoplasm,0
60,2,PERJETA,Infusion related reaction,1
,0,NEULASTA,White blood cell count decreased,0
68,1,DABIGATRAN,Haemoptysis,0
56,1,CAPECITABINE,Intestinal obstruction,0
41,2,TECFIDERA,Intestinal obstruction,1
,2,POMALYST,Hypokinesia,0
,1,REVLIMID,Atrial thrombosis,0
69,1,POMALYST,Speech disorder,1
15,1,NEUPOGEN,Malaise,1
69,2,ENBREL,Haemorrhage,0
,2,MIRENA,Malaise,0
42,2,TECFIDERA,Flatulence,0
82,1,NILANDRON,Cardiac disorder,1
72,2,OXALIPLATIN,Nausea,1
67,2,EXJADE 500MG NOVARTIS,Diarrhoea,0
50,2,ENBREL,Mobility decreased,0
50,2,NEULASTA,Bone pain,1
75,1,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,Fat embolism,1
64,1,REMICADE,Blindness unilateral,0
50,2,BETASERON,Gallbladder disorder,1
46,1,HYDROCODONE +PARACETAMOL,Completed suicide,0
49,2,CETIRIZINE 10 MG,Limb injury,0
76,1,CETIRIZINE 10 MG,Extra dose administered,0
64,2,RANITIDINE TABLETS 150 MG OTC,Nervousness,0
,2,CETIRIZINE,Extra dose administered,0
54,2,CETIRIZINE,Depression,0
76,2,CETIRIZINE 10 MG,Dry mouth,0
77,2,CETIRIZINE 10 MG,Drug effect decreased,0
43,1,CETIRIZINE 10 MG,Drug ineffective,0
,2,CETIRIZINE 10 MG,Faeces discoloured,0
70,2,MIRALAX,Drug ineffective,0
84,1,LANSOPRAZOLE DR CAPSULES 15MG OTC,Blood pressure increased,0
38,1,ENBREL,Diverticulitis,1
81,1,RITUXIMAB,Abdominal pain,1
,2,BETAFERON,Lung neoplasm malignant,0
21,0,NUVARING,Inappropriate schedule of drug administration,0
,0,SOLIRIS 300MG,Cardiopulmonary failure,1
83,0,EYLEA,Death,0
81,1,SIMVASTATIN,Muscular weakness,0
,2,MOLSIDOMINE,Abortion missed,0
51,1,VALACYCLOVIR,Therapeutic response changed,0
58,1,PANTOPRAZOLE,Drug ineffective,1
92,0,EYLEA (AFLIBERCEPT) (INJECTION) (AFLIBERCEPT),Death,0
,0,GABAPENTIN,Tooth loss,0
22,1,KETOPROFENE,Bone marrow failure,1
91,0,EYELEA,Death,0
67,1,AMOXICILLIN.,Angioedema,1
53,1,WARFARIN,Prothrombin time prolonged,1
86,0,EYELEA,Death,0
,0,EYELEA,Death,0
,2,COPAXONE,Endometrial cancer,0
,1,VICTRELIS,Osteoarthritis,0
54,2,PEGASYS,White blood cell count decreased,0
63,2,SYMBICORT,Product quality issue,0
94,0,EYLEA,Death,0
,1,BRILINTA,Death,0
82,0,EYELEA (AFLIBERCEPT) (INJECTION) (AFLIBERCEPT),Death,0
86,1,REVLIMID,Fracture,0
69,1,REVLIMID,Road traffic accident,1
75,1,OXALIPLATIN,Hypersensitivity vasculitis,1
27,2,OSMOPREP,Hypocalcaemia,1
1,1,QUETIAPINE (QUETIAPINE),Maternal drugs affecting foetus,0
,2,BETASERON,Depression,0
,2,BETASERON,Convulsion,0
47,1,BETASERON,Multiple sclerosis relapse,0
66,2,BETASERON,Swollen tongue,0
,1,BETASERON,Multiple sclerosis relapse,0
28,1,ENBREL,Haemoptysis,0
61,2,ENBREL,Urinary bladder haemorrhage,1
,2,BETASERON,Injection site reaction,0
71,2,SITAGLIPTIN PHOSPHATE,Cerebral ischaemia,0
68,2,REVLIMID,Blood calcium increased,1
71,2,METFORMIN (METFORMIN),Faecaloma,1
61,2,AVASTIN,Proteinuria,0
49,1,REVLIMID,Blindness,0
65,2,CETIRIZINE 10 MG,Somnolence,0
34,1,PHENYTOIN SODIUM,Drug interaction,1
73,1,CETIRIZINE 10 MG,Somnolence,0
75,1,CETIRIZINE 10 MG,Somnambulism,0
,1,CETIRIZINE 10 MG,Drug ineffective,0
,1,CETIRIZINE 10 MG,No adverse event,0
11,1,CETIRIZINE 10 MG,Extra dose administered,0
,1,CETIRIZINE 10 MG,Drug ineffective,0
57,1,CETIRIZINE 10 MG,Extra dose administered,0
,2,FEXOFENADINE HCL OTC,Asthenia,0
76,2,FEXOFENADINE HCL OTC,Hypertension,0
,1,XARELTO,Inappropriate schedule of drug administration,1
73,2,XARELTO,Bedridden,0
42,1,XARELTO,Deep vein thrombosis,1
,2,XARELTO,Eye haemorrhage,0
79,1,XARELTO,Thrombocytopenia,0
79,1,XARELTO,Thrombocytopenia,0
82,1,TAMSULOSIN,Pleural effusion,0
70,2,XARELTO,Haemorrhage intracranial,1
,1,LEVETIRACETAM,Epilepsy,0
,1,XARELTO,Haemorrhage intracranial,1
,0,XARELTO,Gastrointestinal haemorrhage,0
59,1,XARELTO,Diarrhoea haemorrhagic,1
51,1,XARELTO,Nephrolithiasis,0
,2,XARELTO,Deep vein thrombosis,0
83,2,XARELTO,Deep vein thrombosis,0
66,2,RIVAROXABAN,Pulmonary alveolar haemorrhage,1
,1,XARELTO,Pulmonary embolism,0
,0,XARELTO,Investigation,1
77,1,XARELTO,Cerebrovascular accident,0
64,1,SIMVASTATIN,Muscle spasms,0
69,2,ENBREL,Neoplasm malignant,1
37,2,ENBREL,Tibia fracture,0
58,2,NEULASTA,Investigation,1
63,1,NEULASTA,Adverse event,1
54,2,NEULASTA,Hospitalisation,1
65,1,VERAPAMIL (VERAPAMIL),Convulsion,0
40,1,NEULASTA,Investigation,1
62,1,PROGRAF,Flushing,1
,1,ENBREL,Incorrect route of drug administration,0
46,2,RISPERIDONE,Galactorrhoea,0
68,2,CELLCEPT,Neuralgia,1
49,1,SERTRALINE,Alopecia,0
54,1,RISPERIDONE,Nightmare,0
18,1,MIRTAZAPINE,Off label use,0
,2,"LAMOTRIGINE ^AUROBINDO^, TABLETTER 25 MG (LAMOTRIGINE) TABLET, 25MG",Alopecia,0
52,0,AVASTIN,Anaemia,0
,0,REMICADE,Mycobacterial infection,0
75,2,REVLIMID,Upper respiratory tract inflammation,1
,1,METFORMIN,Dysentery,0
,1,REVLIMID,Headache,0
,2,PROLIA,Hypoglycaemic unconsciousness,0
35,1,BETAFERON,Angina pectoris,0
,1,LEVOFLOXACIN,Lip oedema,0
49,2,XOLAIR,Asthma,0
,2,BISOPROLOL (BISOPROLOL),Asthenia,1
64,1,MODAFINIL,Somnolence,1
,2,OXYTROL FOR WOMEN,Application site pain,0
,0,ETONOGESTREL IMPLANT- IMPLANON NEXT,Complication of device insertion,0
50,1,VERSATIS,Pyrexia,1
35,1,FINASTERIDE,Myopathy,1
,2,POMALYST,Cerebrovascular accident,0
,0,METFORMIN,Renal failure,1
,0,ETONOGESTREL IMPLANT- IMPLANON NEXT,Complication of device insertion,0
,1,REVLIMID,Diabetes mellitus,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,0,METFORMIN,Renal failure,1
,0,METFORMIN,Renal failure,1
30,2,IMPLANON,Unintended pregnancy,0
78,2,PRALIA,Interstitial lung disease,0
71,2,STIVARGA,Electrocardiogram repolarisation abnormality,1
,1,REGORAFENIB,Fatigue,0
,0,METFORMIN,Lactic acidosis,1
17,2,IMPLANON,Polymenorrhoea,0
81,2,CETIRIZINE 10 MG,Joint swelling,0
,2,PROVENTIL,Therapeutic response decreased,0
69,1,CETIRIZINE 10 MG,Drug ineffective,0
52,2,CETIRIZINE 10 MG,Drug ineffective,0
44,2,CETIRIZINE,Drug ineffective,0
51,2,CETIRIZINE,Dyspnoea,0
,2,CETIRIZINE,Drug ineffective,0
88,2,CETIRIZINE 10 MG,Wrong technique in drug usage process,0
3,1,CETIRIZINE 10 MG,Accidental exposure to product by child,0
,1,CETIRIZINE,Drug dose omission,0
79,2,CETIRIZINE 10 MG,Expired drug administered,0
16,2,BROMOCRIPTINE,Pathological gambling,0
26,2,NEXPLANON,Incision site complication,0
45,1,RIBAVIRIN,Rash generalised,0
,1,BETAFERON,Hemiparesis,0
55,2,BETAFERON,Gait disturbance,0
42,2,ENBREL,Rotator cuff repair,0
87,2,ARANESP,Investigation,1
,2,BETAFERON,Syncope,0
,2,LITHIUM CARBONATE,Palpitations,0
81,2,SIMVASTATIN,Hepatitis toxic,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
57,2,AMOXICILLIN,Chest pain,1
54,1,HUMIRA,Interstitial lung disease,1
30,2,BETAFERON,Multiple sclerosis relapse,0
1,1,PAROXETINE,Maternal drugs affecting foetus,0
86,2,GABAPENTIN,Altered state of consciousness,1
44,1,FLUOXETINE,Diplopia,0
27,1,SUBOXONE 8 MG,Substance abuse,0
36,2,BETAFERON,Multiple sclerosis relapse,0
51,2,BETAFERON,Multiple sclerosis relapse,0
,2,BETAFERON,Multiple sclerosis,0
59,1,BETAFERON,Multiple sclerosis,0
78,2,CITALOPRAM,Fall,1
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
18,1,DULERA,Chest discomfort,0
66,1,AVASTIN,Cholecystitis,0
77,2,ALENDRONIC ACID,Femur fracture,0
,2,"AMOXICILLIN+CLAVULANIC ACID (CLAVULANIC ACID, AMOXICILLIN)",Dermatitis psoriasiform,0
67,1,METFORMIN,Vomiting,1
25,1,CITALOPRAM,Drug abuse,1
32,2,RAMIPRIL,Oligohydramnios,0
,2,RAMIPRIL,Foetal heart rate deceleration abnormality,0
,1,LERCANIDIPINE,Kidney duplex,0
60,2,ADCIRCA,Cardiac failure,1
,1,METOPROLOL,Blood pressure inadequately controlled,0
,1,REVLIMID,Blood electrolytes abnormal,1
,1,REVLIMID,Adrenal gland injury,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
81,2,POMALYST,Syncope,0
,0,ASACOL,Gastrointestinal disorder,0
,,BEVACIZUMAB,Abdominal pain,0
78,2,CLEXANE,Somnolence,1
63,2,HUMIRA,Angioedema,1
60,2,CISPLATIN,Rash generalised,1
51,2,ALBENDAZOLE,Conjunctival haemorrhage,1
75,1,REVLIMID,Peripheral vascular disorder,1
,2,ENBREL,Uterine leiomyoma,0
89,2,PROLIA,Death,0
69,2,RITUXIMAB,Scleroderma,1
55,1,LANTUS,Respiratory arrest,1
57,1,ENBREL,Gait disturbance,0
15,2,ENBREL,Face oedema,0
72,1,FERROUS SULFATE,Malignant melanoma in situ,0
41,2,ALBENDAZOLE,Headache,1
48,1,FLUOXETINE,Urinary tract infection,0
32,1,ALBENDAZOLE,Depressed level of consciousness,1
69,1,RITUXIMAB,Adenocarcinoma,0
20,1,CETIRIZINE 10 MG,Extra dose administered,0
35,1,ALBENDAZOLE,Diarrhoea,0
52,1,PROLIA,Muscle rupture,0
82,0,CLOPIDOGREL,Thrombosis in device,1
48,1,CETIRIZINE 10 MG,Fatigue,0
88,1,CETIRIZINE 10 MG,Drug ineffective,0
45,2,CETIRIZINE 10 MG,Drug ineffective,0
30,2,CETIRIZINE 10 MG,Extra dose administered,0
27,2,CETIRIZINE,Drug ineffective,0
82,1,JANUVIA TABLETS 50MG,Interstitial lung disease,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
75,1,CETIRIZINE 10 MG,Sedation,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,CETIRIZINE 10 MG,Abdominal discomfort,0
25,2,CETIRIZINE 10 MG,Extra dose administered,0
9,1,CETIRIZINE 10 MG,Extra dose administered,0
56,1,SITAGLIPTIN PHOSPHATE,Epistaxis,0
68,2,RANITIDINE HYDROCHLORIDE 16028/0122 83.75 MG,Dyspnoea,0
72,2,OXYTROL FOR WOMEN,Drug ineffective,0
69,2,ANASTROZOLE,Headache,0
68,1,METFORMIN,Cerebrovascular accident,1
20,1,ALBENDAZOLE,Conjunctival haemorrhage,1
80,2,JANUVIA TABLETS 50MG,Interstitial lung disease,1
37,2,NAPROXEN 250MG 16028/0144,Skin exfoliation,0
16,2,ASPIRIN 81MG,Vomiting,0
57,2,IBUPROFEN 16028/0027 200 MG,Renal impairment,1
70,1,LOSARTAN POTASSIUM.,Myocardial infarction,0
13,1,IBUPROFEN 20 MG/ML 16028/0034,Stevens-Johnson syndrome,1
74,2,TOFACITINIB CITRATE,Small cell lung cancer,1
70,2,ETANERCEPT,Gastric cancer,1
83,2,PROLIA,Headache,0
,2,RIZATRIPTAN BENZOATE,Dizziness,0
,1,OXYCODONE HCL,Drug diversion,0
52,2,RIZATRIPTAN BENZOATE,Headache,0
,1,RIZATRIPTAN BENZOATE,Migraine,0
,2,RIZATRIPTAN BENZOATE,Hypotension,0
,0,RANITIDINE HYDROCHLORIDE 16028/0122 83.75 MG,Insomnia,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,0,FLUOROURACIL (FLUOROURACIL)(FLUOROURACIL),Cholangitis,0
,1,JANUMET,Death,0
59,2,PEGASYS,Pancytopenia,0
27,2,PARAGARD 380A,Device expulsion,0
33,2,SUBOXONE,Exposure during pregnancy,0
67,2,ACEON,Paralysis,1
,2,OXYCODONE HCL,Incorrect route of drug administration,0
79,1,OXYCODONE HCL,Drug diversion,0
77,2,PACLITAXEL,Bronchospasm,0
78,1,ZYTIGA,Liver function test abnormal,1
51,1,VALGANCICLOVIR HYDROCHLORIDE.,Mycobacterium avium complex infection,1
75,1,XGEVA,Gingival inflammation,0
74,1,OXYCODONE HCL,Drug diversion,0
71,2,PRALIA,Lumbar vertebral fracture,1
81,1,LACTULOSE,Clostridium difficile colitis,0
75,1,ZYTIGA,Blood glucose increased,1
15,1,EVOLTRA,Confusional state,1
,1,OXYCODONE HCL,Overdose,0
29,2,HEPARIN,Splenic rupture,1
56,0,IRINOTECAN HYDROCHLORIDE DIHYDRATE,Skin toxicity,0
66,2,OXYTROL FOR WOMEN,Abdominal pain upper,0
,0,CAPECITABINE,Pneumonia,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
36,1,CETIRIZINE,Drug ineffective,0
,2,CETIRIZINE,Extra dose administered,0
49,1,CETIRIZINE 10 MG,Somnolence,0
79,1,CETIRIZINE 10 MG,Drug ineffective,0
30,2,CETIRIZINE 10 MG,Extra dose administered,0
62,2,CETIRIZINE 10 MG,Dizziness,0
,2,CETIRIZINE,Drug ineffective,0
73,2,CETIRIZINE,Somnolence,0
70,2,CETIRIZINE 10 MG,Somnolence,0
46,1,CETIRIZINE,Blood pressure increased,0
,0,FENTANYL,Drug abuse,0
73,1,ARICEPT,Dermatitis exfoliative,0
78,1,SPIRIVA,Cough,0
55,1,FINIBAX,Pneumonitis,1
,0,DUROTEP MT,Pain,0
,0,ONEDURO,Drug prescribing error,0
63,1,FENTANYL TRANSDERMAL SYSTEM,Hepatic function abnormal,0
70,2,FENTANYL TRANSDERMAL SYSTEM,Impaired healing,0
,1,OXYCODONE HCL 5MG,Drug diversion,0
,1,OXYCODONE HCL,Road traffic accident,0
,2,OXYCODONE HCL,Drug diversion,0
,2,OXYCODONE HCL 30MG,Drug abuse,0
,0,CAPECITABINE,Leukopenia,0
90,1,DRONEDARONE,Gastrointestinal haemorrhage,1
54,2,HERCEPTIN,Febrile neutropenia,0
,1,OXYCODONE HCL,Drug diversion,0
,1,OXYCODONE HCL 30MG,Drug ineffective,0
54,1,HALDOL,Self injurious behaviour,0
52,2,ENBREL,Myocardial infarction,1
70,2,COZAAR,Drug hypersensitivity,0
54,2,PREGABALIN,Overdose,0
21,1,OXYCODONE HCL 30MG,Drug dependence,0
,0,FLUOROURACIL (FLUOROURACIL)(FLUOROURACIL),Febrile neutropenia,0
61,2,AMPYRA,Disability,1
80,1,DRONEDARONE,Gastrointestinal haemorrhage,1
46,2,ENBREL,Renal cancer,1
71,1,DRONEDARONE,Lower gastrointestinal haemorrhage,1
50,1,METRONIDAZOLE,Stevens-Johnson syndrome,0
57,2,TILDIEM,Rash maculo-papular,0
68,2,XYREM,Bladder neoplasm,1
60,1,PROPOFOL (MANUFACTURER UNKNOWN) (PROPOFOL) (PROPOFOL),Anaphylactic shock,0
31,1,PROPOFOL (MANUFACTURER UNKNOWN) (PROPOFOL) (PROPOFOL),Hypertriglyceridaemia,1
,0,BENET (RISEDRONATE SODIUM) TABLET,No adverse event,0
44,1,PIPERACILLIN/TAZOBACTAM,Acute generalised exanthematous pustulosis,1
,2,OXYCODONE HCL,Nausea,0
,1,OXYCODONE HCL 30MG,Drug ineffective,0
74,1,CHLORHEXIDINE,Anaphylactic reaction,0
88,2,URSODEOXYCHOLIC ACID,Faecalith,1
79,1,KEPPRA,Convulsion,0
82,2,OXYTROL FOR WOMEN,Application site erythema,0
58,2,OXYTROL FOR WOMEN,Pollakiuria,0
39,2,DIPROSTENE,Flushing,0
74,2,JANUMET XR,Blood glucose increased,0
44,1,PREDNISOLONE (PREDNISOLONE),Chest pain,1
73,1,DRONEDARONE,Haemorrhage,1
57,2,AUBAGIO,Hypertension,1
57,2,AUBAGIO,Oedema peripheral,1
55,2,FENTANYL,Renal disorder,0
,1,DIANEAL LOW CALCIUM,Incarcerated hernia,1
34,2,FROVA TABLETS 2.5MG,Abortion spontaneous,0
75,2,DRONEDARONE,Large intestinal haemorrhage,1
73,1,NEULASTA,Adverse event,1
,2,OXYCODONE HCL 30MG,Rash,0
,2,DIANEAL LOW CALCIUM,Hernia,0
,2,DIANEAL PD2 (ULTRABAG),Cardiac disorder,1
,2,DIANEAL LOW CALCIUM,Muscle spasms,0
,1,DIANEAL LOW CALCIUM,Hernia,1
,2,DIANEAL LOW CALCIUM,Peripheral artery thrombosis,1
,0,DIANEAL LOW CALCIUM,Renal failure chronic,1
,2,DIANEAL LOW CALCIUM,Swelling face,0
62,1,HEPARIN SODIUM,Renal failure acute,1
,1,DIANEAL LOW CALCIUM,Malaise,0
,1,DIANEAL LOW CALCIUM,Pneumonia,1
,1,DIANEAL PD2,Clostridium difficile infection,1
,0,DIANEAL LOW CALCIUM,Peritonitis,1
,2,DIANEAL LOW CALCIUM,Diverticulitis,1
63,2,DORYX,Circulatory collapse,1
44,1,SUBOXONE,Headache,0
61,1,VANCOMYCIN (MANUFACTURER UNKNOWN) (VANCOMYCIN) (VANCOMYCIN),Toxic epidermal necrolysis,0
,0,ANDAZOL,Pyrexia,0
,0,FLUOROURACIL,Interstitial lung disease,0
62,2,DIPHENHYDRAMINE,Toxicity to various agents,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Hypotension,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Poor peripheral circulation,1
,2,DIANEAL LOW CALCIUM,Cellulitis,1
,2,FENTANYL CITRATE,Death,0
32,1,DIPHENHYDRAMINE,Toxicity to various agents,0
73,1,DIPHENHYDRAMINE,Toxicity to various agents,0
71,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
78,1,NEULASTA,Hospitalisation,1
,1,JANUVIA,Pancreatitis,0
74,1,NEULASTA,Investigation,1
,2,DIANEAL LOW CALCIUM,Malaise,0
72,1,CETIRIZINE 10 MG,Constipation,0
59,2,PROLIA,Intervertebral disc operation,0
,,BACLOFEN INTRATHECAL,Muscle spasms,0
,1,DIANEAL LOW CALCIUM,Chest pain,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Cardiac disorder,1
,2,DIANEAL PD2 (ULTRABAG),Pulmonary thrombosis,1
,1,DIANEAL LOW CALCIUM,Death,1
,2,DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,Renal cancer,0
13,1,DIANEAL LOW CALCIUM,Convulsion,1
,2,DIANEAL LOW CALCIUM (2.5 MEQ/L) PD SOLUTION WITH 2.5% DEXTROSE ^BAXTER,Pleural effusion,1
,2,DIANEAL LOW CALCIUM,Peritoneal dialysis complication,0
,1,DIANEAL LOW CALCIUM,Peritonitis bacterial,0
77,1,DIANEAL LOW CALCIUM,Death,0
50,1,DIANEAL LOW CALCIUM,Heart rate irregular,1
,2,DIANEAL LOW CALCIUM,Hernia,0
51,2,SODIUM VALPROATE (SODIUM VALPROATE),Stevens-Johnson syndrome,1
,2,DIANEAL LOW CALCIUM,Head injury,1
,1,BAXTER EXTRANEAL PERITONEAL DIALYSIS SOLUTION WITH 7.5% ICODEXTRIN,Pneumonia,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
48,1,DIANEAL LOW CALCIUM,Blood pressure increased,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Hypotension,0
66,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
,1,DIANEAL PD2,Acute myocardial infarction,1
,1,DIANEAL LOW CALCIUM,Fluid overload,0
,1,DIANEAL LOW CALCIUM,Swelling,0
79,1,DIANEAL LOW CALCIUM,Cerebrovascular accident,1
31,2,ZOLPIDEM TABLETS,Drug-induced liver injury,0
,1,DIANEAL LOW CALCIUM,Fluid overload,0
,2,DIANEAL LOW CALCIUM,Pneumonia,0
75,1,DIANEAL LOW CALCIUM,Anaemia,1
61,1,DIANEAL LOW CALCIUM,Scrotal swelling,1
51,2,VENLAFAXINE,Drug ineffective,0
32,2,YAZ,Deep vein thrombosis,1
,0,DRONEDARONE,Gastrointestinal haemorrhage,1
25,2,VENLAFAXINE,Pre-eclampsia,0
40,2,YAZ,Pulmonary embolism,1
62,1,ACETYLSALICYLIC ACID (} 100 MG),Angioedema,0
36,2,YAZ,Deep vein thrombosis,1
35,2,ACYCLOVIR [ACICLOVIR],Anxiety,0
,1,TAMSULOSIN,Retinal disorder,0
,2,SUBOXONE (RECKITT BENCKISER),Rash,0
34,2,YASMIN,Pulmonary embolism,1
46,2,YAZ,Deep vein thrombosis,1
25,2,YAZ,Deep vein thrombosis,1
21,2,YAZ,Pulmonary embolism,1
28,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
80,2,XIAPEX (CLOSTRIDIAL COLLAGENASE),Anaemia,0
83,2,DIANEAL LOW CALCIUM,Atrial fibrillation,1
,1,DIANEAL LOW CALCIUM,Diabetic complication,1
24,2,YAZ,Deep vein thrombosis,1
53,2,EXTRANEAL 75MG/ML - SACO - 5 UNIDADE(S) - 2000 ML,Acute myocardial infarction,0
43,2,YAZ,Deep vein thrombosis,1
42,1,DIANEAL PD2,Cardiac arrest,1
54,1,DIANEAL LOW CALCIUM,Local swelling,0
,1,DIANEAL LOW CALCIUM,Device related infection,1
82,1,DIANEAL LOW CALCIUM,Fall,1
,2,DIANEAL LOW CALCIUM,Peritonitis bacterial,1
61,2,DIANEAL LOW CALCIUM (ULTRABAG),Death,0
,0,DIANEAL LOW CALCIUM,Renal failure acute,1
,2,DIANEAL LOW CALCIUM,Anaemia,1
44,1,DIANEAL LOW CALCIUM,Fall,1
,2,DIANEAL LOW CALCIUM,Abdominal distension,0
52,1,RIBAVIRIN,Abdominal pain upper,1
,2,DIANEAL,Haematuria,1
,2,DIANEAL PD2,Myocardial infarction,0
66,1,DIANEAL PD-2 PERITONEAL DIALISIS SOLUTION ULTRABAG WITH 1.5% DEXTROSE,Myocardial infarction,0
,1,DIANEAL LOW CALCIUM,Chest pain,1
,0,DIANEAL LOW CALCIUM,Feeling abnormal,0
,2,SARAFEM,Ovarian germ cell cancer stage II,0
30,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
,2,DIANEAL LOW CALCIUM,Lethargy,0
,1,DIANEAL LOW CALCIUM (ULTRABAG),Hernia,1
,2,SUBOXONE,Foetal exposure during pregnancy,1
,,SOLIRIS,Underdose,0
,1,DIANEAL LOW CALCIUM,Hypertension,0
54,1,DIANEAL LOW CALCIUM,Infection,1
56,1,OXYCODONE HCL 30MG,Drug ineffective,0
2,1,SABRIL (FOR ORAL SOLUTION),Respiratory distress,1
45,1,NEULASTA,Investigation,1
72,1,NEULASTA,Hospitalisation,1
35,2,HEPARIN,Maternal exposure during pregnancy,0
81,1,NPLATE,Transfusion,0
,2,EYLEA (AFLIBERCEPT) (SOLUTION FOR INJECTION) (AFLIBERCEPT),Blindness unilateral,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Rash,0
70,2,PROLIA,Cardiac failure congestive,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
87,2,EYLEA (AFLIBERCEPT) (SOLUTION FOR INJECTION) (AFLIBERCEPT),Eye pain,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
63,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
60,1,PEGINTERFERON ALFA-2B,Drug reaction with eosinophilia and systemic symptoms,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,DEPAKOTE,Physical disability,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
49,1,CARBAMAZEPINE,Abnormal behaviour,0
60,1,POMALYST,Plasma cell myeloma,1
60,1,DIANEAL LOW CALCIUM,Myocardial infarction,1
68,2,OMEPRAZOLE,Subacute cutaneous lupus erythematosus,0
76,1,SIMVASTATIN,Myalgia,0
56,1,NEULASTA,Hospitalisation,1
86,2,PROLIA,Death,0
82,2,OXYTROL FOR WOMEN,Pollakiuria,0
,2,COMBIVENT,Off label use,0
,0,REVLIMID,Intra-abdominal haemorrhage,0
61,1,DIPHENHYDRAMINE,Toxicity to various agents,0
,0,OXYTROL FOR WOMEN,Drug ineffective,0
,0,ISENTRESS,Wrong technique in drug usage process,0
37,2,YAZ,Pulmonary embolism,1
70,2,(CARBOPLATIN),Colonic abscess,1
35,2,YAZ,Pulmonary embolism,1
17,2,GADAVIST,Hypoaesthesia eye,0
,2,YAZ,Deep vein thrombosis,1
24,2,YAZ,Pulmonary embolism,1
41,2,YAZ,Pulmonary embolism,1
,2,GADAVIST,Sneezing,0
81,2,XGEVA,Upper limb fracture,0
29,2,YASMIN,Deep vein thrombosis,0
46,1,CHLORHEXIDINE ACTIVE SUBSTANCES: CHLORHEXIDINE,Condition aggravated,0
24,2,YAZ,Pulmonary embolism,1
,2,GADAVIST,Pruritus,0
,2,GADAVIST,Nausea,0
,1,GADAVIST,Nausea,0
26,1,(METHOTREXATE),Demyelination,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
61,2,GADAVIST,Vomiting,0
,1,GADAVIST,Nausea,0
,1,GADAVIST,Nausea,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
37,1,SUBOXONE,Jaundice,1
,2,DOTAREM,Confusional state,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
26,1,EYLEA (AFLIBERCEPT) (SOLUTION FOR INJECTION) (AFLIBERCEPT),Blindness,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
69,1,DOTAREM,Contrast media reaction,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
31,2,METHYLERGOMETRINE,Peripartum cardiomyopathy,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
8,1,SUBOXONE,Foetal exposure during pregnancy,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
26,2,FENTANYL,Loss of consciousness,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
38,2,HUMIRA,Thyroid neoplasm,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,DABIGATRAN,Epistaxis,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
63,2,OMEPRAZOLE,Drug interaction,1
63,1,ELIGARD,Malignant melanoma,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,ZOLMITRIPTAN,Drug interaction,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
61,2,PROLIA,Back pain,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
60,1,STELARA,Large intestine polyp,0
,1,STELARA,Conduction disorder,1
74,1,STELARA,Haematochezia,1
65,1,THEO-DUR,Drug interaction,0
,1,BRILINTA,Haemorrhage urinary tract,0
75,2,CETIRIZINE,Dyspnoea,0
46,2,HERCEPTIN,Disease progression,0
2,1,CETIRIZINE 10 MG,Accidental exposure to product by child,0
,2,CETIRIZINE,Insomnia,0
78,2,CETIRIZINE 10 MG,Extra dose administered,0
39,2,CETIRIZINE 10 MG,Drug ineffective,0
32,2,CETIRIZINE,Drug ineffective,0
,2,JANUVIA,Pancreatic carcinoma,0
25,1,CETIRIZINE 10 MG,Drug ineffective,0
73,2,CETIRIZINE 10 MG,Drug ineffective,0
79,2,CETIRIZINE 10 MG,Fatigue,0
30,1,OMEPRAZOLE,Swelling face,0
89,2,EYELEA,Death,0
,2,NEXPLANON,Implant site infection,0
6,1,SUBOXONE (RECKITT BENCKISER),Foetal exposure during pregnancy,0
8,1,SABRIL (TABLET),CSF shunt operation,1
79,2,NEXAVAR,Hypoglycaemia,0
57,2,RISPERIDONE,Toxicity to various agents,0
24,2,YAZ,Deep vein thrombosis,1
77,2,XARELTO,Cyst rupture,0
,2,STELARA,Cardiac failure,1
27,2,STELARA,Multiple sclerosis,0
87,2,XARELTO,Diverticulitis,1
85,2,XARELTO,Ischaemic stroke,1
74,1,XARELTO,Retinal artery occlusion,0
80,2,XARELTO,Gastrointestinal haemorrhage,1
83,0,EYELEA,Death,0
56,1,LOMUSTINE,Malignant neoplasm progression,1
,1,OXYCODONE HCL 15MG,Drug effect decreased,0
,1,OXYCODONE HCL,Drug effect decreased,0
,1,OXYCODONE HCL,Constipation,0
,0,REMICADE,Lung neoplasm malignant,0
,1,REMICADE,Cardiac disorder,0
17,1,REMICADE,Colitis,1
21,1,REMICADE,Gastrointestinal stoma complication,1
15,1,5-ASA,Acute psychosis,1
17,1,REMICADE,Crohn^s disease,1
65,2,REMICADE,Malaise,1
65,1,CYTARABINE.,Disease progression,0
,1,REMICADE,Acute psychosis,1
69,1,REMICADE,Herpes zoster,0
87,2,GENTAMICIN SULFATE,Clostridium difficile infection,1
46,1,LIPCUT,Arthritis,1
74,2,REMICADE,Disseminated tuberculosis,1
,2,OXYCODONE HCL 30MG,Somnolence,0
,2,OXYCODONE HCL 30MG,Drug ineffective,0
,1,OXYCODONE HCL,Hot flush,0
,2,OXYCODONE HCL,Vomiting,0
,1,OXYCODONE HCL 30MG,Abdominal discomfort,0
,1,OXYCODONE HCL,Withdrawal syndrome,0
41,1,ALLOPURINOL (ALLOPURINOL) (ALLOPURINOL),Anaemia,1
58,2,OXYTROL FOR WOMEN,Application site irritation,0
90,1,TRAMACET,Eczema,1
,2,CETIRIZINE,Poor quality sleep,0
46,2,STELARA,Cataract,2
61,2,CETIRIZINE 10 MG,Somnolence,0
,1,CETIRIZINE 10 MG,Blood pressure increased,0
75,2,CETIRIZINE,Extra dose administered,0
,1,CETIRIZINE,Drug ineffective,0
,2,CETIRIZINE 10 MG,Extra dose administered,0
29,2,CETIRIZINE 10 MG,Drug ineffective,0
22,1,CETIRIZINE 10 MG,Extra dose administered,0
,2,CETIRIZINE,Dyspnoea,0
67,2,CETIRIZINE,Nausea,0
43,1,CETIRIZINE 10 MG,Extra dose administered,0
80,1,CETIRIZINE 10 MG,Fatigue,0
29,2,CETIRIZINE,Expired product administered,0
64,1,CARBOPLATIN,Radiation pneumonitis,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,SIMVASTATIN,Muscle injury,0
,2,OXYTROL FOR WOMEN,Rash,0
42,1,ACETYLSALICYLIC ACID (} 100 MG),Analgesic asthma syndrome,0
45,1,PONATINIB,Chronic myeloid leukaemia,0
1,2,SABRIL (FOR ORAL SOLUTION),Petit mal epilepsy,0
,0,VELCADE,Neutropenia,0
60,1,RISPERDAL,Electrocardiogram repolarisation abnormality,0
,0,RISPERDAL,Road traffic accident,0
21,2,CIRCADIN,Attention deficit/hyperactivity disorder,1
,0,VELCADE,Rheumatic disorder,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,REMODULIN (INJECTION FOR INFUSION) (TREPROSTINIL SODIUM),Death,0
66,2,PONATINIB,Pulse absent,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
75,2,ACEON,Diarrhoea,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,FLUOROURACIL,Pneumonitis,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,FLUOROURACIL,Off label use,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,VIMPAT,Brain neoplasm,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,"GAMMAGARD S/D 10, POEDER VOOR INFUSIEVLOEISTOF",Drug effect incomplete,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,2,REMODULIN,Death,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH),Abortion,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
38,1,CEREZYME,Hernia,1
,1,OMNISCAN,Nephrogenic systemic fibrosis,0
,1,RISPERDAL,Impulse-control disorder,0
68,2,DOXORUBICIN,Hepatitis B,1
,0,XARELTO,Tooth abscess,0
74,1,XARELTO,Anaemia,0
73,2,CRESTOR,Memory impairment,1
,2,XARELTO,Thrombosis,0
59,2,JAKAVI,Splenomegaly,0
,2,PARAGARD 380A,Device breakage,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
66,2,SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP,Throat irritation,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
72,1,SALINE,Cardiovascular disorder,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,2,DIANEAL LOW CALCIUM,Dermatitis contact,0
80,1,DIANEAL LOW CALCIUM,Local swelling,0
23,2,MEPROBAMATE,Unresponsive to stimuli,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
49,2,SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP,Throat irritation,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,SPIRIVA,Migraine with aura,0
,1,ZETIA,Hypersensitivity,0
,0,DIANEAL LOW CALCIUM,Delusion,0
,0,CISPLATIN,Chronic obstructive pulmonary disease,0
38,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
81,1,NEXAVAR,Skin haemorrhage,1
26,2,MIRENA,Ectopic pregnancy with contraceptive device,0
40,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
48,1,NEXAVAR,Hepatocellular carcinoma,0
41,2,MIRENA,Hepatic adenoma,0
35,2,KINERET,Amniotic fluid volume decreased,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
40,1,NEXAVAR,Asthenia,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,GAMMAGARD LIQUID,Extravasation,0
68,2,DIANEAL LOW CALCIUM,Peritonitis,0
,0,STERILE WATER FOR INJECTION,Renal failure acute,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,STERILE WATER FOR INJECTION,Renal failure acute,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
50,1,"LACTATED RINGER^S INJECTION, USP",Drug dispensing error,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
61,1,ETOPOSIDE.,Epistaxis,0
,0,STERILE WATER FOR INJECTION,Renal failure acute,0
,0,STERILE WATER FOR INJECTION,Renal failure acute,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,KINERET,Foetal exposure during pregnancy,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,STERILE WATER FOR INJECTION,Renal failure acute,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
58,2,GAMMAGARD LIQUID,Ear infection,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
36,1,MEPROBAMATE,Drug abuse,0
69,1,DOXORUBICIN,Neutropenic sepsis,1
,0,TREANDA,Nausea,0
,1,OXYCODONE HCL 30MG,Drug effect decreased,0
,0,CISPLATIN,Haemorrhagic stroke,0
64,2,OMNISCAN,Nephrogenic systemic fibrosis,0
30,2,OXYCODONE HCL 5MG,Hypersensitivity,0
41,2,PARAGARD 380A,Feeling hot,0
64,2,INSULATARD FLEXPEN HM(GE),Injury,1
35,2,SUBOXONE,Hepatic enzyme increased,0
,2,OXYTROL FOR WOMEN,Application site burn,0
,1,KINERET,Caesarean section,1
,2,LAZANDA,Death,0
25,2,BUPRENORPHINE W/NALOXONE,Convulsion,0
61,1,RITUXAN,Death,0
38,2,KINERET,Abortion spontaneous,0
40,2,HYDROCHLOROTHIAZIDE,Lactic acidosis,1
,2,EXEMESTANE PFIZER,Sleep disorder,0
70,2,REMICADE,Enterocutaneous fistula,0
,0,DICLOFENAC,Vanishing bile duct syndrome,1
65,2,ENBREL,Pulmonary mass,0
60,1,VICTOZA,Pancreatic carcinoma stage IV,1
85,1,"XENAZINE (12.5 MILLIGRAM, TABLET) (TETRABENAZINE)",Death,0
63,2,BYETTA,Pancreatic carcinoma,1
53,2,METFORMIN,Nausea,1
,1,VICTOZA,Cardiac failure,0
,1,"XENAZINE (12.5 MILLIGRAM, TABLET) (TETRABENAZINE)",Death,0
53,1,VICTOZA,Cholecystitis,1
56,2,LANTUS,Pancreatic carcinoma,1
55,1,OXYCODONE HCL 30MG,Drug ineffective,0
67,1,IRBESARTAN,Abdominal pain upper,1
57,1,ROPIVACAINE,Lethargy,0
,1,OXYCODONE HCL 30MG,Drug ineffective,0
,1,OXYCODONE HCL 5MG,Back pain,0
,1,OXYCODONE HCL,Pain,0
103,1,ARICEPT,Decreased appetite,0
,1,OXYCODONE HCL 30MG,Drug ineffective,0
,0,BACLOFEN INTRATHECAL,Death,0
28,2,TASIGNA,Dyspnoea,0
,2,MIRENA,Cerebral cyst,0
39,1,REMICADE,Abscess,0
70,1,COMTESS,Akinesia,1
,2,XYREM,Death,0
46,2,OXYCODONE HCL 30MG,Eyelid oedema,0
82,1,EXELON,Memory impairment,0
,2,OXYCODONE HCL,Feeling abnormal,0
,2,OXYCODONE HCL,Malaise,0
56,2,BEVACIZUMAB,Coma,1
53,2,FLUDARABINE,Drug-induced liver injury,1
61,1,FLUDARABINE,Drug-induced liver injury,0
,0,MYCOPHENOLATE MOFETIL,Infection,0
,2,CLARAVIS,Loss of consciousness,0
,0,CHANTIX,Drug interaction,0
42,2,CHANTIX,Intervertebral disc protrusion,1
49,2,SOMATULINE AUTOSOLUTION 90MG,Hepatic embolisation,1
71,1,DECITABINE,Decreased appetite,1
8,1,CEREZYME,Staphylococcus test positive,1
58,0,CHANTIX,Drug interaction,0
24,2,PLAN B ONE-STEP,Urine abnormality,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
,1,CELEBREX,Arthropathy,0
47,2,PREMARIN,Systemic lupus erythematosus,0
,2,CELEBREX,Spinal disorder,0
,0,LYRICA,"Hallucination, auditory",0
,2,LYRICA,Pneumonia,1
27,1,GEODON,Pneumonia,0
56,2,XELJANZ,Hypersensitivity,0
,2,LIPITOR,Type 2 diabetes mellitus,0
72,2,RABEFINE,Haematochezia,1
56,1,IRINOTECAN HCL,Proteinuria,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
,1,LYRICA,Aphagia,0
47,2,CHANTIX,Pneumonia,0
71,1,DABIGATRAN,Abdominal pain upper,0
,2,STILNOX,Electrocardiogram QT prolonged,0
95,2,RISPERDAL,Somnolence,0
70,2,VFEND,Blood calcium abnormal,0
69,2,OXYTROL FOR WOMEN,Incorrect drug administration duration,0
,2,LYRICA,Cerebrovascular accident,0
54,2,KYNAMRO,Hepatic enzyme increased,0
26,1,VENLAFAXINE,Drug ineffective,0
,1,RABEPRAZOLE,Gastrooesophageal reflux disease,0
50,1,ERLOTINIB TABLET,Death,0
,1,ERLOTINIB TABLET,Atrial fibrillation,0
35,2,CHAMPIX,Face oedema,0
64,1,TACROLIMUS MR4 CAPSULES,Multi-organ failure,1
,1,ADDERALL XR 30MG,Treatment failure,0
90,2,LYRICA,Myocardial infarction,1
,2,PROGRAF,Renal transplant,1
29,1,CELLCEPT,Mental disorder,1
46,1,FUNGUARD,Drug ineffective for unapproved indication,0
,1,PROGRAF,Drug ineffective,0
82,1,ALDACTONE A,Urinary retention,1
,1,XTANDI,Angina pectoris,1
,1,TARCEVA,Off label use,0
51,1,SUTENT,Death,0
27,2,LAMOTRIGINE,Depression,0
63,1,MYCAMINE,Endocarditis,1
,1,TARCEVA,Death,0
,1,XTANDI,Investigation,1
,1,ERLOTINIB TABLET,Death,0
2,2,EVOLTRA,Renal failure acute,0
65,2,ERLOTINIB TABLET,Neutropenia,0
89,2,MYRBETRIQ,Dizziness,0
26,1,PROGRAF,Drug ineffective,0
3,1,TACROLIMUS,Drug ineffective,0
,1,PROGRAF,Renal failure,0
28,1,FUNGUARD,Drug ineffective for unapproved indication,0
,0,PRISTIQ,Maternal exposure during pregnancy,0
63,2,LEVOTHYROXINE,Product substitution issue,0
,1,ERLOTINIB,Malignant neoplasm progression,0
,2,VESICARE,Hepatocellular injury,0
63,1,TACROLIMUS,Drug ineffective,0
49,2,TARCEVA,Incorrect dose administered,0
73,2,AFINITOR,Performance status decreased,1
43,1,PROGRAF,Drug ineffective,0
48,1,ERLOTINIB TABLET,Off label use,0
,1,PROGRAF,Drug ineffective,0
,1,XTANDI,Cardiac arrest,0
64,2,GILENYA,Clostridium difficile infection,1
,0,CIPROFLOXACIN,Arthralgia,0
67,2,ERLOTINIB,Blood pressure increased,0
,2,PRIVIGEN,Rectal prolapse,1
52,2,ONBREZ,Cough,0
44,1,CHOLECALCIFEROL,Upper respiratory tract infection,1
75,1,JANUVIA,Pancreatic carcinoma,2
45,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
56,2,RIVOTRIL,Escherichia pyelonephritis,1
42,1,PROGRAF,Renal transplant,0
47,2,LIPITOR,Type 2 diabetes mellitus,0
7,2,LEVOTHYROXINE,Diarrhoea,0
3,1,PRIVIGEN,Haemolytic anaemia,1
13,1,TACROLIMUS OINTMENT,Anal abscess,1
59,1,XTANDI,Death,1
,1,ZOLOFT,Maternal exposure during pregnancy,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,PROGRAF,Drug ineffective,0
54,1,ATROVENT INHALATION SOLUTION,Dyspnoea exertional,0
67,2,MEVACOR,Type 2 diabetes mellitus,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
32,2,LEVOFLOXACIN,Arthralgia,0
0,2,PROGRAF,Pulmonary artery atresia,1
,1,NEULASTA,Red man syndrome,0
,1,ZEMAIRA,Cardiac disorder,0
,2,OXYTROL FOR WOMEN,Drug effect decreased,0
68,1,XTANDI 40MG ASTELLA PHARMA,Myalgia,0
63,1,XTANDI,Death,0
42,1,STELARA,Pneumonia,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
18,2,LORYNA,Metrorrhagia,0
13,1,TACROLIMUS,Drug ineffective,0
48,1,OMNISCAN,Nephrogenic systemic fibrosis,0
70,2,ESTRADOT,Varicose vein,1
36,2,IMATINIB,Chronic graft versus host disease,0
25,1,CLARITIN-D-12,Underdose,0
,0,RISPERDAL,Gynaecomastia,0
50,2,IMATINIB,Leukaemia recurrent,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
44,2,IMATINIB,Leukaemia recurrent,0
,0,INVEGA SUSTENNA,Injection site nodule,0
43,2,LIPITOR,Nephropathy,0
,1,OLYSIO,Convulsion,0
,0,LIPITOR,Type 2 diabetes mellitus,0
37,1,REMICADE,Disseminated tuberculosis,1
50,1,MABTHERA,Respiratory failure,0
50,2,PARACETAMOL,Renal colic,1
69,1,VISIPAQUE,Blood creatinine increased,1
64,2,COMBIVENT,Choking,0
26,1,RISPERDAL,Alanine aminotransferase increased,0
60,2,ACLIDINIUM,Swollen tongue,0
,2,SOLIRIS,Transfusion,0
22,2,MIRENA,Off label use,0
35,2,MIRENA,Amenorrhoea,0
,2,REMICADE,Herpes zoster,0
14,1,CONCERTA,Growth retardation,0
,2,OXYCODONE HCL 30MG,Joint injury,0
,2,CANESTEN (KAINITING),Maternal exposure during pregnancy,0
,2,MIRENA,Abdominal pain lower,0
,1,AFINITOR,Feeling abnormal,0
60,2,CETIRIZINE 10 MG,Memory impairment,0
63,2,SYMBICORT,Drug dependence,0
,1,OXYCODONE HCL 30MG,Incorrect dose administered,0
,2,OXYCODONE HCL,Psychotic disorder,0
,2,MIRENA,Injury,0
63,2,ACTHAR H.P.,Headache,0
46,2,MIRENA,Device allergy,0
55,1,KALETRA,Inguinal hernia,1
44,2,SANDOSTATIN,Post procedural swelling,2
56,1,OXYCODONE HCL 30MG,Drug screen negative,0
,0,XARELTO,Atrial fibrillation,0
61,1,XARELTO,Cerebral haemorrhage,1
,1,XARELTO,Haematuria,0
,1,SUBOXONE,Overdose,0
65,1,BLINDED: BYDUREON,Renal cyst haemorrhage,1
,2,RETROVIR,Foetal exposure during pregnancy,0
,,DOCETAXEL.,Neurological symptom,1
57,2,REMICADE,Cardiac failure congestive,1
19,2,AMPICILLIN,Drug ineffective,0
53,1,ANDRODERM,Tinnitus,0
36,1,GILENYA,Visual acuity reduced,0
,2,ACLASTA,Device failure,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
71,1,SANDOSTATIN (OCTREOTIDE ACETATE),Death,1
23,1,SUBOXONE,Substance abuse,0
59,1,MELPHALAN.,Malignant neoplasm progression,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,AROMASIN,Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
59,1,AMLODIPINE (UNKNOWN),Joint swelling,0
40,2,AMLODIPINE (UNKNOWN),Angioedema,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
52,2,SILDENAFIL,Blindness,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
51,2,SUBOXONE,Hallucination,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
83,1,TYVASO,Death,0
39,2,CAMPATH,Death,0
,0,CORICIDIN HBP CHEST CONGESTION AND COUGH,Insomnia,0
65,2,EXJADE,Ulcer,0
35,1,GILENYA,Syncope,1
,1,MIRALAX,Blood glucose,0
60,2,BAYER ADVANCED ASPIRIN EXTRA STRENGTH,Depressed level of consciousness,1
80,2,STIVARGA 40MG BAYER,Blister,0
,2,CLARITIN-D-12,Drug ineffective,0
72,2,REMODULIN,Cystic fibrosis lung,0
59,1,VICTRELIS,Pancytopenia,0
,2,SILDENAFIL,Visual impairment,0
,2,FASLODEX,Fungal infection,1
,2,"REMODULIN (1 MILLIGRAM/MILLILITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Dyspnoea,1
,1,OCTREOTIDE,Post procedural complication,0
46,1,LOVENOX,Ulcer,0
36,2,PARAGARD 380A,Device dislocation,0
85,1,ATENOLOL,Red blood cell abnormality,0
,2,AFINITOR,Fluid retention,1
59,2,ATENOLOL,Urticaria,0
25,1,SUBOXONE,Liver disorder,0
78,2,"REMODULIN (2.5 MILLIGRAM/MILLILITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Pulmonary arterial hypertension,1
57,2,ZEMAIRA,Drug interaction,0
,1,GLEEVEC,Nephrolithiasis,0
77,1,REMODULIN,Chronic obstructive pulmonary disease,0
,2,SUBOXONE,Convulsion,0
,2,TINACTIN SPRAY POWDER,Pain,0
,1,SOLIRIS,Aplastic anaemia,0
,1,BAIN DE SOLEIL SPRAY TRANSPARE CONTINUOUS SPRAY SPF-10,Circumstance or information capable of leading to medication error,0
59,1,PLAVIX,Chronic obstructive pulmonary disease,0
,2,OXYTROL FOR WOMEN,Pruritus,0
38,2,REMODULIN,Cardiac failure,0
71,1,RISPERIDONE,Incontinence,1
55,1,GILENYA,Cerebrovascular accident,1
64,1,BRIDION,Pneumothorax,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
65,2,LIPITOR,Type 2 diabetes mellitus,0
63,,ATORVASTATIN CALCIUM.,Cerebrovascular accident,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
66,1,GENOTROPIN,Lung neoplasm malignant,0
76,1,NORVASC,Pneumonia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
91,2,ZOSYN,Interstitial lung disease,1
63,2,LIPITOR,Type 2 diabetes mellitus,0
75,2,"REMODULIN (10 MILLIGRAM/MILLILITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Death,0
65,1,INLYTA,Cerebral infarction,1
69,2,SUTENT,Ruptured cerebral aneurysm,0
,0,LIPITOR,Type 2 diabetes mellitus,0
63,2,AMLODIPINE BESILATE,Nausea,0
59,1,METOPROLOL TARTRATE,Myocardial infarction,0
,0,LIPITOR,Type 2 diabetes mellitus,0
74,1,REMODULIN,Death,0
60,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
76,2,REMODULIN,Staphylococcal infection,0
,0,LIPITOR,Type 2 diabetes mellitus,0
44,2,LIPITOR,Type 2 diabetes mellitus,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,TIKOSYN,Colon cancer,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
76,2,LIPITOR,Blood pressure increased,1
,0,LIPITOR,Type 2 diabetes mellitus,0
58,1,EZOGABINE 50MG GLAXO SMITHKLINE,Pyrexia,1
64,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
56,2,"REMODULIN (2.5 MILLIGRAM/MILLILITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Death,0
52,2,LIPITOR,Type 2 diabetes mellitus,0
50,2,LIPITOR,Type 2 diabetes mellitus,0
67,2,AMLODIPINE BESYLATE.,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
73,2,LEVEMIR INSULIN,Rash maculo-papular,0
55,2,EFFEXOR XR,Intentional drug misuse,0
52,1,MS CONTIN,Transaminases increased,1
,2,LATUDA,Asthma,0
61,1,LIPITOR,Arterial occlusive disease,0
,,LIPITOR,Type 2 diabetes mellitus,0
28,2,SUBOXONE,Drug withdrawal syndrome,1
55,2,AZILECT,Tremor,0
83,1,REMODULIN,Death,0
,2,POMALYST,Influenza like illness,0
53,2,ORENCIA,Osteoarthritis,0
65,1,CARBOPLATIN.,Febrile neutropenia,1
88,2,COUMADINE,Haematemesis,1
65,0,CAMPATH,Mental status changes,0
75,2,OXALIPLATIN,Feeling cold,1
,1,JANUVIA,Rash,0
47,2,FOSAMAC TABLETS 35MG,Breast cancer,1
55,1,ABATACEPT SUBQ INJECTION 125MG/ML,Glycosylated haemoglobin increased,0
18,1,ABILIFY,Impulse-control disorder,1
59,2,DIAZEPAM,Toxicity to various agents,0
75,1,WARFARIN SODIUM,Abdominal wall haematoma,0
,2,JANUVIA,Anaphylactic reaction,0
,2,PREDNISONE,Asthma,0
6,1,PRADAXA,Gastrointestinal haemorrhage,1
74,2,BYETTA,Cataract,0
79,1,COMBIVENT,Pneumonia,0
64,1,SPIRIVA,Incorrect route of drug administration,0
,2,CALCIUM CARBONATE,Drug dependence,0
30,2,SUBOXONE 8 MG,Hypersensitivity,0
,1,BYETTA,Pancreatic carcinoma,0
,2,PRADAXA,Dermatitis exfoliative,0
70,2,SPIRIVA,Incorrect route of drug administration,0
73,2,COMBIVENT,Hypoaesthesia,0
60,1,PRADAXA,Atrial fibrillation,0
60,1,INFIURMORPH,Seroma,1
75,0,WARFARIN SODIUM,Post procedural haemorrhage,0
82,1,PRADAXA,Gastrointestinal haemorrhage,1
,2,VELCADE,Nausea,0
53,1,WARFARIN SODIUM,Post procedural haemorrhage,1
,,SOLIRIS,Cerebrovascular accident,0
63,2,NIVOLUMAB,Intestinal perforation,1
88,2,COUMADINE,Subdural haematoma,1
12,1,ONCASPAR,Pneumonia,1
,0,CHLORAPREP,Product packaging issue,0
,0,ARIPIPRAZOLE,Chronic obstructive pulmonary disease,0
70,1,ONGLYZA TABS 5 MG,Left ventricular dysfunction,0
43,2,INVOKANA,Metabolic acidosis,1
17,1,TYVASO,Lung transplant,1
23,2,NEXPLANON,Device deployment issue,0
62,2,PREDNISONE,Cerebrovascular accident,0
,1,SOLIRIS,Transfusion,0
,,BRILIQUE,Vascular stent thrombosis,0
59,2,CRESTOR,Rectal haemorrhage,0
23,2,PRENATAL VITAMINS,Genital infection fungal,0
73,2,CARBOPLATIN,Hypocalcaemia,1
26,2,CLARAVIS,Self-injurious ideation,0
43,2,PLAN B ONE-STEP,Menstruation irregular,0
27,1,ONCASPAR,Hepatic cirrhosis,1
36,2,SUBOXONE,Convulsion,0
54,1,ALFA 2 INTERFERON 2B,Neutrophil count decreased,1
41,2,"REMODULIN (2.5 MILLIGRAM/MILLILITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Respiratory failure,1
,1,CLOZAPINE,Oesophageal carcinoma,0
10,1,PREDNISOLONE,Cushingoid,0
66,2,PANTOLOC,Sudden death,0
53,2,"REMODULIN (0.075 MILLIGRAM/MILLITERS, INJECTION FOR INFUSION) (TREPROSTINIL SODIUM)",Loss of consciousness,1
,1,GILENYA,Dysarthria,1
69,1,OMNIPAQUE,Renal failure acute,0
,1,VIMPAT,Parkinson^s disease,0
38,2,BOCEPREVIR,Depression,0
68,1,WARFARIN,Haemorrhage,1
66,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
52,2,LIPITOR,Type 2 diabetes mellitus,0
87,2,DOXAZOSIN MESILATE,Local swelling,0
,1,ZOLOFT,Maternal exposure during pregnancy,0
,0,LIPITOR,Type 2 diabetes mellitus,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
68,2,CHAMPIX,Mood altered,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
38,2,LIPITOR,Type 2 diabetes mellitus,0
46,2,LIPITOR,Dizziness,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
52,2,LIPITOR,Type 2 diabetes mellitus,0
52,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
61,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,COREG,Type 2 diabetes mellitus,0
86,1,ZYTIGA,Confusional state,0
,0,LIPITOR,Type 2 diabetes mellitus,0
57,2,NEUPOGEN,Vomiting,0
64,2,AFINITOR,Death,0
,2,PARAGARD 380A,Device dislocation,0
76,1,AMYTRIL,Tremor,1
56,1,REMODULIN,Arthralgia,1
,2,REMICADE,Crohn^s disease,1
56,1,PLACEBO,Cervical spinal stenosis,1
,2,DIOVAN,Pneumonia,1
,2,PLAN B ONE-STEP,Menstruation irregular,0
55,2,PROLIA,Lung infection,0
,1,SABRIL (FOR ORAL SOLUTION),Pneumonia,1
84,2,REMERON,Bundle branch block left,0
73,0,REMODULIN,Epistaxis,1
95,2,FORTEO,Pruritus,0
79,2,TASIGNA,Tendonitis,0
48,2,REMODULIN,Hypertension,1
21,2,CITALOPRAM,Somnolence,1
,1,TRILEPTAL,Death,0
,0,CARBAMAZEPINE,Oesophageal atresia,0
,0,SOLIRIS,Haemoglobin decreased,0
58,2,FUROSEMIDE,Arthralgia,1
,0,CARBAMAZEPINE,Cleft palate,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
46,2,LIPITOR,Type 2 diabetes mellitus,0
40,2,LIPITOR,Cardiomyopathy,0
68,2,LIPITOR,Type 2 diabetes mellitus,0
,1,SABRIL     (TABLET),Head banging,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
72,2,SPIRIVA,Candida infection,0
,2,LIPITOR,Type 2 diabetes mellitus,0
94,2,SPIRIVA,Incorrect route of drug administration,0
62,1,SPIRIVA,Incorrect route of drug administration,0
72,1,SPIRIVA,Incorrect route of drug administration,0
90,2,OXYTROL FOR WOMEN,Somnolence,0
72,2,SPIRIVA,Incorrect route of drug administration,0
,0,BUDESONIDE,Placental insufficiency,0
63,2,PLAVIX,Loss of employment,1
79,1,SPIRIVA,Nausea,0
43,1,ONCASPAR,Hepatic cirrhosis,0
,1,CLARITIN CHEWABLE TABLETS,Heart rate increased,0
23,2,NEXPLANON,Device deployment issue,0
,1,JANUMET,Pruritus,0
,1,CLARITIN-D-24,Hypersensitivity,0
,0,JANUMET,Diarrhoea,0
,0,CARBAMAZEPINE,Meningomyelocele,0
69,2,GLACTIV,Enterocolitis,1
78,2,HYDROCHLOROTHIAZIDE,Oedema mouth,0
56,1,BAKTAR,Pyrexia,1
23,2,PLAVIX,Multiple injuries,1
41,1,HUMIRA,Tuberculin test positive,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
44,1,FLUOXETINE (UNKNOWN),Diplopia,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
1,2,CITALOPRAM (UNKNOWN),Motor developmental delay,0
1,1,CITALOPRAM (UNKNOWN),Small for dates baby,0
,2,LETROZOLE (UNKNOWN),Arthralgia,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
93,1,EYLEA (AFLIBERCEPT) (INJECTION) (AFLIBERCEPT),Blindness,0
,2,TAMOXIFEN CITRATE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
66,1,DICLOFENAC (UNKNOWN),Ischaemic stroke,1
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
63,2,DOXYCYCLINE HYCLATE (UNKNOWN),Circulatory collapse,1
51,1,PLAVIX,Multiple injuries,1
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,0,SOLIRIS,Road traffic accident,0
,1,MIRALAX,Inappropriate schedule of drug administration,0
62,1,PLAVIX,Multiple injuries,1
22,1,GATTEX,White blood cell count increased,1
40,2,CYMBALTA,Maternal exposure during pregnancy,0
61,2,CLOZARIL,Fall,1
72,1,CYMBALTA,Electrocardiogram QT prolonged,1
44,2,XERISTAR,Somnambulism,0
80,1,CYMBALTA,Alanine aminotransferase increased,0
71,1,HYDROCHLOROTHIAZIDE,Mycosis fungoides stage II,0
,1,"SUBOXONE (8 MG, 8 MG)",Joint injury,1
,2,DULOXETINE HYDROCHLORIDE,Suicidal ideation,0
,1,ZYPADHERA,Malaise,0
35,1,ZYPREXA,Pulmonary embolism,1
61,2,OLANZAPINE,Anxiety,1
0,2,ZYPREXA,Temperature regulation disorder,0
,1,SOLIRIS,Transfusion,0
72,2,AFINITOR,Duodenal ulcer,1
55,2,GLIVEC,Fatigue,0
,2,CLOZARIL,Schizoaffective disorder,1
,2,GLIVEC,Superinfection,0
,0,CARBAMAZEPINE,Congenital ureteric anomaly,0
33,2,PARAGARD 380A,Glucose tolerance test abnormal,0
61,0,CLOZARIL,Urinary retention,1
55,1,SANDOSTATIN LAR,Abdominal pain,0
31,2,OMNIPAQUE,Throat tightness,1
28,2,PARAGARD 380A,Uterine leiomyoma,0
,2,"PROCYSBI (CYSTEAMINE BITARTRATE) CAPSULE, DELAYED RELEASE",Nausea,0
64,1,SIMVASTATIN,Muscle spasms,0
21,2,CLOZARIL,Meningitis,1
,1,CLOZARIL,Brain abscess,1
43,2,PARAGARD 380A,Device expulsion,0
74,2,COUMADIN TABS 5 MG,Pneumonia,0
61,2,GLIVEC,Malnutrition,0
51,2,AFINITOR,Death,0
,1,REVLIMID,Acute myeloid leukaemia,0
,1,CATAFLAM,Death,0
72,2,CRIZOTINIB,Oedema peripheral,1
,2,GLEEVEC,Death,0
48,1,EVEROLIMUS,Febrile neutropenia,0
67,1,SANDOSTATIN LAR,Death,0
,2,GLIVEC,Death,0
,0,NUVIGIL,Swollen tongue,0
,2,VOLTAROL,Pain,0
,2,AFINITOR,Death,0
59,2,OXYTROL FOR WOMEN,Application site burn,0
,0,CARBAMAZEPINE,Atrial septal defect,0
,0,SUBOXONE,Accidental exposure to product by child,0
5,1,THYMOGLOBULINE,Acute lymphocytic leukaemia recurrent,0
,2,RANEXA,Hypotension,1
35,2,AUBAGIO,Bladder dysfunction,1
,0,RIBAVIRIN,Pancytopenia,0
75,1,HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) (HYDROCHLOROTHIAZIDE),Mycosis fungoides,0
63,2,AUBAGIO,Basedow^s disease,0
,2,INFLIXIMAB,Small intestinal resection,0
62,2,BAXTER HEALTH CARE L2B9710 DIANEAL PD 2 1.5% 6 LITER,Dialysis,1
,,METHOTREXATE,Haematochezia,0
36,2,REMICADE,Loss of consciousness,0
60,2,SPIRIVA,Eye disorder,0
70,2,LETAIRIS,Diarrhoea,1
76,1,OMNISCAN,Nephrogenic systemic fibrosis,0
43,2,SPIRIVA,Incorrect route of drug administration,0
73,2,SPIRIVA,Incorrect route of drug administration,0
38,1,THYMOGLOBULINE,Pancytopenia,1
57,2,ENBREL,Furuncle,0
72,2,TOPROL XL,VIIth nerve paralysis,0
34,1,NICOTINE,Overdose,0
36,1,NASONEX,Retinal vein occlusion,0
,2,BRILINTA,Pneumonia,0
,2,CLARITIN,Headache,0
,0,NIQUITIN MINI LOZENGES,Dependence,0
62,1,SOVALDI 400MG GILEAD SCIENCES,Insomnia,0
37,1,SUBOXONE,Urinary retention,0
57,2,LIPITOR,Type 2 diabetes mellitus,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
66,1,IMBRUVICA,Back pain,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
76,2,LIPITOR,Type 2 diabetes mellitus,0
44,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
,0,CARBAMAZEPINE TABLETS CHEWABLE USP 100MG,Bicuspid aortic valve,0
61,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
70,2,LIPITOR,Type 2 diabetes mellitus,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
66,2,LIPITOR,Type 2 diabetes mellitus,0
,0,CARBAMAZEPINE,Meningomyelocele,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
38,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
16,1,LAMOTRIGINE (UNKNOWN),Epilepsy,0
51,2,LIPITOR,Renal neoplasm,0
57,2,LIPITOR,Type 2 diabetes mellitus,0
39,2,PACLITAXEL ACTAVIS,Dyspnoea,1
,2,BUPRENORPHINE-NALOXONE (AELLC),Drug withdrawal syndrome,0
72,1,AMOXICILLIN (UNKNOWN),Anaphylactic shock,0
,0,CARBAMAZEPINE,Polydactyly,0
31,2,BUPROPION HYDROCHLORIDE,Hallucination,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,1,GEMCITABINE (UNKNOWN),Haemolytic uraemic syndrome,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
67,2,CALCIUM CARBONATE,Milk-alkali syndrome,1
81,1,AFINITOR 10MG NOVARTIS,Drug ineffective,0
87,2,AMLODIPINE ACTAVIS,Cholestasis,1
,2,TAMOXIFEN (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
31,1,PHENYTOIN SODIUM EXTENDED CAPSULES USP 100MG,Convulsion,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
60,1,ZYTIGA 250MG,Drug ineffective,0
,2,BENLYSTA,Systemic lupus erythematosus,0
,2,TUDORZA PRESSAIR,Cystocele,0
84,2,OFATUMUMAB,Febrile neutropenia,1
80,0,TREANDA,Pleural effusion,0
69,2,PARACETAMOL,Haemolysis,1
27,1,SUBOXONE,Hypersensitivity,0
67,2,AUBAGIO,Memory impairment,1
69,1,VIDAZA,Acute myeloid leukaemia,0
71,1,CLOZARIL,Lower respiratory tract infection,1
59,2,CLOZARIL,Viral infection,0
,2,GLIVEC,Death,0
,1,REVLIMID,Musculoskeletal disorder,0
10,1,VIMPAT,Renal failure acute,0
,1,AMIODARONE,Clavicle fracture,1
55,1,CLOZARIL,Pleural effusion,1
,0,LIPITOR,Type 2 diabetes mellitus,0
69,1,VINBLASTINE,Cough,0
27,2,INCREMIN,Atrial flutter,1
,0,DABIGATRAN,Drug interaction,0
,0,LIPITOR,Type 2 diabetes mellitus,0
79,1,XALKORI,Death,1
63,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
42,2,CYTARABINE (MANUFACTURER UNKNOWN) (CYTARABINE) (CYTARABINE),Myelopathy,1
,,LIPITOR,Type 2 diabetes mellitus,0
62,2,METOPROLOL,Type 2 diabetes mellitus,0
,0,GLIPIZIDE,Pancreatic carcinoma,0
,0,LIPITOR,Type 2 diabetes mellitus,0
12,0,SUBOXONE,Accidental exposure to product by child,1
,0,LIPITOR,Type 2 diabetes mellitus,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
55,,LIPITOR,Type 2 diabetes mellitus,0
79,2,LIPITOR,Type 2 diabetes mellitus,0
59,2,OPTICLEANSE GHI CHAHI,Palpitations,0
,0,LIPITOR,Type 2 diabetes mellitus,0
71,2,BUPROPION,Intentional overdose,1
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
89,2,XALATAN,Death,0
,0,LIPITOR,Type 2 diabetes mellitus,0
52,2,LIPITOR,Hepatic steatosis,0
51,,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
61,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
65,1,LISINOPRIL,Angioedema,1
9,0,BUPRENORPHINE/NALOXONE,Exposure via ingestion,1
47,2,LIPITOR,Chest pain,0
52,2,SUBOXONE,Off label use,1
,1,FLUCONAZOLE,Asthenia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
72,2,SUTENT,Fatigue,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,EXEMESTANE,Ascites,1
,0,LIPITOR,Type 2 diabetes mellitus,0
79,2,REVLIMID,Yellow skin,0
80,2,CARBOPLATIN,Neutrophil count decreased,1
91,2,XALATAN,Death,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
,1,REVLIMID,Gait disturbance,1
,2,CALCIUM (UNSPECIFIED),Knee arthroplasty,1
59,2,LIPITOR,Type 2 diabetes mellitus,0
64,1,HUMIRA,Intestinal stenosis,1
15,2,IBUPROFEN,Incorrect dose administered,1
68,1,SAMSCA,Ammonia increased,0
77,1,SULBACILLIN,Acute respiratory distress syndrome,0
68,1,HUMIRA,Tuberculin test positive,0
,1,EPILIM,Body height abnormal,0
18,2,CYCLOPHOSPHAMIDE,Myelodysplastic syndrome,0
,1,CLARITIN,Somnolence,0
25,1,LAMIVUDINE-HIV,Immune reconstitution inflammatory syndrome,1
,2,SUBOXONE,Local swelling,0
66,1,5-FLUOROURACIL,Dizziness,1
8,2,DOXORUBICIN HYDROCHLORIDE,Acute myeloid leukaemia,1
91,2,EYLEA (AFLIBERCEPT) (INJECTION) (AFLIBERCEPT),Uveitis,0
68,2,ALEMTUZUMAB (CAMPATH),Hyponatraemia,0
62,1,LYRICA,Diarrhoea,1
42,2,IMPLANON,Paraesthesia,0
60,2,VIMPAT,Upper limb fracture,0
,1,AVANDIA,Myocardial infarction,1
,2,AVANDIA,Respiratory failure,1
86,2,RECLAST,Bone marrow failure,1
92,1,EYLEA,Uveitis,0
70,2,BIBW 2992,Anuria,1
56,2,GLIPISIDE,Renal failure,1
68,2,VOTRIENT,Ejection fraction decreased,1
,2,SPIRIVA,Dizziness,0
73,1,TETRACYCLINE HCL,Drug hypersensitivity,0
,1,SPIRIVA,Pain in extremity,0
67,2,AVELOX,Swelling,0
58,1,ADVAIR,Cerebrovascular accident,1
53,1,ADVAIR,Diabetes mellitus,1
47,2,ADVAIR,Basal cell carcinoma,0
46,2,AUBAGIO,Pollakiuria,0
,2,METFORMIN,Coeliac disease,0
,0,MORPHINE SULFATE,Drug hypersensitivity,0
,2,VOTRIENT,Death,0
82,2,LETAIRIS,Nausea,0
,1,LAMICTAL,Epilepsy,0
27,1,LAMICTAL,Psychotic disorder,0
56,2,LAMICTAL,Affect lability,0
60,2,WELLBUTRIN,Lymphoma,1
45,1,LIPITOR,Drug hypersensitivity,0
40,2,ARIXTRA,Pneumonia,1
,2,SUBOXONE,Intentional drug misuse,0
39,2,HUMIRA,Ligament sprain,0
71,2,ADVAIR,Cerebrovascular accident,0
,1,TAMSULOSIN,Fall,1
80,2,OXYTROL FOR WOMEN,Dizziness,0
,2,ADVAIR,Post-traumatic stress disorder,0
26,2,ARIXTRA,Road traffic accident,0
45,1,VOTRIENT,Disease progression,0
,2,LYRICA,Drug ineffective,0
39,1,OMEGA-3-ACID ETHYL ESTERS,Post procedural haemorrhage,0
39,2,ABACAVIR,Dialysis,0
0,2,ABACAVIR,Acute hepatic failure,0
71,2,HUMIRA,Medical device complication,1
,1,HUMIRA,Rash generalised,0
,2,HUMIRA,Skin ulcer,0
50,1,VENTOLIN,Malaise,1
,,CLOPIDOGREL BISULFATE.,Platelet aggregation increased,0
39,1,POTIGA,Convulsion,1
,1,MORPHINE SULFATE,Drug hypersensitivity,0
59,1,ADVAIR,Diabetes mellitus,0
,1,ADVAIR HFA,Death,0
70,2,FLONASE,Renal surgery,1
84,2,OMEGA-3-ACID ETHYL ESTERS,Haemorrhage,0
75,1,HYDROCHLOROTHIAZIDE,Neuropathy peripheral,0
75,2,METHYLPREDNISOLONE,Gastrointestinal haemorrhage,1
73,1,HUMIRA,Gastric cancer stage IV,0
29,2,PREDNISONE,Multi-organ failure,0
83,2,AUGMENTIN (ORAL),Rash maculo-papular,0
,2,OXYTROL FOR WOMEN,Rash,0
15,1,ZENATANE,Acne cystic,0
,0,TREANDA,Fatigue,0
,0,TAXOTERE,Cardiotoxicity,0
56,1,MATRIFEN,Monoparesis,1
,2,LYRICA,Drug ineffective,0
43,1,EPZICOM,Lactic acidosis,0
67,2,LAPATINIB,Pleural effusion,1
,1,VALTREX,Renal failure acute,1
11,2,RELENZA,Epilepsy,1
71,1,VOTRIENT 200MG,Cerebellar haemorrhage,1
48,1,BAYER CHILD CHW ASA,Peripheral swelling,0
46,1,VALTREX,Urinary retention,0
63,1,CLEXANE,Anuria,1
48,1,EVEROLIMUS,Pneumonitis,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
49,1,CALCIUM FOLINATE,Rectal obstruction,1
14,1,LIORESAL,Dystonia,1
69,1,ALKERAN,Peripheral sensorimotor neuropathy,0
49,1,ALKERAN,Rectal adenocarcinoma,0
,2,NEXPLANON,Pain in extremity,0
54,1,ARIXTRA,Arthralgia,1
85,1,CILOSTAZOL,Erythema,0
45,2,LAMICTAL,Genital haemorrhage,0
,2,FLECTOR,Drug ineffective,0
42,1,MALARONE,Dermatitis bullous,0
57,1,CIALIS,Astigmatism,0
,2,"HUMALOG 25% LISPRO, 75% NPL",Endometrial cancer,0
,2,HUMALOG LISPRO,Blood glucose increased,0
19,2,CIMETIDINE,Unintended pregnancy,0
,2,EVISTA,Fracture,0
68,1,ALKERAN,Chronic myeloid leukaemia,1
52,2,NARAMIG,Drug dependence,0
,2,LIORESAL INTRATHECAL(BACLOFEN INJECTION) 2000 MCG/ML,Pigmentation disorder,0
70,2,NARAMIG,Drug dependence,0
47,1,NEURONTIN,Drug ineffective,0
89,2,DABRAFENIB,Ejection fraction decreased,0
67,1,IBUPROFEN,Gastrointestinal disorder,0
57,1,ESIDREX,Retroperitoneal fibrosis,1
73,2,OXYBUTYNIN,Vision blurred,0
,2,PRISTIQ,Drug dose omission,0
65,1,AMIODARONE,Sudden cardiac death,0
51,2,BACLOFEN,Paralysis,0
,2,KALETRA,Premature baby,0
56,2,GABAPENTIN,Tooth loss,0
61,2,EFFEXOR,Drug hypersensitivity,0
64,1,PRAVASTATIN,Rash erythematous,0
67,1,BACLOFEN,Syncope,0
,0,"INFLIXIMAB, RECOMBINANT",Cerebral ischaemia,0
21,1,HUMIRA,Decreased appetite,1
,0,"INFLIXIMAB, RECOMBINANT",Uveitis,0
,1,CREON,Impaired work ability,0
,1,HUMIRA,Infarction,1
,0,"INFLIXIMAB, RECOMBINANT",Pulmonary embolism,0
,2,NITROSTAT,Drug ineffective for unapproved indication,0
63,2,TIKOSYN,Drug ineffective,0
,2,HUMIRA,Intestinal obstruction,0
,2,DR. SCHOLL^S ONE STEP CORN REMOVERS,Blister,0
81,2,NEURONTIN,Lethargy,0
,0,PROLIA,Contusion,0
58,1,CISPLATIN,Haematemesis,1
70,1,CISPLATIN,Lower respiratory tract infection,1
,0,KEPPRA,Thrombocytopenia,0
32,1,HUMIRA,Cognitive disorder,0
50,2,SUBOXONE,Convulsion,0
65,2,ZITHROMAX,Drug hypersensitivity,0
60,2,CISPLATIN,Swelling face,1
32,2,CISPLATIN,Haematotoxicity,0
85,2,METHOTREXATE,Musculoskeletal disorder,0
58,2,ACETAZOLAMIDE,Dyspepsia,0
79,2,VERAPAMIL HCL,Chest pain,0
56,2,METHOTREXATE,Ovarian cancer,1
64,2,ETUMINA,Neuroleptic malignant syndrome,1
39,2,ESLICARBAZEPINE ACETATE,Hypokalaemia,1
42,2,CARBOPLATIN,Disease progression,0
57,1,CISPLATIN,Pneumonitis,1
65,2,SODIUM CHLORIDE,Cellulitis,1
,1,LYRICA,Suicidal ideation,0
78,2,METHOTREXATE,Plasmablastic lymphoma,0
79,2,CIPROFLOXACIN,Faecal incontinence,1
63,2,METHOTREXATE,Hypomagnesaemia,1
73,2,RIFAMPIN,Intestinal obstruction,1
57,2,NEURONTIN,Drug ineffective,0
,1,"HUMALOG 50% LISPRO, 50% NPL",Aneurysm,0
,2,FLUOROURACIL,Lung infection,1
,0,ZOSYN,Haemolytic anaemia,0
65,2,METHOTREXATE,Sarcoma of skin,0
38,2,CISPLATIN,Haematotoxicity,0
71,1,IRINOTECAN,Sepsis,1
61,2,DEXAMETHASONE,Abdominal pain,1
,1,REPAGLINIDE,Hypoglycaemia,1
56,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Fibromyalgia,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
57,2,LISINOPRIL 5MG,Cough,0
,1,SUTENT,Convulsion,1
55,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
58,,LIPITOR,Type 2 diabetes mellitus,0
73,1,CASODEX,Cough,0
,2,LYRICA,Facial pain,0
,0,LIPITOR,Type 2 diabetes mellitus,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
69,2,LIPITOR,Cataract,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
54,1,VANCOMYCIN,Stevens-Johnson syndrome,0
26,2,VYBRIID 10 MG,Dizziness,0
,1,ADVIL,Oropharyngeal pain,0
51,1,STELARA,Cellulitis,0
55,1,KEPPRA,Systemic lupus erythematosus,0
,0,DARUNAVIR,Toxicity to various agents,0
61,2,FLUOROURACIL,Dehydration,1
,2,OXYTROL FOR WOMEN,Drug ineffective,0
64,2,CARVEDILOL.,Abdominal pain upper,0
,0,RISPERIDONE,Blood glucose abnormal,0
,2,OXYTROL FOR WOMEN,Rash erythematous,0
65,2,AZITHROMYCIN,Chronic obstructive pulmonary disease,0
,2,ASMANEX TWISTHALER,Drug dose omission,0
57,2,ATORVASTATIN CALCIUM.,Type 2 diabetes mellitus,0
29,2,HUMIRA,Nephrotic syndrome,1
,1,ADVIL,Dizziness,0
91,2,LASIX,Dyspnoea,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,CELEBREX,Drug hypersensitivity,0
,1,MIRALAX,Drug effect decreased,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
59,,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
59,2,COUMADIN,Forced vital capacity decreased,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
47,,LIPITOR,Type 2 diabetes mellitus,0
,0,LYRICA,Insomnia,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
24,2,DOXYCYCLINE,Gastric ulcer,0
,1,SOLIRIS,Haemoglobinuria,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
,2,MORPHINE SULFATE.,Pharyngeal oedema,0
,0,LIPITOR,Type 2 diabetes mellitus,0
45,2,SPIRIVA,Incorrect route of drug administration,0
,2,REVLIMID,Hernia,0
70,1,SPIRIVA,Incorrect route of drug administration,0
,0,CELEBREX,Back disorder,0
,1,SOVALDI,Rash,0
,2,SPIRIVA,Incorrect route of drug administration,0
79,2,SPIRIVA,Wheezing,0
,1,SOVALDI,Rash,0
90,2,MICARDIS,Fall,1
57,2,MACLADIN,Angioedema,1
69,1,SPIRIVA,Incorrect route of drug administration,0
20,2,HUMIRA,Diarrhoea haemorrhagic,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,MORPHINE SULFATE,Overdose,0
,1,TUDORZA PRESSAIR,Urinary retention,0
56,1,HUMIRA,Small intestinal obstruction,1
33,1,BUPRENORPHINE W/NALOXONE,Drug dependence,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,ALAVERT,Drug ineffective,0
39,1,IMATINIB,Leukaemia recurrent,0
,1,REVLIMID,Spinal disorder,1
60,1,OMNIPAQUE,Hypotension,0
62,2,"INFLIXIMAB, RECOMBINANT",Arthritis salmonella,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
55,1,REMICADE,Incisional drainage,0
46,2,XELJANZ,Vomiting,0
8,1,CICLOSPORINE,Drug effect incomplete,1
72,2,FLECAINIDE,Toxicity to various agents,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
50,2,LYRICA,Altered state of consciousness,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
71,1,HUMIRA,Syncope,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,VIAGRA,Cyanopsia,0
,2,AROMASIN,Pericardial effusion,0
43,2,TYSABRI,Ileus,1
,2,REBIF,Multiple sclerosis relapse,1
,0,LIPITOR,Type 2 diabetes mellitus,0
41,1,IMATINIB,Leukaemia recurrent,0
,2,NUVARING,Device expulsion,0
43,2,LYRICA,Feeling abnormal,0
42,2,DAYTIME PE ORIG LIQ 656,Hypersensitivity,0
66,2,OXYTROL FOR WOMEN,Application site dryness,0
79,2,LIPITOR,Type 2 diabetes mellitus,0
82,1,SUTENT,Diarrhoea,0
,0,ENBREL,Liver injury,0
,2,LIPITOR,Headache,0
,2,GILENYA,Gastric haemorrhage,0
60,1,CELECOX,Retinopathy,0
62,1,ESOMEPRAZOLE,Diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,0,ZOLOFT,Drug hypersensitivity,0
64,0,ZOLOFT,Drug hypersensitivity,0
,0,LIPITOR,Type 2 diabetes mellitus,0
11,2,GENOTROPIN,Cholelithiasis,1
85,1,SUTENT,Fatigue,0
74,2,LIPITOR,Dementia,0
50,1,RELPAX,Delirium,0
,0,LIPITOR,Type 2 diabetes mellitus,0
46,1,PRISTIQ,Drug hypersensitivity,0
75,1,SUTENT,Dehydration,1
,0,LEVOXYL,Influenza,0
53,2,ELLENCE,Death,0
55,1,SUTENT,Haematochezia,0
51,1,SUTENT,Death,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,2,LYRICA,Drug ineffective,0
50,2,TRACLEER,Leg amputation,0
,2,REVLIMID,Gastric disorder,1
,0,NEURONTIN,Drug ineffective,0
,2,SILDENAFIL CITRATE,Restless legs syndrome,0
,2,ALAVERT,Dizziness,0
36,2,SUBOXONE,Hypersensitivity,0
,1,SOLIRIS,Haemoglobin decreased,0
59,2,OPSUMIT,Pneumonia,1
,2,LYRICA,Drug ineffective,0
80,2,HUMIRA,Myocardial infarction,0
67,1,ZOLOFT,Drug hypersensitivity,0
47,1,TRACLEER,Peripheral vascular disorder,1
84,2,REVLIMID,Heart rate irregular,1
,2,OXYTROL FOR WOMEN,Hypersensitivity,0
40,2,IMPLANON,Amenorrhoea,0
70,1,LYRICA,Drug effect incomplete,0
,0,SOLIRIS,Bone marrow disorder,0
70,2,TRACLEER,Cardiac failure congestive,0
56,2,ESTROGENS CONJUGATED,Hypersensitivity,0
,2,SOLIRIS,Bone marrow transplant,0
76,1,TRACLEER,Subdural haematoma,1
,2,ERYTHROMYCIN,Drug hypersensitivity,0
68,1,TRACLEER,Death,0
72,2,PROLIA,Acute myocardial infarction,0
,2,TINACTIN CREAM,Drug administered at inappropriate site,0
58,2,ASPIRIN.,Therapeutic response unexpected,0
,2,ADVIL,Drug ineffective,0
42,2,XANAX,Drug hypersensitivity,0
57,2,SPIRIVA,Productive cough,0
28,2,ATACAND,Coronary artery occlusion,1
3,1,TRACLEER,Clostridium difficile infection,1
,2,GILENYA,Grand mal convulsion,0
61,2,XALKORI,Vomiting,0
,1,SOLIRIS,Transplant,0
51,1,AMPYRA,Transient ischaemic attack,1
52,1,LEVOTHYROXINE.,Mobility decreased,0
73,2,IBUPROFEN,Drug ineffective,0
31,1,GILENYA,Electrocardiogram abnormal,1
86,2,OPSUMIT,Death,1
,0,NEORAL,Melaena,0
75,2,AFATINIB,Malignant neoplasm progression,1
32,2,LYRICA,Loss of consciousness,0
31,2,VELETRI,Neuropathy peripheral,1
57,2,TRACLEER,Gastroenteritis viral,1
30,2,FORASEQ,Breast cancer,0
52,0,DOXYCYCLINE HYCLATE,Photosensitivity reaction,0
54,2,TRACLEER,Hypertensive crisis,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,1,ONBREZ,Hypertension,1
55,2,REVATIO,Pulmonary hypertension,1
58,2,LIPITOR,Type 2 diabetes mellitus,0
49,1,ARTHROTEC,Diarrhoea,0
54,2,VENTAVIS,Renal failure chronic,1
45,2,SILDENAFIL.,Dependence on enabling machine or device,1
78,2,TRACLEER,Depressed level of consciousness,1
46,1,INDAPAMIDE (UNKNOWN),Electrocardiogram QT prolonged,0
78,2,SUTENT,Platelet count decreased,0
52,2,LOSARTAN (UNKNOWN),Paraesthesia,0
41,2,LETROZOLE (UNKNOWN),Breast cancer,0
97,2,GALANTAMINE (UNKNOWN),Gastrointestinal haemorrhage,1
53,2,DEPO-PROVERA,Pain,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
71,1,DOXAZOSIN (UNKNOWN),Loss of proprioception,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
65,2,LIPITOR,Neuropathy peripheral,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
59,2,LEVOTHYROXINE SODIUM,Drug hypersensitivity,0
69,1,RAMIPRIL (UNKNOWN),Gingival swelling,0
47,2,LETROZOLE (UNKNOWN),Breast cancer,0
18,1,IBUPROFEN (UNKNOWN),Pulmonary haemorrhage,1
81,2,VENTAVIS,Infection,0
40,2,VELETRI,Herpes zoster,1
,0,ZOSYN,Injury,0
65,1,ARANESP,Death,0
71,1,ACLASTA,Cerebral haemorrhage,1
55,1,MEDROL,Drug hypersensitivity,0
55,2,OXYTROL FOR WOMEN,Application site pain,0
,2,MIRALAX,Abdominal pain upper,0
,1,SOVALDI,Accidental overdose,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
48,2,XELJANZ,Pruritus,0
68,2,LIPITOR,Type 2 diabetes mellitus,0
,0,CUBICIN,Death,0
38,2,INVOKANA,Vomiting,0
32,2,RAMIPRIL (UNKNOWN),Oligohydramnios,0
,0,DILANTIN-125,Drug hypersensitivity,0
74,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
77,2,ALENDRONIC ACID (UNKNOWN),Femur fracture,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
69,1,ZOLOFT,Drug hypersensitivity,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
70,2,CHANTIX,Nausea,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
72,2,AFINITOR,Death,1
,2,DIOVAN,Malaise,1
71,2,AMBRISENTAN,Melaena,0
48,2,HUMIRA,Cough,1
51,2,TESSALON,Drug hypersensitivity,0
25,2,PARAGARD 380A,Vulvovaginal pain,0
,1,CLOZARIL,Psychotic disorder,1
,2,TAREG D,Asthmatic crisis,1
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,PARAGARD 380A,Pain,0
59,2,TOVIAZ,Lactose intolerance,0
,2,TEGRETOL,Cerebral haemorrhage,0
,0,OXALIPLATIN,Diarrhoea,1
,1,EXFORGE,Diabetes mellitus,0
,2,LEVOTHYROXINE SODIUM,Rash,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,JANUMET,Pancreatic carcinoma,0
85,1,EXELON PATCH,Death,0
50,2,LETROZOLE (UNKNOWN),Breast cancer,0
,0,PREMARIN,Urinary tract infection,0
64,2,LIPITOR,Arteriosclerosis,0
,2,LETAIRIS,Pneumonia,1
,2,GABAPENTIN,Malaise,0
78,1,METHOTREXATE,Blood pressure increased,1
,2,SOLIRIS,Transfusion,0
,2,ADVIL,Malaise,0
62,2,LIPITOR,Type 2 diabetes mellitus,0
65,1,MYFORTIC,Pulmonary oedema,0
86,2,KLOR-CON TABLETS,Large intestinal obstruction,1
71,1,LIPITOR,Drug hypersensitivity,0
,2,RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH),Abortion,0
,2,REBIF,Uterine leiomyoma,0
,0,NITROSTAT,Drug ineffective,0
68,2,ABILIFY TABS,Diverticulitis,0
,2,VX-950 (TELAPREVIR),Abortion spontaneous,0
27,2,EFAVIRENZ,Abortion induced,0
60,2,INCIVEK,Pneumonia,1
13,1,CORTEF,Nausea,0
,2,OXYTROL FOR WOMEN,Erythema,0
,0,INCIVO,Herpes zoster,0
,0,LYRICA,Drug ineffective,0
61,2,INCIVO,Gastroenteritis,1
49,1,COPEGUS,Drug interaction,0
41,1,ADVIL PM,Poor quality drug administered,0
87,1,BRILINTA,Cerebral haemorrhage,0
6,2,ALDOMET,Hypertension,1
58,2,LYRICA,Drug ineffective,0
52,2,PROAIR HFA,Asthma,0
14,2,VX-770 FDC,Infective pulmonary exacerbation of cystic fibrosis,1
,1,SIFROL,Muscular weakness,1
,2,LYRICA,Swelling,0
,0,CUBICIN,Multi-organ failure,1
68,2,IBUPROFEN.,Syncope,1
61,1,BARACLUDE,Transplant failure,1
,2,CELEBREX,Pain,0
50,2,INCIVO,Pyrexia,1
,,SOLIRIS,Fatigue,0
66,2,SPIRIVA,Dyspnoea,0
,2,OXYTROL FOR WOMEN,Drug administered at inappropriate site,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LYRICA,Malaise,0
47,1,TRAMADOL (SIMILAR TO NDA 21-745),Blindness unilateral,0
21,2,PARAGARD 380A,Device dislocation,0
58,2,LIPITOR,Type 2 diabetes mellitus,0
68,1,DIFLAL,Therapeutic response decreased,1
47,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,DEPO-PROVERA,Pain,0
,2,RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH),Abortion,0
30,2,TRAMADOL (SIMILAR TO NDA 21-745),Drug interaction,1
,1,MIRALAX,Inappropriate schedule of drug administration,0
47,2,ENBREL,Pancreatitis,1
63,2,ENBREL,Pruritus,0
,0,ALPRAZOLAM,Drug ineffective,0
36,1,CATAPRESSAN,Pancreatitis,0
89,1,CARVEDILOL.,Confusional state,1
67,2,HUMIRA,Renal failure,1
51,1,SEVORANE,Coronary artery disease,1
71,2,XELJANZ,Diarrhoea,0
,1,HUMIRA,Hepatic lesion,0
,2,PARAGARD 380A,Hot flush,0
37,1,SAIZEN,Cerebrovascular accident,0
,0,XALKORI,Bradycardia,0
,2,SAIZEN,Self injurious behaviour,0
,0,XELJANZ,Weight increased,0
50,1,STELARA,Latent tuberculosis,0
,1,CELEBREX,Blood creatine increased,0
,0,LIPITOR,Type 2 diabetes mellitus,0
77,2,MEDROL,No adverse event,1
11,1,NEURONTIN,Drug interaction,0
62,2,SERTRALINE HCL,Drug ineffective,0
35,1,CLOZARIL,White blood cell count decreased,0
,0,LIPITOR,Type 2 diabetes mellitus,0
40,2,SERTRALINE HCL,Overdose,1
68,2,AMLODIN,Pyelonephritis,0
,0,LIPITOR,Type 2 diabetes mellitus,0
63,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
8,1,BARIUM SULFATE,Barium impaction,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
61,2,HUMIRA,Bladder prolapse,0
60,2,OXYGESIC 10 MG,Nightmare,0
57,2,CORICIDIN HBP COUGH AND COLD,Drug ineffective,0
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,CAYSTON,Bronchiectasis,0
64,2,XARELTO,Deep vein thrombosis,1
,0,LIPITOR,Type 2 diabetes mellitus,0
,1,XARELTO,Retroperitoneal haemorrhage,1
,2,SOLIRIS,Transfusion,1
,1,XARELTO,Intra-abdominal haemorrhage,0
83,1,XARELTO,Interstitial lung disease,0
,2,OXYTROL FOR WOMEN,Application site erythema,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
55,2,LIPITOR,Type 2 diabetes mellitus,0
,2,PARAGARD 380A,Pregnancy with contraceptive device,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
,2,PLAN B ONE-STEP,Menstruation irregular,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
21,2,CONCERTA XL,Anxiety,0
53,1,REMICADE,Drug ineffective,1
35,2,FENTANYL,Toxicity to various agents,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,1,PEGINTRON,Drug ineffective,0
,1,CORICIDIN HBP COLD AND FLU,Therapeutic response decreased,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
,2,TINACTIN SPRAY POWDER,Throat irritation,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
82,2,METHOTREXATE,Gastrointestinal mucosal necrosis,1
54,2,RANOLAZINE,Death,0
56,2,INDERAL,Hypertension,0
,2,BUDESONIDE,Stillbirth,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Dizziness,0
,2,HUMIRA,Osteoarthritis,1
36,1,DIPRIVAN,Lipase increased,0
54,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,PARAGARD 380A,Pregnancy with contraceptive device,0
53,1,INCIVEK,Thrombosis,1
87,2,PROLIA,Blood pressure abnormal,1
46,2,VITAMIN B12,Abdominal pain,1
,2,SEROQUEL,Suppressed lactation,0
,,RIBAVIRIN.,Haematotoxicity,0
,2,DIOVAN,Infarction,0
,2,OXYTROL FOR WOMEN,Pruritus,0
,2,RANOLAZINE,Cardiac operation,1
,2,GILENYA,Trendelenburg^s symptom,0
26,1,MYFORTIC,Bowel movement irregularity,1
27,1,GILENYA,Seizure,1
,2,HUMIRA,Hip fracture,1
,2,NEULASTA,White blood cell disorder,0
74,2,PROCRIT,Death,0
,2,HUMIRA,Anal stenosis,1
64,1,SANPILO,Corneal erosion,0
38,2,CORICIDIN HBP COLD AND FLU,Therapeutic response decreased,0
2,2,SABRIL (FOR ORAL SOLUTION),Drug dose omission,0
,2,CLARITIN REDITABS,Unevaluable event,0
13,2,PARACETAMOL,Pulmonary haemorrhage,0
15,1,IBUPROFEN UNKNOWN PRODUCT,Gastric ulcer perforation,1
,2,LETROZOLE (UNKNOWN),Breast cancer,0
56,2,LETROZOLE (UNKNOWN),Breast cancer,0
,1,GEMCITABINE (UNKNOWN),Haemolytic uraemic syndrome,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
48,2,LORAZEPAM (UNKNOWN),Sopor,0
5,1,PREDNISOLONE (UNKNOWN),Diabetes mellitus inadequate control,0
3,2,PREDNISOLONE (UNKNOWN),Diabetes mellitus inadequate control,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
49,1,ATENOLOL (UNKNOWN),Muscle contractions involuntary,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
80,1,TRELSTAR (WATSON LABORATORIES),Hyperhidrosis,1
,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,OXYTROL FOR WOMEN,Incorrect drug administration duration,0
,2,DIOVAN,Heart valve incompetence,0
,0,GILENYA,Intracranial aneurysm,0
84,2,PROLIA,Hip fracture,1
27,2,PARAGARD 380A,Device dislocation,0
51,2,HUMIRA,Sinus disorder,0
53,2,RAMIPRIL.,Drug interaction,0
61,2,CORICIDIN HBP COLD AND FLU,Pain in extremity,0
,2,OXYTROL FOR WOMEN,Dry mouth,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
74,2,EXEMESTANE,Atrial fibrillation,0
62,2,LIPITOR,Neuropathy peripheral,0
30,2,KALETRA,Foetal death,1
54,2,LIPITOR,Type 2 diabetes mellitus,0
,0,LIPITOR,Type 2 diabetes mellitus,0
53,2,LIPITOR,Type 2 diabetes mellitus,0
67,1,LUNESTA,Paranoia,0
,0,LIPITOR,Type 2 diabetes mellitus,0
56,2,LIPITOR,Type 2 diabetes mellitus,0
,2,LIPITOR,Type 2 diabetes mellitus,0
51,2,LIPITOR,Type 2 diabetes mellitus,0
51,1,ZEBINIX (ESLICARBAZEPINE ACETATE),Electrocardiogram QT prolonged,0
57,2,LIPITOR,Type 2 diabetes mellitus,0
,2,HUMIRA,Lower extremity mass,0
,2,AMPYRA,Convulsion,0
83,1,REVLIMID,Refractory cytopenia with multilineage dysplasia,0
37,1,TRIFLUCAN,Renal failure acute,1
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
17,1,HUMIRA,Pyrexia,1
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
,2,SPIRIVA,Drug administration error,0
,1,HUMALOG LISPRO,Loss of consciousness,0
,2,ORENCIA,Death,0
26,2,CLOZARIL,Suicidal ideation,1
,2,HUMALOG LISPRO,Dementia Alzheimer^s type,0
,1,PRAMIPEXOLE,Blood pressure systolic increased,0
66,1,DULERA,Drug dose omission,0
,2,MIRALAX,Inappropriate schedule of drug administration,0
75,2,LIPITOR,Type 2 diabetes mellitus,0
,2,OXYTROL FOR WOMEN,Application site erythema,0
59,2,LIPITOR,Type 2 diabetes mellitus,0
905,2,FULVESTRANT,Adverse drug reaction,1
,0,TRIBENZOR,Palpitations,1
21,1,SEROQUEL,Intentional overdose,0
,2,ARICEPT,Amylase increased,0
40,1,CORICIDIN HBP COLD AND FLU,Somnolence,0
,2,OXYTROL FOR WOMEN,Rash,0
,1,RIBAVIRIN,Hepatitis C,0
,1,CORICIDIN HBP COLD AND FLU,Therapeutic response decreased,0
79,2,TELAPREVIR,Bradycardia,1
,2,KALYDECO,Nasopharyngitis,0
22,2,CARBAMAZEPINE,Drug-induced liver injury,0
66,2,ABRAXANE,Leukopenia,0
65,1,NEXIUM,International normalised ratio abnormal,1
25,1,TINACTIN LIQUID SPRAY,Swelling face,0
80,2,TRACLEER,Inflammation,1
52,1,VELETRI,Upper limb fracture,1
,1,CLOZARIL,Cellulitis,0
,2,ARMOUR THYROID,Loss of consciousness,0
66,1,REVLIMID,Foot fracture,0
,2,SOLIRIS,Renal failure chronic,0
81,1,EXELON,Pancreatic carcinoma,1
41,1,RIBAVIRIN.,Red blood cell count decreased,1
83,2,DIOVAN,Pulmonary embolism,1
67,1,REVLIMID,Mucoepidermoid carcinoma of salivary gland,0
,0,AMLODIPINE BESILATE W/ OLMESARTAN MEDOXOMIL,Bronchitis,1
35,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
,1,DULERA,Dyspnoea,0
,2,OXYTROL FOR WOMEN,Cerebrovascular accident,0
14,1,SUBOXONE,Accidental exposure to product by child,0
,2,OXYTROL FOR WOMEN,Peripheral swelling,0
40,1,VICTRELIS,Impaired work ability,0
71,2,TRACLEER,Myocardial infarction,0
22,2,REBIF,Viral infection,1
73,2,ACLASTA,Death,0
38,2,HUMIRA,Abdominal pain lower,0
,1,HUMIRA,Malaise,1
28,2,HUMIRA,Back pain,0
63,2,RITUXIMAB,Hodgkin^s disease,0
4,2,SUBOXONE 8 MG,Foetal exposure during pregnancy,1
10,1,CARBAMAZEPINE,Respiratory failure,0
,2,OXYTROL FOR WOMEN,Drug ineffective,0
62,1,TRACLEER,Cardiac arrest,1
44,2,CORICIDIN HBP COLD AND FLU,Therapeutic response decreased,0
,1,MIRALAX,Drug ineffective,0
,1,CARDURA XL,Dysuria,0
,0,LIPITOR,Type 2 diabetes mellitus,0
76,2,RESTEX,Capillary leak syndrome,1
,2,EXEMESTANE,Appendicitis,1
,0,EXEMESTANE,Sinusitis,0
71,2,ADVIL,Back disorder,0
74,1,ALPRAZOLAM,Agitation,1
80,2,PREGABALIN,Fall,1
22,1,SUBOXONE,Drug hypersensitivity,0
80,2,ACETYLSALICYLIC ACID,Subdural haematoma,1
,0,ABILIFY MAINTENA,Death,0
,1,OTRIVIN,Drug abuse,0
59,2,PRADAXA,Renal infarct,1
,2,PRADAXA,Cerebrovascular accident,0
46,1,VOLTAREN GEL,Tachycardia,0
,0,EXCEDRIN UNKNOWN,Dependence,0
39,2,NAPROXEN,Flushing,0
,0,PRADAXA,Pulmonary embolism,0
49,1,SUBOXONE,Weight decreased,1
,1,PRADAXA,Cerebral haemorrhage,1
64,2,PURSENNID,Death,0
,2,MIRALAX,Expired drug administered,0
,1,CORICIDIN HBP COLD AND FLU,Somnolence,0
56,2,VOLTAREN GEL,Rotator cuff syndrome,0
49,1,VOLTAREN GEL,Abasia,0
,0,EXCEDRIN UNKNOWN,Nephritis,0
,0,TRISENOX,Deafness,0
56,2,BUCKLEY^S UNKNOWN,Hyperthyroidism,0
66,2,VOLTAREN GEL,Palpitations,0
90,2,KERI ORIGINAL,Femur fracture,1
52,2,ACETYLSALICYLIC ACID,Blood disorder,0
,2,PROAIR HFA,Drug ineffective,0
74,2,ASCRIPTIN BUFFERED REG STRENGTH TABLETS,Heart valve incompetence,0
63,2,TENORMIN,Transient ischaemic attack,0
83,1,VOLTAREN GEL,Disability,0
,1,PRIVATE LABEL STRENGTH UNKNOWN,Nicotine dependence,0
68,2,LETROZOLE (UNKNOWN),Ankle fracture,0
86,2,KERI ADVANCED,Brain neoplasm,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,0,TRISENOX,Deafness,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,,SOLIRIS,Death,1
21,2,LAMOTRIGINE (UNKNOWN),Lymphadenopathy,0
44,2,TAMOXIFEN CITRATE (UNKNOWN),Hypertriglyceridaemia,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
48,1,RAMIPRIL (UNKNOWN),Orthostatic hypotension,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
47,2,CARBIDOPA/LEVODOPA (AELLC),Dopamine dysregulation syndrome,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
79,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
77,2,OXYTROL FOR WOMEN,Drug ineffective,0
,2,MERCILON,Cholecystectomy,0
35,2,ACZ885,Tumour necrosis factor receptor-associated periodic syndrome,0
80,0,TREANDA,Death,0
64,2,TREANDA,Blindness unilateral,0
19639,2,VANDETANIB,General physical health deterioration,1
33,1,JAKAFI,Death,0
,1,CLOZARIL,Schizophrenia,1
55,2,ALISKIREN,Malignant glioma,1
,0,WELCHOL,Lymphoma,0
,0,RISPERIDONE,Ischaemic stroke,1
64,2,METHOTREXATE,Labelled drug-drug interaction medication error,1
58,1,IMBRUVICA,Renal failure acute,1
,2,ZOLEDRONIC ACID,Blood calcium increased,1
54,2,DOXYCYCLINE,Congestive cardiomyopathy,1
,1,IMBRUVICA,Pain,1
83,1,OMEPRAZOLE,Weight decreased,0
,1,INCIVO,Myocardial infarction,0
57,2,DOCUSATE AND SENNA,Urinary tract infection,1
43,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,2,AFRIN SINUS SPRAY,Wrong technique in drug usage process,0
73,1,IBRUTINIB,Cytomegalovirus infection,1
26,2,MULTIHANCE,Dyspnoea,0
54,1,GEMCITABINE,Hypophosphataemia,1
59,2,ATORVASTATIN,Dysgeusia,0
48,1,CO-AMOXICLAV,Insomnia,1
20,2,VX-770,Renal pain,1
,2,OXYTROL FOR WOMEN,Drug administered at inappropriate site,0
47,1,TRAMADOL,Hypotension,0
,2,OXYTROL FOR WOMEN,Application site irritation,0
,2,SIMVASTATIN.,Myalgia,0
,2,PARAGARD 380A,Vaginal haemorrhage,0
34,2,PARAGARD 380A,Device expulsion,0
40,1,VENLAFAXINE,Memory impairment,0
26,2,PARAGARD 380A,Device breakage,0
28,2,PARAGARD 380A,Device breakage,0
,2,PARAGARD 380A,Device expulsion,0
,2,FOSAMAX,Femur fracture,0
41,2,PLAN B ONE-STEP,Nausea,0
,2,CLARITIN-D-24,Drug effect decreased,0
30,2,PARAGARD 380A,Pelvic pain,0
57,1,HUMIRA,Intestinal stenosis,1
34,2,HUMIRA,Back crushing,0
,2,ZELDOX,Neuroleptic malignant syndrome,1
66,2,ARTHROTEC,Meniscus injury,0
66,2,RAMIPRIL,Musculoskeletal stiffness,0
,2,LYRICA,Schizophrenia,0
58,2,LYRICA,Lung neoplasm malignant,0
,2,NITROGLYCERIN,Myocardial infarction,0
,1,PROTONIX,Cerebrovascular accident,0
52,1,VICTRELIS,Pruritus,0
47,1,CHAMPIX,Dizziness,0
72,1,CARBIDOPA/LEVODOPA (AELLC),Dopamine dysregulation syndrome,0
60,2,TAMOXIFEN (UNKNOWN),Granuloma,0
26,1,METRONIDAZOL ACTAVIS,Mental impairment,0
40,1,XANAX,Suicidal ideation,0
18,2,PLAN B ONE-STEP,Menstruation irregular,0
79,1,CARBIDOPA/LEVODOPA (AELLC),Dopamine dysregulation syndrome,0
98,1,PANTOPRAZOLE (UNKNOWN),Thrombocytopenia,0
,2,LUPRON DEPOT,Hysterectomy,0
59,1,SPIRIVA,Incorrect route of drug administration,0
73,2,METHOTREXATE (UNKNOWN),Hepatitis B,0
,2,CELEXA,Pathological fracture,0
17,2,VX-770,Bronchitis,0
47,1,CHAMPIX,Laryngeal cancer,0
35,2,OXALIPLATIN,Hepatic failure,0
,1,REYATAZ,Stillbirth,0
64,2,SYMBICORT,Dyspnoea,1
,2,IMUREL,Lymphadenopathy,1
39,2,DOSTINEX,Skin hypopigmentation,0
,2,ZOMIG,Rebound effect,0
49,2,CARBIDOPA/LEVODOPA (AELLC),Dopamine dysregulation syndrome,0
41,1,BARACLUDE,Hepatic cirrhosis,0
34,1,EFAVIRENZ CAPS,Meningitis cryptococcal,1
60,2,CITALOPRAM,Abnormal dreams,0
76,1,SLO-NIACIN,Fatigue,0
,2,OXYTROL FOR WOMEN,Dysuria,0
39,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
21,2,BOTOX,Respiratory distress,0
59,2,ORENCIA,Blindness unilateral,0
,2,CORICIDIN HBP COLD AND FLU,Insomnia,0
71,1,NORVASC,Cough,0
55,2,LYRICA,Intervertebral disc protrusion,0
45,2,LYRICA,Pain,0
,2,VIAGRA,Drug ineffective for unapproved indication,0
45,2,SAVELLA,Drug hypersensitivity,0
65,2,PIOGLITAZONE,Foot fracture,1
,0,PRISTIQ,Off label use,0
,0,ZOMIG,Abnormal behaviour,0
62,2,ZOMIG,Drug eruption,0
,0,LANSOPRAZOLE,Multi-organ failure,1
67,1,ALOGLIPTIN,Loss of consciousness,0
77,1,BLINDED ALLOPURINOL,Cardiac failure congestive,1
3,2,BRINTELLIX,Agitation,1
,1,BRILINTA,Ventricular asystole,1
25,1,ZOMIG,Gastric disorder,0
,1,ZOMIG,Sleep disorder due to a general medical condition,0
63,1,SOVALDI,Convulsion,1
,0,CANCIDAS 50MG,Death,0
,2,COPPERTONE SPORT LOTION SPF 15,Skin cancer,0
,2,ZOMIG,Migraine,0
79,2,PLAVIX,Tongue oedema,1
,2,ZOMIG,Headache,0
83,1,OMEPRAZOLE,Weight decreased,0
25,1,CITALOPRAM (UNKNOWN),Drug abuse,1
67,1,METFORMIN (UNKNOWN),Pulmonary oedema,1
82,1,FUROSEMIDE (UNKNOWN),Hyponatraemia,1
,1,KETOCONAZOLE,Adverse event,0
,2,ZOCOR,Eating disorder,0
39,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
44,2,MEROPENEM.,Respiratory failure,0
49,1,BENAZEPRIL HCL,Depressed mood,0
56,1,TEMSIROLIMUS,Neuralgia,0
35,2,TOFACITINIB CITRATE,Staphylococcal sepsis,1
80,2,SIMVASTATIN (UNKNOWN),Rhabdomyolysis,1
49,1,EMTRICITABINE/RILPIVIRINE/TENOFOVIR DF,Diabetes mellitus,1
57,2,RAMIPRIL (UNKNOWN),Bronchospasm,1
24,2,PARAGARD 380A,Device expulsion,0
,1,SOVALDI,Accidental overdose,0
72,1,REVLIMID,Open angle glaucoma,0
45,2,DIABETES MEDICATIONS NOS,Electrocardiogram QT prolonged,0
23,2,PLAN B ONE-STEP,Menstruation irregular,0
41,2,OXYTROL FOR WOMEN,Pollakiuria,0
,1,AMITRIPTYLINE,Toxicity to various agents,0
,2,VX-770,Headache,0
56,2,OZURDEX,Eye disorder,0
,1,ELVITEGRAVIR/EMTRICITABINE/TENOFOVIR DF/COBICISTAT,Death,0
,2,VX-770,Eating disorder,0
66,1,SINVASTACOR,Hyperhidrosis,0
34,1,HUMIRA,Generalised tonic-clonic seizure,0
,2,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,No adverse event,0
20,1,HUMIRA,Lipase increased,1
86,2,BRINZOLAMIDE,Anaphylactic reaction,0
,2,MOBIC,Drug ineffective,0
64,2,GAMMAGARD LIQUID,Death,0
65,1,THALIDOMIDE,Atrial flutter,1
,1,CORICIDIN HBP COLD AND FLU,Somnolence,0
9,1,AZATHIOPRINE,Vitamin D deficiency,1
51,2,BENAZEPRIL HYDROCHLORIDE,Lethargy,0
40,1,CORICIDIN HBP COLD AND FLU,Somnolence,0
20,2,NUVARING,Metrorrhagia,0
67,2,FUROSEMIDE,Renal failure,0
96,2,MIRALAX,Inappropriate schedule of drug administration,0
45,1,ESCITALOPRAM,Intentional overdose,0
,2,REVLIMID,Adverse drug reaction,1
,,RAMIPRIL.,Chronic kidney disease,1
,1,REVLIMID,Cyst rupture,1
,1,SAMSCA,Hypotension,0
25,2,THALOMID,Hodgkin^s disease nodular sclerosis,0
,0,SOLIRIS,Menometrorrhagia,1
85,2,OXYTROL FOR WOMEN,Drug ineffective,0
,1,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
59,1,TEMOZOLOMIDE,Keratitis,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
84,2,LETROZOLE (UNKNOWN),Breast cancer,0
74,2,LETROZOLE (UNKNOWN),Breast cancer,0
65,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Disease progression,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
57,2,LETROZOLE (UNKNOWN),Blood test abnormal,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
45,2,HUMIRA,Loss of consciousness,0
31,1,HUMIRA,Pneumothorax spontaneous,1
53,1,HUMIRA,Inguinal hernia,1
,1,ADVIL GELCAPS,Hypersensitivity,0
91,2,AMOXICILLIN,Dyspnoea,1
,2,ADVIL GELCAPS,Blood potassium increased,0
,0,DEPO-MEDROL,Injection site erythema,0
66,2,NORVASC,Local swelling,0
,1,VIAGRA,Nasopharyngitis,0
71,2,ADVIL GELCAPS,Migraine,0
,2,FLECTOR,Rash generalised,0
,0,VIAGRA,Drug ineffective,0
32,2,REVATIO,Intentional drug misuse,0
,0,ADVIL COLD AND SINUS,Drug effect incomplete,0
,2,SOMAVERT,Headache,0
,2,PREMARIN,Malaise,0
54,1,LYRICA,Drug ineffective,0
66,1,XALKORI,Off label use,0
,1,NORVASC,Drug hypersensitivity,0
70,1,VIAGRA,Drug ineffective,0
84,2,ADVIL,Drug effect delayed,0
,1,VIAGRA,Gastrooesophageal reflux disease,0
,2,ADVIL MIGRAINE,Oral discomfort,0
,1,VIAGRA,Chloropsia,0
64,1,XALKORI,Peripheral swelling,0
78,2,ADVIL,Haematoma,0
59,2,ZITHROMAX,Drug hypersensitivity,0
,0,ARGATROBAN,Aspartate aminotransferase increased,0
8,2,GENOTROPIN MQ,Influenza,0
12,1,GENOTROPIN,Drug ineffective,0
58,2,LYRICA,Suicidal ideation,0
,1,ALTACE,Drug ineffective,0
36,1,LYRICA,Fluid retention,0
77,1,XALKORI,Peripheral swelling,0
25,1,ZOMIG,Nephrolithiasis,0
30,2,ZOMIG ZMT,Migraine,0
,2,RANEXA,Abdominal pain upper,0
,2,GAMMAGARD LIQUID,General physical health deterioration,0
50,1,OMNIPAQUE,Kidney infection,1
,2,ZOMIG,Migraine,0
61,2,GAMMAGARD LIQUID,Thrombosis,1
,2,ZOMIG,Migraine,0
604,2,ZOMIG,Vomiting,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
,2,LETROZOLE (UNKNOWN),Breast cancer,0
55,1,JANUVIA TABLETS 100MG,Drug eruption,1
,2,ZOMIG ZMT,Malaise,0
78,2,GENERIC LISINOPRIL,Pneumonia,1
,2,ZOMIG,Headache,0
45,2,FETZIMA,Hypothermia,1
75,2,HUMIRA,Skin lesion,0
,2,ZOMIG,Headache,0
,1,LOTRIMIN ULTRA,Drug ineffective,0
79,1,INEXIUM,Renal failure acute,1
55,2,ZOMIG,Medication overuse headache,0
56,2,ZOMIG NASAL SPRAY,Nasal dryness,0
36,2,CORICIDIN HBP COLD AND FLU,Somnolence,0
,2,OXYTROL FOR WOMEN,Hiccups,0
,2,METFORMIN HYDROCHLORIDE.,Blighted ovum,0
,2,CHORIONIC GONADOTROPIN,Blighted ovum,0
34,1,JANUMET,Hepatomegaly,0
,2,FOLLITROPIN ALFA,Blighted ovum,0
43,1,KALETRA,Coronary artery disease,1
92,2,PREDNISOLONE,Confusional state,0
65,2,DEXAMETHASONE,Superficial spreading melanoma stage unspecified,0
93,2,HALOPERIDOL,Unresponsive to stimuli,1
79,1,DEXAMETHASONE,Death,1
,2,OXYTROL FOR WOMEN,Drug effect delayed,0
,0,JANUVIA TABLETS 25MG,Adverse reaction,1
42,2,VIT D CALTRATE,VIIth nerve paralysis,0
,2,LYRICA,Erythema,0
50,1,LYRICA,Feeling abnormal,0
60,2,EFFEXOR XR,Product quality issue,0
65,1,LORAZEPAM,Drug hypersensitivity,0
,2,TOVIAZ,Drug effect incomplete,0
,0,SERTRALINE HCL,Drug ineffective,0
,2,MORPHINE SULFATE,Drug hypersensitivity,0
,2,NORVASC,Local swelling,0
,1,TIKOSYN,Malaise,0
61,1,GENOTROPIN MQ,Weight increased,0
,1,XALKORI,Platelet count decreased,0
,2,LYRICA,Blindness,0
,1,TIKOSYN,Nasopharyngitis,0
,2,VENLAFAXINE HCL,Presyncope,0
,2,ARTHROTEC,Drug withdrawal syndrome,0
87,2,DICLOFENAC SODIUM\MISOPROSTOL,Drug ineffective,0
,2,TOVIAZ,Drug ineffective,0
,2,FELDENE,Drug hypersensitivity,0
75,1,CLINDAMYCIN HCL,Drug hypersensitivity,0
16,2,GENOTROPIN,Headache,0
,0,ESTRING,Vaginal odour,0
52,2,CHANTIX,Drug intolerance,0
47,1,DEPO-TESTOSTERONE,Blood test abnormal,0
,2,CHANTIX,Aggression,0
56,2,LYRICA,Epistaxis,0
42,2,EFFEXOR,Drug hypersensitivity,0
,1,PANTOPRAZOLE,Hypersensitivity,0
,2,NORVASC,Drug hypersensitivity,0
55,1,VIAGRA,Flushing,0
80,2,NORVASC,Hypoacusis,0
55,1,VIAGRA,Sinus congestion,0
50,2,LYRICA,Tooth disorder,0
87,2,ADVIL,Hypotension,0
,2,LYRICA,Drug hypersensitivity,0
65,2,CELEBREX,Drug hypersensitivity,0
,2,NORVASC,Renal disorder,0
37,1,VIAGRA,Drug ineffective,0
,2,LYRICA,Withdrawal syndrome,0
,2,LIPITOR,Type 2 diabetes mellitus,0
,2,QUILLIVANT XR,Wrong drug administered,0
47,2,PREMARIN,Liver disorder,0
84,1,INLYTA,Disease progression,0
44,2,ZOLOFT,Drug ineffective,0
49,1,VIAGRA,Headache,0
,1,LYRICA,Pain,0
,2,FLECTOR,Muscular weakness,0
,2,MORPHINE SULFATE,Drug hypersensitivity,0
,1,LYRICA,Vomiting,0
,1,VIAGRA,Premature ejaculation,0
66,1,INLYTA,Diarrhoea,0
,2,CORTISONE ACETATE,Drug effect incomplete,0
60,1,LIVALO,Granulocytopenia,1
69,1,PRAZAXA,Lacunar infarction,0
67,1,ALENDRONIC ACID,Swelling,0
41,1,LACTULOSE,Haematemesis,1
,2,PRADAXA,Breast cancer,0
,2,CORICIDIN HBP COLD AND FLU,Drug effect decreased,0
78,1,FEBURIC,Embolic stroke,0
76,2,REVLIMID,Haemarthrosis,1
,0,PRADAXA,Transient ischaemic attack,0
80,1,PRADAXA,Cerebrovascular accident,0
14,2,TEMOZOLOMIDE,Nausea,0
67,2,COMBIVENT,Anxiety,0
,1,JANUMET,Chest pain,1
,2,NEXPLANON,Medical device complication,0
59,2,PHENYTOIN,Sepsis,0
,2,ZOMIG,Cardiac disorder,0
54,2,ZOMIG-ZMT,Hypothyroidism,0
,1,HUMIRA,Ileal stenosis,1
52,2,ZOMIG ZMT,Thirst,0
,2,ZOMIG,Pain,0
82,2,SYMBICORT,Fall,1
57,2,LISINOPRIL,Blood pressure increased,0
65,1,GAMMAGARD LIQUID,Cardiac arrest,0
,0,ABRAXANE,Death,0
63,1,REVLIMID,Squamous cell carcinoma of the hypopharynx,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
78,1,OMNISCAN,Nephrogenic systemic fibrosis,0
,2,DIANEAL LOW CALCIUM,Fluid overload,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
80,2,DIANEAL LOW CALCIUM,Angina unstable,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
43,1,DIANEAL PD2,Acidosis,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
38,2,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
80,2,OXYTROL FOR WOMEN,Overdose,0
83,1,DIANEAL PD4 SOLUTION WITH 2.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Myocardial infarction,0
,0,CORICIDIN HBP COLD AND FLU,Drug ineffective,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
53,1,HUMIRA,Oropharyngeal pain,1
,2,HUMIRA,Local swelling,0
31,2,NUVARING,Caesarean section,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
61,2,DIANEAL LOW CALCIUM,Respiratory arrest,0
67,2,DIANEAL LOW CALCIUM,Peritonitis,1
,1,DIANEAL LOW CALCIUM,Arrhythmia,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
83,1,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Cystitis,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
47,2,DIANEAL LOW CALCIUM,Ultrafiltration failure,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
74,2,DIANEAL LOW CALCIUM,Anxiety,1
,1,DIANEAL LOW CALCIUM,Unevaluable event,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Leukaemia,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
63,2,DIANEAL LOW CALCIUM (ULTRABAG),Skin lesion,1
30,2,DIANEAL PD2,Peritonitis bacterial,1
86,1,EXTRANEAL ZESTAW DO DIALIZY OTRZEWNOWEJ,Cardiovascular insufficiency,0
,2,DIANEAL LOW CALCIUM,Procedural pain,0
,2,DIANEAL PD2,Sepsis,1
,1,DIANEAL LOW CALCIUM,Cellulitis,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
35,2,DIANEAL LOW CALCIUM (ULTRABAG),Gastroenteritis,1
53,2,GAMMAGARD S/D,Plasma cell myeloma,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,DIANEAL-N PD-4 1.5 PD SOLUTION,Pneumonia,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,2,DIANEAL PD2,Cellulitis,1
,1,DIANEAL PD2,Influenza,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
71,1,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Coronary artery occlusion,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
46,1,EXTRANEAL,Oesophageal disorder,1
,1,DIANEAL PD2 WITH 1.5% DEXTROSE,Multi-organ failure,1
,1,DIANEAL LOW CALCIUM,Aphagia,0
,1,DIANEAL LOW CALCIUM,Fluid overload,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Blood pressure fluctuation,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Local swelling,0
62,1,DIANEAL LOW CALCIUM,Blood pressure increased,0
20,1,DIANEAL PD2,Fatigue,0
70,1,DIANEAL LOW CALCIUM,Death,0
49,1,DIANEAL LOW CALCIUM,Death,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Blood pressure fluctuation,0
65,2,DIANEAL PD2 WITH 1.5% DEXTROSE,Cardiac arrest,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,DIANEAL LOW CALCIUM,Weight fluctuation,0
,2,DIANEAL LOW CALCIUM (ULTRABAG),Hypertension,1
,2,DIANEAL LOW CALCIUM,Catheter site extravasation,0
50,2,DIANEAL LOW CALCIUM,Impaired gastric emptying,0
,1,DIANEAL LOW CALCIUM,Herpes zoster,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,DIANEAL LOW CALCIUM,Hyperparathyroidism,1
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
68,2,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Myocardial infarction,1
,1,DIANEAL LOW CALCIUM,Weight increased,0
,1,DIANEAL LOW CALCIUM,Swelling,0
,2,GAMMAGARD LIQUID,Anaphylactic shock,1
27,2,DIANEAL LOW CALCIUM,Fluid retention,0
,2,DIANEAL LOW CALCIUM,Lung carcinoma cell type unspecified stage IV,0
83,2,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Lower gastrointestinal haemorrhage,1
,1,DIANEAL LOW CALCIUM (ULTRABAG),Dyspnoea,0
,1,DIANEAL LOW CALCIUM,Cardiac failure,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
73,1,DIANEAL LOW CALCIUM,Transient ischaemic attack,1
43,2,DIANEAL LOW CALCIUM,Gastric infection,1
36,2,DIANEAL LOW CALCIUM,Herpes zoster,0
,2,DIANEAL LOW CALCIUM,Fluid overload,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
87,1,DIANEAL LOW CALCIUM,Asthenia,1
,2,DIANEAL LOW CALCIUM,Peritoneal effluent abnormal,0
31,2,DIANEAL LOW CALCIUM,Fluid overload,0
,1,DIANEAL LOW CALCIUM,Fluid overload,0
68,1,DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM,Multimorbidity,1
,1,DIANEAL LOW CALCIUM,Hip fracture,1
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
75,1,EXTRANEAL,Transient ischaemic attack,0
53,2,GAMMAGARD LIQUID,Bronchitis,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,LETAIRIS,Right ventricular failure,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,,SOLIRIS,Blood lactate dehydrogenase increased,1
,2,NASONEX,Drug dose omission,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,CLINIMIX E? -SULFITE-FREE (AMINO ACID WITH ELECTROLYTES IN DEXTROSE WI,Product outer packaging issue,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,CLINIMIX E? -SULFITE-FREE (AMINO ACID WITH ELECTROLYTES IN DEXTROSE WI,Product outer packaging issue,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,1,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION,Heparin-induced thrombocytopenia,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
61,1,DIANEAL LOW CALCIUM,Peripheral swelling,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Hypoacusis,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,1,DIANEAL LOW CALCIUM,Incisional hernia,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
68,2,DIANEAL PD2 WITH 1.5% DEXTROSE,Death,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
5,1,GAMMAGARD LIQUID,Sinusitis,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,0,DIANEAL LOW CALCIUM,Procedural pain,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
5,1,CYCLOPHOSPHAMIDE INJECTION 1G,Progressive multifocal leukoencephalopathy,0
65,1,DIANEAL LOW CALCIUM,Chronic obstructive pulmonary disease,1
62,1,DIANEAL LOW CALCIUM,Influenza,0
,0,"SEVOFLURANE, USP",Hyperthermia malignant,0
,0,CLINIMIX E? -SULFITE-FREE (AMINO ACID WITH ELECTROLYTES IN DEXTROSE WI,Diarrhoea,0
31,2,PARAGARD 380A,Device expulsion,0
,0,"FORANE (ISOFLURANE, USP)",Hyperthermia malignant,0
,2,SABRIL (FOR ORAL SOLUTION),Constipation,0
,1,POMALYST,Contusion,0
76,1,REVLIMID,Death,0
40,2,LYRICA,Vision blurred,0
63,2,ZOLOFT,Trismus,0
81,1,POMALYST,Lumbar vertebral fracture,1
62,1,REVLIMID,Bone marrow leukaemic cell infiltration,0
,2,PRISTIQ,Drug intolerance,0
65,2,LYRICA,Anxiety,0
,1,CELEBREX,Drug ineffective,0
40,1,ZOLOFT,Nervousness,0
,2,PRISTIQ,Drug intolerance,0
54,2,XELJANZ,Pruritus,0
,2,LYRICA,Drug withdrawal syndrome,0
55,2,LYRICA,Drug hypersensitivity,0
60,2,LYRICA,Pain,0
,2,PRISTIQ,Off label use,0
26,1,GEODON,Feeling abnormal,0
,2,CHANTIX,Suicidal ideation,0
,2,CELEBREX,Cardiac disorder,0
,2,LYRICA,Breast cancer female,0
,2,LYRICA,Drug withdrawal syndrome,0
71,2,XELJANZ,Myalgia,0
62,2,RELPAX,Intentional drug misuse,0
33,2,CHANTIX,Irritability,0
46,2,EFFEXOR XR,Drug ineffective for unapproved indication,0
67,2,LYRICA,Malaise,0
87,2,CELEBREX,Intentional drug misuse,0
,2,XELJANZ,Intentional product misuse,0
49,1,LYRICA,Pain,0
,2,LYRICA,Suicidal behaviour,0
,0,CELEBREX,Palpitations,0
73,2,GABAPENTIN,Hypertension,0
63,2,XELJANZ,Blood pressure increased,0
,0,NEURONTIN,Drug intolerance,0
,2,LYRICA,Confusional state,0
42,2,SERTRALINE HCL,Drug hypersensitivity,0
,0,CHANTIX,Weight increased,0
,2,LYRICA,Fibromyalgia,0
,1,EFFEXOR,Dizziness,0
46,1,ZOLOFT,Erectile dysfunction,0
43,2,EFFEXOR XR,Product quality issue,0
70,2,ATORVASTATIN CALCIUM,Drug ineffective,0
71,2,PAXIL,Drug hypersensitivity,0
63,1,CELEBREX,Hypoacusis,0
,2,CELEBREX,Abdominal discomfort,0
40,1,XANAX,Feeling abnormal,0
73,2,GABAPENTIN,Drug ineffective,0
,1,LYRICA,Drug ineffective,0
46,2,EFFEXOR XR,Heart rate increased,0
,2,LYRICA,Malaise,0
,2,LYRICA,Infection,0
,2,LYRICA,Drug ineffective,0
50,1,LYRICA,Back pain,0
56,2,LYRICA,Weight increased,0
48,1,LIPITOR,Drug hypersensitivity,0
,2,LYRICA,Dizziness,0
,2,LIPITOR,Arthralgia,0
